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Abstract
The advent of big data in health care is a topic receiving increas-
ing attention worldwide. In the UK, over the last decade, the Na-
tional Health Service (NHS) programme for Information Technology
has boosted big data by introducing electronic infrastructures in hospi-
tals and GP practices across the country. This ever growing amount of
data promises to expand our understanding of the services, processes
and research. Potential benefits include reducing costs, optimisation
of services, knowledge discovery, and patient-centred predictive mod-
elling. This thesis will explore the above by studying over ten years
worth of electronic data and systems in a hospital treating over 750
thousand patients a year.
The hospital’s information systems store routinely collected data, used
primarily by health practitioners to support and improve patient care.
This raw data is recorded on several different systems but rarely linked
or analysed. This thesis explores the secondary uses of such data by
undertaking two case studies, one on prostate cancer and another on
stroke. The journey from data to knowledge is made in each of the
studies by traversing critical steps: data retrieval, linkage, integra-
tion, preparation, mining and analysis. Throughout, novel methods
and computational techniques are introduced and the value of rou-
tinely collected data is assessed. In particular, this thesis discusses
in detail the methodological aspects of developing clinical data ware-
houses from routine heterogeneous data and it introduces methods to
model, visualise and analyse the journeys that patients take through
care. This work has provided lessons in hospital IT provision, integra-
tion, visualisation and analytics of complex electronic patient records
and databases and has enabled the use of raw routine data for man-
agement decision making and clinical research in both case studies.
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Chapter 1
Introduction
Tempora labuntur, tacitisque senescimus annis.
Tempora mutantur, nos et mutamur in illis.
Time is ticking and we grow older through the silent years.
Times change and we change with them.
– Ovidio, Fasti, 8 AD; William Harrison, Description of England, 1577.
The last decade has seen an exponential growth in the amount of electronic data
collected by public and private institutions across the world. Large databases
now store records from a wide range of interactions, from everyday purchases to
hospital admissions and social interactions. The primary uses of this data are
largely intertwined with the core institutional activities (sales, service provision,
reporting) while its secondary uses only received interest later. Organisations are
now actively seeking ways to harness the statistical power of their data to optimise
operations, increase productivity, reduce costs, or understand behaviour. As a
result, descriptive and predictive analytical techniques have been applied across
a wide range of areas with varying degrees of success. The most prominent
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obstacles to the success of such techniques are not purely technological. Instead,
the manner in which information is recorded, its meaning, context and format
are challenges that often require an interdisciplinary approach. Institutions are
now attempting to link and integrate information across distinct service-area
databases and in some cases the efforts are cross-institutional. It is expected
that this big data is able to generate new knowledge that will transform policy
making, improve service provision, understand behaviour, increase productivity
or further research and innovation.
This is particularly true in health care, where the untapped potential of the vast
amounts of health data could unearth new knowledge that could revolutionise
the way in which we practise medicine. Access to linked clinical, social and ad-
ministrative information could reduce costs and optimise the delivery of health
care services; Integrated electronic medical records (EMR) and clinical decision
support systems can improve and change evidence-based medicine and its time-
liness; knowledge discovery and predictive modeling tools and techniques have
the potential to identify vulnerable patients or factors leading to poor clinical
outcomes before these occur; patients could access their data, engage with the
services, and explore their own and others’ journeys through care. The potential
for revolutionising the delivery of care by searching hidden patterns within large
databases are considerable and are increasingly thought to be feasible with the
advent of big data.
In 2012 an estimated 500 petabytes of digital health care data was spread across
the globe and 25,000 petabytes are expected by 2020 [10]. Fueling this steep
growth are, among others, an increasing number of patients visiting health ser-
vices, the increasing burden of disease [11], but also advances in bioinformatics,
genomics, computing, and in mobile health. In the early 1990s, the Human
Genome Project was one of the first projects to explore the limits of available
data processing technology and by 2003 a whole human DNA sequence was stored
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electronically. That is 3 billion letters of genetic code. The development of com-
puting techniques in medicine, however, dates back to the early 1960s, where the
first database systems appeared. In the 1970s, the first clinical system accepting
medical images for angiographies was implemented [12]. Later, clinical decision
support and expert systems began to appear (MYCIN [13], Internist-I [14]). In
the last two decades, health systems and providers have been making a slow yet
steady progress in adopting computational tools and techniques and digitising
medical records.
In the UK, over the last decade, the National Health Service (NHS) programme
for Information Technology (NPfIT) has further boosted big data by introducing
electronic infrastructures in hospitals and GP practices across the country. In
addition, the growing prevalence of chronic disease is adding pressure to health
services and multiplying data [11]. Over the last 5 years, the English NHS alone
saw a 13% increase in hospital admissions to a total of 15.1 million admissions in
2012-13 [15]. If each admission accounts for only 1 kilobyte of information that
would be 15.1 gigabytes of new admissions data just last year, then multiplied by
imaging, referrals and any other procedures and tests. This ever growing amount
of data, most of it resulting from routine service activities, promises to introduce
novel ways of exploring and understanding the services and their processes, and
to boost research and data mining activities. However, underlying technical and
social challenges still need to be addressed before biomedical data can have its
full influence on health care [16].
Several government projects and initiatives both nationally and internationally
have focused on top-down approaches to improve and innovate the ways in which
health data is recorded, organised and used [17; 18; 19]. Conversely, evidence-
based bottom-up approaches revealing current practices and data are scarce. In
an increasingly digital world, such approaches are now becoming feasible and
could provide additional evidence for making decisions about the ways in which
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data and systems are implemented and organised.
Despite national and local initiatives to organise health data and the adoption of
standards, medical data continues to be infamous for its complexity and hetero-
geneity [20; 21] and hospitals arguably provide one of the most challenging envi-
ronments for the development and application of computational techniques. In-
deed, state-of-the-art data or process mining algorithms often need to be adapted
to cope with the uniqueness of medical data. The research field of health and
biomedical informatics has dealt with some of these issues and pioneered solu-
tions. In fact, health informatics research has boosted other research in comput-
ing sciences and introduced new tools and techniques with wider applicability
(for example, the Entity-Attribute-Value data model [22]). However, persistent
issues and challenges still remain [16]. This thesis will address them by exploring
the journey from raw data to knowledge in a large English NHS hospital with a
catchment area of up to 822,500 people. Further introductory notes as well as
the research objectives, contributions and the thesis outline are given in the next
sections.
1.1 A Consilience of Disciplines
Health and biomedical informatics is arguably the most comprehensive term en-
compassing the core and applied research that deals with the “optimal use of
information, often aided by the use of technology to improve individual health,
health care, public health, and biomedical research”[4]. However, this discipline
can also be defined as biomedical, medical or health informatics and the “adjec-
tive problem” [4; 23] is ongoing. Nevertheless, one of the first definitions was
coined by Robert Greenes and Edward Shortliffe in 1990: “Medical informatics
is the field that concerns itself with the cognitive, information processing, and
communication tasks of medical practice, education, and research, including the
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information science and the technology to support these tasks”[24]. In 1995,
Perry Miller defined medical informatics as a field that focuses on the creative
use of computers in support of patient care, medical education and biomedical
research [25]. In the early 2000s, Enrico Coiera gave a more encompassing defini-
tion of health informatics [26] as the rational study of “the way we think about
patients, and the way that treatments are defined, selected and evolved”; “how
we organise ourselves to create and run health care organisations”; and “how
clinical knowledge is created, shaped, shared and applied”.
Emerging as a distinct academic entity, health informatics brings together clin-
icians, scientists and engineers to find solutions for a wide range of problems
pertaining, in most cases, to the optimal use of information and knowledge in
biomedicine and health. The field is, therefore, broad and several subcategories
have been proposed. William Hersh has recently published a diagram that illus-
trates the major subcategories of the field [4] (Figure 1.1).
Figure 1.1: Major subcategories of the informatics field, from [4].
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The activities across the subcategories may share similar goals with other es-
tablished sciences such as epidemiology, that aim to study patterns, causes, and
effects of health and disease in populations. Indeed, epidemiological methods and
tools have been implemented in several health informatics projects such as hospi-
tal infection control software [27; 28; 29]. However, despite authors stressing the
benefits of interdisciplinary work, there is still scant evidence of a strong collabo-
ration between such sciences in the literature. As E.O. Wilson envisaged in [30],
a consilience of disciplines providing the synthesis and linkage of knowledge from
different fields of human endeavour is key to future advances in research. It is
crucial, therefore, that the sciences be able to understand each other and be open
to collaborative work in a way that medical informatics, a consilience between
medicine and computing, has already demonstrated with some success.
One of the early efforts to describe the science in medical informatics was that
of Charles Friedman. In 1995, Friedman introduced the tower of achievement as
one way of representing the creative work in this field [31]. Friedman’s tower is
widely accepted scientifically and it is comprised of four levels [31]:
• At the bottom of the tower lies the formulation of models for acquisition,
representation, processing, display, or transmission of biomedical informa-
tion or knowledge;
• Then comes the development of innovative computer-based systems, and
using these models, that deliver information or knowledge to health care
providers;
• Next, the challenge is to install such systems and make them work reliably
in functioning health care environments;
• Finally, at the apex of the tower, lies the study of the effects of these systems
on the reasoning and behavior of health care providers, as well as on the
organization and delivery of health care.
6
1. Introduction
Friedman’s tower is exceptionally accurate, in particular when developing clinical
decision support or expert systems, and it demonstrates how different actors
working in medical informatics need to work together and contribute equally
in health care settings. Recent technological advances, however, have resulted
in a rising interest in applications and solutions that expand beyond the realm
of health care providers. There is now a growing interest in linking information
available in health services with other organisations, biological databases, or even
individuals through mobile devices and social media. This would lead to an
involvement of social scientists so as to help illuminate the complexity of the
interactions between users and systems or to play a “crucial role in the discovery of
the biases that are intrinsic to digital data” and “in the construction of convincing
stories about what those data reveal” [32].
This, however, is only possible if complete and accurate data elements are col-
lected in a consistent and canonical form. Despite years of health informatics
research, the unique nature of medical data and systems has, among other less
technical factors, continued to hinder substantial progress. This is particularly
true in hospitals and it is investigated in this thesis.
1.2 Origins and Nature of Information in Medicine
The organisation of medical knowledge is among the oldest applications of classi-
fication, dating to Aristotle’s efforts in biology and formal descriptions [33]. The
subsequent history shows increasingly detailed classifications of causes of death
in the 16th century London Bills of Mortality and recently, the World Health
Organisation International Classification of Diseases (ICD), the SNOMED Clin-
ical Terms, and even the Health Level-7 (HL7) for data interchange. The origins
of data in medicine rely on classification systems, but it is the collection of data
points, the practice of medicine and the continuous communication between prac-
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titioners that generate most of the data and allow comprehensive studies to be
carried out. The benefits of collecting information on disease have been thor-
oughly demonstrated in epidemiology. An early example is that of 1854’s cholera
outbreak in Broad Street, London, where John Snow relied on a collection of
geographical and other information on mortality to trace the origin of the out-
break. Since then, epidemiology has continued to play a crucial role in informing
medicine and public health.
To a general practitioner or a hospital clinician, collecting information from pa-
tient observations is essential to making a diagnosis and deciding on treatment.
Such information comprises patient symptoms and complaints, histopathology
and biochemistry findings, medical imaging techniques, and even genomics infor-
mation. Medical datum, therefore, derives from multiple sources and comes in
a variety of ways: numerical measurements, recorded signals, images, narrative
text, genes and discrete data. This data is stored across the services’ databases
and used primarily to support the delivery of care. In some cases, however, the
data is heavily bound to commissioning or billing activities which tend to improve
its quality, but neglect other potentially relevant clinical information.
Information is also generated by the need of clinicians to communicate with one
another, and some of the properties of the communications media may not ac-
count for such interactions [34]. However, it has been noted that, for example,
computerising the communication of laboratory requests from, and reports to,
clinicians leads to improved efficiency throughout the cycle of reporting and re-
questing [34], and further work is required to make use of new technology in
laboratories. Hospital information systems (HIS) can play an important role in
achieving greater efficiency and improved communication.
In 1984, Peter Reichertz gave a lecture on “Hospital Information Systems past,
present and future” [35]. At the time, hospital systems had already been in use
for over a decade. Reichertz foresaw most of the core developments in HISs (pic-
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ture archiving, data processing and transmission, and linkage of expert systems to
databases) and indicated what the goals and tasks of information systems should
be. The most important goal of a hospital information system is to “map the real
environment into a formal representation, through the bottleneck and restriction
of data acquisition” [35]. HIS would, therefore, encompass the following function-
alities: acquisition of information, processing of information, and presentation of
information.
Beyond the necessary system management functions of HISs, Reichertz also fore-
saw additional aspects. Such as problem solving tasks that would require the
development of expert systems using artificial intelligence and statistical meth-
ods [35]. Reichertz also anticipated that further architectural changes would be
needed as HIS become health information systems (regional or global rather than
local). In the UK, the latter has been, to some extent, a reality as most NHS
hospitals currently submit data for national audits or for overall commissioning
or planning and performance management. However, data that is not required by
clinical audits or other programmes is unlikely to be consistently collected or its
quality assessed. Indeed, the information available in HIS, its completeness and
quality, are not well understood and researchers and clinicians can have unreal-
istic expectations about the extent in which such data can be re-used. Quality
data available in such systems, however, has the potential to be re-used for clinical
research although it is often difficult to access.
In hospitals, the autonomy of each department and clinical speciality introduce
additional challenges and heterogeneity to the systems and the quality of the data
[21]. Having distinct data owners, targets and objectives, hospital departments
behave in a similar fashion to different organisations and, albeit often sharing
an internal patient identification number, they provide an extremely challenging
environment for the integration and analysis of linked health data. The retrieval
and uses of routinely collected hospital data is a central topic in this thesis as are
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the transformations needed for this voluminous raw data to become knowledge.
Figure 1.2 shows the knowledge pyramid, an enlightening illustration of the per-
spective on the volume and value of data. The top levels of the pyramid see
the most valuable knowledge and decisions, and at the lowest level lies complex
heterogeneous data [20; 21]. A recent definition of medical knowledge is given by
Paul Taylor [18] as “the principles or heuristics that we abstract from experience
and use to guide future action”. In turn, the process of finding useful information
and patterns in data is called knowledge discovery in databases and data mining
is the use of algorithms to extract such information and patterns from databases
[36]. The latter have been characterised as “highly heterogeneous with respect to
the data models they employ, the data schemas they specify, the query languages
they support, and the terminologies they recognize” [21].
Figure 1.2: The knowledge pyramid.
In addition to the above, there are issues with data quality across five dimen-
sions (completeness, correctness, concordance, plausibility, and currency) and,
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currently, there is little consistency or generalisability in the methods used to as-
sess them [37]. Assessments of the quality of the data often expose several types
of errors and in some cases these may not just be typographical or missing infor-
mation. In 1999, To Err is Human was one of the first high impact reports that
described patient safety and the extent of human errors in medicine [38]. The
report revealed that between 2% to 4% of all deaths in the United States were
being caused by medical errors. In England and Wales, medical error (or adverse
events) accounted for 2.2% of all episodes in 2004 [39]. While progress has been
made in this respect [40], errors are part of the nature of medical data, and the
role of computerised order entry and decision support systems in preventing them
is still precarious [41].
The complexity and heterogeneity of medical data is present throughout its own
life cycle: from when it is first created with its initial (or lack of) structure,
through all the changes needed for it to be communicated effectively, and up
to the point when it is forgotten in hospital databases or libraries. This thesis
will explore the journey of retrieving, cleaning, linking and analysing the digital
footprints left behind by patients as they visit (and re-visit) hospital.
1.3 Objectives and Problem Domain
There are great expectations about the potentials of big data stored routinely in
hospitals but the extent to which this data can be used and studied is largely
unknown. The primary objective of this thesis is to study the journey from
routine data to knowledge in a secondary health care centre, and to investigate
the extent of the secondary uses of this data. The journey from data to knowledge
is made by traversing critical steps, each addressing specific secondary objectives:
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• Investigate and develop methods to extract routinely collected data from
multiple heterogeneous data sources and to store this data in integrated
repositories;
• Explore and introduce existing and novel techniques to preprocess routinely
collected data;
• Study and develop data modeling techniques suitable for complex, hetero-
geneous and patient-centric data so as to model patients’ journeys through
care;
• Develop methods, tools and techniques to model, integrate, visualise and
analyse such data.
The setting used in this research is the Norfolk & Norwich University Hospital
(NNUH) NHS Foundation Trust, a large academic teaching hospital in England
with a catchment area of up to 822,500 people. The time period selected in this
study is over 10 years, from 2001 to 2011. This time period was selected to
capture any changes in data and in systems over time.
Routine clinical data is recorded across several hospital systems but is rarely
analysed or linked. Upon linkage and integration, it is expected that important
and useful information can be obtained and benefit patients, their doctors and
health service planners. Methodologies, data mining and other computational
techniques are tested and developed in this thesis, and the importance of clean
integrated health records is demonstrated using two clinical case studies: prostate
cancer and stroke.
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Prostate Cancer
Prostate Cancer is the most common male cancer in the UK [42] and one that
varies in behaviour between individuals and over time; it may be an incidental
finding which never causes any problems or it may change to a progressive and
lethal cancer, which can be treated to some extent with various degrees of suc-
cess. A major problem is when it escapes from control with hormonal drugs and
metastasises to bone and, at present, there is no reliable way of predicting which
cancers will behave aggressively and which will not. With regards to mortality,
about 90% of men diagnosed with localised prostate cancer (confined within the
prostate) live for more than 5 years after diagnosis and between 65-90% live for
at least 10 years. This contrasts with locally advanced cancer (spreading outside
the prostate capsule) where 70-80% live for at least 5 years after diagnosis, and
with advanced cancers (metastatic) where only 30% survive 5 years [42].
In recent years, there has been a generalised increase in reported incidence but,
despite this, the mortality rates have been on the decline [42; 43; 44]. Neverthe-
less, the economic burden of prostate cancer will continue to rise due to increased
diagnosis, diagnosis at an earlier stage and prolonged survival [44]. It has been
reported that new strategies need to be devised to improve the efficiency of health
care provision for this type of cancer in order to tackle the increasing burden [44].
Prostate Specific Antigen (PSA), a biochemical marker used clinically for prostate
cancer detection and prognosis, is associated with substantial overdiagnosis and
excessive treatment [45], which makes its utility as a screening test controversial,
and warrants the need for further studies. Further background information on
prostate cancer is provided in Appendix B.
The case study on prostate cancer looks at the utility of routinely collected hos-
pital data in understanding the patients’ journeys through care. This case study
is of particular relevance given the chronic nature of cancer and the propensity
of patients to use multiple hospital resources (radiology, histology, radiotherapy
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and theatre, among others) over longer periods of time. This requires data points
to be collected over large time windows and across multiple systems, which, in
turn, provides a sound environment for observing data quality. In addition, this
case study has also carried significant clinical interests and gathered a team of
experts including a urology consultant, prostate cancer geneticists, a consultant
oncologist, a histopathologist and a chemical pathologist. Even though the initial
aims of this study were to explore clinical findings, the bureaucratic, complex and
time-consuming nature of the work leading up to the analyses hindered this goal.
Nevertheless, work on clinical studies is ongoing and descriptive and summary
statistics are included in this thesis.
Stroke
Stroke is the third most common cause of death and the first cause of long-term
disability in the UK [46]. Every year in the UK more than 150,000 people suffer a
stroke and the costs of treatment and care for the NHS was of 8 billion pounds in
2010 (approximately 5% of the total UK NHS costs [46]). Stroke incidence rises
steeply with age and despite better preventative measures, the total number of
strokes will continue to rise in the UK [47]. Furthermore, stroke care in the UK is
far from ideal. Patients have worst outcomes when compared to other European
countries [48] and the situation has become widely known following the recent
publication of the Royal College of Physicians’ National Stroke Audit [49].
Stroke is often regarded as an acute and episodic disease in secondary care yet it
leads to long-term disability and its causes are longstanding. The literature now
emphasises the need for prevention and a reorientation of practice so that stroke
can be considered a chronic disease with acute events [50; 51]. Indeed, appropriate
prevention can lower the risk factors leading to stroke events [51]. From a data
perspective in hospitals, stroke contrasts sharply with cancer due to its acute
and episodic nature. As a result, it is expected that a greater number of clinical
parameters can be found in secondary care databases. This is particularly true
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during a patient’s stay which lasts, on average, 16 days across all stroke subtypes
in England [15].
In addition, the Norfolk & Norwich University Hospital has been collating a in-
house stroke register database since 1998. This database, however, is disconnected
from hospital systems, its data is input by data entry clerks, and its platform
and role have changed over time. Appropriate data models will be explored,
and this thesis will also investigate methodologies and techniques to enable this
database to be linked to other hospital systems and used for further clinical
research. Furthermore, clinical studies using data mining and other statistical
and epidemiological methods were undertaken during this research and others are
still ongoing, and not included in detail in this thesis. A full list of contributions
is given in the next section.
1.4 Summary of Contributions
In this thesis, the journey from data to knowledge in a secondary health care
centre is explored in detail and novel computational methods for the retrieval,
linkage, integration, modeling visualisation and analysis of routinely collected
data are introduced. This has not been previously researched in full, and attention
has only been given to segments of the journey. The contributions of this work
are summarised below:
• A novel methodology for extracting patient-centric data from multiple het-
erogeneous data sources was developed and published in a leading health in-
formatics journal [52]. This methodology was developed using the prostate
cancer case study, tested with the stroke study and work is ongoing for
it to be applied to other hospitals. The methodology also resulted in the
development of the largest and most comprehensive repository of prostate
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cancers in Norfolk.
• Over 10 years of Hospital Information Systems and their data from a large
NHS hospital were studied. This was explored in parallel with the above
methodology and provides a comprehensive list of challenges that needed
to be addressed for the systems’ data to be integrated.
• Tools and techniques for the linkage and preprocessing of routinely collected
data were introduced, including an algorithm for extracting relevant text
from histopathology reports, and a novel imputation method for continuous
values. These techniques were applied extensively to the routinely collected
data, contributed to ensuring its quality, and have wider applicability.
• Methodological steps were proposed to develop clinical data warehouses
with routine hospital data from HISs. This work led to the development
of the new Norfolk & Norwich Research Stroke & TIA Register, a unique
integrated repository of strokes and transient ischaemic attacks (TIA) with
over 25 thousand patients from 1998 to present. Both the stroke register
and the prostate cancer repository were developed to enable high quality
cohorts of routinely collected data to be selected for clinical, epidemiological
and health services research. A publication in a health informatics journal
is expected (Appendix E).
• The concept of a data-driven patient-centric pathway was introduced to
describe the journey that patients take through care based on the available
electronic data. A pathways data model was proposed and tested, and the
feasibility of current data and process mining techniques to analyse the
pathways was explored. A research paper has been submitted to a leading
health informatics journal (Appendix E).
• A new clinical decision support system was developed based on the prostate
cancer pathways. A novel graphical representation was introduced along
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with software that aggregates similar sequential pathways and compares the
outcomes of given patients’ profiles. Both the pathways and the software
have a wider applicability in other domains and an application to stroke is
planned.
• Clinical studies were undertaken while others are still ongoing. These are
not described in detail in this thesis yet they are included in the list of
research publications resulting from the work carried out in this thesis (Ap-
pendix E).
1.5 Thesis Outline
Chapter 2 focuses on the problem of multi-source data collection from multi-
ple heterogeneous sources and summarises over 10 years of hospital information
systems; this is the first step of the journey from data to knowledge, in which
routine data is retrieved from multiple hospital information systems. Chapter 3
covers data preprocessing, record linkage, and data warehousing; these are tech-
niques required for quality assessment and data cleansing before any analyses
can be undertaken. Chapter 4 deals with the modeling of prostate cancer path-
ways and the tools and techniques to analyse them; these include algorithms and
the development of clinical decision support and other software. Each chapter
critically evaluates its own topic and concluding remarks are given in Chapter
5. Not all chapters refer to the stroke and prostate cancer case studies, and this
is summarised in Figure 1.3, along with relevant information pertaining to each
chapter.
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Figure 1.3: Thesis Layout.
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Chapter 2
Multi-Source Data Collection
This chapter explores in detail the cumbersome process of accessing and retrieving
patient-centric data from multiple hospital information systems (HIS) for the
creation of a data repository for future data analyses.
Section 2.1 introduces the problem of multi-source data collection from secondary
care centres; section 2.2 provides the background and preliminary work carried
out for the development of a methodological process for data collection.
The process is explained in section 2.3 whilst section 2.4 describes the develop-
ment of a semi integrated data repository from the collected data. The process
roadmap was developed using the case study on prostate cancer, and validated
by a second study, on stroke (section 2.5).
Discussion and evaluation of the data collection approach are given in section 2.6.
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2.1 Introduction
The use of electronic medical records (EMR) in clinical research has already been
envisaged by the medical informatics community [53; 54; 55]. Indeed, different
types of EMR systems can be used to select and, in some cases, retrieve data for
epidemiological studies, clinical trials or other clinical study data management
systems [56]. In longitudinal or other observational studies, however, legacy pa-
tient information may be collected from regional or national data sources such
as registries. The latter is often federated with data from primary, secondary
and tertiary care centres which are, in turn, required to submit the datasets and
respective mandatory fields. However, such regional or national approaches gen-
erally target a rather specific dataset with limited parameters and uses. This
reductionist approach to data collection may not fulfil the needs of other, more
complex, retrospective studies requiring more detailed clinical parameters.
In the National Health Service (NHS) in the UK, primary care specialists work
in the community and refer patients to secondary or tertiary care centres (hos-
pitals and specialised treatment centres respectively). Perhaps because of their
organisational structure, secondary and tertiary care centres generally implement
Hospital Information Systems (HIS). The latter were initially designed to sup-
port and monitor patient care, specific medical tasks and hospital management
[35]. Only recently has attention been given to clinical research [57] and other
secondary uses of such patient data [19].
Historically, HIS developed from central to modular and distributed systems [58].
Central and modular systems perform better in homogeneous environments, but
this poorly reflects the reality of medical information in hospitals, which is het-
erogeneous and complex [20; 58]. Similarly, the distribution of information pro-
cessing and uniqueness of medical data [20] pose obstacles to data integration
[58]. Commercially available HIS often focus on administrative tasks and lack
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knowledge-based functionality [59]. According to Sujansky, hospitals may opt
for implementing several commercial departmental systems, creating islands of
information across various departments [21], which further hinders the retrieval
of patient-centric data. This problem is augmented by a lack of semantic interop-
erability (i.e. clinical coding), particularly in outpatient events in the NHS [60].
Nevertheless, in-house projects such as the Oxford Clinical Intranet [61] have
been able to link and centralise patient information from multiple HIS and other
sources. Other in-house projects have also achieved integrated centralised sys-
tems [62] but they rely on strong organizational support, funding, resources, and
a software design strategy focused on the caregivers information needs [62]. Some
of these systems may be used to extract cohorts of patient-centric data, however,
in most cases, such functionalities are not supported, particularly in commer-
cially available systems. Apart from cases where there is strong organisational
support and a forward-thinking strategy, most hospitals will have environments
that pose similar challenges to those identified by Sujansky [21]. Furthermore,
it is expected that future projects carrying out inter-organisational data linkage
exercises will face similar challenges, and hospitals with multiple heterogeneous
systems provide a sound environment to study how patient or person-centered
data can be collected and linked.
Collecting patient-centric data and EMRs from one or multiple HIS in a secondary
care centre is often reported to be an ad hoc process, and it is poorly described
in the literature. Indeed the description of methods for data collection has been
mentioned as a key point for the improvement of the quality of the literature [63].
A methodology for data collection was constructed based upon expert consulta-
tion and driven by a case study on prostate cancer. Previous work on knowledge
discovery in databases (KDD) methodologies [64; 65], KDD methodologies tai-
lored to medical domains [5], and work on clinical data integration [6], were
important in shaping the methodology which is described in detail in section 2.3.
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2.2 Background and Preliminary Work
The methodology for collecting patient-centric data from multiple HIS was drafted
by initial consultation with domain experts as well as input from relevant seg-
ments of other KDD methodologies. Because collecting data from multiple sources
ultimately results in data integration, input from previous work on this topic [6]
was also crucial. The forthcoming sections will address such topics in detail.
2.2.1 Knowledge Discovery Methodologies
In medical data mining, large data-sets of prepared data allow the discovery of
patterns in sets of records. For these patterns and rules to be successfully derived
and contextualized, a knowledge discovery methodology (or process model) is es-
sential. KDD methodologies have been developed to provide guidance to data
mining and other data analysis and knowledge discovery projects using large
databases. According to Cios [66], the goal of designing a DMKD methodology is
to come up with a set of processing steps to be followed by practitioners when ex-
ecuting their DMKD projects [66]. The benefits of such process can be measured
in terms of development time, reliability, efficiency and overall cost [5].
Methodologies reviewed include Fayyads 9-step model [67], Debuse et al. KDD
Roadmap [64], Cabena’s 5-step model [68], the Cross Industry Standard Process
for Data Mining (CRISP-DM [65]), and Cios 6-step data mining and knowledge
discovery [5]. The latter has been applied to medical data mining exercises and
is the most appropriate to be explored in detail in this section. Nevertheless
a comparison between the abovementioned methodologies is given later in this
section.
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2.2.1.1 The 6-Step DMKD
The 6-step data mining and knowledge discovery (6-step DMKD) is a modified
version of CRISP-DM (used primarily in business contexts) and has been success-
fully applied to medical problem domains [69; 70; 71]. The methodology, shown
in figure 2.1, comprises the following steps:
Understanding the medical problem domain
This is an essential step where a list of well defined outcomes is put together.
Indeed a key goal of this step is to translate medical goals into data mining
goals. However, the latter can only be achieved after a previous understanding
of the problem domain and hence a background survey of the domain is often
necessary. This step should also identify problem requirements, restrictions and
determination of success [5] and involvement from the domain experts is expected.
The following tasks are defined within this step:
• Define the problem
• Determine medical objectives
• Identify key people
• Learn about current solutions to the problem
Understanding the data
Data should be retrieved and a preliminary analysis is performed in this step. It
may be necessary to obtain ethics and governance credentials from the institu-
tional review board and/or local, regional or national ethics committees to grant
access to the data and/or data sources. The data may also need to be anonymized,
de-indentified or encrypted [20] and summarisation (described below) may be of
help in achieving this.
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An understanding of the data, its usefulness, along with their semantics and
syntax, is expected in this step. This leads to analyses of completeness, relevance,
missing values, attribute values, extremes, among others.
Data preparation
The 6-step DMKD states that preparation of the data is a key step of the en-
tire DMKD project [5]. Indeed this step has been previously acknowledged as
the hardest step in a KDD process [72]. In this step, decisions must be made
regarding which data to input in the data mining algorithms and significance
and correlation tests will be performed together with sampling of the database
[5]. Furthermore, this step will also account for the cleansing of the data, which
includes, for example, handling of missing values or noise.
Once clean, the data can be further processed by feature selection and extraction
algorithms (to reduce dimensionality), by derivation of new attributes (such as
by discretisation), and by summarisation of data (granularisation) [66].
Overall, it is important for the information to be accessible from a computational
point of view not only because medical data is heterogeneous in nature [20],
but also because many data mining methods cannot cope with voluminous or
malformed data.
The results of such changes may be new attributes, values or records that should
meet the specific input requirements for the data mining algorithms [66]. Training
and test sets can be used to make sure that data mining techniques work and
present interesting results. Indeed training sets are often used to develop the
specific parameters required by the techniques [36].
Data mining
In this step, data mining techniques are applied to the data. The techniques
may have been previously selected in the preceding steps, however, other algo-
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rithms can be applied if necessary. There is a wide range of techniques including:
Bayesian methods, neural networks, clustering, machine learning, decision trees,
among others. The scalability of DM techniques is important because some may
not work with large volumes of data.
Evaluation of the discovered knowledge
The results obtained from previous step are interpreted here. This step is often
performed along with a domain expert that should confirm the importance and
utility of the results. It may be necessary to go back to step one (Understand-
ing the problem domain) or to step four (Data mining) of the DMKD process.
This recursive feature of the 6-step DMKD process allows the identification of
alternative actions that could improve the results.
Using the discovered knowledge
The involvement of domain experts is also essential in this step. In fact, this is
the step where database owners or problem domain experts decide how to use the
discovered knowledge. The discovered knowledge, when interesting, may result
in research publications of novel clinical findings [72] or changes and optimisation
of the involved services or systems, among other possible outcomes. A plan to
monitor the implementation of the discovered knowledge is also created here, and
the entire project documented [66].
Figure 2.1 shows the 6-Step DMKD methodology and the relations between steps.
Regarding time spent on each step, data preparation is the most time/effort
consuming step (45%), followed by data mining (15%), understanding the data
(15%), and understanding the problem domain (15%). Data mining may, how-
ever, may require more effort than the other two steps that equally stand at
15%.
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Figure 2.1: Cios 6-Step Data Mining and Knowledge Discovery Methodology
adapted from [5].
2.2.1.2 Comparing Methodologies
Five DMKD methodologies were reviewed and the 6-step was selected as an exam-
ple because it is tailored to medical domains [69; 70; 71]. A summary of the steps
in each methodology reviewed is given in Table 2.1. Transversely, the overarching
common steps across methodologies are:
• Domain understanding
The data understanding step is present in almost all methodologies reviewed
and is part of domain understanding or data preparation. It is an essential
step as semantics and syntactical differences are often reported, particularly
in medical domains [73]. Some methodologies [5; 65], identify this step on
its own, whilst the Cabena’s 5-step methodology [68] misses it entirely as
it assumes this as previous knowledge.
26
2. Multi-Source Data Collection
• Data preparation
Data preparation, also be referred to as data cleansing or preprocessing, is
present in all methodologies and it can be included as a step of its own or
broken down into several smaller steps [67].
• Data mining
Data mining, also referred to as modelling or data analysis, is defined as a
single step across all methodologies.
• Evaluation of the discovered knowledge
The process of evaluating the discovered knowledge is, in all methodolo-
gies, broken down into an analysis, evaluation or interpretation phase and
deployment or application of the knowledge.
Cabenas 5-step methodology is too broad and it may not be ideal for medical
domains unless it is used by physicians within a health care organisation, in a
situation where the data and the problem are already well understood. In fact,
the incompleteness of Cabenas process model has already been reported by Hirji
[74]. Conversely, Fayyads 9-step model [67] is complete and thorough but it does
provide less freedom to the data miners. For instance, data miners may want
to reduce dimensionality and project the data before cleaning it, and not the
opposite.
It would also be expected that methodologies would account for the process of
seeking credentials with the health care organisations or the retrieval and po-
tential linkage of the study data, which is not the case on any of the reviewed
methodologies.
Overall, the most detailed methodologies may be more useful and efficient to
less experienced data miners, or in environments where little is known about the
problem domain and its data. Simpler methodologies such as Cabena’s 5-step
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may be more efficient to those who are experienced and where knowledge of the
domain is well understood.
A well balanced methodology is the 6-step DMKD which provides enough freedom
to the data miners, is based on the widely accepted and used, CRISP-DM [65],
and has been successfully applied to several medical domains. Another important
feature of this methodology is the additional recursion between steps (illustrated
in figure 2.1).
With regards to the application of the above methodologies, and using the Else-
vier citation index, Fayyad’s 9-step is by far the most widely cited in academic
papers [75]. Other methodologies have been substantially less cited (approxi-
mately 40 times less than Fayyad’s) in equal measure. A reason for this difference
lies in the fact that Fayyad’s paper describing the methodology also introduced
the most commonly used definitions of DM and KDD [75]. This reveals that a
search of citation indexes, even if thoroughly carried out, may provide insufficient
accuracy in determining the number of applications of the methodologies.
However, two polls carried out by KDnuggets (http://www.kdnuggets.com) in
2002 and 2004 revealed that the majority of respondents use the CRISP-DM
methodology or their own methodology. Applications in medical domains have
been reported in all methodologies, however, the 6-step has been used almost
exclusively in this area [75].
The overall common steps in all methodologies are illustrated in Table 2.1 and
provide the framework to embrace the data collection exercise presented in detail
this chapter (section 2.3).
The analysis of the main methodologies guiding knowledge discovery or data
analysis projects depicts that data collection (retrieval or extraction) has never
been mentioned as a step in its own right. Indeed it is often assumed the data is
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Step Cios 6-Step [5]
Fayyad 9-Step
[67]
CRISP-DM
[65]
Cabena 5-Step
[68]
KDD
Roadmap [64]
Domain
Understanding
Understanding
the problem
domain
Understanding
domain and
identifying
DMKD goals
Business
understanding
Business
objective
determination
Problem
specification
Understanding
the data
Creating target
data set
Data
understanding
Data preparation Resourcing
Data
Preparation
Preparation of
the data
Data cleansing
and preprocessing
Data preparation Data cleansing
Data reduction
and projection
preprocessing
Matching goal to
a particular data
mining method
Exploratory
analysis and
model hypothesis
selection
Data Mining
or Analyses
Data mining Data mining Modelling Data mining Data mining
Knowledge
Evaluation &
Application
Evaluation of the
discovered
knowledge
Interpreting
mined patterns
Evaluation
Analysis of
results
Evaluation
Using the
discovered
knowledge
Consolidating
discovered
knowledge
Deployment
Knowledge
assimilation
Interpretation
Exploitation
Table 2.1: Comparing steps across DMKD methodologies.
readily available, or made available by the domain experts. Researchers carrying
out projects in secondary care centres using multiple HIS are faced with the
additional workload of retrieving and collating data, which are non-trivial tasks.
The data collection methodology presented in section 2.3 can be seen as an ex-
pansion of the data preparation step, or ultimately a new step to come between
domain understanding and data preparation. Although some emphasis is given
to the neighbouring steps, this work focuses primarily on the method for data
collection since this has received the least attention in the literature.
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2.2.2 Data Integration
Data collection and preparation in KDD methodologies in medical environments
may be achieved by following an information pipeline architecture described in
[6]. The pipeline, as illustrated in figure 2.2, channels data from their sources
to an operational data store (ODS) where the information is stored before it is
further validated, cleaned and merged during the Extract-Transform-Load (ETL)
process [6] to create a core database. The functionality of an ETL process can
be summarized in the following tasks:
• Extraction: the identification of relevant information at the source side
and the extraction of this information;
• Transformation: the customisation and integration of the information
from multiple sources into a common format and the cleansing of the re-
sulting data set;
• Loading: the propagation of the data to the data warehouse and/or data
marts, or in this case the propagation to the operational data store.
The ETL process is frequently used in building data warehouses and will be
discussed again later in chapter 3. The core database implements a data model
and is used to draw more specific data marts for reporting, visualisation, analysis
and data mining [6].
The method for data collection presented focuses firstly on the journey of extract-
ing data from a single source, and secondly, on how the retrieved data is used
to build an ODS. The process can be repeated to include multiple information
sources. Some of the issues of working with multiple sources have been addressed
in [6; 21; 76; 77]. Furthermore, global query systems have been developed [76; 77]
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Figure 2.2: Information pipeline architecture, adapted from [6].
to facilitate the retrieval of information from multiple databases in distributed en-
terprises. However, such issues are often approached from a database power-user
point-of-view, where a privileged access to the underlying database systems exists
together with a high level of technical proficiency. Ethical issues, data-ownership,
credentials and hospitals’ organisational structures may pose obstacles to gaining
access to systems and patient-centric data.
Nevertheless the use of automatic and intelligent tools and techniques to link and
extract data in the next chapter.
Knowledge of the different types of heterogeneities in distributed database sys-
tems [77] is key for setting important goals when working in such environments.
These types include:
• Technical differences in database systems
– Structure, where different data models provide different structural
primitives;
– Constraints, where different data models may implement different ref-
erential integrity rules;
– Query languages, where retrieval and manipulation of query results
may differ.
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• Semantic Heterogeneity
This type of heterogeneity pertains to the meaning, interpretation, or in-
tended use of the same related data across systems [77].
• Autonomy
Different organisational entities and their independent control over different
systems are the cause of this type of heterogeneity. In particular, auton-
omy involves the design, communication and execution of database systems
components.
Indeed to address some of the above issues the concept of metadatabases evolved
from the traditional data dictionaries [76; 78]. In traditional data dictionaries,
information about the data (i.e. metadata) is gathered to facilitate software de-
velopment and the control of data sharing among different programs and systems
as well as supporting the lifecycle of a database system [78]. Metadatabases
were developed to tackle higher levels of management and control of information
models (metadata), and to include information on process models and business
rules [78]. This is particularly important since medical information is essentially
bound to the context of its production [55]. Indeed, one of the outputs of the
data collection process described here is a metadatabase comprising of metadata
files for each data source.
One of the benefits of using a metadatabase in the context of the work carried
out is to aid the critical review and evaluation of not only the data and their
sources but also the future quality of any studies that can be derived from the
collected data. It has been suggested [56] that this evaluation should include the
protocols, record layout and codes, data entry instructions, published material,
analyses, technical reports, and the carrying out of appropriate completeness and
validity studies, all with respect to the specific context of the study [56].
32
2. Multi-Source Data Collection
The two sections below define the problem specification (section 2.2.3) and explain
the initial process of selecting and identifying the data sources (section 2.2.4.
These two sections may be regarded generically as domain understanding. It
is, however, in section 2.3, that the approach for data collection is thoroughly
described. Data cleansing and integration are discussed in section 2.4.
2.2.3 Problem Specification and Ethical Approval
The criterion used includes patients diagnosed with prostate cancer (ICD C61.X).
The aim of this chapter is to use the inclusion criteria and present a methodolog-
ical approach to data collection from multiple sources in a hospital. A research
protocol comprising this information was agreed with the research team and cre-
dentials were sought and approved by the local research ethics committee and
research governance committee.
This time consuming process involves ethical and research governance approvals
of a research protocol. Patient sensitive data such as names and addresses are
excluded, only key patient identifiers are used for linkage. The research protocol
included an extensive literature survey on the problem domain, and the applica-
tion for credentials also required a list of information systems (data sources) to
be used in the study; however, this was not fully known a priori and subsequent
amendments to the original documents were necessary.
2.2.4 Identifying Data Sources
In order to provide an accurate and holistic view of each patient, the aim was to
collect data from as many authoritative sources as possible, where information
on a patient with prostate cancer exists. When so much data is collected and
analysed, less biased results are expected as a better understanding of comor-
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bidity factors and the pathway of a patient is possible. Nevertheless it has been
argued that requiring data with no practical importance creates a source of mis-
leading information [6]. Efforts need to be put towards the definition of practical
importance or relevance of data required for the study.
The study on prostate cancer involves a wide range of data from several depart-
ments and in order to accurately link this data across systems and departments,
a comprehensive EMR of a patient is needed. Data elements for the sole purpose
of validating or linking data need to be included as well as other fields or datasets
that may have an impact on the understanding of the problem domain. At a first
stage, the primary concern was to gather a list of relevant and authoritative data
sources containing relevant data to the study. Data elements for each data source
will be identified later.
A conceptual data model (CDM) may also be of use in the identification of
the variables for the study and those that are outside of it [6] but this requires
previous knowledge of the sources and data elements. The approach presented
here assumes little or no previous knowledge of the systems, database schemata,
or any other metadata. The cohort definition and an authoritative list of data
sources define the boundaries of the study data. The process of identifying the
sources relied on the cohort definition and the work carried out in section 2 as
well as input from domain experts and hospital staff.
Ranking relevant, authoritative databases is a research topic in modern infor-
mation retrieval and is dependent on a given query input. Methods have been
developed to work with text databases, which involve building inverted indices of
terms for each database and using similarity measures between the databases and
a user query. This would be an interesting approach involving the formulation
of a query that captures the study population. However, it does rely on prepro-
cessing that cannot be achieved without full access to the underlying database
systems.
34
2. Multi-Source Data Collection
The aim is to work with local hospital data and, for this reason, national or re-
gional data sources are disregarded for the most part within the proposed method-
ological approach. Nevertheless, this is later discussed as a way of validating the
study data.
Data Source (Information System) Abbreviation Department
Picture Archiving Communication System PACS Radiology
Patient Administration System PAS Administration
Oncology System ONC Oncology
Biochemistry & Histopathology LAB Histopathology
Operating Theatre OPT Operating Theatres
Radiotherapy RAD Radiotherapy Physics
In-hospital Cancer Registry System CRE Information Services
Local Cancer Registry (external) CR East Anglia Cancer Registry
Orthopaedics System ORT Orthopaedics
Table 2.2: Data Sources (Information Systems) identified and the respective de-
partment.
At an initial stage, gathering information on clinical coding was important so that
cohorts of target patients can be retrieved first. This is important because not all
sources provide accurate clinical coding or another way of identifying the target
population. As described in table 2.2, out of the data sources used in this project,
only one contains homogeneous clinical coding for diagnoses and was used as the
primary source for data collection on prostate cancers. Alternatively the local
cancer register (CR) could have been used to select patient data, however, at this
stage we are interested in the sources within the hospital. The use of the local
cancer register is later discussed in this thesis.
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2.2.4.1 Selected Data Sources
The Picture Archiving Communication System (PACS) is a system dedicated
to radiological imaging. In this case study, only textual information (medical
reports) present in this system needed be retrieved. The hospital Patient Ad-
ministration System (PAS) contains important appointment information for all
patients as well as clinical coding (ICD for diagnoses and OPCS for procedures)
for inpatients. The Oncology department system (ONC) is an in-house developed
system which relies primarily on textual reports. Diagnoses, treatments and his-
tory are available in this system. The biochemistry & histopathology system
(LAB) includes important biochemical information such as the prostatic specific
antigen (PSA) and histopathology reports with respective tumour markers.
The operating theatre (OPT) system will contain information on procedures and
the radiotherapy system (RAD) system will include radiotherapy data such as the
number of fractions (sessions) and the body site being treated. The orthopaedics
system (ORT) contains information on any pathological fractures from advanced
metastatic prostate cancer.
The in-hospital cancer registry system (CRE) was introduced in 2007 to aid the
management of cancer pathways for which targets have been set by the govern-
ment. This data was previously uploaded to the National Cancer Waiting Times
Database (NCWTDB) by a lengthy process (comparable to an ETL) and the
purpose of the new system introduced in 2007 was to facilitate this as well as
produce further information for planning and performance as well as clinicians.
This system was not used in this project due to the fact that it would not have
good quality data until 2010. However, the use of the data on NCWTDB is
explored later.
A detailed description of the hospital information systems used is available in
Appendix A.
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In the UK, another resource that may help the initial selection of some data ele-
ments necessary for the study, without previous access to the systems, is the NHS
data model and dictionary. The data model and dictionary were developed as an
attempt to create a reference point for assured information standards throughout
NHS services [79]. Although this service focuses primarily on defining minimum
data sets for standardising health management data such as commissioning, audit
and performance measuring, other attributes such as PSA levels are now avail-
able. This data model was solely used for understanding data elements from
particular national datasets such as the NCWTDB.
2.3 Data Collection
Each of these steps will be described in the following sections and, when applica-
ble, a summary table will present the relevant information gathered from the case
study at each step. The overall process is repeated for each data source identified
and new data sources may be identified or excluded from the initial list. A travel
log of the journeys should be kept. The order in which the identified sources are
put through the process is important as not all systems will necessarily provide
a way of identifying the target patients (as arose in the case study).
The process in Figure 2.3 accepts a data source (HIS, database system or equiv-
alent) as input and returns metadata and a study dataset as outputs. In order
to reach the outputs, four major stages are followed: system understanding (de-
scribed in detail in Section 2.3.1), data understanding (Section 2.3.2), extraction
preparation (Section 2.3.3) and extraction & evaluation (2.3.4).
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Figure 2.3: Process to extract data from a single source.
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2.3.1 System Understanding
2.3.1.1 Establish Domain Experts
The process described above begins with liaising with the domain experts (sys-
tem managers or experienced system users such as data analysts). Ultimately
this allows further assessment as to whether the system does indeed contain rel-
evant data for the study. System experts may overlook the data needs of the
research study. Further investigation can be sought by previewing the system.
Indeed, when available, system training and preview can speed up the process of
understanding the system. When a system is found unsuitable or redundant, the
list of identified sources in section 2.2.4 is revisited and the process in figure 2.3
ended. Domain experts may also be able to point out suitable data extraction
methods, details on how to obtain access to the system, and information on when
the system was implemented.
In this step, important information to be obtained from the system expert is a
data flow chart detailing user actions and system interactions. A context level
diagram is often sufficient to understanding how information flows to and from a
system. Such information is later important when analysing data, particularly to
understand patients pathways. The investigation of whether a system feeds data
to others is an important part of this task as it can potentially make one of the
systems redundant. During this study, it was found that most data fed across
systems are demographics coming from the PAS but this was not implemented
on all systems. When this was implemented, however, this minimised the risk of
double entry as well as improving future record linkage. The frequency of data
updates to systems is also important, as well as relevant data changes that may
occur on a patient’s record after its retrieval.
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2.3.1.2 System Preview and Training
Liaising with experts may not be sufficient to determine whether a system is
appropriate and previewing the system should help to highlight any relevant data.
In some cases, a system preview, often seen as a walkthrough using the graphical
user interface (GUI), can be part of a hospitals system training. Indeed, when
available, system training is an advantage that should be exploited. Depending
on the quality and depth of the training, the information gathered can facilitate
understanding of the system, building a data flow diagram, understanding the
data (step 2.3.2.1 and 2.3.2.2) and obtaining system access (step 2.3.1.3).
With respect to the case study, formal hospital training was undertaken on PAS,
PACS and LAB. The first was a day of foundation training and exercises and a day
of training on a data extraction tool (an On-line Analytical Processing (OLAP)
system), the second a one-to-one session with the domain expert and the third was
an online interactive course. At the end of each training session, system access
credentials were provided. Training is not always available or appropriate for
researchers. For example, there are PAS training modules tailored to particular
administration tasks, some irrelevant to the scope of this research. There may,
however, be training in expert data extraction tools that are normally provided to
IT staff and information analysts. As described above, this was the case for PAS
and, although limited to extracting and linking administration data, it allowed
an initial understanding of the data extraction tool and the data elements. There
was no formal training for the ONC system but the system was previewed during
the first meeting with the domain experts.
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2.3.1.3 System Access
This is a crucial step as without system access data collection can not be achieved.
Obtaining credentials to access the system (read-only accounts) may require pre-
vious system training (covered in step 2.3.1.2 above). In the study, this was
the case for three systems: PAS, PACS and LAB. By reaching this step, suf-
ficient information about the system will have been gathered and a summary
of the metadata pertaining to the three initial steps of the process can now be
produced. Table 2.3 describes the summary metadata for all four information sys-
tems in the case study. The metadata produced during the above steps pertains
to the systems specifications. At this stage the metadata is derived from expert
consultation only. Further, more technical, details are gathered throughout the
remaining steps of the process.
Metadata - Understanding the System Examples from the case study
Appropriateness and authoritativeness of system All identified systems are authoritative and con-
tain crucial information on prostate cancers.
Data flow chart Overall understanding of hospital information
systems data flow.
Data extraction method (if known) PACS - No particular method identified, users
suggest manual extraction to spreadsheets;
PAS - Business Intelligence software; ONC -
Database back-end, liaise with manager; LAB
- Business Intelligence software.
Preview and system training Previewed all systems, training on PAS,
PACS,LAB.
System credentials Read-only access to the systems was issued.
Key data elements present (if known) Hospital number, NHS number, Date of Birth
present on all systems.
System Updates (impact) All systems were live and updates occurred
daily, but no impact on study data.
System Limitations The LAB system was introduced in 2003 and
there is no electronically available data prior to
this date. The PACS system went live in Octo-
ber 2001 and backdated reports were uploaded
to the system in a slightly different format (vis-
ible on the GUI).
System Live Date Date when system went live.
Last System Update Date Date when system was last updated.
Table 2.3: Summary of items gathered when understanding the system.
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2.3.2 Data Understanding
2.3.2.1 Data Familiarisation and Understanding
The identification and ranking of the relevant data fields from the source is es-
sential [66] and can first be achieved by familiarisation using the systems GUI
together with any data extraction tools when available. A set of examples to
achieve database familiarisation has been described in [64] and, from those, the
following were considered important:
• Database field type determination (categorical or numerical)
Numerical types include discrete and continuous. Categorical types include
ordinal (with an implied order) and nominal (no implied order). As pointed
out in [64], in some cases, categorical fields may include numerical values
that should be treated as such, and this is important metadata to add to
a data dictionary. As data types may differ in software packages, it is also
important to deal with this accordingly, making sure that the original data
is not altered in any way, which can affect correlations. Perhaps a common
mistake is to assume different software packages, database systems, or other
information retrieval systems handle decimal places in the same way.
• Determination of database field semantics
Two or more fields, although different, may be based on the same or similar
measurements [64]. An understanding of the data fields is therefore impor-
tant and detailed explanations should be included in the data dictionary.
It is also important to expand any abbreviated field names.
• Determination of field value semantics and their plausibility [5; 66]
Knowledge about the meaning of the field value is essential to understanding
the data; it can be used to spot outliers and erroneous values, and in some
cases, to handle missing values. This is important as it should be considered
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whether missing information means that exposure or outcome has not taken
place or whether it is indeed a missing value [56] and, if so, whether it is
possible for it to be recovered or guessed.
• Reliability
Field reliability impacts data quality. Although at this stage there may
be no collected data to accurately assess field quality, it is still impor-
tant to manually check for data completeness and determine, at an initial
stage, whether the field is reliable or not based on an inspection of the field
throughout different patient records.
Because full data integration can only be achieved by overlapping focal data
elements [6], these need to be sought for each data source. This may be difficult to
achieve at the very first iteration of the process and relies on identifying the fields
that allow linkage. The most common are hospital number, and other ubiquitous
patient details throughout systems such as date of birth and contact details. Input
from domain experts greatly facilitates this. When the data collection process
runs at least two complete iterations, hence evaluating more than one system, it
is possible to compare the focal data elements across sources metadata.
As previously mentioned, if there is no preceding list of target patients (as with the
case study of patients suffering from prostate cancers) it is important that these
can be identified in the system. This is achieved by identifying clinical coding
fields or textual fields where it is possible to retrieve clinical diagnoses. When
clinical coding is stored in a consistent yet textual data field (such as a clinical
report), text mining and natural language processing techniques may be used to
retrieve the correct information. In this case study, the ONC source contains full
text reports, but a single one line text field indicates the primary site (primary
diagnosis).Therefore, a way to retrieve prostate cancers in this oncology system
was to run a database query for where the word prostate appears at least once
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in the primary site field. This method was accurate, mainly because the data
source has a restricted domain, but also because of the various ways in which the
diagnoses are written do not abbreviate the word prostate. Occasionally, tumour
grading or PSA markers are also included in this data field, but are inconsistent
throughout records and further text mining on adjacent text fields would have
to be carried out to retrieve such information consistently. The PAS system,
however, uses ICD-10 and procedure (OPCS) codes but only for inpatients. The
two other systems (LAB, PACS) do not provide consistent diagnosis information
throughout patient records.
Ranking is a process that relies on selecting data elements which have a predictive
value in assigning a correct identity to an individual. This is essential to ensure
linkage is possible at a later stage, once a data repository comprising all datasets
has been compiled. The most common data elements are the basic demographic
details (patient number, age or date of birth), event dates, event types and coding.
Rank PAS PACS ONC LAB
1 Hospital and NHS Number Hospital and NHS Number Hospital and NHS Number Hospital and NHS Number
2 Date of Birth Date of Birth Date of Birth Date of Birth
3 Episode Start Date Study Date Date Registered Date of Entry
4 Diagnosis Code 1 Procedure Code Primary Site Test Code
5 Diagnoses Codes Modality Diagnosis Test Data
Table 2.4: Data fields ranking from the different data sources in the case study.
An example from the case study is given in Table 2.4 in which the most au-
thoritative data elements from each data source have been identified and ranked.
The uniqueness of the value corresponds to high authoritativeness and thus a
high rank. Data elements such as date of birth or age at episode are not consid-
ered to be unique but ensure a more accurate linkage when used together with
a patient identifier. During the case study, and due to patient confidentiality re-
strictions, only patient identification numbers and date of birth were used as the
most authoritative data elements. The record date (episode, diagnosis, procedure
or other) was also important as it allowed selecting the date range of the cohort
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and linkage validation of certain events. Deterministic record linkage can be used
at a later stage to link particular datasets, after the latter have been compiled
into the operational data store (ODS).
2.3.2.2 Data Selection and Building a Data Dictionary
This is a key step where metadata is compiled into a table, and, once all metadata
from all data sources is collected, a final metadatabase is created (Section 2.4).
This is an iterative step, revisited when the finalised dataset is extracted from a
data source. At a first instance, items to include in the dictionary include the
focal data elements identified in the previous step. As the process continues,
further data items may be added, removed or updated from the dictionary. The
typical metadata generated for each field of the data sources in the case study is
illustrated in Table 2.5.
Metadata - Data Understanding Description
Original Field Name Name of the data field (original name from
source)
Field ID Primary key for identifying a particular data
field in a metadatabase
Field Description A detailed description of the field
Data Type (source) Data type of the field as it appears in the data
source
Data Type (converted) Data type to use in final dataset (may be the
same as source data type)
Field Size (source) Size of the field in characters from the source
(when applicable)
Field Size (converted) Size of the field to include in final dataset (may
be the same as source field size)
Expected Outliers (if any) Any outliers or expected erroneous field values
should to be detailed
Field Rank (Importance) The rank number of this field in relation to its
data source
Data Linkage Often useful to use as a Boolean indicating
whether data linkage is possible with this field
Table 2.5: Data fields ranking from the different data sources in the case study.
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2.3.3 Extraction Preparation
Preparing a strategy for extraction relies on liaising with experts at the hospital
(system administrators, analysts, clinicians) but also, when possible, from the
software vendors. There are a number of ways in which information can be ex-
tracted from a single source. Perhaps the most common way to query a database
for information is by writing and running Structured Query Language (SQL)
queries. This may be considered a back-end approach where significant creden-
tials are needed, and, in some systems, a query builder GUI may be available and
embedded in the system itself. It may also be worth investigating whether OLAP
tools exist for the particular data source as this can act as a more complex query
builder, perhaps allowing data from more than just one source to be retrieved.
Ultimately, the approaches depend on the access level to a system. In some cases,
and indeed in the case study presented in this paper, software programs needed to
be developed [73] to extract information from the PACS (further details in Table
2.6). Any software developed to work at a hospital site may need approval by
the information technology department, and the process can be time consuming.
Table 2.6 illustrates the extraction methods chosen for each data source in the
case study: an OLAP tool for PAS and LAB, a back-end SQL query run by the
domain expert for the ONC system, and the software developed during the case
study to extract data from PACS. As part of the extraction preparation step,
sample datasets were also retrieved in order to validate the extraction methods.
This was particularly useful to validate the extraction method with the OLAP
tool in the case study.
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Data Source Extraction method used in the case study
PAS OLAP software tool available was used to retrieve the data
elements in this source. Training and liaison with experts
was needed in order to build queries.
PACS Because of access restrictions, a software program was de-
veloped to copy textual imaging reports from a PACS GUI
to a canonical, spreadsheet format (special attention is re-
quired to ensure data formats are not lost in this process).
The program needs to be assisted by a user, and hence, it
is a time consuming method of retrieving data. Later in the
project the Radiology System (RIS) was able to pull partial
results from PACS and hence this was the preferred method.
ONC The domain expert agreed to run a back-end SQL query to
search for the cohort.
LAB The same OLAP software as above was used but using a
different schema to access a different data source and this
required different access credentials.
Table 2.6: Extraction methods for each data source identified in the case study.
2.3.4 Extraction and Evaluation
2.3.4.1 Cross-Validation
Using the method selected in step 2.3.3, a sample dataset is extracted and cross-
validated this means that the sample data (or a random part of it) is manually
compared to the system data using its interface. This clerical review process
ensures that the data coming from the system is indeed as expected. It may also
be possible to select a smaller cohort and compare it with patient notes or with
independent reference sources (e.g. registries) in which the whole or part of the
target population is registered [56]. This can be investigated further in the data
quality step but, in the current step, the major concern is to ensure the data
retrieval method is extracting the desired data. Query optimisation methods in
relational databases [80] may also be useful to increase the performance of certain
lengthy operations, especially when working with OLAP systems, but they are
hard to implement and may require further expert consultation.
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From the case study, it was evident that the retrieval methods often produced
an output in the form of comma or tab separated value, and that this may be
a source of error. When working with textual data fields, the comma separated
value creates a source of erroneous vertical field separation because several text
reports include commas as part of their natural language. In some cases, tab
separation was appropriate, but in others, rare symbols were used to effectively
separate the data fields (e.g. the dollar symbol was found to be a rare symbol in
text reports in the case study).
2.3.4.2 Extract Finalised Dataset and Data Quality
Upon a satisfactory cross-validation, the final dataset is extracted using the
method selected in 2.3.3. However, the dataset should still be carefully exam-
ined for missing or erroneous values, and simple statistical measures produced
to provide a basic understanding of the nature of the fields and the data [64].
Indeed, such statistics may suggest that data cleansing is necessary [64] and this
is often covered in the next steps of DMKD methodologies (data cleansing and
preprocessing). Nevertheless, it seemed important to include a brief step for
quality assurance checking at the end of the methodology presented in this pa-
per, also because this may contribute to the completeness of a metadatabase. It
is important that the domain experts provide help in this process.
One of the concerns of researchers and epidemiologists working with secondary
data is its completeness. Indeed, inaccurate or missing data tend to bias as-
sociations towards the null hypothesis [56]. The most relevant data cleansing
operations in the course of the case study presented in this chapter were:
• Outlier handling
Many outliers may be classified as either errors or groups of interest [64]
and, at this stage, only erroneous outliers are dealt with as the first should
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be addressed by the research study analyses. Expert knowledge may be
necessary to determine outliers and the corrective action to apply to each
form of outlier [64]. Outliers in numerical data fields may be typically found
by plotting the distribution of the field values, or by sorting the dataset.
• Missing data handling
The missing values may be removed, estimated, or simply marked as miss-
ing. Estimation or imputation, however, may need to be performed in a
separate (training) dataset so that the impact can be assessed before the
data is changed. A simple approach [64] is to replace missing numerical val-
ues in a field with the mean over all known examples. It may also be possible
to apply rough set theory to reduce the amounts of missing data [81], and
more complex, and potentially dangerous approaches, may involve training
a neural network to predict missing values using the remaining fields [80].
The next chapter will further discuss the use of data editing and imputation
techniques.
When possible, a quantification of the amount of missing and erroneous data
in a dataset is important metadata and should be added to the metadatabase.
Further methods to evaluate other data quality dimensions is given later in this
thesis.
The case study on prostate cancer showed the collected data is of acceptable
quality when it comes to missing values (focal data elements had less than 5%
missing data), especially on the administrative systems and other systems that
are often inspected by the quality team, and from which their data is used for
general planning and performance, or part of national data requirements. The
case study showed that, for example, the amount of missing data and outliers
from two highly ranked fields from the LAB source, hospital number and test
data, are 3.22% and 1.66%, respectively, on a total number of records exceeding
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320 thousand. It is common, however, to find greater amounts of erroneous and
missing data in legacy systems collected by clinicians [5]. It is also common to
find non-focal data elements missing, which will not necessarily impact linkage,
but may influence the study results.
Further statistics and detail on the quality of the collected data are given in the
next chapter and throughout this thesis.
2.4 From Data Pool to Integrated Repository
One of the two outputs of the process described in Figure 2.3 is a metadata ta-
ble, for each data source. A metadatabase, based on the information collected,
is a useful resource to help data integration from multiple heterogeneous sources.
This is particularly helpful in building a database schema for the repository based
on the collected metadata. An example of such metadatabase from the case study
is depicted in Figure 2.4, below. In order to build a data repository or research
study database, each dataset should be imported into a password-protected op-
erational data store (ODS). The ODS schema for the case study was built to
resemble the organisation of the hospital information systems, where most tables
represent a source (HIS) and were built using the collected metadata. Exceptions
to this were very large datasets representing sets of biochemistry tests. In these
cases a table per test was the preferred choice to maximise database query per-
formance. Database normalisation rules were helpful in the design of the ODS,
which is a database that employs the relational model. Despite re-formatting
data elements where the extraction method corrupted the data type, no other
data transformations were carried out to build the ODS. This was to facilitate
further data to be added to the ODS in a longitudinal fashion as well as mapping
the host environment. The ODS created for the purpose of the case study will
therefore contain missing values, outliers or any other erroneous data as they
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appear in their original data sources. The main purpose of an ODS is to act as a
data pool from which researchers can query for their study needs. Indeed when
following a knowledge discovery process such as the 6-step DMKD, an ODS can
be used as the main study database or one from which to derive cohorts from. It
is also expected that most of data understanding already occurred as part of the
process presented in this chapter. Nevertheless when a particular study dataset
is retrieved from the ODS, it still needs to go through a data preparation step as
described by knowledge discovery or data analysis methodologies [5; 6; 64]. One
of the challenges in retrieving datasets from the ODS is the matching or linkage
of records. It is often assumed that deterministic matching (i.e. overlapping of
focal data elements) is the most effective technique used on datasets from within
an organisation such as a hospital, mainly due to the use of a patient hospital
number throughout sources. In contrast, probabilistic matching, which weighs a
number of identifiers to ensure pairs of records are from the same individual, is
often used to compare records between organisations, where no common identifier
necessarily exists between them. Examples from the case study in prostate can-
cer reveal that there may be erroneous matches due to double entry of a patient
or due to other, clerical, inaccuracies, when only simple deterministic methods
are used. Record linkage was therefore performed using rules based deterministic
linkage of patient hospital number together with date of birth and episode date
(these are the top three ranked data fields for linkage). A metadatabase allows a
careful and informed choice for linkage, and should also include matching weights,
when computed. It may also be required, at this stage, or earlier, for some of
the data to be deidentified or encrypted. During the case study patient sensitive
information such as names and addresses was never collected. When exporting
datasets from the ODS, the database internal identifier was used to replace pa-
tient number. In order to carry out appropriate clerical review and other spot
checking of preliminarily linked data, a data visualisation tool for the ODS was
developed. The latter is helpful to provide a patient-centric view of the records
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collected; evidence on how well the records were being merged; an assessment of
the correctness of the queries developed; and for communication purposes with
the domain experts.
There are also automatic approaches to database schema matching that can be
useful for heterogeneous data integration [82]. Schema matching is possible using
the metadata collected for each system available in the metadatabase but was
not used during the case study.
The integrated repository can be seen as a data warehouse and indeed some of
the work carried out to develop the repository is similar to that of data ware-
housing techniques (such as the ETL process). Nevertheless we will explore data
warehousing as well as data linkage techniques in more detail in the next chapter,
as the present chapter is primarily concerned with multi-source retrieval.
Figure 2.4: Simplified schema for a metadatabase containing multiple sources and
their respective data fields. Sources table contains the list of sources retrieved
together with their metadata, and the data fields table contains the attributes
collected for each data source, with respective metadata.
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2.5 Validating the Methodology: Stroke Study
The methodology presented in section 2.3 was later tested and evaluated using a
second case study on stroke. The steps taken to collect the required stroke data
and create a study data set are given in section 2.5.2 along with a summary of
the key findings.
This exercise is a validation of the methodology, and resulted in the development
of the Norwich Research Stroke Register at the Norfolk and Norwich University
Hospital (NNUH). Further details of the techniques used to cleanse, link and
integrate this data are given in the next chapter.
2.5.1 Background and Setting
Summary
The local stroke centre at the NNUH admits approximately 900 stroke patients
per year. For every admission, specialist stroke nurses or doctors complete
a stroke register form, which is then manually entered on the stroke register
database by the stroke data team. The stroke database was developed and im-
proved over time by the local stroke team. It stores data elements that are
required at a national level for audits, planning and performance, as well as
particular research studies. This database, partially due to its high volume of
patients, has recently been gaining attention from clinical researchers who are
keen on using it retrospectively.
History and Further Details
The Norfolk & Norwich Stroke Register, initially set up in 1996, has been de-
scribed as routine collection of stroke services data [83]. It includes patients
admitted to the hospital with a diagnosis or suspected stroke made known to the
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stroke team. The clinical data in the register is routinely collected as a part of
the local service development which enables health professionals and managers
to evaluate services and conduct audits [83].
The register was initially set up as part of the European Basic Stroke Register
and has been maintained by the stroke services team at the Norfolk and Norwich
University Hospital.
The stroke services team includes data collectors who manually enter the data
from paper based forms onto the register as a part of a routine service level
agreement. This data is then be used to produce statistics for management and
it is also used for research [83].
The collected data elements changed over time as per service monitoring require-
ments and Appendix A shows the initial and currently collected attributes.
Stroke cases admitted to hospital are prospectively identified, however, the data
may be collected both prospectively as well as retrospectively.
All clinical team members contribute to data collection. Data that can be ob-
tained from paper and electronic records is reviewed by the data team and double
checked with clinical team members for accuracy [83]. Data is collected until the
patient is discharged from the acute hospital or dies as in-patient. No data after
discharge is currently collected.
Figure 2.5 shows the pathway for the management of acute stroke in adults. This
pathway has been adapted from the original [84] , published by the stroke clinical
team at the NNUH and it used here for the purpose of understanding the patient
flow and hence, the data. The points of entry of patient data into information
systems are marked with greyed circles. A complete and up-to-date pathway
describing the management of acute stroke is available in [84].
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FAST - Test for Diagnosis of Stroke 
Positive or sudden onset:  
Dysphasia*, Hemianopia*, Loss of power or 
sensation – face, arm or leg 
 
More than one of:  
Dysarthria*, Vertigo, Diplopia*, Ataxia* 
Ambulance pre-alerts 
Stroke Alert Nurse (SAN), 
SAN contacts Stroke SpR 
Inpatient (including AMU) 
with suspected stroke 
Stroke Alert Nurse (SAN) 
commences assessment 
 
ROSIER* Assessment 
No 
Consider admission to 
Acute Medical Unit 
(AMU) 
Yes 
Ambulance – dial 999 
Contact Stroke 
Alert Nurse (SAN) 
extn 6588 
Direct self referral to 
A&E with stroke 
(A&E triage nurse) 
A&E arrival 
Non Stroke 
Negative Positive 
Thrombolysis candidate Non-thrombolysis candidate 
SAN: Is an urgent CT 
head indicated? (if so 
follow CT head 
pathway) 
Referral for urgent 
CT head (then 
follows CT head 
pathway) 
A&E assessment 
Can patient be clerked 
in < 4 hours? Is Acute 
Stroke Unit bed free? 
CT head  
(then follows CT 
head pathway) 
 
No 
Standard A&E rapid 
assessment, Rapid 
Stroke Assessment 
Proforma commenced 
if possible 
Patient transferred to 
AMU, clerked in AMU 
using Rapid Stroke 
Assessment Proforma 
(SAN to escort patient) 
Rapid Stroke Assessment Proforma 
 
Yes 
SAN to contact 0002 
to add to triage list 
Rapid Stroke Assessment Proforma 
Doctor to 
contact on call 
Stroke 
Consultant 
CT head result 
No evidence of: Haemorrhage 
Extensive infarction (> 1/3 MCA 
territory), Tumour or other 
Discuss with Stroke 
Consultant on call 
Give Thrombolysis in 
A&E, monitor in A&E as 
per protocol until 
infusion complete 
 
Transfer to Acute Stroke Unit 
 
Transfer to Acute Stroke Unit 
 
AE 
AE 
PAS 
RIS 
RIS 
PAS 
PAS 
PAS 
RIS 
SR 
SR 
ICE 
ICE 
ICE 
GP or Specialist Registrar 
(SpR) sees suspected stroke 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glossary 
Dysphasia – partial or complete impairment of speech. 
Hemianopia - decreased vision or blindness takes place in half the visual field. 
Dysarthria – abnormal or difficult articulating caused by problems with the muscles used in speech. 
Diplopia – commonly referred to as double vision. 
Ataxia – lack of voluntary coordination of muscle movements. 
ROSIER – Recognition of stroke in the emergency room test used to establish the diagnosis of stroke 
Thrombolysis – the breakdown of blood clots by pharmacological means. 
Figure 2.5: Annotated stroke management pathway. Shaded circles reveal the
information systems (details in Appendix A) where information pertaining to the
activity is stored.
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Objectives
Despite the retrospective and prospective nature of the collected data, issues
have been reported regarding the inconsistency with which some of the data
elements are recorded over time, as well as the lack of other information such
as haematology or biochemistry readings. An added technical challenge is the
existence of two distinct databases with different schemata, one which contains
legacy data and a second operational database, which is currently in use. In this
case it is important that each database is seen as a separate data source.
The purpose of this exercise is to collect data for the development of the Research
Stroke Register, a data warehouse comprising information on stroke patients from
multiple hospital sources. Details of the development of the data warehouse are
given in the next chapter.
2.5.2 Application of the Methodology
• Identifying Data Sources
Four main data sources were identified for this case study: the new stroke
register (NSR) and the old stroke register (OSR) which together identify
the complete cohort of patients (these already contain some information
from other systems such as radiology, emergency department, and PAS);
the biochemistry system (LAB) where blood tests are stored; the patient
administration system (PAS) where comorbidities and follow-up informa-
tion is present, and a national tracing system (NSTS) where it is possible
to accurately retrieve patient demographic information on a national level,
such as dates of death. Each of these systems were put through the process
depicted in figure 2.3 and a combined summary of each major step is given
below.
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In addition to the above-mentioned systems and as noted in figure 2.5,
other systems that are involved in the stroke pathway are the Accident
and Emergency System (AE) and the Radiology Information System (RIS
which for simplicity, it encompasses the Picture Archiving Communication
System (PACS)). However, information from those systems is written onto
the paper-based stroke register form, which is in turn entered onto the OS-
R/NSR. Information in the AE and RIS systems is then inspected to ensure
the OSR/NSR database contain accurate information. For this reason, and
also because of the nature of the research database to be developed, AE
and RIS were not explored in detail in this case study.
One of the initial requirements set in the methodology is that the first data
sources to be put through the process are those that can allow us to select
the cohort of interest. In the stroke study, the cohort of interest comprises
all records of stroke events in the OSR and NSR databases.
Biochemistry test results from the LAB source need to be carefully selected
to match the respective stroke events. A selected number of blood tests
was defined by the domain experts. Conversely, the data required from the
PAS source was mainly demographics (such as date of birth, death, and
ethnicity) and the electronic discharge letters (ICD coding).
The steps taken to extract data from the sources is summarised below.
• System Understanding
The stroke registers (OSR and NSR) were by far the most challenging sys-
tems to understand due to the sheer volume of records and data attributes
as well as the lack of a data dictionary and consistent formatting and syn-
tax. The two distinct databases, OSR and NSR, are treated separately here
as they need to go through a process of schema matching that can only be
achieved if the sources and their data are understood (semantically and
syntactically).
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A series of consultations were carried out with the stroke data team in order
to preview the system as well as gather necessary credentials to access the
database. As a result, an honorary contract was needed in order to carry
out the work.
The OSR and NSR are password-protected Microsoft Access databases.
The PAS and LAB systems had already been previewed in the prostate
cancer study yet credentials still had to account for access to these systems.
The PAS system contains demographic information and coding, whereas
the LAB system includes information on biochemistry tests carried out.
• Data Understanding
Regarding the understanding of the data, the most time consuming sources
were again the OSR and NSR mainly due to the lack of a data dictionary.
Indeed, the paper based forms used to record patient-specific stroke data in
the NSR and OSR databases was, together with consultation, most useful
for the development of a data dictionary.
The OSR and NSR databases needed to be merged later, and for that reason
it was important at this stage to identify common attributes between them
and gather enough metadata to produce a data dictionary.
Challenges were identified in attributes’ values including patient identifier
fields. Data preprocessing was needed, for example, to split the identifier
field which contained both the patient surname, initials and the hospital
number, inconsistently recorded throughout the records. Furthermore, sev-
eral fields’ values changed overtime from a numeric coding into a descriptive
text (e.g. discharge destination used to be coded as 1 when patients were
discharged home, and this changed to ’home’). Regarding the data collec-
tion methodology, the initial concern is with the fields that allow for the
linkage and retrieval to other sources.
Once the identifier fields were formatted in the OSR and NSR, the other
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Metadata - Understanding the System Examples from the stroke study
Appropriateness and authoritativeness of system All identified systems are authoritative and con-
tain crucial information on stroke events.
Data flow chart Data flows from PAS to LAB (so that records
and hospital numbers are linked), but there is
no systematic flow of information between OS-
R/NSR and any other systems. The stroke data
team does, however, validate some of the data
by manually querying PAS, the emergency sys-
tem, or LAB.
Data extraction method (if known) PAS - Business Intelligence software; LAB -
Business Intelligence software and developed
software; OSR - Back-end database query; NSR
- Back-end database query; NSTS - Information
Services Report.
Preview and system training Previewed all systems, training only required for
NSR an OSR.
System credentials Read-only access to all systems.
Key data elements present (if known) Hospital number, NHS number, Date of Birth
and Date of Event present on all systems.
System Updates (impact) The OSR is no longer updated however, the NSR
is currently updated and records from previous
months may be updated retrospectively.
System Limitations The LAB system was introduced in 2003 and
there is no electronically available data prior to
this date.
System Live Date OSR - 1996 to 2008; NSR - 2009 to present;
LAB - 2003 to present; PAS - 1990 (and earlier)
to present.
Last System Update Date This information was available but changed
throughout the application of the methodology.
Table 2.7: Summary of items gathered when understanding the system (stroke
study).
sources (LAB, PAS) were then investigated. Both sources had been previ-
ously investigated in the prostate study, however, in the case of the LAB
source, additional investigation was necessary to determine the appropri-
ate biochemistry coding for each of the selected blood tests. Apart from
semantic differences, the data types and formatting remained the same as
in the prostate study.
The NSTS system was used in one occasion although it can only be accessed
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by analysts in the Information Services Department at the hospital. The
requirement for the retrieval of data from the national tracing service is
a spreadsheet containing patients’ NHS number and Date of Birth. The
advantage of using the NSTS service is that it is thought to be most reliable
for obtaining dates of death or current postal address, although causes
of death are not stored here. Indeed, causes of death may be stored in
electronic discharge letters (PAS/LAB) when patients die in hospital but
otherwise they are not recorded in the HIS. Nevertheless it is expected that
the PAS system is updated with patient details including dates of death
and as such, it is a valuable source of information, particularly for those
that die in hospital. A data linkage exercise carried out in the next chapter
will study the quality of this data in more detail.
• Extraction Preparation
The first data sources from where the cohort is extracted are the OSR and
NSR. Because they are Microsoft Access databases, a simple query was
designed, taking into account the issues identified in the previous step. The
constraints used to query these sources were based on the attributes that
allow linkage (identifiers).
Subsequently, queries were built using an OLAP software to extract infor-
mation from PAS on patients’ episodes. This was done by deterministic
linkage using the internal identifiers.
The sheer size and number of queries to be run on the LAB source (21 blood
tests for each patient in OSR/NSR), warranted an exploration of retrieval
methods that cope with such volume of data. The information needed for
every stroke episode was a summary for each blood test. The summary
includes the blood readings closest to admission and discharge as well as
a summary of the readings during the stay (maximum, minimum, average,
standard deviation and total number of readings).
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Queries were built using an OLAP software, a first approach used patient
identifiers to extract all information on bloods for a particular time frame.
This method was extremely time consuming not only due to the retrieval
process, but also the fact that OLAP queries are limited in the number of
clauses, meaning that several batches of identifiers needed to be run. A sec-
ond method, need not split into batches yet it generated very large datasets
for each blood test which then needed to be imported into a separate work-
ing database and queried using suboptimal software for large databases.
A third approach was to develop a script that runs a query for each stroke
episode and automatically computes the required variables. This was the
chosen approach due to a considerable improvement in querying time as
well as reduced preprocessing. This is discussed again in more detail in the
next chapter.
Table 2.8 gives a summary of the selected extraction methods for the stroke
study.
Data Source Extraction method used in the stroke study
OSR/NSR Database query with constraints on identifiers.
PAS OLAP software tool to retrieve patient episodes’ records, in
batches of 300 patients per query.
LAB Sets of queries were developed to compute and retrieve bio-
chemistry tests.
NSTS Report run by Information Services analysts.
Table 2.8: Extraction methods for each data source identified in the stroke study.
• Extraction & Evaluation
This step is crucial in assessing the quality of the retrieved data. Regarding
the LAB source, simple queries were first built for individual patients using
the OLAP software. Such queries allowed the manual inspection of the
blood readings over time and the identification of potential sources of error.
In the course of this inspection, some biochemistry codes changed over time
which meant their readings were not consistent throughout. This prompted
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further consultations with the pathology department in order to establish
the correct codes using their coding table. Throughout this project and
particularly during the stroke study, an OLAP query was developed to
inspect the coding table, which includes the codes for all biochemistry and
pathological tests carried out at the hospital. This was an invaluable source
of information that should be made available.
In the OSR/NSR databases, used to produce the cohort of stroke patients,
a small number of patient identifiers was erroneous and so, the extraction
methods had to be re-run based on other identifiers such as NHS number
and date of birth. This was a straightforward task but one which added
further time in retrieval of data.
Because of the previous exercise on prostate cancer, the assessment of the
quality of the other retrieval methods, such as the ones used with PAS, was
greatly facilitated and no further issues were identified.
An analysis of the quality of the data is given later as here the concern is
with the retrieval methods.
Using the data collection methodology a stroke ODS was created containing the
data from the above-mentioned sources. The development of the research stroke
register database is explained in detail in the next chapter along with summary
statistics.
2.6 Conclusions
The collection of patient-centric data from secondary centres, such as the one
described here, is a non-trivial task, and one which has received relatively lit-
tle attention. No methodologies have been developed or tested for this purpose.
In particular, data mining and knowledge discovery methodologies overlook the
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process of multi-source data collection. Existing methodologies for data analysis,
knowledge discovery, and data integration were reviewed and provided the frame-
work to the patient-centric data collection exercise presented in this paper. The
exercise was based on a case study on prostate cancer, validated using the stroke
study, and presents the lengthy journey of retrieving and collating patient-centric
multi-source data for research or other secondary uses. It is hoped that, by ex-
posing the complexity of data retrieval in hospitals, this experience contributes to
researchers and future data analysis studies, and that analysts are able to ensure
the context of their data is fully understood.
The contextualisation of the retrieved data is critical in health and is important
to understand the ways in which the hospital operates (including how data from
inpatients and outpatients are recorded and coded, as well as other events that
may not be classed as the first two, such as day cases in the NHS).
The work presented in this chapter has also identified that the collection of meta-
data and creation of a metadatabase in parallel with the study data pool are
crucial to its understanding, linkage, and validation.
Furthermore, the practical obstacles of working in a heterogeneous multi-source
environment, where data access is limited, are addressed and the key informa-
tional requirements for a successful data collection task in hospitals introduced.
It has been identified that it is possible to obtain reliable research data from a
secondary care centre. It is my belief that research studies should be encouraged
to use such data, provided that hospitals and the NHS facilitate the process of
retrieval, using a standardised process. It is expected that such process, when
followed, will guide and reduce the time spent by researchers and hospital staff
on data collection and related bureaucracy, whilst at the same time improving
the validity of study data collected from hospitals. It should also be reassuring
that de-identified patient data can be used for public good, and that, by creating
a greater demand for data, their quality and accuracy are improved in hospitals.
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Because each data source is invariably linked to a HIS, the work carried out in
this chapter has also confirmed that the current HIS implemented in this partic-
ular secondary care centre, provide little help to extract or work with cohorts of
patients. Indeed, most HIS are developed to work on a single-patient basis. This
was particularly true with the PACS and LAB where an additional software had
to be developed to extract the data.
2.6.1 Chronology of systems
Often overlooked, a full picture of the history of the implementation of hospital
information systems is key to understanding hospital data as well as identifica-
tion of potential issues arising from an ever changing environment. Figure 2.6
depicts the implementation of hospital systems over time and was compiled with
information obtained during the case study in prostate cancer. However, since
the time of writing, another PACS system was introduced, as was another version
of the Somerset Cancer Registry (CRE) and the LAB systems.
Figure 2.6 illustrates the complex nature of information in hospitals from the
point of view of systems’ implementation. This shows critical changes to the way
data is recorded and its availability over time and poses significant difficulties to
the study of chronic diseases or longitudinal analyses using routinely collected
data.
The case study on stroke was facilitated by the fact that the only sources prone
to major changes were the stroke services databases. This, although increasing
the complexity of schema matching, allowed for the core features of the target
group to be locally available and for the staff to be aware of its changes. Indeed
a major obstacle detected in the prostate study was the overlapping of systems
and hospital departments, where neither information is consistently inspected nor
staff were fully aware of its existence. Some of this has changed with the extension
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Figure 2.6: A chronology of hospital information systems relevant to prostate
cancer.
of the national cancer waiting times data requirements and the introduction of
adequate staffing, such as patient pathway coordinators, that oversee the data
that is required nationally.
The stroke study was also facilitated by the acute and episodic nature of the
disease, where the average patient length of stay is substantially shorter than for
a cancer patient.
2.6.2 Further work
Recent work [85] carried out at the National Centre for Infection Prevention
and Management, Imperial College, London, saw the development of a research
database to facilitate hospital epidemiology and hospital syndromic surveillance.
This work is similar in nature to the one carried out in this chapter. The authors
reported issues and obstacles similar to those presented here and their work fur-
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ther demonstrated the value of a data repository, data linkage and the importance
of “more sophisticated uses of existing NHS data, and innovative collaborative
approaches to support clinical care, quality improvement, surveillance, emergency
planning and research”[85].
Likewise, it was identified that future work is needed to improve collaborative
approaches between hospital departments, systems’ owners and software vendors
to enable the secondary uses of routinely collected hospital data. Given that tech-
nical solutions to data integration, storage and retrieval are possible, the major
challenge will continue to be the top-level organisation of systems and their data
models or ontologies. A sustainable, consistent and replicable approach for the
implementation and organisation of health information systems across hospitals
would greatly benefit their local management, particularly in a National Health
Service environment. At present, the implementation of localised and isolated
systems, each s a particular task or problem, will continue to add obstacles to
the secondary uses of hospital data.
Given such a setting, it would be interesting to carry out further work on auto-
mated or pseuso-automated methods for ranking relevance of databases and data
elements based on the collected metadata and informational needs. A pseudo
search engine using such rankings, together with a retrieval system or OLAP soft-
ware, would make useful the identification and selection of feasible, high quality
data for research or other secondary uses.
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Chapter 3
Preprocessing, Linkage and Data
Warehousing
This chapter is divided into two main sections, the first on the prostate cancer
study and the second on the stroke study. Throughout the two sections, selected
methods and techniques are introduced and describe in detail the most relevant
challenges in data preparation, linkage, integration and quality of routine hospital
data. The section on prostate cancer addresses two problems: mining information
from histopathology text reports (section 3.2.1); and data preparation and con-
tinuous value estimation (the age problem, section 3.2.2). The section on stroke
addresses record linkage methods (section 3.3.1), and data warehousing and in-
tegration (section 3.3.2). The techniques presented here have all been developed
in the course of this research.
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3.1 Introduction
Data preprocessing can be broadly defined as a set of actions taken before a
data analysis process starts [86]. Data preparation, data cleansing and data
preprocessing can be considered analogous terms [67], although cleansing is of-
ten regarded as a preprocessing task. In the previous chapter, data mining and
knowledge discovery methodologies were reviewed and preprocessing was identi-
fied as a key step leading to analyses. The methodology for data collection and
development of a semi-integrated repository already introduced some degree of
data preparation, particularly with respect to key identifiers. However, the main
concern was the retrieval of patient-centric information and the development of
a storage infrastructure that replicated the original hospital environment. This
allowed some obstacles to be overcome (for example, integration), whilst keeping
the data in its original form, to be further inspected and studied. This chapter is
concerned with the inspection of the routinely collected hospital data available in
the repository and the development and application of preprocessing techniques.
The latter are motivated by the need to [86]:
• solve data problems that may prevent analyses on the data;
• understand the nature of the data and perform more meaningful data anal-
yses as a result;
• extract more meaningful knowledge from a given set of data.
Data preprocessing has also been formally defined in [86] as an operation that
transforms raw real-world data vectors into a set of new, useful vectors where
valuable information is preserved and issues with data are eliminated.
Depending on their purpose, preprocessing techniques may not always yield the
results desired. It has been reported that data carefully prepared for warehousing
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proved unsuitable for modelling whereas data that has been prepared specifically
for modelling produces significant improvements in model accuracy [87]. It has
also been reported that some preprocessing techniques may provide little im-
provement in the overall results of analyses, particularly when these represent
summaries [88].
In the field of data mining and machine learning, data preprocessing has been
identified as a key task in determining the outcome of knowledge discovery al-
gorithms [5; 20; 86; 87; 89]. Erroneous, extraneous or inadequate data leads to
less accurate or less understandable results, failure to discover any trends in the
data, or poor generalisability of the developed models [86; 89]. Missing data,
in particular, is a well established barrier to successful data mining and knowl-
edge discovery [5]. As a result, preprocessing has received some attention from
the computing sciences but still remains an ad hoc process and one often aimed
predominantly at increasing the value and generalisability of data mining models.
However, in medical research, epidemiology and, to a degree, statistics, descrip-
tions of preprocessing methods are lacking [7; 63; 86]. Regardless of robust study
designs or reliable data collection methods, studies still have to deal with errors
from various sources and their effects on the results [7]. The data preparation
and cleaning process, as a whole, with its “conceptual, organizational, logisti-
cal, managerial, and statistical-epidemiological aspects”, has not been described
or studied comprehensively [7]. In the peer-reviewed literature, particularly in
medicine and epidemiology, it is rare to find any statements about data-cleaning
methods and respective error rates [7; 63], yet medical data is often described
as most complex, voluminous and heterogeneous to analyse [20]. Study design,
protocol compliance, and the integrity and experience of the investigators often
receive more attention than any preprocessing methods used [7].
In addition, most medical statistics and epidemiology textbooks have scattered
information on data preparation and cleansing techniques, and do not analyse
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them in detail. As such, there are significant gaps in knowledge on data-handling
methodologies and standards of data quality [7; 63; 90]. Furthermore, there is
also a lack of standardised methods for assessing data quality in electronic health
records and systems [18; 91] which further hinders the use of routinely collected
data.
Figure 3.1: Data Cleansing Framework (from [7]).
A framework for the process of data cleaning has been proposed for medical
research and it is depicted in figure 3.1. The framework consists of a three-stage
process with repeated cycles of screening, diagnosing, and editing of suspected
data abnormalities [7]. The screening phase aims at detecting missing or extreme
values, often by inspecting overall summary statistics of the datasets. In the
diagnostic phase, the purpose is to clarify the nature of the identified errors, for
example, by perfoming integrity checks. Lastly, the editing, or treatment phase,
is concerned with the implementation of a method to deal with erroneous data
(either by deleting, correcting or leaving them unchanged). This framework helps
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to illustrates how some preprocessing tasks (i.e. data cleansing) are carried out
as part of a study. In the future, this framework could be generalised to include
other preprocessing tasks, whilst keeping the three key phases.
In this thesis, preprocessing is defined as an activity encompassing all the neces-
sary steps to obtain a dataset or data field for analysis. Examples of preprocessing
tasks include general data cleansing, formatting, imputation and value estima-
tion, information/data extraction or mining, and record linkage. The latter is
often seen as a retrieval technique, however, when it is used for the purpose of
compiling a more complete dataset or for validation, it can be seen as a prepro-
cessing task. This chapter addresses the most significant preprocessing issues and
techniques developed in the course of this research and explores how they impact
the quality of the data. Further preprocessing, however, was still required in the
analyses carried out in other chapters and it is summarised when appropriate.
Four key preprocessing techniques from the case studies on prostate cancer and
stroke are introduced in the following sections. They are:
• a technique for extracting information from text reports (section 3.2.1),
• an algorithm for the estimation and imputation of continuous ordinal data
(section 3.2.2),
• a set of deterministic record linkage rules (section 3.3.1), and
• a proactive approach for data warehousing and integration (section 3.3.2).
Throughout this chapter, m is used to identify the percentage of missing records
or values (so when no data is available m = 100%).
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3.2 Prostate Cancer Study
3.2.1 Mining Histopathology Reports
It is well established in the literature that one of the major challenges in working
with medical data are unstructured text reports [20; 92; 93] and that the discovery
and extraction of new knowledge from unstructured text data is the primary goal
of text mining techniques [93; 94].
The term text mining is often used loosely to describe automatic or semi-automatic
techniques that use or analyse text and natural language. There are, however,
significant differences between disciplines and techniques for the understanding,
extraction or classification of unstructured text documents and these will be ex-
plored in detail in the next section.
Free-text histopathology reports, confirming diagnoses of prostate cancers, were
collected electronically as part of the prostate cancer study. In their original state
they are not usable for analyses because the narrative text, in its natural language,
can not be easily interpreted by computers. It is therefore crucial to mine such
text reports and extract useful information in a canonical form. This section
introduces a technique developed to mine and extract useful information from
the histopathology reports. The definition of useful information in the context of
the prostate cancer case study is given later in section 3.2.1.2.
The following section (3.2.1.1) provides key background on the disciplines of text
mining, information retrieval and natural language processing, which are relevant
to contextualise the developed technique.
Section 3.2.1.2 introduces the histopathology of prostate cancer, and it is followed
by a section on data familiarisation, and another on defining goals and useful
information.
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The algorithm design, testing and results are presented in section 3.2.1.5 followed
by a discussion and evaluation of the developed technique.
3.2.1.1 Background on Natural Language Processing
There are arguably three major areas in computing research competing, in dif-
ferent ways, to gain understanding of unstructured texts: information retrieval,
natural language processing and text data mining.
Classical information retrieval deals with the search for particular documents
based on a predefined set of terms [95]. Examples of classical information retrieval
techniques are those employed by internet search engines using algorithms such
as PageRank [96] or HITS [97]. Such techniques inspect the frequency of the
terms in documents and compare them against another set of terms (such as a
user query), yielding a similarity value between the two. This value can then be
used to rank documents against a particular query. Nevertheless, studies using
such techniques in health informatics and medicine often mislabel their work as
a data mining exercise [98] when it should be information retrieval.
Text data mining, however, is concerned with the classification or clustering of
documents. An example of a text mining technique is the development of a
multilayer neural network trained to classify medical documents in the area of
cell biology [99]. Having achieved a satisfactory accuracy, the neural network
developed in [99] was later used to automatically filter and classify documents
to selected domains of cell physiology. Another example is the classification of
lung cancer tumour stages from free-text reports [100]. The authors of this study
used a support vector machine, trained for each stage category, and based on
word occurrences from a corpus of histology reports. They reported an average
stage classification accuracy between 69% and 75%, illustrating the difficulty of
developing high accuracy text mining algorithms.
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Natural language processing (NLP) is an overarching discipline concerning both
text mining and information retrieval in that it acts as a means of turning text
into data for analysis. It has also been reported that NLP research focuses on
building computational models for understanding natural language [101]. NLP
techniques vary from trivial syntactic analysis to complex semantic representation
and interpretation systems using propositional logic or first order predicate logic
[102]. Modelling context, however, has been described as the most difficult and
least well understood aspect of NLP [102]. An example of a comprehensive NLP
system is one that incorporates existing techniques such as the MMTx (MetaMap
Transfer), a tool for mapping clinical text concepts to a standardized vocabulary,
and NegX, a negation detection algorithm, to automatically extract and identify
medical problems from a predefined list conditions [103].In fact, the negation
detection algorithm can be seen as a NLP technique in its own right, and it is
one that works primarily on syntax using regular expressions.
Having a general pattern notation, regular expressions allow the efficient descrip-
tion and parsing of text [104]. They have been used effectively, for example, in
the identification and extraction of instances of documented blood pressure val-
ues and anti-hypertensive treatment from clinical reports [105]. In this example,
regular expressions can be seen as a NLP technique for the purpose of information
extraction (IE). In turn, IE has been described a specialised sub-domain of NLP
concerned with the extraction of predefined types of information from text [101].
A review of the state of the art of information extraction from clinical texts high-
lighted five major characteristics of such texts, which are also seen as challenges
[101]:
• Clinical texts are ungrammatical and composed of short, telegraphic phrases.
• Clinical narratives are repleted with shorthand (abbreviations, acronyms,
and local dialectal shorthand phrases). It has been estimated that acronyms
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are overloaded about 33% of the time and are often highly ambiguous even
in context [106].
• Misspellings are common in clinical texts, particularly in notes without
rich-text or spelling support.
• Clinical narratives can contain any characters that can be typed or pasted
such as pasted sets of laboratory values or vital signs.
• Attempts to bring structure and consistency to otherwise unstructured clin-
ical narratives, templates and pseudotables are common (for example,, plain
text made to look tabular by the use of white space).
The same review pointed out the difficulty in evaluating NLP systems and the
need for clinical texts to be annotated in order to help increase the effectiveness
of IE or NLP techniques. Furthermore, the issue of portability of available tech-
niques has also been identified. Most algorithms are domain-specific and hence
not replicable with the same accuracy elsewhere.
The work carried out here pertains to the extraction of key information from
prostate cancer histopathology reports. The techniques presented in the next
sections may be described as information extraction techniques and the challenges
and issues described above will be later discussed in regards to this case study.
3.2.1.2 Histopathology and Tumour Grading
The most definitive diagnosis confirmation of prostate cancer relies on a biopsy
of the prostate tissue. The biopsy histology is analysed by histopathologists and
the diagnosis and prognosis largely depend on the degree of differentiation of
the neoplastic or malignant cells [107], for which a grading system is used. This
histopathological grading should not be confused with the TNM Classification of
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Malignant Tumours (TNM) staging [1], which is widely used for all cancers. The
TNM staging for prostate cancer describes the extent of the cancer, whether it
is localised in situ, extracapsular (beyond the prostate capsule), invading lymph
nodes or metastatic. The TNM may also be assessed pathologically; however,
this is not an assessment of the differentiation of the tumour’s cells, but rather,
its extent or invasion. The histologic grade, on the other hand, is centered on the
tumour itself.
Several grading systems have been proposed in the last three-quarters of the
20th century yet the most commonly used worldwide [108] and at the NNUH
is the Gleason system. The Gleason grading system is based exclusively on the
histologic pattern of arrangement of the carcinoma cells [107; 108]. Such patterns
have been consolidated into five grades, depicted in figure 3.2.
Figure 3.2: Standard Gleason grades [8]
A histologic score ranging from 2 to 10 is created based on the addition of the
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two most common occurring patterns (i.e. the first most predominant in area by
simple visual inspection, and a second most common pattern [108]). Histopathol-
ogists may also indicate a tertiary score, although this is less common than tra-
ditionally reporting two grades. When only one grade is present in the tissue
sample, that grade is multiplied by two to give the final score [108]. The score
can then be divided into low-grade (2-6) and high-grade (7-10). The higher the
grade, the most differentiated the cells are and consequently the more aggressive
the tumour is likely to be. The Gleason grading method is exclusive in human
cancers as other malignancies are often based on the worst grading observed [108]
rather than an addition of the most common grades.
Histologic tumour grading poses a degree of subjectivity. Indeed pathologist
training and experience can influence the degree of interobserver agreement [107].
According to Allsbrook et al. [109], ’nonconsensus’ cases in prostate cancer in-
clude low-grade tumours and those on the border between Gleason patterns. The
same study concludes that although there is some variability in interobserver
agreement among urologic pathologists, interobserver reproducibility of Gleason
grading is in an acceptable range. These findings should reassure that the Glea-
son grading system provides somewhat consistent observations among different
pathologists.
As previously mentioned, high Gleason grades are associated with aggressive
tumours. In fact, increasing Gleason grades are directly related to a number of
histopathological end points[107]: lymphvascular space invasion by carcinoma,
tumour size, positive surgical margins (what should be a normal tissue margin
at the edge of the specimen is also positive for carcinoma), pathological stage
(including risk of extraprostatic extension and metastasis).
Neverthelss, patients with lower-grade (2-6) carcinomas are still at risk for hav-
ing cancer spread beyond the prostate and not all patients with a high-grade
carcinoma component (7-10) will have extra-capsular extension of the carcinoma
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(extension beyond the prostate)[107].
The same author concludes:
’Prediction of pathologic stage by needle biopsy Gleason grade alone
is possible but is not absolutely accurate for the individual patient’.
As such, clinically, the Gleason grade is usually combined with other pretreatment
factors, such as serum total PSA, % free PSA, local clinical tumour stage, and
amount of tumor in needle biopsy, in order to predict pathologic stage [107].
Partin et al. [110] identified that PSA level, together with TNM clinical stage [1],
and Gleason score, contributed significantly to the prediction of pathological stage
(p < .001). As a result, the same team created the Partin tables (a nomogram)
which estimates the risk for extraprostatic (extracapsular) extension, seminal
vesicle invasion, and lymph node metastasis. Partin et al. continued collecting
data and later revised the Partin tables in 2001 [111]. Further studies confirming
the predictive ability of the Partin tables have been carried out in Wales [112]
and other countries. However, a 2009 study in Canada [113] and another in
Ireland [114] recommend caution in their clinical utilisation as the tables show
poor predictability of pathological staging at radical prostatectomy. Later, in
2010, researchers from the Irish study presented two novel predictive models
based on the Partin tables [115].
Despite the controversy surrounding the Partin tables, the key informational ele-
ments conveyed in them are highly relevant for the prognosis of prostate cancer.
Indeed, the National Institute for Health and Clinical Excellence (NICE) guide-
lines states that Partin tables are the most commonly used clinical nomograms
for determining the risk of nodal spread (i.e spread to lymph nodes) and uses
the same informational elements to compute risk stratification for men with lo-
calised prostate cancer [116]. As such, tumour TNM staging and PSA value
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are important elements to use together with the Gleason grade and should be
extracted from the histopathology text reports when possible. This defines the
informational elements needed from histopathology reports in the case study.
After a first inspection of the histopathology reports retrieved as part of the
prostate cancer case study (in section 3.2.1.3), section 3.2.1.4 will discuss the
feasibility of extracting such data based on concrete examples from the case study.
3.2.1.3 Data Familiarisation
The histopathology dataset, as retrieved from the ODS, contains a total of 5,083
reports with the following data attributes:
• HospNo, the patient identifier;
• DateOfEntry, the date when the histopathology report was produced;
• Age, the age of the patient at the date of entry;
• FullReport, the free-text histological report.
From the above attributes, only Age had missing data (m=28.5%). The most im-
portant attribute to investigate is FullReport, containing the full semi-structured
histopathology text report in natural language.
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The following is an anonymised example of a typical histopathology text report
in its original format:
ADDRESS FOR REPORT: XXXX, Urology,Copy To: Report to Can-1
cer Registry,, HISTOPATHOLOGY REPORT,LAB No: XXXX,,CASE2
HISTORY:,PSA = 6.4 on 5 February XXXX. Known carcinoma of3
prostate,(Gleason 3+5 = 8 in right lobe; XXXXXXX). Post DXT. Ab-4
normal,hypoechoic left peripheral zone on scanning.,, MACROSCOPIC:,5
1. Right: four cores of pale tissue, 1.8 cm, plus fragment., 2. Left:6
four cores of pale tissue, 1.8 cm. YG.,, MICROSCOPY:, 1. Two7
cores of prostatic tissue contain Gleason 4+5 = 9,adenocarcinoma.8
There is focal perineural invasion., 2. Cores of prostatic tissue, which9
show no evidence of high-,grade PIN or carcinoma.,, DIAGNOSIS:10
,PROSTATIC BIOPSY: ADENOCARCINOMA (GLEASON SUM = 9),,11
REPORTED BY: Dr X Consultant Histopathologist, Dr X Consultant12
Histopathologist,,REPORT DATE: XX.XX.XXXX13
Upon a first inspection, the text reports presented an overall average length of
972 ± 493 characters and 129 ± 73 words. From the above example report, it is
possible to observe an overall general structure is present. The reports appear
to be structured; divided in sections, each providing short descriptive sentences
on the patient and the tissue sample(s) observation(s). However, a preliminary
inspection revealed that not all reports have the same sections. An algorithm
using regular expressions was developed to identify and quantify the sections in all
histopathology reports. The following sections were identified, with corresponding
missing values:
• Address for Report / Copy To (m=0.01%)
The name and address where the report is sent to.
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• Case History (m=5.76%)
The patient history, any symptoms, results of other examinations or pro-
cedures. This section needs to be ignored by mining algorithms since it
includes information that is not directly related to the findings of the re-
port and can produce false positive results.
• Macroscopic / Macroscopy (m=0.06%)
The macroscopic observation (for example, enlarged size of prostate).
• Microscopic / Microscopy (m=0.16%)
The microscopic observation of the tissue sample.
• Diagnosis (m=0.06%)
The diagnosis of adenocarcinoma, benign hyperplasia, prostatitis or other.
• Reported by (m=0.01%)
The consultant histopathologist who analysed the tissue sample and others
who reviewed the specimen and/or contributed to writing the report.
5.8% (n=293) of all reports did not have a Case History section and all other
sections had a marginal number of missing values. It is possible to say that,
apart from Case History, which is not a field required for the analyses, over 98%
of reports have all remaining sections and that the overall structure of reports is
somewhat homogeneous.
3.2.1.4 Defining Useful Information
When observing the sentences within the reports, the presence of certain terms
such as adenocarcinoma or hyperplasia does not, on its own, reveal a positive or
negative observation of that term. In order to understand the observations, the
complete sentence and text report need to be understood. Sentences describing
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prostate tissue with no malignancy (see example report, line 10) and others with
adenocarcinoma (example report, line 8) are common. This is misleading for
naive mining algorithms that do not attempt to understand the document yet
extract information on a sentence-level context. Therefore, prior to any analyses
it is essential to determine the most relevant information to extract from the
reports.
The first most authoritative source of conclusive information from histopatho-
logical reports on prostate cancers are the Gleason grades. Indeed, in a given
report, there may be more than one grading, for different specimens, and so the
most relevant would be the highest grade reported. A preliminary regular ex-
pression search revealed that all reports had at least one occurrence of the term
Gleason. However, Gleason grades are present in reports in different natural
language structures and not all reveal a clear staging (typos were also found, for
example, “Gleeson”). Therefore a successful algorithm to mine such information
needs to first focus on the correct extraction of different structures throughout
reports (section 3.2.1.5). In some reports, the only reported grades are the total
Gleason sum and there is no discrimination between the first and second values.
In such cases it is not possible to assume whether a total Gleason of 7 is the result
of 4+3 or 3+4, which are histologically different. In order to cover all reported
grades, the total Gleason sum should be computed and when possible, the two
(or three) individual values should be extracted.
As previously discussed, other informational elements such as TNM staging and
PSA are also important. Using regular expressions, it was possible to identify
that tumour staging is present in 21% of histopathology reports in the form of
′pT1a′ or simply ′T1a′ (i.e. T1a denotes the tumour was incidentally found in
less than 5% of prostate tissue resected, accoring to TNM [1]). This notation
uses the TNM parameters with a prefix modifier, p, denoting the stage was given
by a pathologic examination of a surgical specimen. However, because in the
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databases it was not possible to consistently retrieve TNM staging, any exercise
to retrieve the staging, whether clinical or pathological, would be worthwhile.
Nevertheless, the number of reports including TNM in the above format is low
and so a careful inspection of the tumour grades available in the reports is carried
out later in section 3.2.1.6.
The PSA readings are a biochemistry test and, as such, are present in a more
canonical form in a different database. PSAs are “easily” retrievable in a canon-
ical form from the ODS and can be linked using the patient identifier. There-
fore, no algorithms were developed to identify or extract PSA values from the
histopathology reports.
The following sections introduce the systematic approach to developing the tech-
niques to extract the Gleason grades and potentially TNM staging from the re-
ports.
3.2.1.5 Algorithm Design
Designing algorithms to retrieve information from unstructured text is a chal-
lenging task in two major areas: the accurate extraction of information, and the
validation or evaluation metrics. The extraction of information relies on a thor-
ough understanding of the natural language and its structure. Validating the
accuracy of the algorithm, particularly in NLP exercises, often relies on a manual
clerical review of a selected number of reports [117]. The first objective of the
information extraction algorithm developed and presented below is to retrieve the
Gleason sum and, when possible, the two (or three) values used to compute it.
A second objective is to extract TNM staging when available.
A first, feasibility algorithm was built to analyse and understand the structure of
the text adjacent to the keyword Gleason and is described below.
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Symbols Numeric Values
Type = + neither 0 (none) 1 2 or 3
Coverage 63.11% 89.47% 10.17% 0.28% 6.63% 93.09%
Table 3.1: Text Mining Feasibility algorithm: Total number of symbols and num-
bers in relevant text segments and their respective coverage.
Sentence breaking or sentence boundary disambiguation (SBD) was used such
that ′.′ and ′ :′ are the only symbols that unambiguously denote the end of sen-
tences, given the general text report structure (as seen in the example report).
This approach will miss sentence boundaries when the reports’ sections are seg-
mented by commas and have no other punctuation. Nevertheless this was con-
sidered sufficient to highlight the most common structures of the text adjacent
to the keyword of interest:
“GLEASON 4+3=7”1
“Gleason pattern 3”2
“GLEASON SCORE 4+3”3
“Gleason score 7, (3+4)”4
“Gleason patterns 4 + 5 (and some 3)”5
The above led to an investigation of the total number of symbols (addition and
equal signs) and numeric values often present in the Gleason text segments.
This is an important step in shaping an algorithm that can accurately retrieve
the Gleason grades.
Table 3.1 shows that 90% of the Gleason text segments contain the addition
sign, 63%, the equal sign and 93% contain two or three numeric values. This
feasibility analysis was carried out on the first occurrence of the word Gleason
in 5,083 reports, and leads to the definition of concrete rules to extract Gleason
grades from the histopathology reports.
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Based on the feasibility analysis, three baseline rules to retrieve the Gleason
grades from identified text segments were defined:
• Baseline Rule 1
IF symbol “=“ exists AND is followed by a numeric value THEN
Gleason grade ← numeric value
• Baseline Rule 2
IF “+” exists AND is surrounded by two numeric values THEN
Gleason grade ←
∑
of the two numeric values
• Baseline Rule 3
Gleason grade ← the first occurring numeric value
The baseline rules, together, generate three different possible Gleason scores. An
algorithm was developed to implement the above rules on all sentences (text
segments) where the word Gleason occurrs in a single document. The maximum
grade found in a document, for each rule, is used. The developed algorithm
first strips off the sections that are not relevant and could bias the results (i.e.
case history, address for report, reported by), then identifies every segment of
text where word Gleason occurrs and applies the baseline rules to that segment,
yielding a result for each baseline rule.
The results from the baseline rules can be combined together to maximise the
accuracy of the retrieved Gleason grades. A hierarchical selection of rules (or
combination of baseline rules), allowing the selection of most relevant and accu-
rate information was identified:
R0 If Baseline Rule 1 and Rule 2 retrieve the same number, then this number
is the most authoritative Gleason grade. This is because there is evidence
85
3. Preprocessing, Linkage and Data Warehousing
that the total Gleason grade was indeed computed as a sum of the other
two observed grades. E.g: “Gleason patterns 4+3=7”.
R1 The result of a valid Baseline Rule 1 is the second most authoritative.
The equals sign is the second most reliable source of evidence of the final
(computed) Gleason grade as it reiterates the given score and it is unlikely
to be entered by accident. E.g: “Gleason score=8”.
R2 Results from Baseline Rule 2 are the third most authoritative. The clear
structure of two integers and a addition sign allows for the computation of
the total Gleason grade. E.g: “Gleason (4+3)”.
R3 A valid Baseline Rule 3 is the least authoritative of the rules, only taking
into account the very first occurrence of a numeric value in the identified
text segments. E.g: “Gleason grade 7”.
A discussion and evaluation of the application of the developed rules is given in the
following section. Regarding the technical aspects of this work, the dataset was
stored as a Microsoft Excel document and the algorithms were written in Visual
Basic for Applications (VBA) programming language with a Regular Expressions
library. VBA is an event-driven programming language and in this case was
used with Microsoft Excel allowing full control of spreadsheets and their data.
Although the running time for the developed algorithms was slow, automatically
populating the Excel spreadsheets with their results proved fruitful; it allowed a
thorough debugging, fast inspection and analysis.
3.2.1.6 Algorithm Results and Evaluation
The results of the application of the above hierarchical rules (R0 through to
R3) are shown in figure 3.3. The figure shows the individual and cumulative
percentage of reports classified as having satisfied each hierarchical rule. Records
86
3. Preprocessing, Linkage and Data Warehousing
Figure 3.3: Results of the application of hierarchical rules for information extrac-
tion. When R0 = “Yes”, the R0 rule was satisfied, and when R0 = “No” it was
not possible to find a Gleason with that rule.
that do not satisfy a rule are further evaluated with the next most authoritative
rule. The order in which the rules are applied is relevant because of the initial
feasibility analysis and understanding of the rules’ authoritativeness.
The overall coverage for each rule, and cumulative coverage are illustrated in
figure 3.3. When rule R0 is used alone, it allows the extraction of Gleason grades
for 73.3% of reports. However, when rules R0, R1 and R2 are used together,
a total of 95.7% reports are covered. There is a 20% gain in coverage by using
the first three rules as opposed to the first two alone. A further gain of 2.5% in
coverage is achieved if all rules are applied.
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Nevertheless an evaluation of the true accuracy of the rules is needed to ensure
that they are indeed retrieving the correct Gleason grade. This is discussed below.
Evaluation of the Algorithm
In order to evaluate the results, a number of reports were selected at random and
manually inspected. Table 3.2 presents the overall results by hierarchical rule.
Rule
R0 R1 R2 R3 Total
Valid 50 14 22 12 98%
Invalid 2 2%
Total 50% 14% 22% 14% 100%
Table 3.2: Results of the evaluation of the hierarchical rules.
A randomised set of 100 unique reports was selected: 50 from the subset identified
with R0, 14 from the subset R1, 22 from R2 and 14 from R3. The number of
selected reports is based on an even distribution of the first 48% for each rule
(baseline of 12 reports), and the remaining 52% are distributed based on the
overall percentage of reports identified by each hierarchical rule (for example,
overall R0 has 73% coverage on the original dataset which translates into 38
reports, then adding the baseline number 12 giving a total of 50 reports for R0).
There is also an even distribution of the years in which the reports were produced,
between 2003 and 2010.
The above results show two incorrectly classified reports for rule R3 and no
incorrect reports on any of the other rules. This should reassure that R0, R1 and
R2 provide the most reliable results, yet R3, also because of the naive nature of
this rule, should be used with caution.
Classification as Benign or Malignant
It is established that a Gleason grade positively identifies malignancy. However,
the absence of such a grade does not confirm or deny this. It is therefore essential
to investigate the reports where no Gleason grade was found, or where a degree
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of uncertainty exists (i.e. reports not covered by rules R0, R1 or R2).
Because of the relatively small number of reports, this inspection was performed
manually. Indeed the vast majority of reports identified by R3 = 0 are benign
prostate hyperplasias and were classified as “benign”. There are also reports
where histopathological grading was not possible due to the small size of the
focus.
The manual classification into “benign” and “cancerous” together with the ex-
tracted Gleason grade resulted in two new fields, appended to the Histopathology
dataset. The first field indicates whether the biopsy result is a malignancy, and
the second, discretises the Gleason grade sum into low-grade, high-grade or in-
conclusive.
The number of reports classified a high-grade is 4,654 (91.5%), whereas 335 (7%)
reports were classified with a low-grade and 94 (1.9%) were not graded. Further
results will be given in the next sections.
Examples of reports classified as malignant include: diagnoses of adenocarcinoma
but no Gleason given, focal adenocarcinoma, metastases, lymph nodes, or diffi-
cult to grade but cancerous cells detected. Examples of benign reports include:
no evidence of malignancy in the prostate, hyperplasia, post-treatment biopsy
showing no malignancy.
There are also reports where a biopsy of bladder tissue is also present. This
does not affect most (malignant) reports as the Gleason grade is only present
for prostate cancer tissue. Reports affected by this were accounted for during
the manual inspection. Such cases are also identifiable by inspecting the TNM
staging, when present, as depicted in the next section.
Extraction of Tumour Staging
The developed algorithm was enhanced to extract TNM staging from histopathol-
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Parameter T N M
Description Primary tumour Regional lymph nodes Distant metastasis
Values TX, T0, T1,
T1(a,b,c), T2,
T2(a,b,c), T3,
T3(a,b), T4
NX, N0, N1 M0, M1, M1(a,b,c)
Table 3.3: Simplified TNM Staging parameters and values, adapted from [1].
ogy reports. A simplified list of all possible TNM staging parameters, its values
and a description are given in table 3.3.
This algorithm retrieves 1) any occurrences of “pT” and 2) any of the possible
“T” stages, as listed in table 3.3. When an instance is found the algorithm
iterates through the subsequent characters until it finds a break (defined here
as a non alphanumeric character). The algorithm will also ignore the “history”
section and also a “scan” subsection which includes information previous to the
histopathological analysis. This approach resulted in the positive identification
of TNM staging for 1,090 reports (21%).
Outliers were found when the algorithm failed to identify when to break, i.e. a
suffix of alphanumeric characters continues beyond the TNM stage (for example,
“pt3aaatlleast” or “pt2ciisaappropriate”). Such outliers were inspected and re-
moved using filtering. An alternative aproach would be to limit the length of the
TNM string to its maximum (three characters and the pathological prefix “p”)
but this approach would misclassify cases, such as “pt2and” for “pT2a” rather
than the correct form “pT2”.
Overall, the algorithm identified the following TNM stages: “T1” - 358 reports,
“T2” - 377 reports, “T3” - 333 reports, “T4” - 21 reports, “NX” - 516 reports,
and “MX” - 632 reports some of which are cumulative (i.e. reports may be of the
form “pT2b, NX, MX”).
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Interpretation and Evaluation of TNM staging
When more than two TNM stages are identified, only the one with the poorest
prognosis is used as the final tumour staging. In some cases, a histopathology
report may contain two specimens, one from the bladder and a second from the
prostate. In this situation, should the bladder have a higher TNM stage, the
latter will be used as the final TNM stage. Bladder tumours should be identified
or removed after linking with other data sources, which will confirm the primary
tumour. The maximum number of potential bladder biopsies identified is 11% of
the total number of records identified with a TNM staging. This was determined
by checking for at least one occurrence of “bladder” in the report using regular
expressions.
Overall the algorithm was able to extract the TNM staging correctly and high-
lighted outliers (extreme cases, n=18), which were manually fixed. Despite the
encouraging results using the developed algorithms, the overall number of reports
with a pathological TNM staging was low and therefore its use is limited. Should
histopathologists consistently report TNM staging, under the same or a similar
report structure, the approach presented here would allow the retrieval of the
vast majority of cases.
3.2.1.7 Intraobserver and Interobserver Analysis
The Intraobserver and Interobserver Analysis is an interesting analysis that not
only inspects the validity or accuracy of the histopathological findings, but also,
the completeness and structure of the reports, and possibly, the validity of NLP
algorithms, which has not been explored. Any conclusions from this analysis are
based on the results of the algorithms presented and the cohort of known prostate
cancers.
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This analysis consists of identifying and assigning unique IDs to the histopathol-
ogists who wrote the reports (using regular expressions) and then grouping re-
ports by ID of the first author (note that reports are often written and/or double
checked by more than one author). In this task, the authors anonymity is ensured
by the unique ID number, created for this purpose.
A total of eight author groups were created:
• six groups of individual histopathologists with a relatively high number of
reviewed reports over time: groups C1 (n=929), C2 (n=191), C3 (n=448),
C4 (n=420), C5 (n=864), and C6 (n=686);
• one group of reports whose histopathologists were in advanced training, i.e.
specialist registrars: SpR (n=431);
• and a final group, containing all remaining reports: Others (n=1114).
Figure 3.4: Frequencies of reported and unreported TNM staging and Gleason
grades from 2003 to 2010.
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Figure 3.4 shows the underlying trends of histopathology reports on prostate cases
(frequencies of reports against year); it reveals the steady increases, particularly
in recent years, of the reported Gleason grades and the unreported TNM stages.
The number of unreported Gleason grades is mostly constant at ∼ 20 reports
a year. There is an increase in the total number of cancerous biopsies analysed
by the histopathology department of the NNUH but it is interesting to observe
that although the number of reported pathological TNM staging shows a slow
increase, a much steeper increase is observed in the number of unreported TNMs.
It is not clear, at the time of writing, why histopathologists show increasingly
little interest in reporting pathological staging.
Another interesting set of analyses are those where a relation is made between
the different histopathologists’ groups, the reported Gleason grades, and TNM
staging, over time. Figure 3.5 shows the percentage of high-graded Gleason grades
(7-10, n=4654) reported among the eight histopathologists’ groups; it shows an
overall increasing trend of high-grades being reported. It is interesting to note
that a particular consultant, C3, has consistently graded the least number of
high-grade Gleasons (from 2006-2010) and that the SpR (specialist registrars)
group has graded the most high-grade Gleasons in the last two years including
100% (n=50) in 2009. Apart from the SpR group, only one other, C2, reported
100% high-grades in 2006 (n=2) and 2008 (n=59).
When observing low-graded Gleason grades (2-6, n=337), figure 3.6 shows the
percentages among the eight histopathologists’ groups. The low-graded Glea-
sons show a seemingly symmetrical trend to the previous figure, where the total
number of reported low-grades is mostly on the decline until 2009.
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Figure 3.5: Percentage of high-grade Gleasons reported among the different
histopathologists’ groups.
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Figure 3.6: Percentage of low-grade Gleasons reported among the different
histopathologists’ groups.
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Figure 3.7: Percentage of non-reported Gleasons among the different histopathol-
ogists’ groups.
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Figure 3.7 shows the percentages of non-reported Gleason grades among the eight
histopathologists’ groups. Because of mostly low numbers, the lines are more
dispersed, but it is still interesting to note the differences in non-reporters, par-
ticularly among the SpR group, only non-reporting by 3.9% in 2007. Overall it
is not possible to say that non-reporting is either on the increase or decline over
time. It is also important to note that there are other reasons, unknown here, as
to why particular histopathologists have a higher rate of reports with no Gleason.
One reason may be a tendency of a a particular pathologist to analyse and report
on more difficult specimens.
Lastly, when observing the number of reported TNM staging, figure 3.8 shows
the percentages among the eight histopathologists’ groups. A steady decline in
TNM reporting in the SpR group since 2007 is observed. It is also possible to
observe that two consultants, C1 and C4, were consistently better at reporting
TNM than any of the other groups. However, it is not possible to say whether
these consultants report TNM because they have received different training, have
a different reporting technique or style, or whether they were given specific cases
where TNM reporting was needed.
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Figure 3.8: Percentage of TNM tumour stages reported among the different
histopathologists’ groups.
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Nevertheless, the intra/interobserver analysis points out that the differences in
reporting authors should not be ignored. Indeed, should these numbers be made
available more easily and in near real-time, they would inform histopathologists
how their reporting compares with their peers, and alert them when significant
changes or deviations ocurr.
Another interesting observation of the intra/interobserver analysis was that there
was no particularly signigicant relation between the way in which histopatholo-
gists write the reports and the accuracy of the algorithms.
When observing typographical errors in reports, the typo “Gleeson” mentioned
earlier, was found in a total of 13 reports, all belonging to the same first author,
C1. It is important to note that the reports containing this typo all had different
second authors. When inspecting all reports for their total number of words and
characters, author C1 had written the most words (163±94), i.e. 34 words above
the mean and 18 words above all other peer groups. It could be argued that
authors writing the most extensive reports would be more prone to typos than
their peers, but on the other hand they may produce more comprehensive reports.
A more detailed analysis of typographical errors, grammar and style would be
required for conclusive assertions to be made. This was, however, an interesting
finding that illustrates how certain systematic errors, otherwise overlooked, can
be identified using the proposed methods.
Intra/interobserver analysis can be a useful resource for the evaluation of the NLP
algorithms as it could highlight a particularly difficult writing style for algorithms
to interpret, or even systematic errors and outliers. With the exception of the
“Gleeson” typo, there was no particular relation between structures, styles or
errors found in the above exercise.
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3.2.1.8 Discussion and Conclusions
As described earlier in this chapter, and commonly reported in the literature [118],
there are two major challenges for text mining and natural language processing
techniques: standardisation and structure, and measuring success.
Standardisation and Structure
The lack of a report structure and/or standardisation is a problem that perva-
sively affects medical data and, in particular, narrative reports. This challenge
was encountered in this chapter but did not pose a significant barrier to extracting
the Gleason grades from prostate cancer histopathology reports. Although there
were different ways in which reports were written, the nature of the problem do-
main (particularly the existence of a Gleason grading system) greatly facilitated
this exercise. This reassures the importance of a thorough understanding of the
problem domain, and a detailed investigation of the ways in which histopatholo-
gists report cases.
Overall it is possible to say that, despite the multitude of ways in which nat-
ural language was used in the histopathology reports analysed, an underlying
structure was present, and natural language processing techniques can be used
to successfully extract information from the reports.
Retrieving tumour stages (TNM), however, was more challenging in terms of
contextualisation. TNM staging is common not only on prostate cancers but
other cancers and therefore bladder tumours, which may be present in the cohort
of prostate cancers, may be incorrectly identified. This issue can be dealt with at
a later stage when further information from other data sources is linked in and
other cancers and comorbidities are easily identified.
Another important part of the exercise presented in this section was the classi-
fication of reports as either malignant, benign or inconclusive (i.e. the overall
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conclusion of the report). This classification enabled the highlight and correction
of issues where a TNM value is present but there is no malignancy. Indeed this
can partially solve the problem of multiple tumours.
Measuring Success
Measuring the success of a text mining or natural language system is one of
the most difficult challenges. Current evaluation methods are based on manual
clerical review and are highly dependent on the reviewers’ knowledge [102; 118].
Nevertheless, as it was identified in this chapter, it is possible to extract in-
formation from the reports, which help in the validation of the accuracy of a
classification rule or other information retrieved. These were still complemented
by a manual clerical inspection to ensure validity.
Furthermore, a resulting dataset built with the proposed or similar techniques,
should only be used in combination with other data sources, so as to increase
its accuracy as well as to ensure the correct contextualisation. Even then, data
sources where coded information is entered by trained staff or migrated from
other databases may not always be reliable. A particular study on postoperative
complications showed that a natural language system can outperform standard
coding [118]. Another study on NLP analysis of free text medical records [118]
also revealed better performance (higher sensitivity and lower specificity) for NLP
techniques than a coded patient indicator. It is therefore important to be aware
of such issues when linking data across sources.
Another analysis that may help to validate and highlight issues in NLP algorithms
is one of the writing style and trends in which histopathologists write reports.
Conclusions
Overall the work carried out in this section reassures that natural language pro-
cessing techniques remain ad hoc exercises, heavily bound to the context of their
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production. It is arguable that heuristic rule-based models, tailored to a spe-
cific domain, are reliable and accurately extract information from text. It would
also be interesting to evaluate and compare different NLP approaches and mod-
els. However, this proved difficult to achieve and it remains a current topic of
research and further work [117].
The work presented here pointed out some additional benefits of extracting infor-
mation from text reports. In particular, it enabled the intra/interobserver analy-
sis in which interesting results were found. Further work is still required to better
interpret and make sense of those analyses. The extraction techniques here pre-
sented would be facilitated, however, if reports were annotated or coded. Indeed
it would be of interest to develop natural language writing systems where users
can easily highlight key terms (or terms are suggested to them by the computer)
to facilitate identification of positive or negative findings. Indeed annotations
have already been pointed out as one of the ways of improving the quality of
reporting as well as the accuracy of natural language processing techniques [106].
The objectives set for the information extraction algorithms were achieved and
all patients in the prostate cancer cohort now have Gleason grades, and when
available, pathological TNM staging, assigned to them in a cannonical form.
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3.2.2 Data Editing and Imputation
Another commonly reported challenge when using medical databases is handling
errors, outliers and missing data [20; 80; 92; 119]. In large medical databases,
almost every patient-record is missing values for some feature, and almost every
feature is missing values for some patient-record [20]. In some cases, erroneous
or missing values may be estimated and automatic imputation methods or other
techniques used. Common approaches to dealing with missing or erroneous data
include substituting them with most likely values, or replacing their values with all
possible values for that attribute [20]. Other approaches, such as training a neural
network to predict missing values, are possible, yet dangerous [80]. The problem
of missing data together with methods to handle them have been studied by
statisticians, particularly in regards to survey data. Data editing and imputation
are well established terms in statistics and are discussed in detail below (in section
3.2.2.1).
This section discusses the issues of data preparation with examples from the case
study, and it introduces a method for estimating continuous, ordinal data, such
as age. Data preprocessing methods and techniques presented here are based on
the prostate cancer biochemistry datasets, namely the Prostate Specific Antigen
(PSA) dataset. They illustrate the typical challenges encountered, and techniques
used in datasets with attributes of a similar nature.
3.2.2.1 Background on Data Editing and Imputation
Official statistics institutes and other similar entities providing high-quality sta-
tistical information need to be as up-to-date and as accurate as possible [88].
Traditionally, such entities collect data in the form of surveys (such as a census)
and administrative data, and these inevitably contain errors [88]. Statistical data
100
3. Preprocessing, Linkage and Data Warehousing
editing emerged in the 1950s as a process of improving or correcting the effects
of erroneous data. Techniques were developed and have been extensively applied
since the mid-1950s [88; 120]. Over the years, several studies showed that it is
not necessary to correct all data in every detail and that such, “over-editing”
often leads to little improvement in the overall results. In fact, errors caused
by incorrect data are acceptable as long as they are small in comparison to the
sampling error [88].
Missing data can be seen as a form of erroneous data and one that is easier to iden-
tify yet often more difficult to correct [88]. Examples of sources of missing data
encountered in early statistical exercises are questions not answered by respon-
dents either because of a lack of understanding or refusal [88]. However, missing
data has a more complex set of reasons for existing in medical databases. A brief
description of such reasons was given as “value(s) accidentally not entered, or
purposely not obtained for technical, economic, or ethical reasons”[20]. Also, the
integration and use of retrospective clinical data can introduce additional sources
of missing data, often difficult to understand. Reasons for collecting information
often change over time and are poorly documented in legacy, routinely collected,
database systems (as seen in the previous chapter). An understanding of the
sources of erroneous or missing data would be benefitial to the development of
data editing techniques to cope with them.
The process of replacing missing data with substituted values, which can be used
in combination with other editing techniques, is called imputation [88]. Some
authors, however, see imputation as the process of replacing values, regardless of
whether they are true missing values or identified measurement errors [88; 121].
In this thesis the latter definition of imputation is used.
Data editing has been described as techniques by which statistical data are
checked and made correct with respect to both individual values and “mutual
compatibility between the values for different variables”[122]. Similar to other
101
3. Preprocessing, Linkage and Data Warehousing
preprocessing steps and techniques (for example, those in a DMKD process),
data editing can consume up to nearly half of the total resources spent on a
project [123].
The purpose of data editing, as defined by Granquist, is threefold [124]:
• it creates the foundation for the improvement of statistical data in the
future,
• it produces information about the quality of statistical data,
• it cleans the data errors (they should be analysed for their overall impor-
tance).
Five editing categories have also been defined [122]: Completeness edits (for ex-
ample, missing data), Validity and range edits (where only certain codes or ranges
of values are permissible), Consistency edits (comparison of different answers from
the same record to check logical consistency), Historical edits (for example com-
parison of response for a survey with a previous response), and Statistical edits
(checks based on statistical analysis of data where suspicious values are identified,
this could include historical data). Certain datasets and problems may require
the use of more than one category.
Regarding imputation, three main categories have been defined by statisticians
[122]:
• Logical (or deductive) imputation, used when a reliable, explicit solution
exists given appropriate assumptions (deterministic imputation);
• Model based imputation, where a model is fitted to the data (including
probabilistic approaches);
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• Real donor imputation, where the imputed observation value is “donated”
from another respondent.
Furthermore, imputation rules should: be derived from the corresponding edit
rules, satisfy all edits by changing the fewest possible items of data; and maintain
data structure and frequency [125].
Another issue that often needs to be tackled as part of edits or imputation meth-
ods are outliers. An outlying observation (outlier) is “one that appears to deviate
markedly from other members of the sample in which it occurs” [126]. Measure-
ment errors or heavy-tailed distributions often result in outliers. Methods to
minimize the effects of outliers include trimming and Winsorisation [122]. Such
techniques can work alongside imputation and editing techniques, but have also
been described as imputation rules [127]. Trimming consists of identifying and
stripping the extremes, whilst Winsorisation (sometimes Winsorising) is the pro-
cess of moving extreme values towards the centre of the distribution [122].
The next section introduces the PSA dataset, its attributes and values, and the
motivations for the development of a data editing technique.
3.2.2.2 The PSA Dataset
Prostatic Specific Antigen (PSA) is a widely used blood test for the early detec-
tion of prostate cancer. Men with abnormal PSA concentrations usually undergo
further examinations such as the digital rectal examination (DRE), transrectal
ultrasonography (TRUS) and prostate (needle) biopsy for a diagnosis. Further
discussion and background on the PSA is given later, in Chapter 4, where re-
sults are analysed. This section is concerned with the preprocessing methods of
potential erroneous values.
The Prostatic Specific Antigen (PSA) dataset is similar to other Biochemistry
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datasets in respect to attributes, their syntax and, to some degree, semantics.
This dataset was originally retrieved from the Biochemistry data warehouse at
the NNUH, where other biochemistry readings are stored in a similar fashion.
Upon consultation with the head of pathology at the NNUH, it was understood
that the local laboratory is responsible for most, if not all, PSA tests carried out
in Norfolk. However, there may be a small number of instances where tests are
carried out in other laboratories. This makes the PSA dataset more valuable in
that it allows the inspection of PSAs not only for the cohort of cancers, but for
all others, including potential “screening” patients.
The complete PSA dataset collected in this research contains over 150 thousand
readings, yet here, a subset was used and should be considered sufficient to high-
light and generalise missing and erroneous values. The dataset used here covers
a five year period (from 2003 to 2007), contains 80,738 records (33,013 unique
hospital numbers), and the following key attributes:
• Hospital Number (m = 3.1%) - Patient identifier;
• Clinical History (m = 4%) - Free text field describing clinical history;
• Date of Entry (m = 0%) - Measurement date;
• Time of Entry (m = 0%) - Measurement time;
• Test Data (m = 5.3%) - The biochemistry test value (eg. PSA reading);
• Age at Episode Date (m = 0%) - Patient age when blood sample was taken.
A small percentage of hospital numbers was missing. It could be possible to
recover hospital numbers using a patient’s other attributes, including history and
dates, but this process may still not provide accurate results and would likely
result in over-editing. It would also be important to link the records to other
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clinical data in the future, which is why other methods would not work here.
Records with missing hospital number were therefore removed from the dataset.
The Clinical History attribute contains 4% missing data, calculated as values
with less than two characters. The remaining 96% of records, however, contain
varied information: regarding drugs the patients were taking (for example “pt
on Zoladex”); diagnoses (for example “Advanced prostate Ca”); symptoms (for
example “Painful feet plus problems with Nocturia”); and references to previous
tests or procedures (for example “PSA retest”, “pre-op”). These examples illus-
trate how the attribute is not used consistently with regards to semantics, which
make it difficult to understand and derive information. Upon visual inspection,
syntax and typographical errors seem common and systematic. This field was
not used in this section but kept in the ODS should further investigations be
required.
The date and time of entry attributes are automatically filled in by the bio-
chemistry software and so there is no missing data in them and the values, upon
inspection of descriptive statistics, are not expected to be erroneous.
The Test Data attribute, however, shows that 5.3% of its values are missing. This
attribute stores the PSA, a numeric value with one decimal point. The data type
and format are not consistent and valid, non-numeric values such as “< 1”, are
common. It is not possible nor trivial to recover PSA values because of their
broad range and sparseness (in this dataset the range is from 0 to 23,750 with
mean 30 (SD 284)). Probabilistic methods for automatic imputation would be
difficult, but may be possible upon normalisation. Because future analyses in
this research will not always group and summarise data, missing or erroneous
fields should be identified and removed. Becasue accepted PSA values include 0,
the values identified for removal were: missing values, text values, and negative
values. Values indicating an approximation (such as “> 100”) were corrected as
follows:
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• value “< .1” modified to 0.05 (in n=8,532 cases)
• value “< .2” modified to 0.1 (n=7)
• value “< .4” modified to 0.1 (n=1)
• value “< 1” modified to 0.5 (n=2)
• value “> 100” modified to 100 (n=5)
• value “> 10, 000” modified to 10,000 (n=12)
Regarding the Age at Episode Date (age) attribute, no missing data was found.
However, upon an observation of its range, [−25; 127], erroneous values and out-
liers were suspected. This field is indeed the result of clerical data entry in a
busy laboratory and it is not consistently retrieved nor validated against hospital
administration systems. In fact, the laboratory often takes samples from patients
who are not registered with the hospital or even treated there. Given that there
is no date of birth field available in this dataset, it is not possible to accurately
determine whether a patients age at episode date is correct. It is possible, how-
ever, to link this dataset to other hospital sources on patient number, but that
will restrict the working dataset to the number of matching links between the
two. Indeed for mismatches it would not be possible to determine the correctness
of the values, and hence, the quality of the age attribute. Because the interest in
the PSA dataset is greater than just the subset of the prostate cancers identified
in the ODS, it is important to have reliable key demographic attributes such as
age. This led to further investigations and the development of an algorithm to
solve the Age problem, described below.
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3.2.2.3 The Age Problem
Upon deleting records with identified errors in Test Data and Hospital Number
the total number of records in the dataset was 73,902.
A preliminary assessment of the age values together with an understanding of
their origins revealed that the Age at Episode Date attribute had poor reliability.
It is essential to ensure the age values are correct for the validity of analyses using
biochemistry data. It is possible to retrieve the correct patients age by linking to
other datasets where a date of birth attribute exists. This is, however, unfeasible
for patients not seen at the hospital (i.e. without any further records available to
us). Yet a subset of linked, positive matches may be used to test the accuracy of
any new methods developed.
When plotting a frequency distribution of the age attribute, missing and possible
erroneous values were detected in the data. This is illustrated in figure 3.9.
The latter shows erroneous, outlier, values that do not seem to follow a normal
distribution. This is particularly obvious for age 0 (0.3%) and any negative age
values (< 0.1%). A well-known normality test, the Kolmogorov-Smirnov, failed
for the age attribute. Indeed it is expected that, given its age range, a prostate
cancer dataset is negatively skewed. This is confirmed by the skewness test of
asymmetry that scores -1.048. Further descriptive statistics are given in table
3.4.
Erroneous outlier values (i.e. age ≤ 0) were identified and their impact on the
normal distribution assessed. Table 3.4 shows the potential impact of cleaning
outliers from the age attribute on its normal distribution. Records with other
erroneous attributes had already been removed.
This analysis, although sufficient to highlight the extent of outliers, does not help
to determine whether the values are indeed correct. However, the PSA dataset
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Figure 3.9: Histogram showing frequency distribution of age in the PSA dataset.
Age (raw) Age (clean)
Statistic Value Std. Error Value Std. Error
Records 73,902 73,804
Range 152 96
Minimum -25 5
Maximum 127 101
Mean 70.19 .043 69.57 .040
Median 71 70
Mode 72 72
Std. Deviation 11.611 10.805
Variance 134.813 116.758
Skewness -1.048 0.009 -.469 .009
Kurtosis 3.846 0.018 .369 .018
Table 3.4: Statistics showing the impact of cleaning the age values.
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contains age values recorded each time a patient carried out a PSA examination
and on average, there are 2.4 (SD 1.1) records per patient. Working with other
records from the same patient may help determining whether age readings are
correct. The Age Problem is then defined as the evaluation of integrity among
multiple age readings over time and any subsequent corrections. A solution algo-
rithm could be seen as consistency and historical edits resulting in the imputation
of correct, best estimate, values.
3.2.2.4 Age Integrity Check
The first analysis carried out relied on the integrity of pairs of patient episodes
(i.e. a chronological sequence of measurements). Pairs of episodes are ordered
chronologically by date of entry. For each pair it was possible to compute the
difference between expected and observed chronological events using the date of
record entry and age at episode. The results of this analysis are listed in table
3.2.2.5. Two methods for computing the integrity were investigated. A first, less
accurate, was calculated using year and age as integers and a second, with higher
sensitivity, was calculated in days.
Let r1, r2 be a pair of age values and v1, v2 a corresponding pair of date entry
values where v1 ≤ v2. The integrity of a sequential pair of records (r1, v1; r2, v2)
is satisfied in the integer space (in years) iff
(v1 − v2)− (r1 − r2) = 0. (3.1)
The above can be improved to increase accuracy by measuring days instead of
years. Then the difference between the age values and time interval between two
episodes is valid iff
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0 ≤ (v2 − v1)− (r2 − r1) ≤ 365.25. (3.2)
The average year length accounting for leap years is 365.25. This is important
for accuracy over long periods of time. The results of the above computations
are given in table 3.5 and represent an initial estimate of the number of possible
erroneous values in the data. The most reliable results, i.e. most consistent, are
given in of course days.
Years Days
Integrity Check Result Frequency Percent Frequency Percent
Possible Inconsistent Record 14,333 19.4% 237 .3%
Consistent Record 59,569 80.6% 73,665 99.7%
Total 73,902 100% 73,902 100%
Table 3.5: Results of the age integrity check for consistency.
3.2.2.5 Assessment using Linked Data
A data quality assessment using date-of-birth (DOB) in the PSA cohort was
carried out to quantify the magnitude of erroneous records. This was only feasible
for those patients that link to other hospital sources. It was possible to link 21,966
patients from the PSA dataset with the administration dataset. The date of birth
was calculated in the PSA dataset using Date of Entry and Age at Episode Date.
The difference between the two was computed in years. The linkage exercise
revealed that 0.5% (n=104) were erroneous.
This exercise showed that records from patients that are simultaneously on the
administration database (i.e that have at least one inpatient record with prostate
cancer diagnosis) and on the PSA cohort are correct 99.5% of the time. The
latter may not be true for records that do not link to the administration system,
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as the laboratory would not be able to double-check their age.
Table 3.6 shows the number of invalid records after linkage to the administration
system (n=104) and from those, the number of cases highlighted by the integrity
check (n=83, 79.8%).
Frequency Percent
Validation Invalid 104 .5%
Valid 21,862 99.5%
Total 21,966 100%
Cases highlighted by the Highlighted 83 79.8%
Integrity Check Missed 21 20.2%
Total 104 100%
Table 3.6: Results of assessment using linked data. True error rate for age fields.
3.2.2.6 The Age Problem Algorithm
The above results led to the development of an algorithm to estimate patients’
age. This is also important because future studies need to be carried out using
other biochemistry tests (datasets with the same specifications and issues) for
which we cannot recover patients age at episode in days.
Let x be the number of days since a patient was last seen, and y the corresponding
date at episode in days. Given a sequence of n pairs (x1, y1), . . . , (xn, yn) where
0 < x1 < . . . < xn, xi ∈ Z and y1, y2, . . . , yn ∈ Z is there a base number z (the
age at which patients were first seen) such that
bz + xi
k
c = yi (3.3)
for i = 1, 2, . . . , n.
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If the above is true, the set {(xiyi) | 1 ≤ i ≤ n} is k consistent. A simple
algorithm to determine this is based on the observation that if
bz + xi
k
c = yi (3.4)
then kyi ≤ z + xi < k(yi + 1).
that is kyi − xi ≤ z < k(yi + 1)− xi.
.: There is a base number z iff
∩ [kyi − xi, k(yi + 1)− xi[ 6= 0 (3.5)
The purpose here is to find the largest k consistent sequence where k = 365.25.
Let z0 be the lowest value, and z1 be the highest value such that
bz0 + xi
k
c = yi bz1 + xi
k
c = yi (3.6)
for some i
We then seek z0 ≤ z ≤ z1 such that
Ni = | {i : bz + xi
k
c = yi} | (3.7)
is maximised.
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This is found by iterating through m = (z1 − zo) values of Z and evaluating Ni
for each one. This is a pseudo-polynomial algorithm O(n ∗m).
The algorithm was written in Python programming language and integrated with
SPSS Statistics version 16 programmability extensions. The performance of the
algorithm is evaluated in the next section.
3.2.2.7 Evaluation and Performance of the Algorithm
In order to assess the algorithm’s performance the age values were computed on
the set of linked data (test set, n=21,966 total records) where the true patients’
age is available from another data source.
The algorithm computed the correct (exact) value 53.2% of the time and was one
year off 46.5% of the time. Therefore, the algorithm computed the correct age
within one year 99.7% of the time, in a set of 6,076 patients (test set). This is
illustrated in figure 3.10. The remaining 0.3% of records (not visible in the figure)
were incorrectly computed due to outliers or missing values and can be manually
corrected.
However, the algorithm’s performance was poorer when working with individual
episodes (rather than by patient). Only 77.2% were correct within one year and
99.9% were correct within two years. The frequencies are illustrated in figure
3.12. Likewise, the remaining 0.1% of records (not visible in the figure) were
manually corrected.
Other methods to estimate age were investigated using the mode, mean and mean
of computed year of birth as possible estimations for sets of patient records. These
approaches achieved low accuracies (between 5% and 6.1%) on the test set of
linked data.
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Figure 3.10: Frequency distribution of the accuracy of the algorithm (difference
in years) for individual patients on the test set.
3.2.2.8 Discussion and Conclusions
The primary objective of the developed algorithm was to compute the correct
patient’s age at first presentation. Subsequent values can be estimated by adding
the elapsed time intervals. Therefore, the AP algorithm introduced here can
compute the patient’s age correctly (within a year) with an accuracy of 99.7%
which is considered sufficient for the purpose of future work.
The AP algorithm was applied to the main PSA dataset (n=73,902) and extremes
were removed. Figure 3.12 shows the frequency distribution of the age attribute
after erroneous values were fixed by the algorithm. Table 3.7 compares key dis-
tribution statistics of the age attribute against values corrected by the algorithm
and the same attribute when a simpler cleansing was performed (same as Table
3.4). Although the mean and median are now closer to the dataset’s initial pre-
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Figure 3.11: Frequency distribution of the accuracy of the algorithm (difference
in years) for all records on the test set.
sentation (i.e. without any transformations), there are no significant changes in
any of the statistics.
This would confirm the literature’s findings [88], in that efforts to correct individ-
ual values may introduce “over-editing” and provide little overall improvement.
Simpler methods to identify and remove outliers, such as the cleansing described
in 3.2.2.3 should suffice when the data is to be summarised. However, when ac-
curacy of individual records is required, an approach such as the AP algorithm
can provide most reliable results.
All cleansing and editing operations were carried out using IBM’s SPSS Statis-
tics Software (version 16). The SPSS programming language (SPSS Syntax) was
used to compute statistics, the age integrity checks as well as remove outliers and
other cleansing operations. The linkage exercise involved running database op-
erations and SPSS syntax scripts. The AP algorithm was written in the Python
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Figure 3.12: Histogram showing the distribution of age values after corrections
were made by the AP algorithm.
programming language together with SPSS 16 Programmability Extension, an
API allowing full control of the SPSS data and functions. Despite the implemen-
tation in Python, the extensive use of SPSS’s API significantly slowed down the
algorithm’s run time. When handling large datasets such as the ones used in this
section, the SPSS API would not be recommended.
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Age (corrected) Age (clean)
Statistic Value Std. Error Value Std. Error
Records 73,729 73,804
Range 96 96
Minimum 5 5
Maximum 101 101
Mean 70.54 0.040 69.57 0.040
Median 71 70
Mode 72 72
Std. Deviation 10.99 10.805
Variance 120.880 116.758
Skewness -0.505 0.009 -0.469 0.009
Kurtosis 0.388 0.018 0.369 0.018
Table 3.7: Statistics showing the impact of the algorithm (age corrected) against
simple outlier cleansing (age clean) in the distribution of the age attribute.
3.3 Stroke Study
3.3.1 Record Linkage
Data or record linkage is a common preprocessing step in data mining or data
analysis projects. It allows the aggregation of data to create information that
would not be available otherwise, and the identification and removal of duplicates
(deduplication) [128]. A typical linkage exercise consists of identifying records on
two or more sources belonging to the same entity or event (i.e. a patient or
episode). An example of a simple record linkage was given in the previous section
(3.2.2.5), where, for the age problem, a biochemistry dataset was linked to an
administrative dataset.
Data linkage exercises are common in the support of projects in clinical, health
services or public health research, with the purpose of associating records of ex-
posures with those of outcomes [9]. These are known as ad hoc linkage exercises.
Alternatively, linkage of health data may be undertaken in a proactive and sys-
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tematic fashion, with a view to support future research and analyses [9]. The
latter involves the development of a data linkage system. In the context of the
work carried out in this thesis, data linkage exercises should be perceived as ad
hoc exercises, essential for the aggregation of information that is scattered across
hospital databases. Nevertheless, the work presented here introduces methods
that can be used proactively to feed information into integrated repositories.
In this section, two deterministic record linkage exercises are described:
• The first exercise aims to select the correct blood tests from the biochem-
istry system with respect to a cohort of stroke admissions from the stroke
register. Record linkage is necessary to complement the stroke datasets
with accurate blood readings from biochemistry databases.
• The second exercise involves linking the stroke register with the administra-
tion system and an external, national demographics database, in order to
validate the patients’ dates of death over a period of 15 years. At present,
it is not well established how reliable hospital administration databases are
at providing accurate dates of death, in particular for those that die after
they are discharged from hospital.
The next sections introduce key background information on record linkage (3.3.1.1),
a formal definition of data matching (3.3.1.2), and the linkage process (3.3.1.3).
The section on the first deterministic linkage exercise (3.3.1.4) presents the tech-
nique used to match stroke admissions to their corresponding sets of blood tests
(in this case, only haemoglobin is used). The second exercise on the accuracy of
mortality dates using hospital databases is given in section 3.3.1.6.
Results and discussion for each exercise are given in their respective sections and
general conclusions are given in section 3.3.1.8.
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3.3.1.1 Background on Matching
Matching is the process by which record linkage occurs and it involves the use of
key common variables or identifiers. The uniqueness or commonness of identifiers
such as names, addresses or national insurance numbers is an important factor
contributing to a successful matching process. However, even the most reliable
identifiers yield incorrect matches [129]. Traditional data linkage is, hence, prob-
abilistic in nature and weights should be assigned to matching or mismatching
pairs accordingly [128; 129].
Computer assisted data linkage has its first ad hoc heuristic applications in the
1960s and the idea of probabilistic matching was first introduced by Newcombe
and Kennedy in 1962 [130]. The theoretical foundation of probabilistic matching
is later given by Fellegi and Sunter in 1969 [131]. As seen in the previous section,
Fellegi also worked on data editing and imputation techniques at the time. Indeed
linkage often produces datasets where editing techniques can then be applied.
Fellegi and Sunter’s classification process relies on the computation of a vector
with matching weights for each compared record pair. The summation of the
vector weights yields a final composite score (likelihood ratio) for a given pair or
records. An upper and lower threshold are subsequently assigned to classify pairs
as matching, non-matching and possible matches. The thresholds are selected
based on desired error rate bonds [132].
Probabilistic methods are particularly effective in the absence of unique identifiers
such as a national insurance number. In contrast, should reliable unique identi-
fiers be available, deterministic methods may be preferred due to the simplicity
of their implementation and accuracy.
Deterministic methods differ from probabilistic ones in that linkage is tradition-
ally performed based on a matches for a set of identifiers. An example would be
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a database query, using structured query language (SQL) to join two tables on a
primary key (the identifier).
Probabilistic methods are, therefore, commonly used on inter-organisation linkage
exercises [133; 134; 135] and deterministic ones on intra-organisation exercises.
The latter, however, often do not reveal their methods and techniques in detail in
the literature [136]. This is mostly due to the specific and ad hoc nature of such
exercises within the organisations. However, sharing methods and techniques
would be beneficial to other researchers as the challenges are often similar.
Large organisations, where several departments have a high level of indepen-
dence in the way they store and manage their data, may fall in the category of
inter-organisation linkage However, these issues may be addressed by introducing
further constraints to the matching process. This can be regarded as a rule-based
deterministic method and it is the technique used in this section.
3.3.1.2 Formal Definition
A formal definition of data matching is given in detail by Gomatam [136] and
summarised here.
Let A and B be two data sources with na and nb records, respectively. Each of
the nb records in source B is a potential candidate match for any of the na records
in A. Hence, there are na×nb record pairs to be assigned as match or non-match
[136]. Disjoint sets M and U can be defined from the cross-product set A × B.
Therefore a record pair is a member of set M if that pair represents a match, or
U if it is a non-match. A typical record linkage process attempts to classify each
record pair as belonging to either M or U [136; 137].
Matching problems, however, often need further constraints. For instance, if
each record in data source B refers to a distinct entity, a record in data source A
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cannot be matched to two records at the same time in data source B. This has
been described in the literature as the constrained matching problem [138]. It
is more generally referred in databases as 1-1 (one-to-one) linkage and contrasts
with an alternative 1-many (one-to-many) linkage. 1-1 linkage, since it has more
constraints, is a more difficult problem [138].
3.3.1.3 The Linkage Process
Holman [9] defined five practical steps in the process of data linkage, similar to
those also reviewed in [137]. The process can accommodate ad hoc as well as
systematic (proactive) linkage exercises; it is described below and in figure 3.13.
Figure 3.13: The Linkage Process, adapted from [9].
1. Preparation
As with most data analysis methodologies, data preparation is a key step
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where data transformations and cleansing occur. When working with per-
sonal identifiers’ attributes, preparation techniques include the use of pho-
netic compression (i.e. transformation of names into their phonetic codes,
similar to the use of stemmers in text mining), equivalences dictionary (i.e.
compression of forename aliases), or geocoding (i.e. identification and cat-
egorisation of location). In linkage projects, it is also important to identify
the file (or source) types. They have been defined [9] as:
• Type 1 : files have one valid record per individual (for example, death
registration)
• Type 2 : mostly one record per individual (for example, cancer noti-
fications)
• Type 3 : mostly multiple and variable records per individual (for
example, hospital episodes)
The above has also led to the definition of simple and complex file groups.
In a simple group there is only one type 3 file whereas complex groups
contain two type 2 or 3 files. The latter is also true if none of the files
contains a full census of all the individuals in the analysis.
2. Blocking
In this step, records are ordered and/or filtered to improve the efficiency of
searching of matches. The most reliable fields with the least missing data are
best suited for blocking. This is particularly important when probabilistic
matching is used. The term blocking can also be referred to as a block
of records pertaining to the same individual, however, this is a different
meaning to the one used in this linkage process.
3. Matching
This is the step where potential linkable pairs of records are systemati-
122
3. Preprocessing, Linkage and Data Warehousing
cally compared against all candidate records. This may be probabilistic or
deterministic, as detailed above.
4. Storage
This is exclusive to data linkage systems, and it may be skipped in ad hoc
data linkage exercises. The storage of matching results and weights enables
future studies to be carried out without having to repeat all steps of the
process. In ad hoc linkage exercises the matching results may be discarded
and the overall linked dataset is kept.
5. Merging
The data from the different sources is amalgamated in a way that they can
be analysed as a set of composite records for each individual. This step
also includes validation checks, error detection and correction of the linkage
process.
3.3.1.4 Rule-Based Linkage for Biochemistry Values
The exercise carried out here pertains to the matching of records from the stroke
register to biochemistry records using relational databases. The purpose is to
find, if any, the most relevant reading of a blood test for each record in the stroke
register. This can be seen as a complex file group exercise since the main table
of the stroke register is a type 2 file and the bloods table is a type 3 file.
The preparation and data transformations of the identifiers from the stroke reg-
ister are omitted here but more detail is given in section 3.3.2 and a full list of
the original stroke register attributes is given in Appendix A. A subset of bio-
chemistry readings was used to design and test the deterministric rules presented
in this section.
Let A be a relation containing the stroke register and B a relation containing the
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biochemistry database with na and nb records, respectively. AID and BID are the
identifiers for each source, and ADate and BDate are the event (or episode) dates
for A and B respectively.
In the first instance, we want S to be the resulting set of the equijoin of A with
B where AID = BID. This can be defined in relational algebra as the selection:
S = σAID=BID(A×B). (3.8)
We then compute, t, the difference in days, ADate − BDate, for each record in
S. Upon this transformation, the purpose is to select a set M containing all
minimum absolute values of t in S, for each record:
M = σmin(|t|)(S). (3.9)
The first operation (3.8) results in a set where each record in the stroke register
is linked with a record from the biochemistry dataset, and has an associated
distance, t, between the date of the stroke and the date of the biochemistry test.
The second operation (3.9) selects the records with the minimum distance from
the first set.
However, the two operations above may not always yield the correct matches
as there are no constraints in regards to time, min(|t|). Hence, in some cases, a
further selection query is needed to restrict records to the time period in question.
Selecting min(|t|) ≤ d, for instance, would ensure the matching records are within
an absolute limit of d days. The value assigned for d is determined by the clinical
time dependency between records in source A and B, i.e. determined by domain
experts with a particular clinical interest.
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In this study, the threshold d was set to 7 days by the clinical team. Hence,
blood records closest to admission with a limit of 7 days were matched against
the stroke episodes. The same exercise was carried out for discharge events.
Figure 3.14 shows a graphical representation of two possible deterministic ap-
proaches based on an example from the study. The horizontal lines represent a
patient’s timeline. The smaller white circles intersecting time illustrate biochem-
istry tests, with example readings above them. The two large circles in the first
approach (I in figure 3.14) are centered in the admission and discharge dates re-
spectively; their radius, d, is the threshold set above, in days. Any biochemistry
readings within d would be considered as potential candidate values for admission
or discharge. The distance between admission and discharge is the length of stay
(LoS). In the second approach, the larger circle shows the LoS, and at its upper
and lower bounds, admission and discharge circles were placed.
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Figure 3.14: Deterministic methods (I and II) to find the appropriate biochem-
istry records for linkage. Circles were used to create a figurative radius (d) of
individual blood tests (in white) pre-admission, post-discharge and the distance
between the latter two (length of stay, LoS).
The figure illustrates, with an example from the study, that the first approach
would retrieve the biochemistry readings closest to admission and discharge but
ignore the period of time between them, the LoS. This is a typical approach used
when running database queries and indeed the result of the abovementioned op-
erations. The second approach, however, shows how other values can be included
instead. When using the first approach, a biochemistry reading with value 13.6
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is chosen as the admission value. The second approach, however, would choose
the biochemistry test with value 13 instead.
This is important because of the potential effects that admission (and the time
between admission and the first reading) may have had on the values of the
biochemistry reading. Hence, the most correct reading for admission, in the
example, would be 13. This can be achieved by introducing a constraint on t ≥ 0
meaning AD ≥ BD for admission. Regarding discharge, however, the absolute t
closest to discharge date would still be most correct.
As such, the operations involved in this exercise are:
1. Perform selection, S = σAID=BID(A× B) to match all records in A with B
where AID = BID, and append t = ADate −BDate.
2. Obtaining the value for Discharge:
(a) Select from S the records where |t| ≤ 7, resulting in set
M = σ|t|≤7(S).
(b) The resulting value for discharge, AID, is the minimum value in M .
3. Obtaining the value for Admission:
(a) Select from S the records where t ≥ 0 and t ≤ 7 resulting in set
M = σt≤7 and t≥0(S).
(b) The resulting value for admission, AID, is the minimum value in M .
4. When no value for Discharge is found, the same value at Admission may be
used.
The above operations were carried out using a subset of biochemistry tests in
order to evaluate the results, described in the next section.
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3.3.1.5 Biochemistry Linkage Results and Evaluation
A set of 7,208 stroke episodes (2003-2011) from the stroke register was used as
the main strokes table. A second table, containing all haemoglobin (Hb) blood
tests from the same time period was retrieved from the NNUH biochemistry data
warehouse. The method for data collection was the same used in the previous
chapter. The Hb table contains 3.5 million haemoglobin readings and this volume
poses an additional challenge to the current and future linkage exercises.
The purpose of this record linkage exercise was to match the correct blood reading,
in this case haemoglobin is used , to two stroke events, admission and discharge.
At least one haemoglobin reading is expected as part of a routine full blood count
near the time of admission, but the extent in which this is consistently performed
across all stroke patients is unknown. As seen in the previous section, different
rules were used to obtain the Hb values at discharge and at admission. The results
of this exercise are presented below and were evaluated by an inspection of the
descriptive statistics and a clerical review of patient notes. The work presented
here uses Hb as an example to demonstrate the linkage and data transformations,
however, the same was techniques were applied to all blood tests identified by
the clinical team.
Admission
Deterministic record linkage was applied to the dataset and 94.3% (n=6,795) of
stroke admissions had a matching haemoglobin reading within 7 days. However,
when observing the distance, t, in days, between the blood records and admission,
only 79.3% matched on the same day (t = 0) yet 91.4% matched within a day of
admission. The frequencies for all t are given in table 3.8. Those patients without
a reading of Hb at admission (n=113) did not appear to belong to a specific year
group or have any other characteristic that would indicate a reason for not having
the blood reading.
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Admission t Frequency Percent
0 5,713 79.3%
1 875 12.1%
2 95 1.3%
3 53 0.7%
4 19 0.3%
5 19 0.3%
6 11 0.2%
7 10 0.1%
> 7 304 4.2%
No Match 113 1.5%
Total 7,208 100%
Table 3.8: Frequency of matching records for admissions. t indicates the number
of days before admission where a blood reading (Hb) was found.
Discharge t Frequency Percent
0 1,052 14.6%
1 1,479 20.5%
2 1,011 14%
3 764 10.6%
4 532 7.4%
5 497 6.9%
6 348 4.8%
7 222 3.1%
> 7 1,190 16.5%
No Match 113 1.6%
Total 7,208 100%
Table 3.9: Frequency of matching records for discharges. t indicates the number
of days before or after discharge where a blood reading (Hb) was found.
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Discharge
Regarding discharges, only 14.6% of patients had a Hb reading on the same day
they were discharged and 34.6% had a day before. According to the deterministic
rules, 81.9% of stroke patients have a relevant reading at discharge (i.e. within 7
days). Table 3.9 shows the distribution of t for discharges.
The number of non-matching records is the same as for admissions (n=113). This
happens because the given rules for discharge can overlap with the admission ones
and so the same number of non-matching records, as measured here, is expected.
Indeed when the length of stay is less than or equal to 7 days and only one blood
reading from the patient was taken at admission, the reading at discharge is the
same as the one at admission.
Discussion, Evaluation and Challenges
The descriptive statistics resulting from the matching exercise were used to eval-
uate the total number of exact matches, partial matches and mismatches. Partial
matches were determined by t, the distance between the admission/discharge and
the corresponding blood reading. A further evaluative part of this exercise was
carried out by a manual inspection of the matching results against patient notes.
Overall no errors were identified and the deterministic linkage provided the cor-
rect values for all records. When no Hb values were found they were also correctly
classified as non-matches. Furthermore, this exercise was carried out for a single
blood test, Hb. The deterministic linkage rules presented here should still be used
carefully in other exercises and manual inspection of the results is also recom-
mended. Further details on other biochemistry tests are given later in this thesis,
together with a discussion on other issues affecting linkage using deterministic
methods.
Regarding technical challenges, this exercise was first attempted using Microsoft
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Access databases as they are installed on hospital computers. However, Microsoft
Access was not able to handle the linkage exercise both due to the sheer size of the
tables and the difficulty of writing and running complex Structured Query Lan-
guage (SQL) queries. A second, most successful approach was to use a portable
database management system, SQLite. The latter is compliant with the prop-
erties that guarantee database transactions’ reliability (Atomicity, Consistency,
Isolation, Durability) and it implements the SQL standards required for the exer-
cise. Even though SQLite is remarkably faster than Microsoft Access in running
queries, the queries above took ∼ 16 minutes to run for admissions and ∼ 10
minutes for discharges. The exercise was carried out using an average computer
at the time of writing (4Gb RAM, Dual Core 2.4 Ghz).
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3.3.1.6 Quality Assessment of Linked Mortality Data
A second linkage exercise, critical to ensure the quality of the stroke dataset
and in particular, mortality data, was undertaken. This exercise attempted to
evaluate the quality of the date of death field present in hospital systems and can
be regarded as an inter- and intra-organisational linkage exercise. This exercise
emphasizes the value of linked health data in the understanding of underlying
processes and data quality.
Upon a patient’s death in hospital, the attending clinician or a coroner complete
a medical certificate of cause of death. The patient is then discharged and the
death is registered (registrations are discussed in more detail below). In hospital,
the administration system (PAS) is updated with the patient’s date of death and,
in the stroke database, the patient is discharged with the respective status. For
the purpose of hospital service data the patient’s records for a deceased patient
can be archived and the quality of the data is thus assured. When the patient
is discharged alive, whether to a rehabilitation center, care home, or home, the
pathway for data collection is also considered complete from a service perspective
but from a research perspective this may not hold true, as further events may
follow that are not recorded in HIS.
Given the negative skewness of the age distribution in stroke patients, this cohort
of patients would naturally see an increased mortality when compared to younger
cohorts, even upon a successful treatment. Any research studying longevity would
need additional follow-up information to assert whether the patient is alive at a
particular time-point after discharge. However, it is unclear how death informa-
tion is reported back to the hospital. Upon spot-checking individual records in
the hospital administration system and consultation with clinicians, it was ob-
served that deaths were being reported to the hospital by GP practices or by the
families of the deceased.
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Further consultation with the hospital’s data quality department revealed that
a weekly process is in place to ensure that information on deaths, among other
details, is fed to the hospital records from the Summary Care Records (SCR)
database. The SCR is a “centrally stored summary of key medical details that
is created from a persons existing NHS record (. . . ) and made available to NHS
staff in emergency and unscheduled care situations” [139]. The SCR is fed data
from GP practices and was first rolled out in 2006 (2007-2009 in around Norfolk).
At the time of writing, only one GP practice with a Norwich postcode was still
planning to commence using SCR. In order to send clinical information to the
SCR, GP practices must synchronise their system with the Personal Demograph-
ics Service (formerly NSTS - National Tracing Service) to identify the correct
patients. It is expected that the quality of the records, including date of death,
has largely improved with the SCR system.
As reported in the previous chapter, the NSTS system was a national database
where services such as NHS Trusts submitted queries to find accurate demo-
graphic information about anyone registered with the NHS. From May 2013 until
the time of writing, the NSTS was unavailable and being replaced by the new
Personal Demographics Service (PDS). Prior to SCR and the PDS, hospitals used
reports from NSTS to gather information on their patients. However, upon local
consultation with the clinical team and administration services, it was not clear
how and when the hospital was feeding this data into its PAS system. The overall
process and reporting times remained unclear.
Constraints to the death registration process could pose additional obstacles.
Indeed, when inquests and post mortems take place, the death is only registered
after the inquest. The overall figure from the 2012 coroners statistics bulletin
[140] states that post mortems were carried out in 30% to 50% of all deaths in
Norfolk and in 42% in England and Wales. The same report states that the
average time to process inquests is between 20 and 30 weeks in Norfolk (27 weeks
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in England and Wales), however, post mortems are usually carried out within a
few days of the patient’s death. Nevertheless, NHS institutions only keep the date
of death, and the NSTS/PDS hold the date of death and a separate indicator of
whether it has been registered or just recorded by an NHS institution. It is not
expected that inquests and post mortems are likely to affect the quality of the
reported deaths. However, with regards to timeliness, in cases where deceased
patients were found some time after they died, post mortem investigations might
reveal an earlier date of death.
The following sections detail an investigation on the quality of the dates of death
present in the hospital’s patient administration system, resulting from a record
linkage exercise between the cohort of stroke patients, the hospital PAS system
and the National Tracing Service (NSTS). The data collected from the NSTS, late
in 2012, was requested by the hospital’s information services department based
on a list of NHS numbers suffering a stroke. This time consuming step resulted in
a matching set containing the most recent and accurate demographic information
for that cohort.
Cohort, Linkage and Validating Identities
The record linkage step consisted of linking the NSTS dataset with the stroke
register and a PAS dataset based on NHS number. This exercise uses a simple
file group with no type 3 files and only one type 2 file (the stroke register). Only
patients with a valid NHS number could be matched accurately to the national
database. In this cohort, all selected patients have a valid date of death (DOD)
in the national system (between 1997 and 2011) and from the stroke register
database, only the patients’ last admission is considered. Some of the records in
the national system, however, may have been previously restricted at the patient’s
request and this may result in a mismatch.
A total of 5,092 records from the NNUH with valid NHS numbers and a date of
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death in NSTS were selected. From this set, 2.2% (n=116) of records were not
accurately matched with NSTS either due to incorrect or inconsistent identifiers
(including date of birth or surname) or because they were restricted or not present
in the NSTS database. It was not possible to ascertain the true reason for the
mismatches, however, the vast majority of those (71%, n=82) died before 2001.
A manual inspection of some of the records revealed that the issues could lie with
NHS numbers but that further inspection and access to the NSTS system would
be needed to understand whether the mismatching pairs were indeed from the
same person.
The mismatches were removed from the dataset and a total of 4,976 patients
(56% female) with average of 331 patients per year (SD 73) and matching NHS
number and hospital numbers was found. The average age of the patients at
stroke episode is 80 years (SD 10) and the average age at death is 82 years (SD
9).
In a first instance, it was important to further validate the identities of the mis-
matching pairs by looking at any mismatches of the identifiers (other than NHS
numbers). Gender and date of birth were used and considered sufficient to val-
idate the links. As shown in table 3.10, no mismatches were found in gender or
NHS number, yet a small number was found in date of birth (0.4%). A larger
number of mismatches was found in date of death (10.4%) and, upon validation
of the links with the identifiers, this is the focus of the work carried out here.
Data Element Frequency
NHS Number 0
Gender 0
Date of Birth (DOB) 0.4% (n=21)
Date of Death (DOD) 10.4% (n=519)
Table 3.10: Overall number of mismatching records for the three patient identifier
elements (three first rows) and date of death.
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An analysis of the distribution of the mismatches in the identifiers (in this case,
only dates of birth), allowed an understanding of the extent of the error (i.e. how
far apart the two dates of birth from the different systems were). All records
had a valid date of birth (no missing values): 38% (n=8) were a day apart, 19%
(n=4) were between 5-61 days apart, and 33% (n=7) were either 365 or 366 days
apart. This leaves two values, one 730 days apart, and another 336 days.
When investigating whether the mismatches would have a potential effect on the
quantification of mismatching dates of death, it was found that only five records
would be affected That is, of the 21 mismatching dates of birth, five also had
a mismatching date of death. Four of those had a mismatching date of birth
within a day and one within 365 days. These could be both due to typographical
errors and not true identity mismatches. Because all other records (n=16) had a
matching date of death and their names were manually inspected, they were also
not considered identity mismatches.
It is possible to state that, from the cohort of 4,976 stroke patients, 0.4% had
an incorrect date of birth, most likely due to typographical error (same day and
month but different year, or a day before or after) or a small delay in the reporting
process. However, it is not possible to ascertain here which data source holds the
true date of birth.
Nevertheless, sufficient evidence was gathered to validate that the linkage and
an analysis of mismatching dates of death should not be affected by incorrect
identities. The validation of identities could be considered a pseudo-probabilistic
exercise in the sense that only matches with a probability of 1 were considered
valid using the available identifiers. The computation of the probability of mis-
matching records belonging to the same person based on the other identifiers
was not necessary. It is now pertinent to inspect the distribution of the 10.4%
(n=519) mismatching dates of death.
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Figure 3.15: Distribution of Date of Death Matches and Mismatches. Difference
in days between the date in PAS and date in NSTS, and percentage of missing
data from PAS. The figure is scaled to show the distribution of missing data
across all time intervals.
3.3.1.7 Mortality Linkage Results and Evaluation
Figure 3.15 shows the distribution of the matching of all records. The negative
values indicate that the date of death in PAS was before the date in NSTS. A
first observation is that there are more positive values (n=135) than negative
ones (n=84), perhaps indicating a natural delay in processing or reporting the
information from the local to the national system. Another important observation
is that 6% (n=300) of mismatches are indeed missing from the PAS system. It
is also important to note that the remaining 4.4% of mismatches do not exceed
a 365 days difference, and hence, when using the PAS source alone to determine
dates of death, the worst case error would be for the dates to be at most within
a year.
Given a distribution of the dates of death (DOD), on average, 20 patient deaths
(SD 14) are missing from the PAS system every year and 15 (SD 5.6) are recorded
incorrectly (within a year). However, this number isn’t consistent throughout
the years. Figure 3.16 shows the yearly rates of missing and erroneous DODs.
Despite the volatile numbers, the proportion of missing DODs has increased over
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Figure 3.16: Distribution of Date of Death Mismatches (erroneous and missing)
by year, from 1997 to 2011. The yearly average is 10.1% (SD 3.6) of which 5.6%
(SD 3.4) is missing and 4.5% (SD 1.7) is recorded incorrectly (within a year).
this time period, having a maximum of 10.2% in 2004 and a minimum of 1.27%
in 1997. The computed average (15 years) for missing deaths is 5.57% (SD 3.37)
and for errors is 4.5% (SD 1.68). When observing the last five years (2007-
2011), the missing average is 5.68% (SD 2.79) and error average is 4.41% (SD
1.94) suggesting little difference before and after the implementation of the SCR.
However, the 2002-2006 and 2010-2011 periods are noticeably high for missing
deaths, both averaging 9% (SD 1 and 0.008 respectively). It was not possible, at
the time of writing, to explain the reasons behind this, even after consultation
with hospital staff.
When observing additional features of those with missing dates of death in PAS
(n=300), a larger number of females was present (66%, n=197). The proportion of
females with erroneous (typographical) errors was found to be 53% (n=118) and
55% (n=2468) for matching records. When grouping errors and matches together
and comparing them against those with missing dates of death, a statistically
significant relationship was found. The odds of having missing dates of death
in females is 1.83 times higher than in males (Confidence Interval [1.423, 2.357],
p-value < 0.001).
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It is not well understood why females have proportionally more missing dates of
death, however, an increased life expectancy is a possible driver. Overall, females
in this cohort died with an average age of 83 (SD 9) whereas males died at 80
(SD 9). Within those with missing information, females died on average at 85
(SD 8) and males at 81 (SD 9). Further information, not available here, could
help to explain whether the missing data exists due to families (or partners)
not reporting the deaths back to hospitals or GP. However, when using other
available data fields such as discharge destination, no significant difference was
found between those who were discharged home alone or home with family.
Table 3.11 shows a distribution of the discharge destination field, discriminating
between OSR and NSR and showing the original values. This exemplifies the
semantic heterogeneity between the systems. Table 3.11 is also in ascending order
of matching percentage. As expected, from those that died in hospital, only one
record was missing a date of death. Indeed deaths in hospital have a significant
effect in lowering the overall number of missing dates of death. When these
are excluded from the dataset, the overall (adjusted) number of missing dates
of death becomes 10.39% and errors, 4.86%. Nevertheless, the above correlation
between females and missing data still holds true when excluding those that died
in hospital (Odds Ratio 1.6, Confidence Interval [1.22, 2.05], p-value < 0.001).
From table 3.11, those in the OSR who had a “long stay hospital” also had
a percentage of missing records below the adjusted average at 9.87%. This is
particularly significant because “long stay hospital” patients make up a quarter
of the total number of patients in the dataset. Those discharged “home with
family [no care pkg]” from the OSR are the third largest group (10%) and also
under the adjusted average at 9.16%. Lastly, the fourth highest (8%) is OSR’s
“Rehabilitation unit” with an above average value of 11.42% and the overall
highest percentage of missing values (22%) pertains to those discharged to another
hospital or department.
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Table 3.11: Original discharge destinations from the OSR and NSR and given
coverage, percent of matches (in descending order), missing and typographical
errors for dates of death.
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When grouping those that were discharged to other institutions (n=437, com-
munity hospital, nursing/care home, other hospital) with those discharged home
(n=800, home with and without family, early supported discharge) a statistically
significant relationship was found. Those discharged to other institutions were
found to be 1.52 times more likely to have missing dates of death when compared
to those who were discharged home (Confidence Interval [1.04, 2.23], p-value =
0.023). The remaining group (n=3,739) includes those that died in hospital, those
discharged to another hospital location, and unknowns.
In this linkage exercise, the identity of each patient was validated against other
identifiers. As such, even though it is a inter-organisational linkage exercise, it
was not necessary to compute the probability of a particular record referring to
the same identity. A simpler, deterministic linkage approach was undertaken.
Key Findings
This exercise allowed important questions that may be useful to other studies, or
in other areas using hospital data, to be answered. In particular, this exercise has
helped with the understanding of how the information flows back to the hospital
after a patient dies. Four major key points, previously unknown, were identified
based on a cohort of 4,976 patients who had a stroke between 1997 and 2011:
• The total number of potentially erroneous or mismatching dates of death
when using PAS data was identified at 10.4%. However, given the available
data, it is expected that erroneous dates, when available (4.4%), lie within
a year of the true date of death.
• The overall number of missing dates of death in PAS for patients who have
indeed died is 6%. From those that died in hospital only one record was
found to be missing (<0.005%). When removing those that died in hospital,
the overall adjusted number of missing dates of death rose to 10.39%.
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• Overall, females were more likely to have a missing DOD than males, and
those discharged to other institutions were also more likely to have a missing
DOD when compared to those who were discharged home.
• A year-on-year distribution of missing DOD over the 15 year period would
be best fitted by a higher order polynomial trend line; it shows periods of
high values followed by, or preceded by, periods of low values. The max-
imum recorded missing value was 10.2% in 2004 and the lowest, 1.27% in
1997. The introduction of the SCR showed no significant or sustained im-
provement in the number of missing DODs, although more data is required
to confirm this assertion.
The limitations of this exercise include the fact that only stroke patients were
considered, which might reduce its generalisability to other domains, despite a
large cohort of mostly elderly patients being used. The lack of consistency in
field values between OSR and NSR made it more difficult to group discharge
destinations and, more generally, to prepare the dataset, as other field values also
had to be mapped. When the cohort was first retrieved from PAS, additional
important data could have aided the interpretation. In particular, GP post codes,
marital status, and free-text notes regarding the date of death would have been
beneficial.
Nevertheless this exercise provided valuable insights into a previously unknown
and unquantified topic. This would not be possible without the linkage of three
distinct data sources. It is now known that, should these numbers be generalised
to other populations, a conservative margin of 10.5% missing values for those who
did not die in hospital should be taken into account. It is expected that, when
SCR are fully implemented across GP practices and records are systematically
synchronised with the PDS system, hospitals can begin to rely on SCR reports to
accurately feed their systems. Further work is still needed and it would be bene-
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ficial to analyse missing data by GP postcode for a longer time period. Despite
the limitations, this exercise allowed the stroke register database to become more
complete as missing values were replaced with dates of death from the national
database.
3.3.1.8 Discussion and Conclusions
This section explored record linkage by undertaking two exercises. A first exercise
examined how rule-based linkage was used to join a set of stroke episodes with
a respective set of blood readings. The second exercise explored how stroke
patients were linked with a national demographics database to assess their follow-
up status. Both exercises revealed that record linkage is feasible and can be used
to enrich the value of the data present in hospitals.
Regarding the first exercise with a complex file group, the purpose was to find, if
any, the most relevant reading of a blood test for each record in the stroke register.
The exercise provided insights into the the availability of electronic biochemistry
records for stroke admissions and discharges. The majority of patients had a
haemoglobin reading at admission (91.4% within a day of admission) yet only
35.1% had a reading within a day of discharge. The distribution of readings at
discharge is scattered, and depends on each patient’s length of stay. Nevertheless,
the number of mismatches was consistent for both admission (1.5%) and discharge
(1.6%). In this exercise, haemoglobin was sucessfully used to develop and test the
linkage technique. The same technique was later applied to 21 other biochemistry
tests, as depicted in section 3.3.2.
The second exercise, aimed at linking the stroke data with mortality data from
PAS and the national demographics system was a simpler linkage exercise from
a technical standpoint. However, this exercises demonstrated the feasibility and
value of linking patient hospital data to national databases. In particular, given
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the observed time-period, it was found that 10.39% of all patients who had a
stroke and died after discharge were missing a date of death (DOD) in the hospital
systems. By linking other data sources and obtaining additional features about
those with missing DODs, females were found to be more likely to have a missing
DOD than males, and those discharged to other institutions were also more likely
to have a missing DOD when compared to those who were discharged home.
Furthermore, changes to hospital services, data quality processes and national
systems are likely to have contributed to a volatile distribution of missing data
over time. This exercise also served to provide correct mortality information to
the stroke database.
The evaluation of data linkage exercises, that is, assessing whether matching
records have indeed the same identity, is often a difficult task, only possible with a
test set of previously known matching and mismatching pairs. This is particularly
true in probabilistic exercises [141] whereas in deterministic exercises, additional
features can be used to inform on the accuracy and reliability of the matches. In
the first exercise described in this section, evaluation was performed by a manual
inspection of patient notes. In the second exercise, other key identifiers were used
to ascertain the true matches. In the latter, 2.2% of records in the initial dataset
were not accurately matched with the national database due to inconsistencies
in other key identifiers. This shows that deterministic linkage, despite relying on
unique identifiers, is also prone to error.
Overall in this section, the data linkage exercises were performed to provide addi-
tional data for research. However, data linkage systems as a research infrastruc-
ture have been described [9] and in the next section, the proactive use of record
linkage is described as part of efforts to build a research data warehouse.
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3.3.2 Data Warehousing and Integration
In the previous chapter, a methodology for multi-source data collection was in-
troduced and used to create a stroke operational data store (ODS). The previous
chapter also briefly discussed how an ODS could be used to develop integrated
repositories or data marts. This section describes this process in more detail and
with regards to the development of a sustainable infrastructure for linkage, stor-
age and reporting of the stroke data. In particular, this section describes how
the stroke data in the ODS was integrated and the development of the Norwich
Research Stroke & TIA Register data warehouse.
Data warehousing is a concept that emerged in the 1980s to tackle the chal-
lenges of using traditional transactional systems for reporting. Upon a thorough
background review, the works of Bill Inmon and Ralph Kimball dominate the
literature [2] but are mostly aimed at IT practitioners. It is not until recently
that academics began to take an interest in the subject, and thus the field has
been mostly driven by the market, rather than by the research community [142].
As such, there is little consistency in the literature regarding the historical fac-
tors that led to the development of data warehousing techniques, concepts and
technologies.
Section 3.3.2.1 introduces a historical perspective on data warehousing; it intro-
duces key ideas, concepts and models and the state of the art developments in
the field. Later, in section 3.3.2.2, this is explored with regards to health infor-
matics and key background information on similar developments tailored to this
area is introduced. In section 3.3.2.3, a thorough understanding of data ware-
housing architectures allowed the adoption of key concepts and methods for the
development of the stroke register data warehouse. In particular, section 3.3.2.4
introduces a methodology to develop the warehouse. This is a novel hybrid ap-
proach, applicable to other domains, with the purpose of supporting and building
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research capacity infrastructure whilst allowing a better understanding of stroke
care over time and new research questions to be answered.
3.3.2.1 A Historical Perspective
The creator and principal architect of the first commercially available database
management system was Charles W. Bachman in 1963 [143; 144]. The Integrated
Data Store, also known as the navigational database, was a revolutionary system
based on a hierarchical model of arranging data. In this model, a tree-like struc-
ture represents information via relationships, for example, a parent node having
one or more child nodes (a one-to-many relationship) [145]. Paths and point-
ers were used to navigate and query the database, creating an emphasis on the
navigation itself rather than “declaratively” selecting the required data [143; 145].
During the 1960s other systems and data models continued to appear[146; 147].
Of particular relevance is the Conference on Data Systems Languages (CODA-
SYL) model which helped to standardise database interfaces. Also known as the
network model, the CODASYL model allowed each record to have multiple par-
ent or child records, forming a graph-like structure rather than a tree-like one,
enabling the representation of more complex relationships [147; 148].
By the end of the 1960s the early database systems were arguably home grown,
ad hoc collections of ideas formulated into systems, originally designed to solve a
particular problem and later extended to become a more general purpose solution
[149; 150]. The shortcomings that then existed in the fields of database manage-
ment and application development (in particular, querying and relating data)
were addressed in 1969 when Edgar F. Codd introduced the relational model
[149; 150]. Codd’s work on the relational model was preceded by David Childs’
feasibility work of a set-theoretic data structure [151], which introduced the idea
of relations in data systems.
146
3. Preprocessing, Linkage and Data Warehousing
In brief, the relational model is a database model based on first order predicate
logic where data is represented in terms of lists of elements (tuples) grouped into
relations (between a tuple and an attribute) [150]. The concept of a relational
database with a tabular organisation where each record (row) has a series of
attributes (columns) was then introduced, and it became one of the most fun-
damental concepts in computing sciences. Using a relational database system,
users were able to query the data tables resulting in a specific set of data (called
a view or resulting set). Developing the relational model, in the following years,
Codd [150] introduced a set of normalisation rules to minimise redundancy (di-
viding large tables into smaller ones) and dependency (utilising relations whereby
modifications to the table could be propagated throughout the database).
Before Codd’s ideas were introduced, businesses had already begun implementing
operational database systems for storage and retrieval of day-to-day activities. In-
deed the concept of On-line Transaction Processing (OLTP) technology emerged
soon after Bachman’s navigational database [143; 145]. An OLTP system focuses
on tasks that are structured and repetitive, consisting of short, atomic, isolated
transactions [152]. Such systems work with detailed, up-to-date data, and read
or update database records [152]. With Codd’s relational model introduced, most
operational systems began to rely on database normalisation and a data model
(such as the entity-relationship model) to ensure data integrity and the timeliness
of recording of their transactions. This model was ideal for businesses’ day-to-day
operations.
Upon sucessful implementations of operational database systems [146], businesses
became interested in harnessing the statistical power of their ever growing data
for reporting, accounting, planning or forecasting. Operational systems, however,
were not at the time built for this purpose. As a result, the increasing demand for
complex analyses and summaries of transactions added pressure to the existing
operational systems, affecting their primary uses. A solution that enabled the
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secondary uses of such systems and their data was much needed.
Data warehousing as a concept dates back to the late 1980s when IBM researchers
Barry Devlin and Paul Murphy developed the “business data warehouse” [153].
At the time, the purpose of a data warehouse was to feed data from operational
systems to decision support environments for analysis [154]. Without a data
warehouse in place this process would be technically difficult for the operational
system and would introduce a significant delay in both reporting and the current
operations. Three main technical difficulties were given by Delvin and Murphy
[153]:
• Ensuring that the performance of the production (operational) systems is
not disrupted by ad hoc queries or analyses.
• Requiring that information needed by end-users is not changing as they use
it (point-in-time data).
• Operational systems designed for high volume processing are not often suit-
able for answering unpredictable queries from end-users.
The concept of a data warehouse was emerging as a way of separating and organ-
ising the data stores according to their intended use. Operational systems would
primarily focus on day-to-day activities (for example, order entry, distribution,
billing) while one or more informational systems concentrated all aspects of re-
porting and analysis. As such, Delvin and Murphy worked on extending the basic
data architecture to support this environment. Based on the existing relational
database environment, they proposed the “Europe, Middle East and Africa Busi-
ness Information System” (EBIS) architecture for informational systems [153].
The core component of this architecture is the business data warehouse (BDW),
regarded as the single logical storehouse of all the information used to report on
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the business [153]. End-users interacting with the BDW are presented with a
particular view, determined by the user’s requirements and containing accessed
data. The BDW connects to the operational system via a data interface (that
feeds data in an agreed-upon format) and to the end-users’ workstations. A
business data directory is also connected to the BDW where information from a
data dictionary (first introduced in 1975 by Uhrowczik [155]) and business process
definitions are made available. The data in the BDW can be retrieved raw or it
can be enhanced (by, for example, aggregation or summarisation), depending on
the level of abstraction needed by the end-user.
The EBIS achitecture fuelled the discussion among practitioners and researchers
on data warehousing improvements and business models adaptations, and is ar-
guably one the foundations of today’s modern data warehousing architectures,
discussed in detail in the next section.
Shortly after EBIS, in 1993, William Inmon introduced the concept of a data
warehouse as a “subject oriented, integrated, non-volatile and time-variant col-
lection of data in support of managements decisions”[156]. Inmon’s work [156]
is widely cited and he is often referred to, in the literature, as the “father of
data warehousing”, having published the first book on the subject. Inmon’s work
became prominent in the 1990s and established four key characteristics of data
warehouses:
• Subject Oriented
In a DW, data should be organised by major topic or subject area. This is
an important characteristic that determines the usability and performance
of the data warehouse.
• Integrated
Data from different operational systems needs to be integrated into a data
warehouse. It is often the case that information across operational systems
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lacks consistency in encoding, naming conventions or physical attributes,
as seen in the previous chapter.
• Non-volatility
Data in the operational system is highly volatile, i.e. it may change over-
time. In data warehouses, data is non-volatile in that only a snapshot of the
data (cross-sectional data) is available. Data warehouses may keep several
snapshots of the data over time.
• Time variancy
Every record in a warehouse must have an associated time (date of transac-
tion or time stamp) indicating the moment in time during which the record
is accurate.
Along with these characteristics, Inmon advocated a top-down approach to de-
veloping data warehouses that adapts traditional relational database tools to the
needs of an enterprise-wide data warehouse [2]. Inmon’s view of a data ware-
house is of a centralised system with all, or almost all, departmental systems in
an organisation feeding data into it.
Also in 1993, Codd introduced the concept of an On-Line Analytical Processing
(OLAP) system to oppose the On-Line Transaction Processing (OLTP) [149].
An OLAP system can be regarded as a informational system (such as a data
warehouse) and a OLTP system would be an operational system. However, there
are also differences between a data warehouse (as defined by Inmon) and OLAP.
Inmon describes OLAP as a technology while data warehousing is an architectural
infrastructure, he also notes that a “symbiotic relationship exists between the
two” [156]. When it comes to organising data, OLAP uses a multidimensional
view of aggregate data to provide quick access to strategic information for further
analysis [157] while a data warehouse is usually based on the relational model.
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The multidimensional model organises data in multidimensional tables (called
data cubes) and it may be implemented alongside a data warehouse [158]. Nor-
malised data from relational databases would typically be denormalised for an
OLAP environment so as to improve performance and facilitate reporting. In an
OLAP system, dimensions include data from a single domain. An example from
a sales environment would be to define the following dimensions: time, product
and geographic area. An OLAP report would then look at sales by specific di-
mensions, where similar information is lined up. Common capabilities of OLAP
also include aggregation, drill-down and roll-up, and slicing and dicing [157; 158].
These operations provide additional ways of selecting data from the cubes and
their dimensions and have been particularly fruitful in answering business ques-
tions [142; 158].
Following OLAP developments in the early 1990s, in 1996, Ralph Kimball in-
troduced a novel model for data warehousing [159]. Kimball’s model opposed
Inmon’s in that building a data warehouse was by him considered a bottom-up
approach, heavily based on the dimensional model. Kimball’s model suggests
creating one database (or data mart, a domain-specific subset of a data ware-
house) per major business process first and then utilising a “data bus” to enable
interoperability and integration between them [2]. Inmon’s model, in contrast,
relies heavily on a single centralised data warehouse. The differences between
Kimball’s model and Inmon’s model are given in more detail the next section.
In addition to the idea of a centralised data warehouse, in 1998, Inmon worked
on the development of the Operational Data Store (ODS). The purpose of this
database, as seen in the previous chapter and the works of Brazhnik and Jones [6],
is to act as a facilitator for the integration of data from multiple sources. An ODS
would then allow transformations and the Extract-Transform-Load (ETL) process
to upload information to the data warehouse. Indeed, an archaic version of an
ODS and ETL had previously been envisaged by Devlin and Murphy whereby an
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interface to operational systems and a transmission manager moved information
from operational systems to the data warehouse [153].
Both Inmon and Kimball continued to perfect their models in the 2000s and
implementations of both together with hybrid models of data warehousing began
to appear. Inmon’s approach tends to be more costly than Kimball’s but it may
suit the sustainable needs of large enterprises. Inmon’s approach may, in addition,
be better suited for developing warehouses where data queries are not repetitive
or recurrent (for example, monthly reports).
Also in the early 2000s, Dan Linstedt [160] introduced the concept of a data
vault. This is a hybrid approach, perhaps the most prominent to date, and it
encompasses “the best of breed between 3rd normal form (3NF) and the star
schema”[160]. In this context, 3NF represents the normalisation form achieved
with the relational model and the star schema is the simplest style of a dimen-
sional data mart where a central main table (fact table) is surrounded by di-
mensional tables that allow operations such as slicing or dicing. In brief, the
data vault model attempts to separate informational elements that are prone to
change from more static ones, and to represent relationships dynamically using
link structures[160]. As a result a vault model is more scalable, flexible, has
a dynamic structure, reduces data redundancy, and copes with data’s rates of
change [160]. Such a model is particularly useful in coping with change in the
environments and would suit large business implementations.
Later, in 2010, Inmon introduced the second generation of data warehousing (DW
2.0) [161], concentrating efforts on the life cycle of data within the warehouse,
the new types of data (for example, multimedia) including unstructured data,
metadata, and the “hunger” for integrated corporate data [161]. The data vault
model was also revisited in 2013 but, at the time of writing, little research was
found in the literature and, to our knowledge, no significant implementations
were reported in research papers.
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Despite the efforts to standardise data warehousing methods, models and archi-
tectures, building a data warehouse continues to be an ad hoc exercise, tailored to
individual problems and domains. The following section discusses key implemen-
tations of data warehousing technologies in healthcare, which has traditionally
been one of the most challenging environments [21].
3.3.2.2 Summary of Data Warehousing in Health Care
In 1966 the Multi-User Multi-Programming System (MUMPS) system was devel-
oped at the Massachusetts General Hospital, Boston by Greenes and Pappalardo
[162]. MUMPS was an interpreted programming language incorporated into a
hierarchical database file system [163; 164] and it worked as an application pro-
gram for clinical data management. This OLTP-like system was optimised for
high-throughput transaction processing and, at its core, lay a database that later,
in 1989, functioned as a clinical-data repository and an on-line data warehouse,
with a querying software called ClinQuery [164; 165].
Another early system had been developed in the US in 1975 at the Latter-day
Saints (LDS) hospital in Salt Lake City, Utah. The HELP system, today, is
one of the oldest active systems [166] and it was arguably the first to integrate
clinical data with a decision support system (DSS) [166; 167]. This system was
the first in healthcare to employ the Entity-Attribute-Value (EAV), a data model
available before commercial relational databases based on Codd’s model. The
EAV represents data vertically, where each row contains three columns describing
the entity, the type of information, and its value [22; 168].
Clinical data management systems continued to be developed [164; 169; 170;
171] and Codd’s description of systems as ad hoc and home grown also held
true in healthcare. Most database systems and data warehousing solutions, even
implementing published data models [163], were mostly in-house solutions for
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particular problems. It would become apparent later that the individual problems
and solutions had similarities throughout institutions [164].
Another example of a home-grown system was made known later, in 1997, after a
report of a successful clinical data warehouse was published [172]. In this study,
datasets were extracted from the production system at Duke’s University Medical
Center, North Carolina, cleaned and mined using exploratory factor analysis.
This is also one of the early publications in medical data mining. Similar reports
continued to follow [164; 173].
It is then, in 1998, that a first survey on clinical data warehousing emerged in the
literature [142; 174]. The authors acknowledged that the use of data warehousing
and other computing technology in healtcare had been hindered by a lack of
understanding of what benefits this technology might bring. It was natural that
only the institutions that had close links with computing scientists or engineers
were able to implement their own solutions.
As reported in the survey, one of the few European efforts in implementing clin-
ical data warehousing systems at the time was at the Turku University Hospital
in Finland [174; 175]. The reported system would integrate data from several
hospital and laboratory systems to provide a broad view of clinical data suitable
for research [175]. Their first studies successfully combined blood readings with
drug prescriptions and it resulted in novel clinical results showing how certain
drugs interfered with particular blood tests [174; 175].
Since then, and as predicted by the authors of the survey, clinical data warehous-
ing have continued to emerge [142; 174] and the development of technology, data
standards, ontologies and other works in health informatics have contributed to
enrich the literature and advance implementations. However, in the early 2000s,
Sujansky reported that the “decentralized nature of our scientific communities
and healthcare systems has created a sea of valuable but incompatible electronic
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databases” [21]. Sujansky’s work highlighted the perennial problem of heteroge-
neous database integration in healthcare, and as discussed in the previous chapter,
this problem continues to exist.
Efforts to address this issue, in the early 2010s and up to date, have focused on
developments of biomedical ontologies, semantic web technologies and also frame-
works for integration of clinical data with other research data. Initiatives such
as the health level-seven, the Clinical Data Interchange Standards Consortium
[176], and the recent DW4TR [177] and i2b2 [178] have seen fuitful applications.
The latter is a system designed in the US for cohort identification of clinical and
research biology data, allowing users to perform queries on integrated health and
research (biological) data. The system was later extended to include reporting
and visualisation tools and its software is now available as open-source, allowing
other institutions to implement and test it. At the time of writing, i2b2 is being
tested at a single UK site, at the University of Leicester, in order to help with data
integration and selection of cohorts. In 2011, an evaluation of four different im-
plementations was carried out in Germany [179]. Although issues were reported
with regards to runtime, querying restrictions and setup process (in particular
where manual interventions were needed to construct valid ontology metadata),
the authors reported that the i2b2 system was a valuable platform for integra-
tion and data query tasks in four different use cases [179]. The i2b2 continues to
improve its software with the focus of integrating clinical and research data (such
as genomics data) but it also continues to depend on existing implementations
of OLTP (such as electronic health records) and OLAP (such as local data ware-
houses) systems. Furthermore it has been noted [180] that the i2b2 was designed
for querying and processing purposes and it does not provide powerful means for
the loading of data into its own database.
In 2013, Inmon reviewed data warehousing in healthcare and highlighted two
overriding architectural differences when compared to corporate environments
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[181]. The first difference is that in healthcare environments, unlike corporate
environments, the information can also be generated outside of the confines of
the provider. The second difference is the high volume of non-numeric, non-
transactional data with which commercial database systems are not designed to
work. There are also, similarities: the high volume of data (some of it transac-
tional), the need to look at data holistically (and “patient-centrically”), the need
for data transformation, and the need to support day-to-day activities as well as
reporting or research.
The use of frameworks such as the i2b2 or DW4TR should help to overcome the
integration of health data and the development of databases or data warehouses
for research. However, there is still little evidence as to how such systems and
implementations can co-exist with hospital operational systems in the long term.
The following section discusses the current approaches on data warehousing ar-
chitectures and methodologies further and introduces the technical background
and foundations of the work presented later.
3.3.2.3 Architectures and Methodologies
Before delving into a particular data model, architecture or methodology to build
a data warehouse, it is customary to adhere to an overall design philosophy guided
by either Inmon or Kimball’s views [182].
Inmon’s model sets out to deliver a sound technical solution based on proven
database methods and technologies while Kimball’s focuses on delivering a so-
lution that makes it easy for end-users to directly query the data and still get
reasonable response times [2]. Table 3.12 shows a summary the differences be-
tween the two models.
In this chapter, the purpose is to build a storage infrastructure that holds the
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Characteristic Kimball Inmon
Nature of the orga-
nization’s decision
support require-
ments
Tactical Strategic
Data integration
requirements
Individual business areas Enterprisewide integration
Structure of data Business metrics, perfor-
mance measures, and score-
cards
Non-metric data and for
data that will be applied to
meet multiple and varied in-
formation needs
Scalability Need to adapt to highly
volatile needs within a lim-
ited scope
Growing scope and chang-
ing requirements are critical
Persistency of data Source systems are rela-
tively stable
High rate of change from
source systems
Staffing and skills
requirements
Small teams of generalists Larger team(s) of specialists
Time to delivery Need for the first data ware-
house application is urgent
Organization’s require-
ments allow for longer
start-up time
Cost to deploy Lower start-up costs, with
each subsequent project
costing about the same
Higher start-up costs, with
lower subsequent project
development costs
Table 3.12: Specific characteristics favouring Kimball or Inmon’s model [2].
Norwich Research Stroke Register and is capable of answering diverse research-
led queries. Clinical data on strokes already exists in operational databases or
legacy systems but additional data needs to be fed from other systems (such as
the laboratory or administration system).
While Kimball’s solution seems appropriate from the point of view of “business
size” by concentrating on an individual business area (strokes), it is limiting from
the point of view of data structure as the dimensional model favours recurrent or
repetitive queries. Inmon’s “relational-friendly” approach satisfies a much wider
range of data queries which is indeed what is expected from the stroke register
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warehouse for research.
The above general design philosophies are discussed in detail and with respect to
their methodological and architectural implications in the next sections.
Selecting an Appropriate Methodology
Inmon and Kimball also propose two distinct yet complementary approaches to
data warehouse development. Inmon proposes a top-down methodology where
the primary interest is that of ensuring that the technical solution works [2]; it
is based on the spiral software development methodology [183], is goal-driven
and supports an organisation long-term in turning strategy into action [184].
Boehm’s spiral methodology can be succinctly summarised by its quadrants [183]:
Determine objectives, alternatives and constraints; Evaluate alternatives, identify
and resolve risks; Develop, verify next-level product (includes implementation and
design validation); and Plan next phases (includes evaluation).
In contrast, Kimball’s bottom-up approach, where multiple data marts are built
first and then integrated, has a short-term focus. It is not as technically demand-
ing and, as a result, engages end-users [2]. Furthermore, the bottom-up approach
“exploits the database and is suited for tayloristic measurement” [184]. Kimball’s
methodology comprises, in its highest level, four planning and design steps [185]:
Requirements & Realities, Architectures, System Implementation, and Test &
Release.
A further distinction has been made between data-driven and user-driven ap-
proaches [184]. Inmon argues that warehousing environments are data-driven as
opposed to being built purposely for users’ needs [156; 184]. A data-driven de-
velopment methodology has also been recommended for data mining and data
exploration purposes [184] and would seem appropriate for the work carried out
in this thesis.
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Overall, methodologies share a common set of tasks: requirements analysis, data
design, architecture design, implementation, and deployment [182]. Other re-
search papers on the methodological aspects of data warehouse design were re-
viewed [2; 182; 184; 186; 187], yet for the purpose of the work carried out here,
the work of Szirbik et al.[3] stood out as most relevant.
Szirbik et al. noted that most methodologies typically only cover partial aspects
and too many gaps are left; however, attempts to fill these gaps would also reduce
the comprehensibility and usability of the framework [182]. The authors intro-
duced six methodological steps specifically tailored for the development of medical
data warehouses [3]. The methodology is an extension of the Rational Unified
Process (RUP), an iterative software development process framework[188], but it
may be used on its own as a streamlined version of RUP [3]. The six-steps of the
methodology are summarised in table 3.13.
The methodology used to develop the stroke data warehouse is introduced later
and is based on the guidelines set out by Szirbik et al. and the above-mentioned
common tasks across data warehousing methodologies.
Selecting an Appropriate Architecture
As previously discussed, the main difference between Inmon and Kimball’s archi-
tectural approaches is the “centralisation” of the data warehouse. In addition,
the data vault architecture is similar to that of Inmon’s but would introduce a
more complex data model which would not bring any particular benefits to a
smaller scale implementation such as the stroke register. As a result, the data
vault architecture and model were not explored further. Other architectures were
considered but only those relevant to the work carried out with the stroke register
are presented here.
A centralised approach would be more appropriate for a system such as the stroke
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Step Description
1. Recognise and resolve the most
critical issue(s)
Identify and prove that the hardest task can
be solved; decide whether to go ahead with
the project.
2. Identifying the scope and gran-
ularity of data sources
Identify and analyse the data sources their
data and complementarities; identify incon-
sistencies; validate data collection.
3. Identify the required data Determine data requirements to achieve
stakeholders’ results; reduce the scope of the
data and simplify schemas.
4. Ontological alignment Build an ontology that maps relevant terms
in the scoped universe of discourse; seman-
tic alignment between data sources schemata
and the repository.
5. Determining update policies Establish update policies for each local
source and estimate the costs involved; pro-
cedures for data transformations.
6. Validating and fine-tuning Real-life data gathering; test the correct in-
formation is deposited in the repository; col-
lected data is analysed and compared with
the results of the analysis of the sources; cor-
rect any problems and fine-tune the reposi-
tory.
Table 3.13: A summary of Szirbik et al. six methodological steps [3].
register because only one main source of data is expected and hence, a main data
table would contain most information, i.e. stroke admissions. The additional
data sources are then expected to provide limited amounts of information (blood
readings, follow-up or comorbidities) to individual records in the main table.
Furthermore, the work carried out in the previous chapter already resulted in an
operational data store with some degree of integration. As a result, a structure
where multiple data marts are created for each data source would not, in this
case, facilitate the development of a warehouse.
Figure 3.17 shows two possible architectures, adapted from [189], where the
extract-transform-load (ETL) process is responsible for propagating information
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from the operational sources into an integrated or pseudo-integrated collective. In
the first architecture (figure 3.17 at the top) that collective is the data warehouse
itself whereas in the second architecture it is the operational data store (ODS)
that acts as an intermediate step to reach the data warehouse.
Figure 3.17: Data warehousing architectures with a centralised warehouse.
One of the benefits of using the latter architecture is that it enables further
applications, such as reporting, directly from the ODS. As seen in the previous
chapter, such applications are of particular interest and an ODS had already
been developed. The centralised data warehouse with operational data store
would therefore be most appropriate.
A further extension of the above architecture is to create data marts directly
from the ODS and/or central data warehouse[189]. This would add benefits with
regards to data control and manipulation. Here, data marts are considered to be
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a possible application of the data warehouse and this is discussed again later.
Selected Model, Architecture and Methodology
In summary, a hybrid approach was chosen to build the stroke warehouse where:
• the data model should be fundamentally relational yet pseudo-dimensions
or additional normalisation could be added should they prove beneficial for
query optimisation;
• the architecture is based on a centralised warehouse (with an operational
data store) rather than on multiple data marts and an integration bus;
• a methodology to build and maintain the data warehouse should be based on
the common of tasks reported in the literature (requirements analysis, data
design, architecture design, implementation, and deployment) and guided
by the methodological steps tailored to clinical environments set out by
Szirbik et al.
3.3.2.4 Methodological Steps
In the previous chapter, a framework for data collection from multiple sources
was introduced. The output was a study dataset and metadata for each identified
data source. An Operational Data Store (ODS) was fed both metadata and study
data from several sources and from it it is possible to link, transform and derive
domain-specific datasets for particular studies.
This section describes the methodology used for the development of a domain-
specific clinical data warehouse with data from several hospital information sys-
tems. The methodology was based on previous literature and reworked with the
experience from the case study. Previous work pointed out that data-driven and
simple methodologies produce better results and maximise users adherence. The
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common steps in data warehousing and software development methodologies were
used as a foundation. The guidelines from Szirbik et al.[3] and experience from
the case study were used to further develop each step and the overall structure.
The work carried out here acknowledges that the issues of time, resources and
project management are important and will be discussed when appropriate, but
the methodology concentrates primarily on the delivery of a sound technical so-
lution and on mapping the key steps to achieve it.
The methodology comprises five incremental steps (each achieving a conceptual
milestone that builds upon the previous step) forming an overall iterative cycle
describing the life cycle of the clinical data warehouse. Each step contains three
states within itself: design, test and completion. The design state indicates
that work is being carried out to achieve a particular milestone, the test state
indicates validations of that work are being carried out, and the completion state
indicates successful achievement of a milestone. Upon achieving a milestone (i.e.
completing a step) the next step can begin. However, in steps where backtracking
is allowed, the design state of the previous step would be revisited. In such cases,
the completion state of the original step is not achieved.
Figure 3.18 illustrates the five steps and their interactions with the ODS (dashed
lines) and the data warehouse (dotted lines). The staging area comprises the
ODS, an “adjuvant” database for testing, a metadatabase, a transformation pro-
cess (Extract-Transform-Load), and the external data sources. In the case study,
the stroke data collection had already happened as described in chapter 2, and
hence, a first version of the ODS was already available. The separation between
the ODS and the “adjuvant” database is important as they serve different pur-
poses. The role of the first is to store the data retrieved from the sources whilst the
latter deals with building and testing a workable solution for the data warehouse
(data model, schema, and architecture). Overall, the methodology emphasises
the supportive role of the staging area and, in particular, the ODS, in the devel-
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opment and deployment of a data warehouse. Each step of the methodology is
described in detail below.
Figure 3.18: Methodology to build and maintain a clinical data warehouse.
I. Requirements
The requirements step is regarded as the phase where investigations take
place to understand the needs for the system development, constraints, and
intended purpose.
The intended purpose is to build an infrastructure (a data warehouse) for
the storage and extraction of data marts for research. The data warehouse
should be a centralised and integrated repository of stroke and TIA cases
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with additional laboratory and comorbid information. Details of the source
systems, data and other technical constraints were already given in the pre-
vious chapter when following the methodology that created the operational
data store.
Previous work from Szirbik [3] suggested that the first step would be to
identify and solve the most critical requirement. When developing the stroke
DW, this was indeed found to be a pertinent step and one that should,
together with data requirements, data collection and quality comprise the
larger requirements step.
Identify the most critical requirement
The most critical requirement in the stroke study was to prove that it was
possible to extract and link data from an existing biochemistry system to
a set of stroke events. Without this, the development of the stroke data
warehouse would not be possible. This requirement, however, only had a
workable solution after the next sub-steps were carried out.
Identify the required data and sources
The identification of operational systems where relevant information is present
is one of the first considerations. Meetings with the stakeholders were held
to determine in a first instance, the required data, the systems where this
data is likely to be present, the technical feasibility of accessing the system
and data, and the likely support and collaboration from the system’s owners.
Five data sources were identified: the patient administration system (PAS),
the biochemistry system (LAB), a legacy system containing strokes from
1996-2008, the current stroke database system, and the transient ischaemic
attack (TIA) database, all having different schemata. The national tracing
service system (NSTS) reported in the previous chapter became obsolete by
the time this work was carried out and, for that reason, it is not included here
as another data source. The information on this system (follow-up, death
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registration) was replaced by the information available from the linkage
exercise carried out in the previous section and, from 2012, PAS was used.
Quality and scope of the data and sources
Much of the information regarding the sources had already been gathered
as part of the data collection methodology in the previous chapter. As such,
metadata and data flow diagrams were produced based on four steps defined
in Chapter 2: system understanding, data understanding, extraction prepa-
ration, and extraction & evaluation. This resulted in a sound understanding
of the systems and their data, and in turn, the solution for the extraction
of biochemistry data. At this stage, only a sample of the data from each
system is needed to ensure feasibility and inspect data quality.
Data quality issues were found with some of the identifiers in some of the
sources and a systematic approach to correct them was devised. For exam-
ple, a sequence of queries would identify anomalies in the hospital number
and attempt to correct them. Key identifiers across the sources included
hospital number, date of birth, and date of event. The first two were suffi-
cient to correctly ensure a patient’s identity and the latter ensured the time
variancy aspect needed for any data warehouse (i.e. the moment in time
when a particular event or transaction took place).
The Requirements step ends with a report and a “go ahead” decision from
the stakeholders. Their decision should take into account the most critical
requirement but also the feasibility report on the above-mentioned points.
II. Data Design
This step is concerned with the development or implementation of an ex-
isting data model and ontology. The data model represents the structure
and integrity of the data elements and sets of elements and can be based on
relational, dimensional or other such as the Entity-Attribute-Value (EAV)
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model. It is the data model that determines the expressive power of the
data queries through data engineering languages such as SQL [190] and it
is also often represented by database schemata.
Ontologies, however, can be seen as a set of formulae intended to be always
true according to a specific conceptualisation [191]. An important applica-
tion of ontologies is interoperability and, indeed, an ontology may not only
facilitate the integration of data but also improve communication with the
stakeholders [3].
Both data models and ontologies must consider the structure and the rules
of the domain that one needs to model [190]. Aligning ontologies with a data
model is therefore a critical milestone to produce a data warehouse. Recent
efforts in the development of biomedical ontologies is relying on semantic web
approaches with technologies such as the Web Ontology Language (OWL)
and Resource Description Framework (RDF) [192].
In the stroke case study, the previously gathered metadata allowed the cre-
ation of a simple ontological table which can be regarded as an extended
data dictionary. Because this is a domain specific database, efforts to model
an elaborate ontology were not deemed necessary and a descriptive dictio-
nary was considered sufficient at this stage. For each data source, a data
dictionary was created. A description of the tables and how they relate to
each other is given in figure 3.19.
167
3. Preprocessing, Linkage and Data Warehousing
Figure 3.19: Stroke data warehouse schema.
Schema Development
The overall purpose of the data warehouse is to gather information on stroke
and TIA episodes and as such, the core tables contains all stroke and TIA
admissions. The staging area and ODS (as seen in Figure 3.18) served as
development and testing grounds.
The first challenge was to map the legacy stroke database to the current
one, where a laborious consultation phase resulted in additional metadata.
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50 common attributes were also identified as present in both the legacy
(OSR) and the current system (NSR). In turn, the intersection of these
two data sources, upon transformations to match formatting, resulted in
the main Strokes table, central to the architecture of the warehouse. The
remaining attributes from each of the two sources were accounted for in
two additional tables (Strokes OSR and Strokes NSR), linked to the main
strokes table. The Patient table was another important table created. It
contains patient sensitive information (name, date of birth, hospital and
national health numbers) that allows the correct identification of a patient.
The exercise carried out in the previous section allowed validation and for
further information to be introduced regarding dates of death.
Two other tables were created, one for biochemistry results and another for
comorbidities. These are row-modeled tables containing transactional data
where each row represents biochemical readings events or hospital admis-
sions and their respective comorbidities’ coding. The linkage exercise carried
out in the previous section was crucial in identifying appropriate biochem-
istry readings for a stroke episode; however, further transformations were
needed to create additional “dimensions” and reduce granularity.
A first approach for the biochemistry data relied on the retrieval and stor-
age of every transaction for the cohort of stroke patients. However, due
to the sheer size of transactional data and computational effort needed for
querying, the table was modeled differently to reduce granularity. A more
elegant solution relied on the summarisation of a stroke or TIA episode into
a single row, for each biochemistry test. The summarised elements (see
table 3.14) were carefully selected with the clinical team so that they are
transversal across a wide range of biochemistry tests. This could be seen
as a pseudo-dimensional table, effectively enabling OLAP features. Never-
theless, as discussed earlier, any dimensional approach has limiting effects
on analyses. For example, a time series analysis of a particular blood test
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Attribute Description Data Type
bloodID Primary key, unique for each row. Natural number
patientID Patient ID, foreign key. Natural number
bloodName The name and internal code for a particular
blood test.
String
totalReadings Total number of blood readings during the
stroke admission.
Natural number
average Computed average of all readings. Real number
stDev Computed standard deviation for the above
average.
Real number
max Maximum value found within the stroke ad-
mission.
Real number
min Minimum value found within the stroke ad-
mission.
Real number
admReading Blood reading closest to admission. Real number
admReadDate Date of blood reading closest to admission. Date
disReading Blood reading closest to discharge. Real number
disReadDate Date of blood reading closest to discharge. Date
Table 3.14: The biochemistry data table attributes.
within a patient’s episode is not possible. However, including attributes
such as average, standard deviations and range for blood readings enables
further analyses and was considered sufficient.
The relations between tables along with some of their attributes are given
in figure 3.19 and further details of the attributes are given in Appendix A.
III. Architecture Design
Data design and its subsequent step, architecture design, are closely linked
in that the first defines the representational model of the data and the latter
focuses on the design and build of an infrastructure that is compatible with,
and optimises the use of, such a data model and schema. A number of
iterations between architecture and data design steps can be expected until
both the data model and architecture are in agreement.
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The architecture affects hardware, software, security, coding practices, per-
sonnel, and operations. Issues with these could compromise data quality
and preserving or improving the quality of the data is paramount at all
stages of data warehousing development.
With regards to hardware and personnel, the preferential database manage-
ment system was Microsoft Access due to its availability on-site, the already
in-use services database operated with the same RDBMS software, and the
fact that no significant additional training was required as staff members are
aware of the software. This system would also speed the delivery of the first
versions of the data warehouse as well as minimise hardware requirements.
Nevertheless, in the long term, it is expected that the DBMS changes to a
SQLite, a portable and powerful DBMS (as seen in the previous section)
or an i2b2-compatible DBMS such as Oracle, PostgreSQL or SQL server.
However, the first implementations will be carried out using MS Access
and software to access the DBMS should use Open Database Connectivity
(ODBC) or a Microsoft Access driver. A split MS Access database archi-
tecture is often used to improve performance and simplify maintenance; it
contains two MS access databases, one with the data tables and another
with a front-end and queries. In the case study, the stroke register database
contains the data, query templates and an integration screen, but a separate
querying interface software was developed in Python to run detailed back-
end queries and automatically produce and export CSV files with results.
Relevant operations in the querying software were loosely determined at first
but, over time, and based on study needs, this became more specific and
constrained. It is during the architecture step that the design and improve-
ments of the software are carried out. Likewise, the hardware infrastructure
should also be thought of, but in this case study given the technologies used,
no particular hardware was needed.
Perhaps the most laborious part of this step is concerned with building
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Extract-Transform-Load (ETL) systems and processes that feed data from
the data sources into the ODS. The methodology developed in the previ-
ous chapter dealt with most of these issues and as a result, standard ETL
processes from the required hospital sources were readily available. Nev-
ertheless it was necessary to agree on coding practices, such as those pre-
viously identified in the data model and schema, and on data updates. It
was determined that each version of the data warehouse would represent a
cross-section of the strokes and TIAs at the hospital and have a determined
follow-up date for all the collected data. In effect, in every version of the
database, new data is added and the follow-up dates are extended. It was
not possible to completely automate updates but processes were developed
and some degree of automation was provided in the extraction and trans-
formation tasks. Indeed it is argued that it is not desirable to completely
automate the ETL process in an environment where the data sources and
systems are volatile. As a result, such automation would likely result in
a continuous dependency of additional technical expertise. Conversely, the
development of semi-automated processes allows existing hospital staff to
adjust their processes to changes and to better understand the origins of
their data.
A full diagram depicting the stroke data warehousing architecture developed
here is given later in the discussion and evaluation.
IV. Implementation & Data Feed
This step is concerned with the implementation of the infrastructure and
data model developed in the previous steps and with populating the data
warehouse with records. The implementation and data feed should also be
considered a validation step in its own right, where the milestones achieved
in the previous steps are finally implemented and tested.
In the stroke case study, the implementation of the data warehouse was
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carried out seamlessly. Both the database and software (implemented as
part of a portable framework) were stored in a research laptop and later
made available in a secure shared folder in the hospital’s intranet under
controlled access. Fine tuning was required when populating the warehouse
with records. The previous steps were often revisited in order to adjust the
ETL processes (for example, introducing further constraints or deduplica-
tion) and data types (for example, inconsistencies with dates or unwanted
conversion of real numbers into natural numbers by third party software).
There were no issues with semantic heterogeneity at this stage as they have
been resolved previously.
Quality handling is a key part of this step. Processes should be in place to
ensure any retrieved data meets quality standards and a number of queries
were built to this end. For example, when populating a later version of
the data warehouse, summary queries allowed the identification of a sudden
drop in certain biochemistry records from a particular time-period. This
was the result of coding changes in the pathology laboratory IT system of
which we had not been aware. The issue was resolved upon consultation
with pathology IT staff and by backtracking to the previous step. Logs of
all transformations and dates when data were fed into the warehouse were
kept.
V. Release & Maintenance
Upon a successful implementation and data feed, the data warehouse is
released with a new version after further functionality checks are carried
out. This step may involve the logistics of moving a fully working solution
to an area where it is accessible by the end-users. In the case study the query
engine required additional software (a portable version of Python 2.7) and
the database requires hospital computers to have a version of MS Access.
The methodological steps to develop the data warehouse (as seen in figure
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3.18) should create a continuous looped cycle while the project and/or the
data warehouse remain active. When the Release & Maintenance step is
reached, the cycle becomes idle (in its testing state) until either a problem
is found, additional data is needed, or a new request for a feature emerges.
When a data top-up or refresh is needed, the previous step is revisited,
and when a new feature request or a problem is detected the methodology
returns to its initial step to assess the requirements for a particular change
or problem.
3.3.2.5 Results and Discussion
The above methodological steps were followed and, at the time of writing, two
versions of the research stroke data warehouse have been completed and a third
was being finalised for release. In the first version, the old and the new stroke
registers were matched to produce the main strokes table, whilst keeping the
additional information in separate tables. This was a time consuming exercise as
it required significant consultation work with clinical and administrative staff as
well as the integration of several data fields (semantically and in format). In this
version, the most laborious steps were Requirements and Data Design.
The second version included data from the biochemistry system (LAB source),
comorbidities and follow-up (PAS source), the TIAs table, and the Patient de-
mographics table (derived from PAS and NSTS). In this version all the required
tables were included but consistent database relations and anonymisation pro-
cesses (for example, automatically assign an anonymised number to each new
patient) were not fully operational. Nevertheless, because of time constraints
and the need to demonstrate and discuss progress with the end-users, this ver-
sion was released as such. Linkage and additional cleansing of some of the data
were carried out after any required study datasets were exported from the ware-
174
3. Preprocessing, Linkage and Data Warehousing
house as needed. In this version, both the Data Design and the Architecture
Design were the steps requiring most resources and time.
Version three was, at the time of writing, under a second iteration of the Im-
plementation & Data Feed step where final adjustments were being made with
regards to refreshing data. The first iteration of this step revealed issues with
data quality as the LAB system recently changed the coding of some of the blood
tests, resulting in a loss of information, that was identified by running data qual-
ity queries in the staging area. The LAB system experienced further issues with
their system and halted any back-end operations, resulting in a delay in the deliv-
ery of a fully working version. Nevertheless, version three also included querying
interfaces for the warehouse provided by a MS Access form (built in the data
warehouse) and a separate Python software was developed to facilitate the ex-
port of linked data in a CSV format via ODBC. Further work is also underway at
the time of writing to provide additional patient demographics data to the TIA
table. The most laborious steps in this version were Architecture Design and
Implementation & Data Feed. A full description of the data warehouse tables
and number of records currently in version three is given in Appendix A.
Across the three versions, a shift in the time spent on each step was observed.
This was expected as the work needed in the second and third versions focused
primarily on architectural designs and feeding new data. Nevertheless, at the
time of writing, further work is planned to improve the functionality, embellish the
querying interface and feed additional data. An additional challenge has also been
identified that will require further work across all steps. A new database system
was recently introduced in the stroke services department and, as such, new
methods for retrieval and matching of this data source with the data warehouse
are needed. A preliminary inspection of this new system reveals that similar
ETL processes are required and the methodology presented here provides the
necessary methodological steps to continue to bring new stroke data into the
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data warehouse.
Overall, the methodology presented in Figure 3.18 accounted for all operations
and interactions needed to develop and maintain the stroke data warehouse and
its three versions. A summary of how the methodology steps presented here are
aligned with Kimball’s methodology and Szirbik’s work is given in table 3.15.
Previous work has been carried out on the alignment of Sbzirks’s steps and the
Rational Unified Process (RUP) [3]. The latter, in turn, fits easily with Bohem’s
Spiral model. For these reasons RUP and Spiral models are not shown in Table
3.15 and only the two methodologies specifically tailored to data warehousing
(Kimball’s and Szirbik’s) are included. The methodology presented here, upon
iterating through a first full cycle, becomes a data-driven methodology in that it
builds on previous efforts utilising both code and processes that have already been
developed. This is similar to the Spiral model and has been previously discussed
by Inmon [2].
Step Szirbik’s Step Kimball’s Step
I. Requirements Prove hardest task can be solved;
Quality and scope of the sources;
Validate Data Collection.
Requirements & Real-
ities.
II. Data Design Data Requirements; Ontological
Alignment.
Architecture.
III. Architecture De-
sign
Establish update policy; Develop
software to adjust granularity.
IV. Implementation &
Data Feed
Validate and Fine-Tuning. System Implementa-
tion; Test & Release.
V. Release & Mainte-
nance
Test & Release.
Table 3.15: Alignment of the methodology steps with Szirbik’s and Kimball’s
approaches.
As seen in table 3.15 the methodology follows Kimball’s overall planning and
design steps, which had been previously said to be simpler and engaging for
the end-users [2]. The methodology presented here allows several versions to be
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released with different degrees of completeness and this was found to be advan-
tageous when engaging with domain experts and end-users.
Also similar to Kimball’s approach, multiple data marts were built first into a
pseudo-integrated ODS and only later were they fully integrated in a working
data warehouse. Kimball’s overall approach is ideal for domain specific projects
such as the one presented in this section. However, the proposed approach to
build the stroke data warehouse did not rely heavily on the dimensional model.
Indeed, Inmon’s model was found to be more robust for a clinical data warehouse
where no predefined or recurrent database queries are expected. As such, the
solution presented here is a hybrid one between Inmon’s relational model and
technical focus, and Kimball’s methodological principles and bottom-up approach
that work well in smaller environments within a large organisation.
In addition to this, Szirbik’s methodological steps were extremely helpful in vali-
dating and refocusing the work on clinical data warehousing. Indeed it was found
that identifying and proposing a solution for the hardest problem was the most im-
portant starting step. Without a demonstrable technical solution to retrieve and
integrate biochemistry and comorbidity data (discussed here and in the previous
chapter) this data warehousing project would have not been possible. Further-
more, it was important to take into account Szirbik’s step on ontology building
when developing a dictionary to map terms and concepts and to facilitate data
integration.
An important feature of the methodology presented here is the staging area and
its interactions with the methodology steps. Throughout the steps, the staging
area was used to retrieve and store the required data in an ODS, to design and
test the data model and conceptual representations, or to design and test ETL
processes. The “adjuvant” database allowed the architecture, data model and
overall database software to be designed, put together and tested before a working
version of the data warehouse was released. It was particularly important to
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keep the retrieved data in the ODS in its original form, not affected by data
transformations, so that it can be accessed for reference, testing, validation, and
data lineage analysis.
The full life cycle of the stroke register data warehouse, developed along with the
above methodology, is depicted in Figure 3.20. The life cycle shows the inter-
actions with end-users (researchers), a data warehousing developer and manager
(practitioner) and the system. Three major cycles are observed: the update cy-
cle, responsible for feeding new data into the ODS and the data warehouse; the
integration cycle, where the information is integrated from the ODS into the data
warehouse using a dictionary or an ontology; and the reporting cycle, where the
data warehouse is used by the end-users to extract study specific cohorts. This
higher level life cycle is compatible with the above methodology and it represents
the overall interactions between users, practitioners and systems.
3.3.2.6 Conclusions
This section reviewed the state of the art in data warehousing both in industry
and in academia since the concept was first introduced in the 1980s. An exten-
sive literature survey has provided a factual and complete historical perspective
that has not been, to our knowledge, previously covered in specialist books or
research papers on the subject. The literature survey was expanded to include
the developments in health informatics and this revealed how the discipline has
traditionally been at the forefront of technological advances. This review allowed
a thorough understanding of the current data warehousing methods and their
origins and, in particular, the leading works of Inmon and Kimball.
An understanding of the latter two, seemingly opposing views, together with
reports of data warehousing challenges in medicine led to the development of a
hybrid approach to clinical data warehouse development that can be applied to
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Figure 3.20: Architecture and Life Cycle of the Stroke Register Data Warehouse.
179
3. Preprocessing, Linkage and Data Warehousing
other domains. This complements the work carried out in the previous chapter
by introducing a methodology to develop a domain specific data warehouse with
limited resources. The work carried out here allowed the Norwich Research Stroke
& TIA Register to be developed with over 25 thousand strokes and TIAs (1997
to 2013) and corresponding biochemistry data (from 2003) and comorbidities.
An empirical assessment of the factors affecting data warehousing success [193]
revealed that higher levels of system and data quality are associated with higher
levels of perceived net benefits. The methodology presented here focuses on data
quality, not only by the recursive and iterative nature of its cycle, but also by the
exhaustive use of the staging area where operational data is stored together with
metadata and conceptual mappings (data dictionaries).
Further work is underway to continue to test and improve the methodological
steps. In particular, future work should focus on the improvement of the querying
interface by developing functionalities similar to those of the i2b2 system. Indeed,
a framework such as the i2b2 could be used as a data warehouse with the proposed
methodology and that would likely reduce the amount of work needed in the
architectural design step.
Additional work is also envisaged on a proactive linkage and retrieval system, akin
to a web crawler used in information retrieval, whereby patient-centric records
are found in existing data sources and, when relevant, they are automatically
retrieved and mapped to the ODS and data warehouse. An agent-based sys-
tem of this kind would be placed between the operational systems and the ODS
in the data warehousing life cycle. Automatic semantic integration of heteroge-
neous information sources has already been suggested in the literature [194] yet
further work is needed to make these and similar approaches available to data
warehousing implementations.
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3.4 Discussion
Data preprocessing pertains to a set of actions taken before any data analysis
processes start. In this chapter, four different preprocessing methods and tech-
niques were studied. Regarding the case study on prostate cancer, a technique
was developed to extract medical concepts from histopathology text reports and
another to estimate and input the correct patient age. In the stroke case study,
a record linkage technique was applied and a data warehousing methodology was
developed to build a unique infrastructure for research. Concluding remarks of
each of the techniques are given in the following sections. A discussion of the value
of the preprocessing techniques in the improvement of data quality in hospitals
is given in section 3.4.3.
3.4.1 Prostate Cancer: Text Extraction and Imputation
In section 3.2.1, a technique was developed to accurately extract Gleason grad-
ing from histopathology reports. This exercise was important as current hospital
databases do not store this information in a canonical form. The developed al-
gorithms successfully allowed the information to be extracted from the reports
and an inspection of the reporting trends in prostate cancer histopathology re-
ports was carried out. The extracted information is used later in this thesis when
prostate cancer data is analysed.
Data editing and imputation was reviewed in section 3.2.2 and an algorithm for
value estimation was introduced. The algorithm solves the age problem that
happens to patients without a matching hospital or NHS record but where demo-
graphic information is available. In such cases, patients who are not registered
with the local hospital yet have their blood specimens sent there for analysis
may have an inconsistent age, recorded at the time of their appointment. The
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algorithm uses multiple readings of the patient over time to determine an accu-
rate age. Because the local laboratory is responsible for the analysis of bloods
for most patients in the region, this algorithm enables the use of their biochem-
istry records (no clinical or demographic information) with accurate ages. In this
thesis, however, only prostate specific antigen readings were used.
3.4.2 Stroke: Record Linkage and Data Warehousing
Section 3.3.1 dealt with record linkage by undertaking two exercises, the first
linking the most relevant biochemistry records to stroke episodes and the second
validating recorded locally dates of death. The first exercise allows biochemistry
data to be made available for further analyses and clinical research on stroke.
The second exercise allows an inspection of the reliability of the date of death
field in hospital, in particular for those who died away from hospital. This was
important as researchers were made aware of the potentials and limitations of
using hospital records for follow-up and, in cases where discrepancies occurred, the
stroke records were made accurate. As a result, the two exercises demonstrated
the value of using record linkage by providing additional data for research and
by validating and correcting follow-up information for the stroke patients.
Data warehousing was reviewed in section 3.3.2, and a methodology was devel-
oped for the design and maintenance of domain-specific clinical data warehouses.
The case study on stroke resulted in the development and successful implementa-
tion of the Norwich Research Stroke & TIA Register data warehouse, containing
over 25 thousand strokes and TIAs for a period of over 15 years. The methodology,
based on previously published research in the area, accounted for all challenges in
the development of three versions of the stroke data warehouse and is applicable
to other domains. The operational data store (ODS) introduced in the previous
chapter proved crucial to the development of the data warehouse. Nevertheless,
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the next chapter will discuss another use of the ODS in the context of the prostate
cancer study.
3.4.3 Data Quality
One of the key objectives of preprocessing methods is improving the quality of the
data. Hospital information systems and, in particular, routinely collected data,
are infamous for the dubious quality and heterogeneity of their data. In partic-
ular, the Norfolk & Norwich University hospital (NNUH) data quality strategy
identifies eight consequences of potential errors in data [195]:
• breakdown in communications;
• wrong patient being contacted;
• incorrect decisions being made;
• good reputation of the hospital being tarnished;
• inaccurate 18 week RTT (referral to treatment period) status of patients;
• inaccurate recording of cancer waiting time targets;
• hospital rating being compromised;
• incorrect level of income being received by the hospital.
The same document reveals that the central hospital information system (the
patient administration system) at the NNUH should ensure that [195]:
• Patients receive the best possible service from the Trust;
• No patient is overlooked for treatment;
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• Assistance is given to clinicians and managers in maximising the service for
the patient;
• The tracking of patients through their 18 week pathway is facilitated by
capturing their RTT history;
• Cancer patients are monitored and tracked through their cancer pathways.
It is important to note the hospital’s efforts to ensure the quality of their data
[195]. However, the sheer number of departmental systems and domain-specific
data being collected results in differences in the way the data is managed by
individual departments with different priorities. It was noted that data with sig-
nificant importance for management, auditing or key operational procedures was
substantially checked, and hence, of higher quality. However, as demonstrated
in this chapter, “less important” data for hospital operations such as dates of
death may not have the same level of reliability. Throughout this chapter, sev-
eral methods and techniques have been presented that can help to identify issues
and improve the quality of this data. It is important to continue to develop meth-
ods and techniques that enable the secondary uses of routinely collected hospital
data. Further discussions on data quality are given in the next chapters.
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Chapter 4
Pathways Modelling, Mining and
Visualisation
The previous chapter introduced key concepts, tools and techniques on data pre-
processing, linkage and data warehousing. The latter highlighted existing data
modelling techniques such as Kimball’s dimensional model [159] and the Entity-
Attribute-Value (EAV) [168]. This chapter introduces a new data model, tailored
to data-driven patient-centric pathways. Together with the data model, a novel
framework is proposed for the summarisation, visualisation and querying of com-
plex clinical information as well as the computation of quality indicators. A new
graphical representation of the data-driven pathways is also introduced and al-
lows the synthesis of such information. The case study on prostate cancer was
used in this chapter yet the methods and techniques have a wider applicability
to other domains.
Section 4.1 introduces the background and concepts on clinical pathways, data
and process mining techniques and prostate cancer. Section 4.2 introduces system-
level paths, examines how patients and data flow between hospital systems and
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the utility of data and process mining techniques. Section 4.3 describes the frame-
work for the development of prostate cancer pathways and the software developed
for their analysis and visualisation.
4.1 Introduction
“Data modeling is not optional; no database was ever built without a plan”
[196]. As seen in the previous chapter, data modelling emerged in the late 1960s
as database management systems were introduced but the concepts changed over
time. Earlier data models typically represented data horizontally while more
recent approaches attempt to represent it vertically or across dimensions. With
the advent of the world wide web, additional data models were introduced to
arrange information on the web. The Resource Description Framework (RDF) is
a semantic web model for data interchange and it is based on statements (RDF
triples with a subject, predicate and object) that relate objects together [192].
This is similar to the EAV model as data is represented vertically, and each
row contains three columns describing the entity, the type of information, and
its value for each row [168]. Such models are flexible for environments where
schemas change often and for performing entity-centered queries as no joins are
required to retrieve all facts about entities [197].
Aligning ontologies with data models is critical to introducing meaning and en-
forcing standards. Data models and ontologies must consider the structure and
the rules of the domain [190] yet be flexible enough to adapt to new knowl-
edge, particularly in biomedicine where information and knowledge grows rapidly
[198]. Recent approaches have relied on semantic web technologies such as the
Web Ontology Language (OWL) [192] and the use of metadata is seen as key
[198]. However, drawbacks have been identified with EAV-like models. Poor
data scanning performance, increased complexity in writing queries and consid-
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erable programming are needed to perform tasks that conventional architectures
would do automatically [199]. As noted in the previous chapter, there are trade-
offs in choosing data models and hybrid approaches may provide overall better
results [197].
This chapter introduces a new data model, based on the EAV model and RDF
triples, that describes the routes that patients take through care. In a first in-
stance, section 4.2 introduces system-level paths, a chronological sequence of ac-
tivities or events used to study how patients interact with hospital departments.
The utility of current data and process mining techniques was explored in this
context. Later, complex clinical information is modelled into pathways (section
4.3) enabling further analysis of prostate cancer data and the mapping of patient
journeys’ through care. A framework and decision support system were devel-
oped to accommodate and analyse this information as well as to produce visual
representations of the pathways. The next sections introduce further background
on clinical pathways and data and process mining techniques.
4.1.1 Clinical Pathways
Clinical pathways, also known as care or critical pathways, have been introduced
in healthcare systems to improve the efficiency of care whilst maintaining or
improving its quality [200]. There are several definitions of clinical pathways in
the literature but in this chapter they are defined as an ordered set of patient-
centric events and information relevant to a particular clinical condition. Using
the prostate cancer case study, particular attention is given to the use of clinical
biomarkers and other indicators (such as blood readings) in pathways, as they
enable a thorough inspection of data quality as well as further clinical studies
observing trends over time. This is discussed in more detail later in this chapter.
In 1995, Pearson et al. [200] described critical pathways as a management plan
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that displays goals for patients and provides the sequence and timing of actions
necessary to achieve these goals with optimal efficiency. More recently they have
been described as a concept for making patient centred care operational and for
supporting the modelling of patient groups with different levels of predictabil-
ity [200]. Clinical pathways are developed by multidisciplinary teams and rely
on evidence from the literature, operational research and patient involvement
methodologies [200].
Over the years, pathways evolved from paper-based to computerised pathways
[201; 202] and there have been efforts to integrate them with electronic health
records[202; 203]. One of the most promising fields for knowledge-based systems
in health care is the support for guidelines and pathways [204]. The standard
functions of pathways have been proposed in [202] and a strong emphasis is
given to the statistics function to implement automated methods for checking the
occurrence of variance (i.e. discrepancies between planned and observed events).
The analysis of clinical pathways is a topic receiving increasing attention from
the field of medical informatics, but techniques often require extensive clinical
expert knowledge and can be laborious. Huang and Duan [205] used process
mining techniques to measure clinical behaviour derived from clinical workflow
logs and to help identify novel process patterns. According to them, clinical
pathway analysis has been defined as the process of discovering knowledge about
clinical activities in patients care journeys. Ultimately the goal is to utilise the
discovered knowledge for pathway (re)design, optimisation, decision support, au-
dit or management. One of the major challenges reported was the derivation of
compact yet high quality patterns that cover the most useful medical behaviours
in clinical practice. Furthermore, the detection of complex patterns within pa-
tient data require higher levels of temporal abstraction [206] and the pathways
introduced in this chapter take this into account.
Process mining techniques are promising analysis techniques in the context of
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clinical pathways. However, it has been reported that traditional process mining
algorithms have problems dealing with unstructured processes like those com-
monly found in a hospital environment [207; 208; 209] and that they may not
produce clinically meaningful visualizations. The heterogeneity and incomplete-
ness of the data are major obstacles in achieving meaningful models, yet an
application to stroke has proved fruitful [209]. One of the aims of this chapter
is to produce clinical pathways that may be suitable for process mining. For
this, data quality is key, but consensus and definitions are lacking [37; 210] and
intelligent agents that can explore quality issues are needed [210].
The use of routine data or workflow logs in the construction of clinical pathways
is a key topic receiving increasing attention in the literature [205; 207; 209]. In
hospitals, such efforts rely heavily on the hospital information systems (HIS) and
electronic health records (EHR), and the availability and quality of the infor-
mation conveyed in them. Indeed hospitals often opt for implementing several
commercial departmental systems, creating ”islands” of information across vari-
ous departments [21]. This can significantly hinder the process of extraction and
collation of detailed patient-centric information to create clinical pathways. The
methods presented in this chapter attempt to overcome these difficulties.
A review on data quality in electronic health records [37] identified five data
quality dimensions described in the literature: completeness, correctness, con-
cordance, plausibility and currency. However, the authors identified that not all
dimensions are commonly or consistently assessed and further work is needed
towards the adoption of systematic, statistically based methods of data quality
assessment. The work presented in this section encompasses the inspection of all
of the above dimensions with a particular emphasis on assessing the completeness
of pathway information using biomarker expert rules.
Overall, this chapter describes a framework for building and visualising prostate
cancer pathways using routinely collected. This approach does not involve work-
189
4. Pathways Modelling, Mining and Visualisation
flow logs produced by HIS or EHR, but rather, the patient-centric data conveyed
in them. The previous work on methods for the collection of patient-centric data
from multiple HIS has underpinned this research.
4.1.2 Mining Techniques
Process mining is the extraction of valuable process-related information from
event logs; it is an area related to business process management (BPM), that is,
the combination of computing and management sciences and their application to
operational business processes [211; 212]. Workflow management (WFM) is also a
related discipline that focuses on automation of business processes but it is often
regarded as a more automated approach with less human interaction than BPM.
The latter is more encompassing in that it ranges from process automation and
analysis to management and the organisation of work [211]. Business processes are
defined in [213] as sets of partially ordered and coordinated activities by which
organisations accomplish their missions. Such processes can only be modelled
and automated if they have the same structure and are repeatedly performed.
This is the aim of WFM systems [212] and process mining aims at analysing
event logs. WFM systems are often implemented in business contexts, and are
common in the manufacturing of products or provision of services. However, as we
have seen in the previous chapters, hospital information systems are not process-
aware, do not incorporate WFM technology, and do not provide event logs. Some
systems, however, will provide event logs as audit trails but their purpose is to aid
with information governance rather than tracking any particular set of clinical
processes. A way to overcome this limitation is to develop event logs based on
live information from the systems, and this is possible by using the data model
presented and used in the previous sections.
A Scopus bibliographic search for process mining in keywords revealed that, up
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to the time of writing, only 1% of process mining publications (n=16) were in
medicine and 2.3% were in biochemistry, genetics and molecular biology. Fur-
thermore, the results are also positively skewed to the university that pioneered
most of this research in the Netherlands [211]. Process mining has not been
extensively applied to health care yet there is a growing interest in this field
both from a service management and optimisation perspective and as well as
in its application to clinical pathways. Challenges and limitations have been
reported in all publications surveyed where process mining is applied to health
care [207; 208; 209; 213; 214; 215], in particular, processes are often dynamic,
ad-hoc, unstructured and multidisciplinary in health care domains. Furthermore
hospital information systems are also not process aware which further hinders the
discovery of useful process models.
In lieu of process mining techniques, some authors have reported using association
rule mining to uncover relationships among data [215]. Association rules, also
referred to as link or affinity analysis [36], were introduced in the early 1990s and
aim at uncovering relations between items and item sets, typically in transactional
databases. They are often used in the retail industry to identify items that
are frequently purchased together [36]. Their application to biomedical domains
has focused on biological data such as gene expressions [216] and other domains
where data is more conveniently organised. The application of association rules in
clinical data, however, is not trivial due to the nature of medical data, and hence
greater efforts in data modelling are needed. Nevertheless association rules have
been suggested for clinical domains in the late 1990s and early 2000s [217] and,
more recently, have been applied to the diagnosis of diseases based on a list of
findings [218] and in a paediatric primary care database [219]. However, authors
concluded that the derived rules were often previously known or explained by
confounding variables.
With the advent of big data and new modelling techniques, association rules are
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becoming increasingly meaningful since datasets and the number of data elements
have been growing. As a result, an increase in the number of publications since
2008 is noted when searching the Scopus bibliographic database for publications
in medicine (a total of 142 documents retrieved between 2000 and 2013 where
association rules appear in the articles’ keywords). Association rules have been
more recently applied to detect factors which contribute to heart disease in males
and females [220], to identify clinical parameters akin to occurrence of brain tumor
[221], and in hospital order-entry systems for management decision making [222].
Binary semantic association rules have also been introduced to cope with the
increasingly complex environments [223].
Association rules and process mining algorithms are discussed further in the next
section and in the context of the system-level pathways. State-of-the-art process
mining and association rule mining techniques are applied and their utility in
understanding frequent patient behaviours across hospital systems is examined.
4.1.3 Prostate Cancer
The latest estimates of global incidence indicate that prostate cancer has become
the second most common cancer in men [224]. In the UK, it is the most common
male cancer, accounting for 25% of all malignancies [42].
The National Institute for Clinical Excellence (NICE) in the UK publishes clinical
guidelines and has recently developed the NICE pathways, a tool that visually
represents the recommendations and guidelines on a specific clinical or health
topic [225]. Following the NICE pathway, patients with suspected prostate cancer
are directed through from referral, to assessment, diagnosis and communication;
their needs are then often discussed at a multidisciplinary team meeting; admis-
sion and treatment options are selected as appropriate and ultimately patients
are followed-up and outcomes assessed. During each step of the pathway, rele-
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vant patient-centric data is produced and often stored in a variety of different
hospital information systems. Clinicians wishing to investigate prostate cancer,
say to establish the merits of alternative treatment and management options,
would have a powerful tool if access to the integrated data was facilitated in an
electronic and canonical form. However, as is often the case with hospital infor-
mation systems, their data are heterogeneous, and data quality, accessibility and
interface vary considerably. The work presented in this Chapter makes it possi-
ble to apply rules to the pathways, inspect their quality and guideline adherence.
Furthermore, prostate cancer is an interesting yet non-trivial domain to build and
analyse pathways as it is a chronic disease that often spans over large periods of
time and consumes resources from several different hospital departments.
The next section presents the lowest level of granularity in the prostate cancer
data, by examining how patients flow to and from hospital departments and their
systems. Later, these are extended to pathways, where higher levels of granularity
model more complex clinical information.
4.2 System-Level Paths
Chapter 2 presented a framework to collect patient-centric data from multiple
hospital systems that emphasised on mapping the host environment. An inter-
esting first exercise is to observe how patients interact with hospital departments.
This can be achieved by listing frequencies and key statistics for each system, but
more interestingly, by comparing and grouping patients’ paths through the hos-
pital systems they visited. This is a first high-level (low granularity) approach to
modelling patient’s journeys.
In this section, a system-level path is defined as a chronological sequence of
digital footprints left in hospital information systems from patients diagnosed
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with prostate cancer. This creates a single path per patient. Each footprint
identifies a boolean (positive) occurrence of an event in a given system with
an associated time stamp and patient identifier. The way in which the events
were collected from the systems is restricted to prostate cancer patients and it
implies some knowledge of the problem domain (previously discussed in Chapter
2). However, it is still possible that certain events are not specific to a prostate
cancer journey. This needs to be taken into account in this chapter, and it is
first addressed in the next section (4.2.1) when selecting an appropriate cohort
of diagnosed prostate cancers.
A formal definition of system paths is given in section 4.2.2 and the understanding
and analysis of the paths is described in section 4.2.3. The latter explores how
association rule mining techniques can be used to mine frequent associations and
how process mining techniques may yield more interesting results.
4.2.1 Data Selection
In this exercise, only patients with a diagnosis of prostate cancer should be con-
sidered from the available data in the operational data store (ODS). Given an
inspection of the prostate cancer ODS, the hospital cancer register system (CRE)
would be the most appropriate source to retrieve a list of diagnosed cancers, in-
cluding those whose treatment is shared with other health care providers. How-
ever, this system only began to store accurate data from 2010. The data stored in
the ODS spans a longer time period and the most relevant systems where prostate
cancer patients are likely to be present were introduced in 2003 (histopathology,
biochemistry, radiotherapy) or earlier (administration, oncology, radiology). In
order to capture a complete count of prostate cancer patients that visited the hos-
pital between 2003 and 2010, it was necessary to investigate three data sources:
the patient administration system (PAS), the histopathology system (HIS) and
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the oncology department system (ONC).
The PAS system contains clinical coding from discharge letters and hospital ad-
missions other than outpatient events (at present these are not coded in NHS
hospitals). The histopathology system contains results of biopsies and the con-
firmation of cancer, yet any patients who were clinically diagnosed may not have
left a digital footprint in this system. Lastly, the oncology system will have diag-
noses of patients who were referred to oncologists in this department instead of
or, in addition to, urology. Any patient diagnosed with prostate cancer will have
an instance with coding (or equivalent) from one or more of this systems.
The ODS contains a large number of patients, some with invalid local hospital
numbers (either NHS numbers or other hospital’s numbers). In this exercise, only
records with valid hospital numbers were included from 2003 to 2010. A Venn
diagram was produced from lists of all unique patients present in each of the
three systems (Figure 4.1). The union of all three systems, PAS ∪HIS ∪ONC,
yielded a list of 4,720 different hospital numbers and this was used to query the
remaining systems.
Figure 4.1 shows additional interesting information that had previously not been
looked at with this level of detail in this hospital. In particular, the majority of
patients (38%, n=1,780) appear in the histopathology system alone. This would
be largely due to biopsies that were carried out at this hospital yet no further
treatment or consultations took place, or the patient decided to have treatment
or monitoring elsewhere (including private hospitals). The second largest group
in Figure 4.1 (29%, n=1,382) results from the intersection PAS ∩HIS. This is
expected as patients who had a positive biopsy also have hospital episodes with
a prostate cancer diagnosis. Only a small number of patients was present in all
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three systems (6.3%, n=296). These are patients followed by the urology and
oncology departments as well as having a biopsy. This interesting analysis, on its
own, does not inform on data quality. It does show, however, that information
on prostate cancers diagnoses is not confined to a single system. This posed
difficulties in accurate data acquisition by the hospital’s administration and for
planning and performance. However, it was addressed when cancer waiting times
were introduced and, in particular, from 2007, with the implementation of the
first version of the hospital cancer registry system (CRE).
A first recommendation to collect prostate cancer diagnoses by hospital staff was
to use the PAS system alone, however, Figure 4.1 shows a gain of 2,710 additional
diagnoses by including HIS and ONC sources. Based on the union of the data in
all three systems, a set of 4,720 different hospital numbers was used to query the
other hospital systems. Table 4.1 summarises the list of selected systems, a short
description of information conveyed in them, the number of unique valid hospital
numbers in the ODS, and the total number of records in each source. The set of
4,720 diagnosed patients was linked to each of the sources, resulting in a table
Figure 4.1: Venn diagram showing unique hospital numbers across Histopathol-
ogy, Administration and Oncology systems.
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with 52,475 records (average of 11 records per patient). Further details are given
in the next sections.
System Information Patients Records
PAS Hospital episodes where Prostate Can-
cer is primary diagnosis.
2,010 7,773
LAB PSA tests. 48,603 138,968
RAD Radiotherapy to prostate (both pallia-
tive or radical).
2,012 2,768
ONC Oncology department admissions (both
new and old systems).
1,411 1,429
OPT Operating procedures to prostate. 4,120 4,636
IMG Radiology imaging to prostate. 866 1,281
HIS Histology report with a Gleason grade. 3,681 4,363
ORT Orthopaedics long bone fractures (only
from 2008).
1,651 1,783
Table 4.1: List of selected systems and the number of records and valid patients
in them.
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4.2.2 Defining a System Path
LetD represent the predefined set of database systems such thatD = {d1, . . . , dn}
is a set of n systems as, for example, described in Table 4.2. A patient’s footprint
in a given system, d, is given by a three-tuple F = (r, t, d) where r is the patient
identifier, and t is the time in days from the first interaction associated with the
hospital. A chronological sequence of systems’ footprints (a system or system-
level path) for patient, r, is represented here as P = 〈F1, . . . , Fm〉 where
i. Fi is of the form (r, ti, di) for 1 ≤ i ≤ m,
ii. t1 = 0 is the time of the first interaction recorded,
iii. ti ≤ ti+1 for 1 ≤ i ≤ m− 1,
iv. when ti = ti+1 then di 6= di+1 for 1 ≤ i ≤ m − 1, so that all Fi are unique
with respect to (ti, di) values (both time and system visited).
When ti = ti+1 and di 6= di+1 for 1 ≤ i ≤ m − 1, however, the corresponding
footprints Fi and Fi+1 are said to be concurrent.
Hence, a simple system path might be P = 〈F1 = (1, 0, d2), F2 = (1, 1, d7), F3 =
(1, 111, d5), F4 = (1, 176, d2)〉. In this example, a patient (r = 1) visited three
different hospital systems. The first encounter was with the LAB system for
blood tests, followed by a biopsy a day later (HIS), surgery at 111 days (OPT)
and his last encounter with a hospital system was for another blood test at 176
days. The total length of time for this path is the latter number of days.
A sequence of the visited systems, S, for this example is can be 〈d2, d7, d5, d2〉, or
using the systems’ codes for simplicity, S = 〈LAB,HIS,OPT, LAB〉.
Based on the above definition of a system path, the cohort of 4,720 patients
identified in the previous section was used to create a data-driven system path for
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each patient (one path per patient). Table 4.2 gives the predefined list of systems
with their respective number of unique patient identifiers and total number of
records.
D System Code Patients Records
d1 PAS 2,010 4,010
d2 LAB 4,037 33,862
d3 RAD 1,533 1,976
d4 ONC 1,411 1,426
d5 OPT 1,479 1,729
d6 IMG 670 814
d7 HIS 3,681 4,359
d8 ORT 31 32
Table 4.2: Predefined list of hospital systems for system-level paths.
4.2.3 Understanding Paths
A first table, containing the ordered set of 4,720 patients (48,208 records) and
their system-level paths was produced. However, this table included paths where
only one system was visited. Although these are valid footprints and paths, they
were not considered in subsequent analyses as no interactions between systems
occurred. As such, any paths with a cardinality |P | = 1 were removed (n=283, 19
from PAS, 65 from ONC, and 199 from HIS). In addition to this, any duplicate
records (records with the same patient identifier, system and day), as defined
above, were also removed. For comparison purposes, only paths with sequential
footprints of the same system on different days are considered. However, sequen-
tial footprints of different systems on the same day are accepted, although these
only occur in 2% (n=1,096) of records in the transactional table. This is because
some systems may have more than one record of the same appointment in the
same day (often due to administration processes), while others will only register
at most one episode a day. This leaves a total of 4,437 patient paths (47,925
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records) each with two or more footprints.
System Path Start Overall Frequency
LAB 74.51% (n=3306) 90.98% (n=4037)
HIS 10.03% (n=445) 78.48% (n=3402)
ONC 6.15% (n=273) 30.34% (n=1346)
PAS 5.25% (n=233) 44.87% (n=1991)
OPT 3.31% (n=147) 33.33% (n=1479)
RAD 0.43% (n=19) 34.55% (n=1533)
IMG 0.25% (n=11) 15.10% (n=670)
ORT 0.07% (n=3) 0.70% (n=31)
Table 4.3: Distribution of hospital systems as a starting footprint of a path and
overall frequency across paths.
Systems Visited 1 2 3 4 5 6 7
N Paths 20 1471 1055 1240 445 185 21
% Total Paths 0.45% 33.15% 23.78% 27.95% 10.03% 4.17% 0.47%
Table 4.4: Distribution of Number of Systems visited in all paths.
A first exercise was to list the distribution of starting footprint of paths (Table
4.3). This is important because it allows an understanding of how patients start
their prostate cancer paths and it may also indicate potential erroneous data.
The most common start is via the LAB system (74%) followed by the systems
where diagnosis was made (HIS, ONC, and PAS total 22%) and 4% start from
other systems. A LAB start would indicate previous PSA testing was done before
diagnosis and a high volume of patients was expected. However, some of the least
frequent starts are also plausible. Patients’ cancers could be detected through
imaging and even after an orthopaedics operation (pathological fractures or bony
metastases). The radiotherapy system, however, is less likely to be a true start
of a cancer pathway. Indeed upon manual inspection of paths starting with
radiotherapy (n=19) it was identified that they were either closely followed by a
diagnosis or the events were at the start of the cohort time (2003). This is taken
into account later when analysing the paths.
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Another inspection, of the distribution of the number of different systems in each
path (depicted in Figure 4.4), revealed that 95% (n=4211) of all paths visited
between 2 to 5 different systems, and none visited all 8 systems. This warranted
further investigations to understand how the systems interact with paths, detailed
later in this section.
A first approach to understanding basic system path behaviour was to list all
possible pairs of systems appearing across all paths (82 possible permutations
given the list of systems). Software was developed to compute the frequencies of
all possible pairs of footprints as well as a graphical representation using a directed
graph (built with Python and networkx library). The latter is also drawn based
on all paths and provides a visual representation of the existing pairs of systems.
The frequency of the starting pairs across paths was also computed. Figure 4.2
shows the missing, most and least frequent sequence pairs between systems given
the cohort of patient’s paths.
This frequency analysis indicates the most common sequence pairs of systems
visited and clues regarding the overall patients’ journey through hospital depart-
ments and the findings are summarised:
• The most frequent sequence across paths is 〈LAB,LAB〉 (n=3508), indi-
cating PSA retesting. It is expected that this could be the most significant
activity for patients with prostate cancer and one that may add a sub-
stantial burden to hospital services also due to its frequency within paths
(average 7 visits per patient).
• The second and third most frequent sequences are between the LAB system
and the HIS system. The HIS system contains a histological confirmation
of diagnosis and it is often preceded or succeeded by a PSA test (here
shown as a visit to the LAB system). When preceded, a raised PSA value
would trigger a biopsy result in HIS. When succeeded, the biopsy result in
201
4. Pathways Modelling, Mining and Visualisation
Figure 4.2: Frequency of pairs of systems for the 4,437 patient paths drawn. The
graphical representation shows the overall cohort and the existing links between
each system base on the sequence of visits; it includes thicker stubs to repre-
sent direction (arrow heads) and each node shows its in-degree and out-degree
respectively. Each table shows the most or least frequent sequence pairs.
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HIS would trigger further monitoring of the PSA either because of active
monitoring or a pre-treatment check (such as PSA check before surgery).
• The above sequences also appear in the most frequent starts of paths:
〈LAB,LAB〉 (n=1743), 〈LAB,HIS〉 (n=1111), 〈HIS,LAB〉 (n=153). This
is important as it may indicate how patients were first diagnosed and
whether they were “screening”. However, biopsies may be undertaken as a
result of a visit to PAS where they are undertaken as an outpatient proce-
dure.
• 〈LAB,PAS〉 and 〈PAS,LAB〉 are similar to the interactions of LAB with
HIS in that a hospital consultant appointment and/or outpatient biopsies
succeeds or precedes a PSA test. Here, however, the appointment is not a
biopsy. The sequence 〈LAB,PAS〉 (n=201) is also one of the most frequent
starts of paths and more so than 〈PAS,LAB〉 (n=93).
• Sequence 〈RAD,LAB〉 (n=1032) revealed that a PSA test is often carried
out after radiotherapy in order to monitor its effect.
• It was interesting to observe, as depicted in the graph, that almost all
systems mutually followed each other. The only exceptions found were in
the ORT system. This was expected due to the overall small number of
ORT events in the dataset and served as a validation for the methods.
The preliminary analyses were carried out based on the system paths data model
and the developed software. A full summary table with the results of this analysis
is given in Appendix C 1.4. Two additional approaches to explore and understand
how patients flow through systems are given in the next sections. A first approach
relies on mining frequent itemsets from within the paths and a second approach
focuses on mining similar sequential paths.
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4.2.3.1 Itemset Mining and Associations
Given the transactional database of system paths and the frequency analysis
previously carried out, an interesting exercise is to mine frequent sets of items
appearing in each path. Mining frequent itemsets (groups of items) is a first
step to mine association rules; it identifies frequent combinations of items that
can later be used to create association rules with a given support and confidence
[36; 226]. Traditional itemset mining or association rule mining does not take
into account time or order, and as such, the work explored in this section will not
have these elements and it focuses on answering questions regarding which items
(systems) appear together in paths. Furthermore, association rule algorithms do
not mine loops of length one but this was covered in the previous section.
The most prominent algorithm for mining itemsets and association rules was
introduced in 1994 by Agrawal and Srikant [226]. The algorithm’s input is a
transactional database and a predefined minimum support value (threshold), of-
ten referred to as minsup. The output is a list of frequent itemsets. A frequent
itemset is an itemset that appears in minsup transactions.
If A and B are two itemsets, an association rule A⇒ B is a relationship between
the antecedent, A, and consequent, B, such that A ∩ B = ∅. The support of a
rule is the number of transactions that contain A∪B and the confidence of a rule
is (A ∪B)/A and can be interpreted as an estimate of probability P (B|A). This
traditional measure of confidence, however, ignores the support of the itemset in
the rule consequent and hence some rules may be misleading[36]. An alternative
measure that takes the support of B is defined as lift(A ⇒ B) = P (A,B)
P (A)P (B)
.
However, this introduces the problem of symmetry whereby there is no difference
between rules A⇒ B and B ⇒ A. Other metrics of interest have been researched
yet in this chapter a manual inspection of the generated rules was sufficient.
The Apriori algorithm (here with an extended step for creating association rules)
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has as inputs a database of transactions, minsup and confidence, and the follow-
ing generalised working steps:
1. From the database of transactions, mine frequent itemset patterns where
each candidate itemset satisfies minsup and store the results in a working
set. This process is repeated as many times as the cardinality of the largest
itemset in the database.
2. The Apriori property is applied after each iteration of the previous step.
The Apriori property (or anti-monotone Apriori heuristic [226]) states that
any subset of a frequent itemset must also be frequent and, removing less
frequent items is often called pruning.
3. Once all valid frequent itemsets have been generated, association rules are
created in the manner described above based on the given confidence.
The Apriori algorithm has known performance limitations mostly due to repet-
itive database scans. This is particularly true when searching for large sets of
candidates and mining long patterns. Over the years more efficient implementa-
tions of the Apriori algorithm have been introduced, for example, storing candi-
date itemsets in a hash-tree format [227]. In 2004, however, an algorithm that
offered overall better efficiency, the Frequent Pattern Growth (FP-Growth) al-
gorithm, was introduced [228] and it is now widely used with the same results
and improved performance. For the work needed to be carried out in this thesis,
however, performance was not an issue due to the size of the dataset and the pro-
cessing speed of the computers used, and the Apriori algorithm was considered
sufficient, in particular because of the small number of items (systems).
Given the transactional database of 4,437 system paths, an itemset of the visited
systems was produced for each path. In this exercise, it is only possible to observe
combinations of itemsets and time and order of the items are not taken into
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account.
The Aprori algorithm to mine frequent itemsets was first applied to the system
paths dataset with a minsup = 0 in order to retrieve all possible combinations
(both frequent and infrequent), and to validate its implementation. Later, a
threshold minsup = 2.23%, was applied to retrieve itemsets appearing in just
over 100 paths. Upon investigation of the first results, this threshold was found
to retrieve a large enough number of paths for consideration. Setting a low
minsup is known to cause combinatorial explosion (too many rules and many of
them are meaningless) leading to the rare item problem [229] of deciding which
rules are of value and which are not. Several mechanisms have been proposed to
tackle this problem, such as using multiple minimum supports [230] or frequent
closed itemsets. The latter were introduced by Pasquier et al. [231] with the
aim of reducing, without information loss, the size of the mined association rule
set, resulting in a condensed representation of the rules [232]. A frequent closed
itemset is a frequent itemset that it not included in another itemset (superset)
with the same support [231]. The process of generating frequent closed association
rules was used to produce rules regarding the system paths with low minsup and
confidence in order to retrieve a larger number or rules for inspection.
First, the Apriori algorithm ran in ≈ 15 miliseconds and returned 16 frequent
closed itemsets (results in Table 4.5). Then, association rules were mined with
the same minsup and a minimum confidence of 10% in order to obtain a larger
number of rules for inspection and only frequent closed association rules were
kept. The results of mining association rules are given in Table 4.6.
Table 4.6 shows the two rules with most confidence for six consequent systems.
The strongest association rules (over 90% confidence) have as consequents LAB
or HIS and this was expected as these systems have the most overall support. As
a result a large number of rules are found with LAB as consequent (see Appendix
C 1.4). The first rule in Table 4.6, {PAS, IMG,HIS} ⇒ LAB, indicates with
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Itemset Support
1. {LAB} 33862
2. {HIS} 4160
3. {PAS} 3991
4. {LAB,HIS} 2748
5. {RAD} 1976
6. {OPT} 1729
7. {ONC} 1361
8. {IMG} 814
9. {OPT,HIS} 762
10. {LAB,OPT} 613
11. {LAB,OPT,HIS} 554
12. {LAB,ONC} 360
13. {ONC,HIS} 147
14. {LAB, IMG} 143
15. {PAS,HIS} 115
16. {LAB,ONC,HIS} 103
Table 4.5: Results of the Apriori Algorithm with minsup = 2.3%.
Rule Support Confidence
1. {PAS, IMG,HIS} ⇒ LAB 203 99.51%
2. {OPT, IMG} ⇒ LAB 166 99.40%
3. {OPT, IMG} ⇒ HIS 160 95.81%
4. {LAB,OPT, IMG} ⇒ HIS 159 95.78%
5. {RAD,ONC,OPT,HIS} ⇒ PAS 134 89.93%
6. {RAD,ONC,OPT} ⇒ PAS 149 89.76%
7. {PAS,HIS} ⇒ OPT 1162 84.08%
8. {PAS,LAB,HIS} ⇒ OPT 1073 83.11%
9. {LAB,ONC, IMG} ⇒ RAD 171 73.71%
10. {ONC, IMG} ⇒ RAD 175 73.22%
11. {RAD} ⇒ ONC 897 58.51%
12. {LAB,RAD} ⇒ ONC 742 58.20%
Table 4.6: Selected Closed Association Rules based on the Apriori Algorithm to
mine frequent closed itemsets with minsup = 2.3% and 10% minimum confidence.
99.5% confidence (support 203) that when a patient visits the administration,
imaging and histology systems, he will also visit the laboratory system for a PSA
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test. The interest here is that both rules 1 and 2 show IMG as an antecedent and
the latter is not a common system across all paths. Nevertheless, the LAB source
is present in over 90% of paths and as a result it appears in a large number of
rules including those with a relatively small support.
66% (n=135) of rules where RAD appears as a consequent (n=203) have ONC
as antecedent. This, together with the rules where RAD appears both as conse-
quent or antecedent, indicates a link between patients who see the radiotherapy
department and those who see oncology. This is indeed expected as the course of
radiotherapy treatment is often given by oncology consultants.
From the association rules it was also possible to identify a strong relationship
between operating theatre (OPT) and histology system (HIS). Indeed a rule not
shown in Table 4.6 but visible in Appendix C 1.4 shows that paths that visit
HIS also visit OPT with 94.25% confidence and strong support (n=1394). The
relevance of this rule is that for patients that had an operation (either extensive
biopsy or prostatectomy) a histological report was produced.
One of the drawbacks of using a predefined minsup is that any itemsets that fall
short of this value will not be included. For this reason, the orthopaedics system
did not appear in any of the results. However, upon manual inspection, all paths
where the ORT system was visited (n=31) had the following other system visits:
100% LAB, 87% HIS, 51% PAS, 39% IMG, 35% OPT, 32% RAD, and 23% ONC.
This is interesting because out of all patients who visited orthopaedics only 39%
had an imaging event where the word prostate was mentioned. This reassures
that minsup values should be set to a low value. This does, in turn, require
a greater effort to inspect the larger number of resulting rules and identify the
meaningful ones.
The Apriori results and association rules provided some interesting, although to
a degree, expected, results and allowed an understanding of which combinations
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of systems are most frequently visited together.
Despite the fact that it is important to understand which systems are visited
together in system paths, these rules do not inform on the timeliness or order
of the visits, which is important if one is to understand the flow of information
across systems. The next section investigates how sequential pattern mining may
address this limitation.
4.2.3.2 Sequential Pattern Mining
The problem of mining sequential patterns was introduced in 1995 by Agrawal
an Srikant [233] and later improved by the same authors [234]. As opposed to
mining association rules, in sequential pattern mining transactions are grouped
to form ordered sequences. A sequence string was exemplified earlier as S =
〈LAB,HIS,OPT, LAB〉 where all elements are ordered chronologically. The
preliminary investigations (Figure 4.2) already covered ordered sequences but
only for pairs of systems so as to gain a basic understanding of their interactions.
The problem of mining sequential patterns is to discover “all sequential patterns
with a user-specified minimum support, where the support of a pattern is the
number of data-sequences that contain the pattern” [234]. This encompasses any
sequences and not just pairs.
An early algorithm is the Generalised Sequential Patterns (GSP) algorithm pro-
posed by Srikant and Agrawal [234] and it is based on Apriori. The algorithm
works by making multiple passes over the data to determine candidates based on
the item’s support (minsup). Then, for each sequence of a determined length, the
database is scanned to obtain support and generate candidate sequences using
Apriori. The process is repeated until no frequent sequence or new candidate are
found. As with Apriori, multiple database scanning make the process less effi-
cient, particularly for long sequences, but pruning remains an advantage. Over
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the years algorithms with increased performance were developed [235] and later
began being used for sequence analysis of biological data such as DNA, RNA
or proteins [236]. The first approaches were Apriori-based until pattern growth
algorithms were introduced in 2000 [237]. Pattern growth algorithms differ in
that they are based on recursively projecting segments of the sequences, resulting
in a more efficient processing. Introduced by Pei et al., PrefixSpan [237] is one
of the most widely known algorithms and it is based on “projecting suffixes” for
all given prefixes. This divide-and-conquer approach can be summarised in three
steps: generating candidate sequences (sequence length - 1), divide search space
according to prefixes, and scan the database to find subsets of sequential patterns.
The algorithm is described in detail in [237] and it is not repeated here.
An open-source Sequential Pattern Mining Framework (SPF) that implements
most sequential pattern mining algorithms [238] was used to run the PrefixSpan
with the transactional database of 4,437 system paths and minsup = 10%. As
with the previous exercise, only frequent closed patterns were mined.
The most common sequence found was 〈LAB,LAB,LAB〉 with a support of
3390 paths. Indeed, when looking at most frequent sequences, the majority of
those with support over 1000 had on average 1.6 (SD 0.5) unique systems and
LAB was present in all. Again, the fact that LAB is so common both within and
throughout paths has introduced additional difficulties in evaluating the results.
As such, the rules are not included here but they are available in Appendix C 1.4.
An additional challenge when applying sequential pattern mining algorithms is
that the results included several similar rules with the same systems and identi-
cal support where only the order of the systems is different. The use of standard
sequential pattern mining algorithms alone was not sufficient to produce mean-
ingful patterns with discriminative support. However, other attempts were made
using more recent algorithms that produce sequential rules. Introduced in 2012,
the CMRules algorithm [239] focuses on mining sequential rules that are common
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to many sequences rather than rules that appear frequently in sequences. The
algorithm finds association rules to “prune the search space for items that occur
jointly in many sequences” and then it removes those rules that do not meet
the confidence and support thresholds according to the time ordering [239]. The
output of this algorithm are rules of the form A⇒ B where A is an itemset with
items that can appear in any order and B is an itemset of items that sequentially
follow A. The rules reveal a sequential relationship between the two sets of items.
An implementation of CMRules algorithm was also available in the SPF frame-
work and the latter was used to produce the rules with a minimum confidence of
10% and, because the previous exercises already yielded most association rules,
a larger minimum support of 10% was selected. The algorithm returned 67 rules
(included in detail in Appendix C 1.4) and selected rules are shown in Table 4.7.
The first three rules in Table 4.7 indicate, with a large support and confidence,
the systems that precede LAB. They are RAD, HIS and PAS, respectively. These
are similar results to those presented earlier but are here given with a degree of
confidence. The two last rules (6 and 7) were selected to demonstrate the difficulty
in interpreting the results. In these two rules OPT is kept in the antecedent set,
HIS is kept in the consequent set, and LAB and PAS are swapped. However,
there is more confidence that LAB and HIS are preceded by PAS and OPT.
Sequential Rule Support Confidence
1. {RAD} ⇒ {LAB} 959 94.13%
2. {HIS} ⇒ {LAB} 2598 91.83%
3. {PAS} ⇒ {LAB} 1464 91.83%
4. {PAS,LAB,OPT} ⇒ {HIS} 688 91.77%
5. {OPT,HIS} ⇒ {PAS} 515 83.91%
6. {PAS,OPT} ⇒ {LAB,HIS} 688 83.54%
7. {LAB,OPT} ⇒ {PAS,HIS} 475 76.66%
Table 4.7: Selected Sequential Rules from the CMRules Mining Algorithm for
System Paths.
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Sequential pattern mining provided rules that indicate which systems are fol-
lowed by others but, given the work carried out in association rule mining and
initial work on sequential pairs there was little new information given by applying
ordering constraints. However, introducing interval time constraints to sequen-
tial pattern mining might provide more interesting results and some knowledge
regarding time windows between systems. This is discussed in the next section
together with other techniques to inspect the timeliness of systems’ visits.
4.2.3.3 Time Constraints
A first approach to understanding how systems are visited in time can be to draw
a scatter plot based on the information in patients’ paths. A software program
was developed to scan all system paths and produce a scatter plot (Figure 4.3)
where the x-axis represents time, the y-axis shows the list of systems, and each
footprint is associated to a system and represented by a tick in the plot. All
paths were grouped together and the scatter plot shows the overall times when
each system was visited in the cohort. In order to distinguish which systems were
visited before and after diagnosis the paths’ time were zeroed at diagnosis date.
Figure 4.3 shows the scatter plot produced for all system paths. The maximum
and minimum range was set to 3000 days in order to cover all paths.
Figure 4.3 is expressive in showing which systems are more frequently used before
and after treatment. The most used system before treatment is LAB where blood
tests are carried out in symptomatic patients but also in those who have no
symptoms but have one or more risk factors. The second most common system
used before diagnosis is the operating theatre OPT. This system would appear
before the diagnosis because extensive biopsies will be carried out in the operating
theatre. Other systems that appear before diagnosis are IMG where imaging was
done to the pelvic region of suspected cancers and the radiotherapy RAD system.
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Figure 4.3: Scatter plot showing the systems visited and their times for all given
system paths. The x-axis represents time zeroed at diagnosis, the y-axis shows
the list of systems and the ticks show when a particular system was visited in
time (range 3000 days).
Upon inspection it was found that the latter are mostly palliative radiotherapy
treatments to the sacral area and hips or pelvic region.
It is also interesting to note the rate at which systems become less used after
diagnosis. In particular, the oncology ONC system and the histopathology HIS
system become less used more quickly than the others. This is because of the
nature in which patients are registered in the ONC system and, in the case of HIS,
once a conclusive biopsy has been carried out, and in particular if the treatment
was surgery, further histopathology reports are less likely to be needed. Again,
the LAB system is the most visited up to the end of all paths. Of interest are
also the gaps in time where no path ever visited a particular system. These are
visible in more detail in the second plot (Figure 4.4) where the time window has
a smaller range of 100 days after diagnosis. The operating theatre system sees
some interesting intervals. In particular, less operations (OPT) were carried out
between 10 and 30 days. It was, however, not possible to accurately explain why
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such gaps exist in this time frame.
Figure 4.4: Scatter plot showing the systems visited and their times for all given
system paths with a set time window of 100 days after diagnosis.
Another approach to study the timeliness between systems visits with more de-
tail is to use Sequential pattern mining with constraints. In 2006, Hirate and
Yamana introduced a novel algorithm to mine sequential patterns with time in-
tervals [240]. Their algorithm discovers time-extended sequential patterns that
are common to several sequences. The algorithm’s input is a time extended se-
quence database where each itemset is annotated with a integer value denoting
time. Also as inputs are the time constraints defined in [240]: minimum support,
minimum time interval (between two subsequent itemsets of a sequential pat-
tern), maximum time interval, and overall maximum and minimum time interval
for the overall sequential pattern. The algorithm works in the same fashion as
PrefixSpan in that it generates candidate sequences and then applies time con-
straints that satisfy minimum support and time intervals. A full description of
the algorithm is given in [240] and it is not repeated here. The SPM framework
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includes an implementation of Hirate and Yamana’s algorithm to generate closed
sequential patterns with time constraints. The algorithm was applied to the sys-
tem paths dataset with the following constraints: minimum support of 2.3% to
capture a wide number of rules; both time intervals minimum were set to 1 day
and maximum set to 3000 days (maximum range) in order to capture as much
information as possible. This resulted in 710 rules, 12 unique pairs of systems
and 6 unique rules where more than two systems are present as itemsets.
Sequential Pattern Support
1. {LAB,PAS} < 1 > HIS 421
2. LAB < 1 > {OPT,HIS} 253
3. {LAB,PAS} < 1 > OPT 196
4. PAS < 1 > {OPT,HIS} 191
5. {LAB,PAS} < 1 > {OPT,HIS} 137
6. {LAB,OPT} < 1 > HIS 131
7. {LAB,PAS} < 3 > HIS 118
Table 4.8: Selected sequential patterns with time constraints based on Hirate
and Yamana’s algorithm. Only rules where more than two systems are present
in itemsets are shown. The angle brackets show the relative time stamp of the
subsequent system, e.g. Rule 2 indicates that at time 0 LAB system was visited
and 1 day later OPT and HIS were visited.
Table 4.8 shows rules that include more than two systems. The remaining rules,
not shown in table 4.8, were less interesting in that they only revealed sequential
pairs with different times and support. The rule with most support indicates
that at time 0 systems LAB and PAS were visited and that one day later the
HIS system was visited. The first and last rules (1 and 7) are the same but
were considered separately by the algorithm due to the time interval. Overall,
the rules produced were difficult to interpret as the order of the systems in the
itemset is not accounted for and also because of the sheer volume of similar rules
with different time cut-off points. Different input parameters were attempted
but yielded a smaller number of similar or uninteresting rules. The algorithm
was therefore not found to be suitable for this particular dataset. However, in
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other situations, it might help to unearth particular combinations of systems that
are consistently followed by others within a given time interval.
As a result, the average times between pairs of systems are explored in more detail.
Software was developed to compute the averages and standard deviations for all
possible permutations of systems. The full list of results is given in Appendix C
1.4 and two graphs were drawn to illustrate pairs with the shortest (≤ 60 days)
and longest times (> 60 days) having a support of at least 100 paths (Figure 4.5).
The standard deviations for the computed averages in Figure 4.5 indicated much
dispersion in the data (descriptive statistics in Appendix C 1.4). Attempts were
made to reduce dispersion by imposing cut-offs for extreme values at 1 year and
later, 100 days, yet only marginal improvements were observed. A better way to
cope with extreme values was, in this case, to use percentiles. As such the 90th
percentile was computed for all connections. Every arch in Figure 4.5 indicates
the computed average and, within brackets, the percentile. The 90th percentile
indicates the threshold (in days) where at least 90% of the data lies.
Overall, the shortest average time between systems occurs from PAS to HIS
(average 2 days, SD 2) and its 90th percentile is 3 days. The latter indicates that
over 90% of the connections from PAS to HIS are within 3 days. This connection
reveals that a histopathology report is produced shortly after a consultant episode
or a procedure in PAS. Indeed, the same percentile and a small average is observed
in another connection, from the operating theatre (OPT) to PAS. This reassures
us that the shortest observed times occur when a histological confirmation is
needed given a biopsy, here represented by a visit to the operating theatre (OPT,
for an extensive biopsy) or the outpatient clinic (PAS, for a less extensive biopsy).
A small number of PAS visits in this connection, may, however, not be to perform
a biopsy and that would account for the remaining 10% of connections.
In addition, Figure 4.5 A shows an interesting relation between the systems where
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Figure 4.5: Two graphs (A and B) showing the average times and the 90th
percentile between systems. Graph A shows the shortest times (less than 60
days) and the graph B shows the longest times (over 60 days). Only connections
with a support over 100 were included. The graphs’ arches show the average time
in days between systems and the 90th percentile.
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shortest connections are observed. These are from PAS to OPT or HIS and from
OPT to HIS or PAS. The latter (OPT to PAS) occurs on the same day more than
90% of the time indicating that these patients are taken to a hospital bed after
visiting the operation theatre. This analysis could also provide an insight into the
systems’ interoperability in that the administration system (PAS) should record
most of the procedures, diagnoses and their respective clinical codes. However,
the available data and limited interoperability identified earlier in this thesis
together with the chronic nature of prostate cancer lead to mostly large time
intervals between systems. Exceptions are the interactions between systems when
patients are admitted as inpatients to undergo surgical interventions.
Figure 4.5 B shows the longest times between systems and the longest time ob-
served (with a support of 100 paths or more) is between HIS and RAD with an
average time of 209 (SD 173) and a 90th percentile of 289 days. This indicates
the amount of time patients take to begin radiotherapy (here including both rad-
ical and palliative) after a histopathology confirmation of diagnosis. However,
in Figure 4.5 it is only possible to assess the times between each two systems
individually and hence it cannot be regarded as an accurate measurement of the
average times taken to begin radiotherapy treatment after a diagnosis is made.
Furthermore, radiotherapy may be delivered as adjuvant or neoajduvant therapy
combined with other treatment types. These are limitations to the interpretation
of these results yet they may be overcome by modelling and analysing the data
differently. This is discussed in more detail in the next sections.
Overall, extending the system paths to include time is an important and worth-
while exercise that provided insights into the timeliness of the sequential flow of
patients between systems. In particular, it highlighted the time intervals where
patients were admitted to a hospital bed. Further work is needed to account for
times across several systems such that, for example, the average time between
PAS and OPT can also be computed in situations where other systems’ visits
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exist between these two. Hirate and Yamana’s algorithm, however, did not dis-
cover any interesting rules that covered more than two systems and, as a result,
it was considered sufficient to compute the averages and percentiles between any
two systems. The results from Hirate and Yamana’s algorithm provided similar
results with this dataset.
Overall, algorithms that introduce time constraints such as Hirate and Yamana’s
can provide additional information that allow a better understanding of the flow
between systems. In addition, scatter plots produced by the developed software
also provided interesting insights into the time distribution of systems across
all paths. The next section explores the utility of process mining to discover
interesting processes within the system paths.
4.2.3.4 Process Mining
This section discusses the use and utility of process mining in finding additional
patterns in the system paths. As previously mentioned, most process mining
algorithms do not provide insightful results in health care domains due to noise,
complexity and heterogeneity of the data. Classical approaches such as the al-
pha algorithm [241] require complete logs with no noise, yet this is not possible
given the nature of health care data, as seen in this thesis. Nevertheless, other
algorithms have been proposed to deal with noisy data [212].
The Heuristics Miner [242] is an advanced process discovery algorithm, and it
has been previously used in a health care domains [208; 215]. Limitations were
identified in [215] and the models produced were spaghetti -like, too complex due
to the sheer size of connections and nodes. A later study [208] informed that the
produced models were able to focus on the most frequent paths but they were
too complex to analyse due to the fact that, in health care, they do not have a
single kind of flow. The authors also reported that breaking down large event logs
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into smaller logs with similar properties (by using clustering techniques such as
self organising maps) provided better results, easier to analyse. Other additional
clustering techniques that facilitate the understanding of spaghetti models were
later introduced [243].
Nevertheless, because the system paths dataset has a small number of unique
tasks (yet a large number of possible interactions), an attempt to produce a
process model was carried out using the Heuristics Miner algorithm. Full details
of the application of the algorithm and the generated process models are available
in Appendix C. The system paths dataset was converted into the appropriate
workflow log format and the Process Mining framework (ProM) software was
used as it implements several of the process mining algorithms including the
Heuristics Miner [244]. In process mining terminology, the dataset including all
system paths is called the event log, a system path is a process instance (or case),
and a patient footprint in a given system is a event (or activity) in a given system
(task) although the latter two are sometimes used interchangeably. In the system
paths dataset there are eight possible tasks (systems).
The Heuristics Miner algorithm was introduced in 2006 by Weijters [242], and
uses a heuristic approach to address the problems faced by the classical alpha
algorithm and, in particular, to deal with noise in event logs. The algorithm is
explained in detail in [211; 215; 242] yet its three key steps are summarised here:
1. Construct Dependency Graph
In this step a dependency measurement is computed for each pair of tasks
in the event log. This is a measurement of strength of an ordered relation
between two tasks given the support of relation.
2. Determining Dependency Types
Establish the input-output expressions between activities so that parallel
or exclusive activities can be captured.
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3. Discover Long Distance Dependency Relations
In this step, indirect relations between tasks are discovered (non-local be-
haviour).
An important concept is the computation of the dependency measure in the first
step of the algorithm [211]. Let A and B be two tasks and |A→ B| the number
of times A is directly followed by B. The dependency relation measure between
A and B is
|A⇒ B| =

|A→B|−|B→A|
|A→B|+|B→A|+1 if A 6= B
|A→A|
|A→A|+1 if A = B
A dependency value is calculated for every pair of tasks in the dataset and gives
the relative strength of A to B in relation to its inverse, B to A. It’s values range
between 1 and -1 and values close to 1 indicate a stronger positive dependency
between A and B. The latter can only be achieved if A is often followed by B but
B is hardly ever followed by A [211]. In the HeuristicsMiner algorithm a depen-
dency matrix and subsequent dependency graph are constructed based on this
measure. The determination of dependency type and long distance dependency
relations are not explained in detail here but are given in [211; 215; 242].
The system paths dataset was divided into a training set (n=2212) and a test
set (n=2225) and the HeuristicsMiner algorithm was applied to both indepen-
dently. In both occasions the models produced had a poor fitness (i.e. how the
observed process complies with the control flow specified by the process model).
The adjustment of the algorithm’s default parameters resulted in a marginal im-
provement yet when artificial start and ends were added to all paths, the best
fitting and least spaghetti -like models were produced. Artificial starts and ends
can be seen as a way to normalise the data so that all paths’ starts now converge
into an overall start task and end points converge into a unique end task. De-
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tails of the models produced as well as input parameters are given in Appendix
C. When comparing the training set with the test set, differences regarding the
placement of the tasks and their connections were observed. As such, only tasks
and connections that were common to both sets could be taken into account and
the overall models were not used.
The following two interesting relations between tasks were identified in both the
training set and the test set:
• ArtificialStart⇒ ONC ⇒ RAD ⇒ ArtificialEnd
Sequence pair ONC,RAD had been previously identified in the simple se-
quential pairs (support 485) and as the fifth most common start sequence
pair (support 138). Rule ONC ⇒ RAD was also identified using the CM-
Rules sequential pattern algorithm with a support of 668 and confidence of
53%. Furthermore, an interpretation of the Apriori association rule results
indicated that 66% (n=135) of rules where RAD appears as a consequent
(n=203) have ONC as antecedent.
In all three cases, the rule did not stand out as particularly relevant. Us-
ing the HeuristicsMiner, however, the dependency measurement value for
relation |ONC ⇒ RAD| was 0.96 both for the training set and the test
set. This indicates a strong relation |ONC ⇒ RAD|, when compared to
|RAD ⇒ ONC|. This would confirm a link between patients who visit
the radiotherapy department followed by the oncology department, as their
treatment plan is often agreed in oncology.
• ArtificialStart⇒ HIS ⇒ IMG⇒ ArtificialEnd
A connection between HIS and IMG alone had not been previously re-
ported in any rule generated by the associations and sequential rule mining
algorithms. It was, however, identified in the sequential pairs summary,
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where HIS, IMG with a support of 207 and IMG,HIS with a support of
19.
The dependency value given by the HeuristicsMiner algorithm was 0.93 for
the training set and 0.90 for the test set. This rule indicates that imaging
is often carried out after histology and the reason for this might be an
elevated Gleason grade or extracapsular extension of the tumour. In this
case imaging would help to investigate the extension of the invasion and
existence of metastases elsewhere.
Given the above results, an alternative approach to capturing interesting con-
nections using the dependency measure was undertaken. The approach relies on
building a dependency map rather than a process model and to apply a lower
threshold filter. This approach was carried out in the following steps:
1. Compute dependency values and create a dependency matrix for the train-
ing set and another for the test set.
2. Eliminate any dependency values below a predetermined threshold from the
matrices.
3. Compute the difference between the values obtained with the training and
test sets and consider removing any values from the matrices below a second,
cross-validation threshold.
4. Draw a dependency map based on the dependency values that meet the
above criteria from the test matrix.
This approach uses the first step of the HeuristicsMiner algorithm and adds addi-
tional validation to ensure that the resulting dependency map is consistent with
both the training and test set (given the cross-validation threshold). The depen-
dency threshold used was 0.5 and, in this case, a cross-validation threshold filter
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was not used as almost all values were within 0.05 and two larger values, 0.26
and 0.15 were highlighted. The resulting dependency matrix and map are given
in Figure 4.6.
This approach bypasses the second and third steps of the HeuristicsMiner algo-
rithm and as such it does not give long distance relations or dependency types,
however, it is simpler to understand and the dependency matrix can be considered
the backbone of process models [211].
Using this measure, two of the most dominant systems in the previous analyses,
LAB and PAS, became disconnected (dangling) activities with a self-loop de-
pendency of 1. They are disconnected because, with the exception of self-loops,
the dependency values were consistently below the threshold, 0.5. In particular,
dependency |PAS ⇒ HIS| had the highest dependency value of 0.41, and all
other connections had values lower than 0.3. According to the dependency rela-
tion, pairs where A is followed by B as many times as B is followed by A have a
dependency value of 0. Values close to 0 will therefore indicate that it is difficult
to assert the true direction of the relation.
This analysis highlighted interesting results and among them were the rules pre-
viously identified in the process models (|ONC ⇒ RAD| and |HIS ⇒ IMG|).
Apart from the latter and self-loops, the relations with greater dependency val-
ues are |HIS ⇒ RAD| (0.92) and |ONC ⇒ OPT | (0.82). Figure 4.6 shows that
the system with most relations is HIS. The relations indicate that after a patient
is diagnosed histologically, he is likely to visit either oncology (0.65), radiother-
apy (0.92), or radiology for imaging (0.9). A further link between oncology and
radiotherapy (0.96) is also observed as it is common for oncology to plan the
radiotherapy treatment.
It is also interesting to note the routes through to the operating theatre (OPT)
in the dependency graph. Patients may flow to from oncology (0.82) or radi-
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Figure 4.6: Dependency map (top) showing all connections in the test set with
a dependency value over 0.5. The two values highlighted with a star have higher
cross-validation thresholds (0.15 or -0.26). Dependency matrix (bottom) showing
all dependency values present in the map and the difference between the value in
the training set and the test set.
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ology (0.77). These contrast with the previous average times analysis in that
the relations do not feature in the latter due to their small cardinality (under
100 paths). Furthermore, the previous analysis revealed a strong short time de-
pendency between OPT, PAS and HIS, and that no similar association rules to
those in the dependency graph were produced. This reinforces that, although the
routes to OPT in the dependency graph may be interesting, they do not include
a minimum support, and that the heuristics miner algorithm does not distinguish
low frequent behaviour from noise. In this exercise, minimum supports were not
included in the dependency graph so that more relations could be discovered.
Process mining techniques may provide some interesting results but they are not,
on their own, considered appropriate in heterogeneous domains and respective
datasets. Further work on combining these techniques with association rules,
time constraints and robust data models is needed to ensure that meaningful
processes can be derived from large datasets.
4.2.4 Results and Key Findings
This section introduced system level paths and explored currently available data
and process mining tools and techniques for the discovery of trends and associ-
ations. The system paths data structure allowed the production of data-driven
and patient-centric paths where the complete set of system visits for a patient is
arranged sequentially. The data structure has also allowed for the system paths
data to be easily analysed using both developed software and exiting mining
software toolkits.
Overall, and partially due to low granularity and nature of the data, most of
the meaningful results revealed association between two systems. In addition,
an average of 7 visits to the LAB system per path introduced additional combi-
natorial explosion and, as a result, most rules with highest confidence have this
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system as consequent. This was aggravated by multiple bi-directional relations
where almost all systems flow to another and back. Nevertheless, the Apriori
algorithm was able to answer questions such as which systems were often visited
together. Rule {PAS,LAB,HIS} ⇒ OPT , for example, indicates with 83%
confidence (1073 support) that the operational theatre is visited when all other
three systems are visited (the administration, the laboratory for a PSA, and the
histology systems). This, however, is not helpful in determining whether the lat-
ter systems were a consequence of a visit to the operating theatre or the contrary.
The sequence in which systems are visited matters and sequential pattern mining
algorithms were explored.
The sequential pattern mining algorithm used in this section narrowed down
the total number of rules produced yet most of these would only include two
systems. Despite this, the algorithm was able to provide more meaningful rules
with greater support. Table 4.9 shows a list of the sequential and association rules
with most confidence where only two systems appear. The sequential pattern
mining algorithm provided, as expected, the same rules with consistently less
confidence than the association rules.
Antecedent &
Consequent
Association
Rule
Sequential
Rule
Avg. Time (%ile)
OPT , HIS 94.25% 88.62% 7 (3)
PAS , LAB 93.87% 91.83% 37 (91)
HIS , LAB 92.91% 91.83% 120 (210)
OPT , LAB 92.56% 90.75% 181 (281)
ONC , LAB 86.63% 84.98% 80 (179)
OPT , PAS 84.04% 83.28% 6 (0)
RAD , LAB 83.17% 94.13% 82 (164)
Table 4.9: Rules with most confidence from both association and sequential rule
mining algorithms and their respective average time and 90th percentile in days.
A subsequent analysis using sequential mining with time constraints provided lit-
tle new information and smaller support because of time cut-offs. As a result, an
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inspection of the times between systems was undertaken and provided interesting
results. In particular, a relation between systems with the shortest paths (PAS,
OPT, HIS) was observed, indicating a time-dependent relation between the oper-
ation theatre, histology, and the administration system. From all relations where
it was possible to compute averages, 75% (n=43) had an average time over 30
days and 26% had an average time over 3 months.
The chronic nature of prostate cancer contributes to larger time windows between
events and consequently large average times and standard deviations. The use
of percentiles was found to provide additional meaningful information on the
time intervals between systems. However, a full map with novel information
on the shortest and longest times between systems was produced as well as a
scatter diagram. Both provided a new way of looking into this data that had not
previously been looked at. Further work is needed to explore how this information
can be made useful for hospital management, clinical staff and patients. The
results presented in this section provide a general picture of the times taken for
patients to flow between systems and hospital departments and a basis for further
work, some of which is undertaken later in this chapter.
Process mining algorithms were also investigated and found unsuitable to model
unstructured processes such as those found in health care, even with small num-
ber of items (systems) as observed in this section. Spaghetti -like models were
produced, however, the underlying dependency measurement was considered of
interest as it highlighted the direction of the relationships between systems.
Table 4.10 shows a list of all the relations included in the dependency model on the
system paths dataset. When available, the respective association and sequential
rules’ confidence are given together with the average time (and 90th percentile) in
days. This provides a basis for comparison between the results of the dependency
measurement and the association rules; it shows that the relations with higher
dependency value have similar rules with low confidence.
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Antecedent &
Consequent
Association
Rule
Sequential
Rule
Dependency
Value
Avg. Time
(%ile)
ONC , RAD 66.64% 53.05% 0.96 105 (160)
HIS , RAD 29.63% 26.31% 0.92 209 (289)
IMG , OPT 24.92% - 0.77 68 (102)
HIS , ONC 23.40% 22.89% 0.65 55 (111)
ONC , OPT 20.50% - 0.82 20 (55)
HIS , IMG 14.30% - 0.9 35 (48)
Table 4.10: Relations included in the Process Mining Dependency Matrix and
their respective association and sequential rules’ confidence, and the average time
and 90th percentiles in days.
The striking difference between confidence levels and the dependency values is
illustrated in table 4.10. The selection of rules with high support and confi-
dence based on frequent itemsets provides different results to those where a uni-
directional tendency is used. The latter tackles the problem of symmetry and
provides interesting information that is not covered in association rules but future
work on a hybrid approach could provide better rules that cover both frequency
and direction between two and more itemsets.
The data structure proposed in this section allowed the aggregation of informa-
tion into system paths for analysis. The work carried out in this section reassured
that association rule mining and process mining algorithms, on their own, do not
provide significant results in heterogeneous and unstructured environments such
as the one found in health care. Different ways of modelling the data can provide
more meaningful results with the above methods. Process mining models, even
when data modelling techniques impose some degree of organisation, do not cope
well with increasing granularity in unstructured environments. Furthermore the
association or sequential mining algorithms techniques are not aimed at discov-
ering end-to-end processes and other techniques such as hidden Markov models
[211] should be explored.
Further research is needed on methods tailored to unstructured environments and
229
4. Pathways Modelling, Mining and Visualisation
hybrid approaches could provide meaningful results. Association rules with se-
mantic constraints and based on a data structure such as the one proposed in this
section are most promising. The work carried out in the next sections provides
a framework for the modelling of complex clinical information that extends the
system paths and introduces a novel approach to the visualisation and analysis
of health care data from multiple heterogeneous sources.
4.3 Pathways
The previous section described the modelling of routine hospital data into system
paths and assessed the utility of data and process mining techniques. Low gran-
ularity and scant semantics were reported limitations. Additional information,
contained in each of the systems, can provide a more detailed understanding of the
patients’ journey through care and their clinical features. This section explores
the development and modelling of pathways with complex clinical information
with a focus on data quality and on the prostate cancer biomarker, the PSA.
The aims of the work presented in this section can be divided into three:
• to extend the system paths data model and generate data-driven patient-
centric pathways for prostate cancer from routinely collected data,
• to develop a framework and decision support software for the integration,
visualisation and analysis of pathways,
• to evaluate the completeness and utility of the generated pathways for in-
vestigating biomarker trends.
The pathways should allow for the selection of high quality data for clinical studies
and decision making, which, in turn, enables the (re)design, management and
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optimisation of clinical pathways. We focus on a definition of a pathway as a data
structure that synthesises knowledge and facilitates the development of methods
for the computation of variance and other statistics. The framework presented
in this section, together with their formalisms, addresses the issues reported in
the literature and should allow and encourage other tools and techniques, such
as process mining or ad hoc algorithms to be used.
The next section formally defines a pathway and it is followed by a section that
describes the methodology used to model the data and to development of a data
dictionary (section 4.3.3).
4.3.1 Defining a Pathway
Let D represent the pathway dictionary where the i-th entry has a code ci (1 ≤
i ≤ n) in a total of n possible codes described in detail in Table 2 and in section
. CE is the subset of codes containing timed events and CI the subset containing
informational elements, such as demographics. By associating a zero time with
informational elements, all events in the pathway can be viewed as timed events.
A pathway activity A is then defined as four-tuple A = (r, t, c, v) where
• r is the patient identifier
• c ∈ C is an event code
• t is the time in days before or since the day of diagnosis recorded for patient
r
• v is a value, numerical or categorical, associated with dictionary code c
A pathway for patient, r, is represented as a chronological sequence of activities,
P = 〈A1, A2, . . . , Am〉, where
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i. Ai is of the form (r, ti, ci, vi) for 1 ≤ i ≤ m,
ii. ti ≤ ti+1 for 1 ≤ i ≤ m− 1,
iii. any Ai with c ∈ Ci has ti = 0,
iv. if Ai = (r, ti, ci, vi) and Ai+1 = (r, ti+1, ci+1, vi+1) then there is no activity
A = (r, t, c, v) where ti < t < ti+1 and
v. all relevant activities involving patient r appear in P .
A simple pathway for patient r = 1 might be P = 〈A1 = (1,−28, P, 45), A2 =
(1, 0, D, 2), A3 = (1, 1, G, ”4 + 3”), A4 = (1, 1, H, ”CyproteroneAcetate”), A5 =
(1, 151, R, ”37”), A6 = (1, 260, P, 0.2), A7 = (1, 340, P, 0.05), A8 = (1, 539, P, 0.05)〉.
In this patient’s pathway the first PSA test was elevated at 45 ng/ml and this led
to the diagnosis of stage 2 prostate cancer with a Gleason grade of 4+3. Note that
the biopsy was performed as an outpatient event and hence it is unavailable in
this pathway, however, the histopathological findings of that biopsy are present.
The patient then agreed to undergo hormone therapy (cyproterone acetate) and
a subsequent 37 sessions of radiotherapy. The number of radiotherapy sessions is
recorded as value of element code R. This was followed by PSA readings of 0.2
ng/ml and two readings < 0.1 ng/ml which indicate a good response to treatment.
This pathway is summarised in Table 4.11 and a description of the pathway codes
and dictionary is given in section 4.3.3.
A pathway may also be succinctly expressed as a sequence of its activities codes
such that, for patient r, S = 〈c1, c2, . . . , cm〉 is the set of c sequence codes belong-
ing to a pathway P with m activities.
Using the above example, for patient r = 1, the corresponding pathway sequence
would be S = 〈P,D,G,H,R, P, P, P 〉. However, sequences may be ambiguous
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Activity, A Identifier, r Time, t Event Code, c Value, v
A1 1 -28 P 45
A2 1 0 D 2
A3 1 1 G 4+3
A4 1 1 H Cyproterone Acetate
A5 1 151 R 37
A6 1 260 P 0.2
A7 1 340 P 0.05
A8 1 539 P 0.05
Table 4.11: Tabular summary of a patient’s pathway with 8 activities and a total
elapsed time of 567 days.
when activities are concurrent in time. A way to overcome this limitation is by
programmatically sorting every set of concurrent elements in S. A sequence may
also be truncated so that repeated elements are removed. The latter enables a
rough aggregation of pathways with similar sequential activities.
The above model of expressing pathway activities is similar to the entity-attribute-
value (EAV) data model [245] where concepts are described in an attribute in a
row. Later, the i2b2 data model [178] expanded on the EAV model to account
for time (start and end dates for each observation). This, together with a star
schema, has been described as an extremely efficient way of querying data as a
large index can be built to encompass all patients’ data in the master table [178].
The above definitions rely on a pathway dictionary that describes the semantics
of patient activities and this is described in detail in the next section.
4.3.2 The Operational Data Store
The data extraction process described in chapter 2 and published in [52] was used
to collect patient-centric data from HIS and to create an operational data store
(ODS). The ODS has been previously discussed in the context of creating system
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paths but it is used more extensively in the development of the pathways and
framework described in this section.
As previously noted, the ODS replicates the hospital environment and it may
contain more data than required for particular clinical studies as the retrieval
process is based on minimum use of constraints. However, this provides a holistic
representation of the patients, including their demographics, comorbidities, test
results and other information, and is limited by the availability of electronic
information in the HISs.
The prostate cancer ODS contains information from the following sources: admin-
istration, cancer waiting times, histopathology, radiology, biochemistry, operating
theatre, orthopaedics, oncology, radiotherapy, and an external source, the can-
cer registry. However, not all sources were used in the development of pathways
as later explained in 4.3.3. The data sources in the prostate cancer ODS were
previously identified in chapter 2 (Table 2.2) and are summarised later in this
section.
The methodological process used to select appropriate data elements from the
ODS and to create a pathways data dictionary is given in section 4.3.3. First, a
formal definition of a pathways is given in section 4.3.1.
4.3.3 Building the Pathways Dictionary and Repository
The ODS contains data from the retrieved hospital sources and metadata which
allows for the inspection, linkage and integration of semantic and syntactically
different data. Nevertheless, the ODS may contain information outside the do-
main of a specific pathway. Therefore, in order to build a pathway dictionary, it is
crucial to identify, select and retrieve key data elements. The process of building
a pathway dictionary from the data in the ODS is illustrated in Figure 4.7 and
234
4. Pathways Modelling, Mining and Visualisation
is inspired by the similar data warehousing technique of Extract-Transform-Load
[6]. The pathway dictionary can be regarded as a simple ontological knowledge
base, built by a bottom-up process, from available data to concepts. Temporal
ontologies have been developed [246] yet for the definition of pathways, the above
time-oriented data structure together with a pathway dictionary was considered
sufficient for this case study.
The dictionary building process, based on input from domain experts, a survey of
the literature and current prostate cancer guidelines, involves gathering relevant
data elements and applying transformations to either create new features or strip
out irrelevant elements (e.g. hospital events that are neither exclusive nor relevant
to the treatment of prostate cancer). At the end of this process, and for each
data element, a flat file with the data corresponding to that element is created in
the four-tuple transactional format described in 4.3.1. The steps involved in this
process are described in detail below.
Figure 4.7: Methodology to build pathways dictionary and database.
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1. Preliminary Inspection and Selection
The domain experts collaborate on a first inspection of the available data
in the ODS to help with the identification of key data elements to be in-
cluded in the pathways. This involves examining summary statistics (such
as frequencies of biochemistry tests) and metadata (such as attributes de-
scriptions, semantics or expected outliers) from the ODS and is important
as it sets the granularity of the pathways and the extent to which they can
be meaningful for a particular disease.
For the prostate cancer study, three classes of information were defined:
demographics, diagnostics (including investigations) and treatment. Hence
the selected elements in this step have an associated class. Further to this,
each element type can either be a timed event, describing a particular ac-
tivity at a given time, or auxiliary information such as demographic data or
other non-event data such as a patients participation in a clinical trial. Both
class and type are two properties common to all elements of the pathway
and can be determined a priori or throughout the process of building the
pathways as explained below. The use of routinely collected hospital data
for timed events indicates with certainty that a particular activity occurred;
however, its absence may not indicate the opposite. Existing data may be
used in validity checks for the completeness of the data, for example, as we
will see later the PSA biomarker can act as an alert for potential missing
activities at particular time intervals.
For each selected data element, the following six steps are carried out to
create a complete pathway dataset and dictionary. Throughout the follow-
ing steps we will use the example of the biomarker test for prostate cancer
(PSA test) as a data element.
2. Assessment
The first step is to inspect the elements values as well as its semantics,
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syntax and data type, and any potential limitations that may interfere
with the consistency of the data element. Additional mapping, linkage and
transformations may be necessary to enforce a consistent format and these
should be identified here. An example arising from the PSA test was the
need for the removal of values that include symbols, such as ” < 1”, meaning
the PSA test value is less than one. In this case such values were replaced
by 0.5. A first classification of the element is also given by assigning a
dictionary code and the element type (informational or timed event); in
this case the code for the timed event PSA test is P.
3. Retrieval
The set of attributes and values for the data element are retrieved from
the ODS. In the case of the PSA test, the attributes in the ODS include
dates of test authorisation, date of entry, value, comments, clinical history,
fasting, blood reading thresholds and the patient identifiers. Rule-based
deterministic record linkage can be used to enforce constraints. In the course
of the case study, this step was used to select data within the study time
period as well as validating data from the hospital sources against the cancer
register datasets, where possible, in terms of completeness, correctness and
concordance. The retrieved attributes must have the information required
by pathway definition. The data for the particular element is then stored
and in this case study a comma separated file is created to this effect.
For PSA tests the attributes selected from the ODS to be included in the
pathway were date of entry (date when the sample was taken from the
patient within the selected time period), the value, and the identifier that
allows linkage.
4. Transformation
The retrieved data file is converted into the pathway data structure, with
attributes Identifier, Code, Date (instead of time), and Value, where Code
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is a constant. Date is used here but it will later be converted into time,
t, zeroed at diagnosis date. The latter, by removing full dates, allows
an additional layer of anonymity to the pathways as well as a basis for
comparison among patients. Any necessary transformations identified in
the previous steps are undertaken here.
5. Summary Statistics
Summary statistics are produced in this step. These include distributions of
the Value attribute, which can help to detect potential bias, together with
overall support (i.e. total number of patients), value-specific support (i.e.
number of patients on each value category), and extremes. Such statistics
may help to detect and correct quality issues, by assessing completeness
(missing data), correctness and plausibility. Additionally, other statistics
may be produced, such as the number of values within a range; this is
particularly useful for producing a summary of abnormal blood readings,
such as raised PSA tests.
6. Inspection
Together with the domain experts, the retrieved data and descriptive statis-
tics are inspected. The values of the attributes are also checked for format
consistency and the quality dimensions described above. At this stage, a
decision regarding the data element is reached.
The element may be:
(a) kept as is, should it contain sufficient information and adequate sup-
port;
(b) rejected, because there may not be enough information or support;
(c) subject to decomposition, into two or more elements, should the val-
ues of the element vary qualitatively creating a source of ambiguous
information, or should the requirements of a particular study involve
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inspecting a particular quantitative range such as the abnormal range
of a blood reading.
In the example of the PSA test, the data element was kept after the values
were set to a canonical form. An example of an element that was rejected
in the case study is biopsy because of insufficient support (this is further
discussed below). A further example of an element that was split was
surgery, into orchidectomy and surgery (prostatectomy). Another example
of an element that was split was radiotherapy, where, for the analysis of the
trend of PSA, only radical radiotherapy was interesting to investigate as it
affects the PSA.
7. Approval and Update
Upon inspection a decision is made regarding the data element and its
values. When the decision is favourable an update is carried out. The
update is concerned with the technical work of merging the table containing
the data element and its values with the pathways database master table.
Further transformations are also carried out to sort the master table by date
and patient identifier, and to compute time t zeroed at diagnosis date. This
can be achieved by either creating an informational element providing the
date of diagnosis or by programmatically isolating the specific date from an
existing element and subsequently setting t for all activities in a pathway.
The pathways dictionary is then updated with summary information.
The first version the pathway dictionary and how the cohort was selected is shown
in the next section.
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4.3.4 Selected Data and Core Dictionary
A list of diagnosed prostate cancer patients was previously selected for the system-
level paths. This was sufficient for the analysing the paths that patients take
through systems, however, this data was not consistently checked for quality
by the hospital until after the CRE system was introduced. Because it is now
pertinent to look at detailed clinical information, a smaller list of patients, with
verified demographics and cancer waiting times information was selected from the
ODS. This list was then sent to the local cancer registry (Eastern Anglia Cancer
Registry) so as to obtain accurate dates of death and additional information, such
as treatments performed elsewhere, when available. Patients who were not in the
registry, who reside in another registry catchment area, or whose tumours were
awaiting a final report or were referenced only, were excluded from the list.
The selected cohort dates were patients diagnosed between 2004 and 2010. This
time period allowed, overall, one year of data on PSA “screening” (2003) as well
as one year follow-up of data (2011). The date when patients were last checked
to be alive or dead was the 1st of April 2012 by the cancer registry. A total
of 2,979 patients were identified in the CRE system, including those patients
where treatment is shared with other hospitals. Deterministic record linkage was
performed and for 149 patients it did not provide accurate matches (these were
removed). A total of 2,830 patients were included in the original dataset. This
data, however, is still part of a large cohort that warranted additional data quality
inspection.
Upon transformation of the data into pathways, a data quality exercise aimed
at matching radical treatment data between the hospital and the cancer registry.
A total of 32% (n=926) of records were labelled as mismatching on treatments.
Overall the treatment types with most mismatching cases were Hormone Therapy
(19%) and Radiotherapy (13%). This is explained as the cancer registry collects
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information that extends beyond the NNUH and it also captures data from GP
practices, hence, providing a more comprehensive information on patient’s treat-
ments. The full implementation of the hospital cancer registry system (CRE)
made possible for this information to be accurately matched between the hospi-
tal and the East Anglia Cancer Registry, in particular from 2010. As a result, a
cohort of 1,904 patients was selected for further study and it is used henceforth
in this chapter.
The data dictionary was created based on the selected data sources from the ODS,
listed in Table 4.12. A total of 16 core elements was selected and it is shown in
Table 4.13. The elements frequency indicates the percentage of pathways in which
that particular element is present. Additional elements were added later and this
is explained in the next sections.
Data source Description of selected data
Administration (PAS) Patient episodic information, co-morbidities and
clinical coding.
Histopathology (HIS) Histopathology reports and extracted Gleason
grades.
Radiology (RAD) Radiological imaging limited by reports where the
word prostate occurs.
Biochemistry (LAB) Prostatic Specific Antigen (PSA) tests. However,
other blood tests can be added.
Operating Theatre (OPT) Operating theatre procedures and coding.
Radiotherapy (RAD) Radiotherapy treatments dates and number of ses-
sions.
Cancer Registry datasets
(CR)
The cancer registry dataset includes some of the
above data, which can be used for quality check-
ing purposes, and additional data such as cause of
death.
Table 4.12: Data sources used for the development of the pathways.
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Class Code Name Type Data source Frequency
Demographics Q Deprivation Score Information CR 100%
Demographics A Age at Diagnosis Information CR 100%
Demographics Z Death Event CR+ODS (ADM) 21.11%
Demographics L Clinical Trial Information ODS (ADM) 1.16%
Demographics X Other Cancers Event CR 21.32%
Diagnostics D Diagnosis & Staging Event CR+ODS (HIST+ADM) 100%
Diagnostics G Histology Grade Event CR+ODS (HIST) 84.51%
Diagnostics I Imaging Event ODS (RAD) 15.28%
Diagnostics P PSA Test Event ODS (LAB) 95.27%
Treatment S Surgery Event CR+ODS (OT) 33.61%
Treatment R Radiotherapy Event CR+ODS (RT) 20.75%
Treatment C Chemotherapy Event CR+ODS (ADM) 0.42%
Treatment O Orchidectomy Event CR+ODS (OT) 0.11%
Treatment H Hormone Event CR+ODS (ADM) 50.42%
Treatment W Active Surveillance Event CR+ODS (ADM) 22.16%
Treatment N No treatment Information CR+ODS (ADM) 2.21%
Table 4.13: Pathway dictionary for prostate cancer.
4.3.5 CaP VIS: A Visualisation and Integration System
Recommendations for further research in process mining [209], clinical decision
support systems and expert systems [247] suggest that software that integrates
complex data and generates graphical representations is needed to support the
analysis and understanding of such data. This is particularly relevant in sys-
tems that provide unique integration by collating routine data, such as the one
presented in this section. Therefore, a system that enables and supports both
analytical processes (such as data/process mining) and clinical decision support
was explored.
This section introduces a novel software and framework developed for the anal-
ysis and visualisation of the pathways and their integration with further clinical
information. The CaP VIS (Carcinoma of the Prostate Visualisation and Inter-
pretation System) software and framework were developed based on some of the
guiding principles of model-driven architecture (MDA). The three goals of MDA
are to provide portability, interoperability and reusability [248]. As such, MDA-
242
4. Pathways Modelling, Mining and Visualisation
based approaches implement models and are capable separating the operation of
a system from the details of its environment or platform. Further details on MDA
are given in [249] and [250] and are not repeated here.
Although MDA architectures often require significant amount of planning, the
development of the CaP VIS software relied on a Rapid Application Development
(RAD) methodology. RAD refers to “a development life cycle designed to give
much faster development and higher quality results than the traditional software
development life cycle”[251]. RAD approaches favour the rapid implementation
and delivery of prototypes and this is important to communicate effectively with
the domain experts during the development. The RAD methodology consists of
the following phases [251]:
• Requirements planning phase: the scope of the project, requirements and
constraints are discussed with the domain experts.
• User design phase: this is a continuous interactive process that allows users
to understand, modify, and eventually approve a working model of the
system that meets their needs
• Construction phase: tasks include programming and application develop-
ment, coding, unit-integration and system testing
• Cut-over phase: further testing and user training is carried out and a full
working version of the software is complete.
The above steps were used as guiding principles in the development of the soft-
ware and framework presented in this chapter. The software was developed in a
platform independent programming language, Python, and the framework archi-
tecture is described in detail in the next section.
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Pathways Database
The pathway database consists of an organised filing system where each patient
pathway is stored in a single file and linked to an inverted index. A pathway en-
gine is responsible for performing typical database operations as well as advanced
operations and script programming. Although this implementation affects per-
formance, typically due to slow file IO scanning operations, it also ensures that
the database is fully portable and that changes can be made to individual patient
files by non-technical staff with access. Full password protection of the environ-
ment was implemented and additional encryption was possible but not deemed
necessary due to the limited number of users requiring access in the course of
this research. Adding a new patient to the database simply requires uploading a
comma separated file in the pathways tabular format into the specific database
folder. Reading operations may be performed concurrently, however, write and
change operations are exclusive to a master (administration) user with access
to the system and pathways engine. Advanced operations including insertion of
new data elements or propagation of model changes through the cohort are also
possible using the pathways engine. Developed scripts also allow the database
to be converted into a single table or multidimensional format for use with other
database management systems. This system was considered robust and adapt-
able to changes in the data model or dictionary and it may hence be considered
a model driven system, where the model is the backbone of the system design
process. Further details on the pathways database are given later in this chapter.
The next section describes the development and version history of CaP VIS.
4.3.5.1 Development and Version History
The first most important system requirement was that the system should enable
the inspection and study of the Prostate Specific Antigen (PSA) biomarker trends.
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A first system was developed in Microsoft Visual Basic (VB) and VB for Applica-
tions and, based on the pathways data model, allowed the automatic computation
of plots with the complete PSA trend for each patient in the dataset. The re-
sulting plots were then divided by treatment type and this provided interesting
results. Together with the domain experts, an analysis of the produced plots was
critical to determining further system requirements and the future developments,
including a novel graphical representation of pathways data. An excerpt of results
of this process, for each treatment type, is available in Appendix C 1.5.
Single Plot Interface, CaP VIS version 1
Upon inspection of the PSA trend plots with the domain experts, it became clear
that these should contain additional information in order to explain the changes
in the PSA. For example, the most significant drops in PSA reading should be
associated with a particular treatment type. This led to the development of
a more sophisticated visualisation system, capable of interpreting the pathways
and transforming them into meaningful yet concise graphical representations.
A single plot interface software was developed (in Python) together with the
pathways engine, and comprised an architecture similar to that of the Model-view-
controller [252] (MVC). In this implementation, the architecture encompasses
three elements with specific purposes:
• the model, responsible for the read, transforms and interpretation of the
pathways data using an extended dictionary (containing information on
how events are drawn);
• the view, that receives the instructions based on the model and generates
a graphical representation of a pathway;
• the controller, that communicates user or system requests and is responsible
for the interaction between the model, the view and the system.
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This MVC architecture implementation allows for changes to happen to the model
without affecting the view or controller. Each element can be updated or changed
independently. In this version, the view produced a static picture file containing
the graphical representation (plot) of a pathway.
Figure 4.8 shows the layout of a plot and the areas where information is dis-
played. The y-axis represents the biomarker values (in this case, PSA) and the
x-axis represents time t as defined in the pathway data structure. The biomarker
readings are plotted in the centre and events (such as treatments or death) are
marked with a vertical line (V-Line). Different treatments can be colour-coded
differently and, above the plot, the corresponding pathway code, c, is shown in
the V-Line headings area. The footer text area displays additional information
pertaining to events (such as Gleason grades or patient age at diagnosis) and the
right column text area on the right of the plot displays additional information on
the patient that is not time-dependent, such as deprivation score, additional diag-
noses or comorbidities. The model and the graphical representation are discussed
in more detail in the next section and examples of pathways are also shown later.
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Figure 4.8: The schematic layout of a pathway plot.
Multiple Document Interface, CaP VIS version 2
Upon achieving a working solution to automatically produce graphical represen-
tations of pathways, a multiple document interface software was built in Python.
This version of the software relies on an organization of the screen into mutually
non-overlapping frames, one showing the static graphical representation of a path-
way for a given patient, and four frames displaying the histopathology reports,
the pathway details (in a similar fashion to Table 4.11), and pathway statistics.
In this version, the software displays the static graphical representations already
produced and saved as picture files. The software then reads information from
the pathways database to compute basic statistics and display additional details.
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This version of the software allowed a detailed inspection of patient pathways and
this was particularly relevant and useful at meetings with the domain experts. A
screen shot of the version 2 of the software is included in Appendix C 1.6.
Dynamic Multiple Document Interface, CaP VIS version 3
The final version of the software, at the time of writing, was comprised of all
the elements in the previous versions with additional interaction capabilities and
analyses tools and techniques. Instead of relying on static graphical representa-
tions of the pathways, the MVC architecture was embedded within the software,
producing real-time plots of the pathways, as they are read from the database.
This version also introduced dynamic visualisation where users have the options
to zoom in, re-scale and navigate the pathway plot. This is particularly impor-
tant as the scales of the plots may render some drawn objects too close to each
other. A mechanism for graphical conflict resolution (i.e. avoiding overlapping
elements) was also introduced. Additional windows and analyses were introduced
and a full description of the architecture and the system functionality is given in
the next section.
4.3.5.2 Architecture and Functionality
This section describes the CaP VIS version 3 architecture and system function-
ality. Figure 4.9 depicts the ways in which the data flows from the sources, and
the steps involved in bringing detailed pathways into the visualisation and inter-
pretation system or into the analysis or query engines. The file system and the
ways in which the system is organised is also shown in Appendix C 1.7.1.
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Figure 4.9: Data flow diagram illustrating the relationship between the opera-
tional data store (ODS, in bold), the pathway and analysis engine, the visualiza-
tion and interpretation software (CaP VIS) and other interactions.
Figure 4.9 shows the process in which datasets were extracted from the ODS and
in the pathway format defined in section 4.3.1 and used to build the pathway
dictionary and raw pathways database. The pathways engine, which works with
the information stored in the raw pathways database, is responsible for the seg-
mentation, summarisation, cleansing and indexing of the raw pathways. Such
operations together allow for the mapping, selection and retrieval of individual or
groups of similar paths using regular expressions or ad hoc algorithms. The de-
tailed pathways are organised by patient identifier and stored as plots that allow
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an interpreter (the MVC) in the visualisation software (CaP VIS) to produce a
detailed graphical representation. The interpreter will parse each activity from
a pathway and, based on the dictionary and a set of rules determined for each
element code, plot the corresponding graphical representation. An important
feature of the visualisation system is to integrate the pathways with histopatho-
logical or further clinical information. A coding lookup table was added in order
to translate and present diagnosis (ICD) and procedures (OPCS) codes. Because
the time length of different pathways can vary considerably, it was important
for the plot to be interactive, allowing zoom and re-scale as well as mechanisms
for graphical conflict resolution. Sample output from the CaP VIS software is
depicted in Figure 4.10 and shows a patient pathway and related information,
including the pathway data format. The analysis engine can be used by the CaP
VIS software to compute statistics for the pathways but it can also be used on
its own to develop algorithms that work with the pathways data. Section 4.3.9
demonstrates the use of the analysis engine in computing completeness (quality)
scores for the PSA values in pathways.
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Figure 4.10: The CaP VIS system illustrating a castration resistant patient path-
way and related information.
Figure 4.10 shows a patient that was first treated with hormone therapy (code
H) and had a subsequent palliative prostatic resection (code S). The pathway
is plotted on the left side of the screen, where the trend of the PSA biomarker
is visible, together with diagnosis line (code D) and treatments (codes H and
S). On the right, there are three sections showing the histopathology report, the
pathway details in the expected format, the annotations section, and a fourth
section (hidden) contains pathway statistics. An overlapping window shows in
detail the PSA kinetics before treatment, computed for this pathway (including
PSA doubling time (DT) and Velocity (V)). The toolbar above the histopathology
section allows the user to zoom and pan the plotted pathway as well as to save
the plotted figure to file, search for particular patient pathway, navigate to the
previous or next patient pathway, and toggle between showing the histopathology
report or additional pathway statistics. The latter shows additional information
such as data quality, computed NICE risk, basis of diagnosis, and availability of
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data elements from the pathways dictionary. An anchor window (hidden) is also
available and presents a summary of the cohort that allows for fast browsing of
the cohort.
CaP VIS’s graphical user interface is underpinned by a console system that logs
the user interactions and provides additional details on operations and data. A
screenshot of a typical console usage is given in Appendix C 1.7.2.
A detailed list of the program’s menus and options is given in Appendix C
1.7.3. An additional and important functionality, explored in more detail later,
is the system’s capability to plot an additional curve alongside the biomarker
curve. This allows the inspection of two curves (for example, PSA and Alkaline
Phospathase) and their interaction over time. The first version of the path-
ways data dictionary included the 16 core data elements already shown, how-
ever, in subsequent versions, additional biochemistry and hospital events were
added. This is explained in more detail later in section 4.3.8 and demonstrates
the flexibility of the model, software and framework in adapting to new data and
specifications.
The next two sections show two additional software modules developed to interact
with the CaP VIS framework but that are independent from the main software
described above.
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4.3.6 Cohort Visualisation
One of the advantages of using the pathway data structure is the ability to pro-
duce succinct sequences of activity codes. Truncating the sequence strings (i.e.
collapsing sequentially repeating elements into one) enables the aggregation of
pathways with similar sequential activities. A web-based software, called Ex-
ploraTree, was developed tp produce and display an interactive tree of the full
cohort of 1,904 prostate cancer patients, and it is based on the data elements
available in the pathways data dictionary. The technologies used include HTML,
CSS, JSON, JavaScript and the InfoVis toolkit. The pathways engine was used
to produce the correct data format for a tree representation using JSON and the
InfoVis JavaScript toolkit.
In order to accurately aggregate patients with similar sequences of activities, new
data elements were introduced in the pathway dictionary for this software. In
the core data dictionary, a patient’s death was encoded by only one data element
(code Z). Patients who died of prostate cancer were kept with code Z while those
who died of other causes were identified with code Y and those who survived,
with code X. This ensures that all patients have a terminal element indicating
whether they are alive. Because in this cohort not all patients are followed-up the
same amount of time, all terminal elements (X,Y,Z) were given additional nodes
that represent the amount of time the patients were followed-up in years (1 to 5
and ’+’ for over 5 years). This is illustrated in Figure 4.11.
253
4. Pathways Modelling, Mining and Visualisation
Figure 4.11: CaP VIS ExploraTree software displaying a selected pathway (pa-
tients with the same sequential activities). The selected pathway nodes are high-
lighted and terminal nodes are marked as red for patients that died and green for
patients that were last seen alive in this cohort.
Figure 4.11 shows the cohort tree and highlighted sequence 〈P,D,H, P,X〉, that
is, patients who started their pathway with one or more PSA tests (code P,
n=1596), followed by a diagnosis of cancer (code D, n=1502), hormone therapy
as first treatment (code H, n=747), other PSA test(s) (n=557) and finally were
last seen alive in this cohort (code X). 90% of patients with this pathway (n=266)
were followed-up 3 or more years and one patient was only followed-up less than
one year.
This aggregation also allows comparing patients that followed similar pathways
but who died of prostate cancer (〈P,D,H, P, Z〉). In the case of patients with a
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sequence prefix 〈P,D,H, P 〉, 9% (n=48) died of prostate cancer (code Z), 13%
died of other causes (code Y), 48% survived, and the remaining patients continued
with other activities (H,W,R,S).
Visualising the cohort in this manner is important as it enables the selection
of subsets of data for specific clinical studies as well as an inspection of the
sequential routes that patients take through care. The sequence highlighted in
figure 4.11 corresponds to the most common route (with most support on each
node sequentially).
It is possible to add more meaning to the visualisation and to the pathways by
introducing additional data elements and remodeling the data dictionary. For
example, instead of using a single code for diagnosis it is possible to have a
breakdown of the tumour staging or Gleason grade at diagnosis so as to group
similar sequences with this information instead. However, due to the small size
of this cohort, increasing granularity in the pathways dictionary would result in
fewer patients in each node. For this reason no additional changes were made to
the pathways dictionary used for the ExploraTree, but future work with a larger
cohort is envisaged and the remodeling of the pathways dictionary is discussed
again later in this chapter.
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4.3.7 Exploring Diagnostic Profiles and Mortality
A second system developed within the CaP VIS framework, called RECON Di-
agnosis, explores the survival of patients with a given diagnostic profile based
on the pathways data in the cohort. The system was also developed in Python
and it works with the pathways database and engine. The user interacts via a
predefined set of commands in a console window. The system requires the user to
enter a diagnosis profile containing one or more of the following variables: PSA
at diagnosis, Gleason grade, tumour staging and age group. The system then
computes the number of patients in the cohort with the same profile and, given a
3 year survival period, the likelihood of those patients dying from prostate cancer
within that time period. Because not all patients in the cohort were followed up
the same amount of time, a smaller subset was selected. All patients diagnosed
between 2005 and 2009 were followed-up at least 3 years and this was the subset
of the cohort used by this program (n=1,416).
Figure 4.12 shows an example output from the system. In this example, the
selected profile was patients with a low PSA at diagnosis (as defined in NICE
guidelines, a reading under 10 ng/mL) and a Gleason grade of 9. The program
identified 52 patients (19% deaths) with this profile and computed a 2x2 table
that compares patients with the profile against those that did not have the pro-
file. Odds ratios (OR), p-value and confidence interval were also automatically
computed. The program then provides an interpretation of the results and in this
example, patients with the selected profile were at a higher risk of death (odds ra-
tio 2.558) and the result is statistically significant (p-value < 0.05). This confirms
that a high Gleason grade is associated with a greater risk of death from prostate
cancer. In addition to survival, the program then shows the different treatment
options that patients with the selected profile underwent and a breakdown of the
number of deaths by treatment modality. In the example, hormone therapy had
the least deaths (14%).
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CaP VIS - RECON Diagnosis
Exploring options for given diagnosis profiles.
When making a profile please give a numeric option
or leave blank to remove filter (include all).
----------------------------------------
NEW PROFILE
----------------------------------------
1. PSA at Diagnosis [0-none ,low -1,med -2,hi -3]: 1
2. Gleason Grade [0-none ,6 ,... ,10]: 9
3. TNM Stage [1-in situ ,2,3,4,6-not possible to grade]:
4. Age Group [1-(<=55), 2-(56-65), 3-(66-75), 4-(76-85), 5 -( >=86)]:
----------------------------------------
RESULTS
----------------------------------------
Profile: low PSA , Gleason 9, *any* TNM , *any* Age Group
Cohort: 1460 patients , 131 deaths (8.97%)
N in Profile: 44 (3.014%)
N Deaths: 8 (18.182%)
Status Alive/Dead checked at 3 years.
----------------------------------------
MEASURE OF ASSOCIATION
----------------------------------------
2x2 Table:
-Dead - -Alive -
Profile 8 36
No Profile 123 1416
Odds Ratio: 2.558 Increased Risk
p-value: 0.025 Significant
95% CI: 2.558 to 2.558
Interpretation: The risk of death within 3 years among individuals with the sele
cted profile at diagnosis ( lowPSA ,G9 ) is 2.558 times that of those who do not
have the same profile.
----------------------------------------
TREATMENT OPTIONS
----------------------------------------
Type N %N Deaths %Deaths
Hormones 29 65.91% 4 13.79% *
Horm+Radio 1 2.27% 0 0.0% *
Surgery 11 25.0% 3 27.27%
WatchWait 3 6.82% 1 33.33%
Quit program? [y/N]
Figure 4.12: CaP VIS RECON Diagnosis System output showing patients with
a profile made up of a low PSA at diagnosis and a Gleason grade sum of 9.
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Variable at Diagnosis Odds Ratio p-value
PSA high >20 ng/mL 6.268 <0.005
PSA med 10-20 ng/mL 0.508 0.009
PSA low <10 ng/mL 0.255 <0.005
Gleason sum 10 11.661 <0.005
Gleason sum 9 3.882 <0.005
Gleason sum 8 1.679 0.154 *
Gleason sum 7 0.102 <0.005
Gleason sum 6 No Deaths
TNM 4: Fixed or invades adjacent structures 8.369 <0.005
TNM 3: Through prostate capsule 0.678 0.178 *
TNM 2: Confined within prostate 0.327 <0.005
TNM 1: Not palpable or visible No Deaths
Age >= 86 4.263 <0.005
Age 76-85 2.562 <0.005
Age 66-75 0.534 0.002
Age 56-65 0.344 <0.005
Age <= 55 0.753 1 *
Table 4.14: List of variables at diagnosis and their effect on 3-year deaths from
prostate cancer. P-values marked with * indicate the variable is not statistically
significant at the 0.05 level.
The previous example indicated that patients with a Gleason 9 and a low PSA
were 2.558 times more likely to die from prostate cancer within 3 years than
those that did not have that profile. Table 4.14 shows the results of the program
for individual variables and allows to compare the improvement in risk against
those who had only a low PSA (OR 0.255) or a Gleason 9 (OR 3.882). The low
PSA combined with a Gleason 9 lowered the risk for those who have Gleason 9
irrespectively of other variables. Table 4.14 also shows that Gleason 10 is the
variable that contributes the most to a higher risk of death from prostate cancer
within 3 years (OR 11.661). This is followed by tumour staging 4 (OR 8.369),
high PSA (OR 6.268) and age over 86 (OR 4.253). The variables with most
protective effect are Gleason sum 7 alone (OR 0.102), a low PSA (OR 0.255),
TNM 2 (OR 0.327), and age 56-65 (OR 0.344).
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The developed program is flexible and can be adapted to different data elements
and changes in the pathways dictionary. Future work includes extending the
profiles to include the computation of risk for any given pathway sequence (or
segment) and different outcomes (for example, hormone escaped, development of
metastases, biochemical recurrence after treatment).
4.3.8 Enhancing the Core Dictionary
The ability of CaP VIS and the pathways dictionary to incorporate new data
elements is key; it enables the remodeling of the data and pathways, and as a
result, a broader scope for studies and inspections that were otherwise not possible
with routine hospital data.
With the CaP VIS framework in place and the core dictionary, new data elements
were added on biochemistry and hospital events from the prostate cancer ODS.
22 biochemistry tests were selected together with the domain experts and are
listed in Table 4.15. The percentage of patients who have at least one reading
of the test in their pathways is also given in Table 4.15. This is important as it
was previously unknown how many of these patients had particular blood tests
throughout their pathway. The reasons for having these test may in most cases
not be specific to the prostate cancer pathway yet they might enable studies with
new data.
259
4. Pathways Modelling, Mining and Visualisation
Biochemistry Test
% Before
Diagnosis
% After
Diagnosis
N
(After Diagnosis)
Creatinine 98.79 88.13 1678
Urea 98.79 88.13 1678
Sodium 98.79 88.08 1677
Haemoglobin (Hb) 98.06 83.25 1585
White Blood Cells 98.06 83.25 1585
Mean Corpuscular Volume 98.06 83.25 1585
Mean Corpuscular Hb 98.06 83.25 1585
Albumin 94.75 78.31 1491
Alkaline Phosphatase 94.64 78.20 1489
Bilirubin 94.28 77.63 1478
Cholesterol 81.30 63.60 1211
Random Plasma Glucose 81.67 63.13 1202
HDL Cholesterol 73.37 54.15 1031
Total Cholesterol / LDL 73.16 53.57 1020
Triglycerides 64.23 49.37 940
LDL Cholesterol 64.18 49.37 940
Calcium 79.67 44.70 851
Fasting Glucose 45.69 22.74 433
Testosterone 12.50 4.41 84
Aspartate Transaminase 1.10 0.42 8
Vitamin D 0.68 0.26 5
Gamma-Glutamyl Transpeptidase 0.00 0.00 0
Table 4.15: List of additional biochemistry tests added to the pathways database
and percentage of patients having each test before and after diagnosis of prostate
cancer.
The new data elements demonstrate the flexibility of the data model and allow
a novel inspection of routine data. Figure 4.13 shows four pathway plots for the
same patient, a 69 year old diagnosed with stage 3 prostate cancer and a Gleason
sum of 9. Plot A shows the original plot where the PSA is seen to have dropped
after the patient underwent hormone therapy. The patient died of prostate cancer.
When producing this pathway’s plots, the dictionary was extended so that the
treatments retrieved from the local cancer registry appear with a suffix “1” in the
vertical lines’ headings. In this case, regarding the date when the patient first
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commenced hormone therapy, a time discrepancy of 51 days was seen between the
two data sources, where the hospital recorded the later date. Indeed additional
data quality inspections are possible and this is explored in the next section.
The discrepancy in dates, in this case, did not introduce uncertainty in this
pathway as the effect of the treatment is seen in the subsequent PSA readings.
The pathway plot then shows a PSA relapse (of two readings from the nadir) and
shortly after the last PSA the patient died of a pulmonary embolism (ICD I26)
and prostate cancer (ICD C61) as a secondary condition leading to death. Also
shortly before death the patient was diagnosed with a secondary and unspecified
malignant neoplasm of inguinal and lower limb nodes (ICD C77.4). This was
revealed by the additional data collected on hospital episodes (and clinical coding
from discharge letters) and discussed again later.
Figure 4.13 Plot B shows an additional blood test, Alkaline Phosphatase (ALP)
and its normal range in the shaded area. When a patient’s advanced cancer
metastasises to the bones, ALP can be increased due to active bone formation.
Indeed studies have shown that prostate cancer patients with a serum ALP read-
ing of more than twice the normal upper limit had a significantly lower survival
rate than their respective counterparts [253]. This is observed in this pathway,
however, other pathways may show an increased ALP due to other reasons such
as an obstructed bile duct or liver disease.
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Figure 4.13: Four pathway plots of the same patient (175) with sequence
〈P,D,H, P 〉. Plot A shows the original plot with the PSA trend alone. Plot
B shows the same information as plot A with additional Alkaline Phospathase
readings and their normal range (shaded area). Plot C shows Creatinine readings
and Plot D shows the same information and hospital events (code K).
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Lastly, figure 4.13 plot C and D show another blood test, Creatinine. Creatinine
has been reportedly associated with more advanced disease and decreased survival
[254], however, any condition that impairs the function of the kidneys is likely
to raise the creatinine levels in the blood and act as a confounding factor. In
plot C, a flare in the values of Creatinine readings was observed within the first 3
months. When introducing additional data elements from the hospital statistics,
in plot D, a hospital episode (marked with pathway code K) was found with an
associated primary diagnosis of acute kidney failure. Although a kidney stone
was not coded in this (or any) episode for this patient, a catheterisation of the
bladder was performed during the same hospital visit, and an inspection of the
patient notes confirmed a kidney stone was the cause of the acute kidney failure.
The second hospital episode in this pathway, also marked with code K, was for
the removal of the catheter, and the last hospital episode included a diagnosis of a
secondary and unspecified malignant neoplasm of inguinal and lower limb nodes
and a pulmonary embolism, caused by the first. This level of information would
also allow, for example, in other cases, to evaluate renal impairment and prostate
cancer. Indeed, in this respect, it has been reported that renal impairment in
men undergoing prostatectomy represents substantial and unrecognised morbidity
[255].
The introduction of additional hospital data helped to explain the Creatinine
flare for this patient and provided interesting insights that would otherwise not
be explored, particularly in any retrospective clinical studies. The pathway plots
provided sufficient information for the interpretation of this pathway and the
patient notes were only used to confirm it. However, this is not possible across
all pathways as information varies in respect to completeness and data quality.
Furthermore, discrepancies in treatment dates across data sources may introduce
additional challenges. As such, it is important to be able to differentiate between
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pathways that have a sufficient information and those that do not. The evalua-
tion of the completeness and utility of the generated pathways for investigating
biomarker trends is explored in detail in the next section.
4.3.9 Assessing Data Completeness using Biomarker In-
formation
Routinely collected data can vary in quality and it is important to assert the
quality of all elements in the pathway so that particular paths can be selected
or discarded for clinical analysis. We already discussed that upon extraction
from the ODS, data elements were cross-validated against a trusted source, viz.
the cancer registry. However, the biomarker information included in this study
enabled additional quality assurance. To this effect, methods of computing the
completeness of pathways from the biomarker information are investigated.
4.3.10 Rule Based Scores
Given the defined dictionary and its underlying format, it is possible to create
a knowledge base of rules to aid the process of computing completeness scores
for particular elements of the pathway. It is often difficult to convey and analyse
biomarkers’ information in pathways but here it was possible to compute their
trends and to allow those computations to inform on the quality of the pathway.
In the particular case of prostate cancer, the trend of PSA readings across the
pathway is of interest. Two major sets of rules in which the biomarker can be
used to assess the completeness of a pathway were identified, guided by domain
experts. The first set of rules relies on the position of biomarker readings in
the pathway, whereas the second relies on identifying clinical interventions that
justify the changes in biomarker values. Rules can be applied programmatically
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using the analysis engine.
Positioning of biomarker readings
As some of the intended clinical investigations pertain to PSA trends and associ-
ated treatments, it is important to have complete PSA trends within a pathway.
In this context, a pathway should include biomarker readings before and after
treatment so that the effect of treatment on the biomarker can be elucidated in
posterior analyses. We can therefore compute a partial score of a pathway as a
result of a set of rules on the occurrence of PSA readings. The rules are presented
in Table 4.16. with their respective score and the percentage of pathways where
the rule applied. The computation of the positioning score involves iterating
through pathways codes and flagging occurrences of the PSA and their position
with respect to treatments (excluding active surveillance). The most informative
pathways should have one or more readings before and after treatment and the
least informative have no PSA readings.
Positioning Score Rule Description Coverage
0 No PSA readings found. 4.70%
1 One or more readings found before treat-
ment (or no treatment) and none after
treatment.
4%
2 One or more readings found after treat-
ment and none before treatment.
8.20%
3 One or more readings found before and
after treatment.
82.90%
Table 4.16: PSA availability and positioning rules with respective scores and
coverage.
Substantiation of biomarker variation
Further rules can be devised to ascertain quality. For example, biological varia-
tions, in this case expressed by the PSA, should often be accompanied by evidence
of some clinical intervention. An analysis of the PSA curve can be undertaken
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to identify major changes in PSA readings. The most significant drop in PSA
should be associated with treatment to the prostate. A complete pathway should
be able to provide explanations for such drops in the form of some clinical inter-
vention. In this case, the computation of a score involves looking at every pair of
PSA readings and then identifying the maximum absolute drop. This is followed
by searching between the pair of values to identify an element of substantiation,
which in this case study was set to be any radical treatment. The result of this
rule is a Boolean value, stating whether substantiation of a large change in the
biomarker trend was detected.
Overall score
An overall score for completeness can then be computed based on both posi-
tioning of biomarker readings and substantiation of major variation. It is worth
noting that pathways that receive a positioning score of 0 or 1 could not have
substantiation by definition as no PSA values appear after treatment. The over-
all score is an ordered set of values in which the highest score is awarded to the
pathways with the highest positioning scores that are substantiated. The overall
scores are given in the next section in Table 4.18.
The next section discusses the main results of the developed framework, the
pathways data model, and the computation of pathway data completeness for
quality assurance.
4.3.11 Results
The development of a framework to build, analyse and visualise pathways from
routinely collected hospital data made it possible to create individual patient
pathways and respective graphical representations for 1,904 patients whilst inte-
grating clinical information from several HIS.
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The core data dictionary contains 16 elements, described in Table 4.13. The
data sources specify whether the elements were collected from the ODS (hospital
systems, together with an abbreviation of the respective system) or the cancer
registry (CR). Elements present on both sources have been cross-validated so
their quality is assured. The data integration and the pathways data model,
however, allowed discrepancies in the timeliness of events to be highlighted. As
a results, not all data elements were kept due to data quality issues.
Regarding biopsies, they are only coded if performed as an inpatient event and
hence only extensive biopsies were retrieved. As a result biopsy events were
removed from the dictionary and are not used in this thesis, but can be kept for
future studies. The frequency of imaging events was low (only captured imaging
events on 15% of all pathways) and it reflects the nature of the retrieval methods
from radiology, which are based on a text search of the word prostate.
The pathway dictionary in Table 4.13 also gives the percentage of patients who
died in this cohort during the time of observation (i.e. pathways including a death
event, 21%). These deaths are not exclusive to prostate cancer and the percentage
should not be used to determine a measure of survival from prostate cancer. It
was possible, however, for the developed CaP VIS RECON and ExploraTree
software to interpret this further by extending the pathways data model. Future
survival analyses are also planned.
Further data elements were also added to the pathways dictionary including bio-
chemistry tests, as co-morbidities and hospital stays which may or may not be
related to prostate cancer. This was explored earlier in this section and it is
briefly discussed again later.
The analysis engine computed descriptive statistics such as the various frequen-
cies of the elements of the dictionary. A summary of the pathway statistics for all
pathways is given in Table 4.17. Descriptive statistics are important as they con-
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vey information about the pathways. They can also give rise to quality indicators
but these methods alone were not sufficient to determine quality.
Statistic Value
Average number of unique activities 4.66 (SD 1.0)
Average pathway length 1,795 days (SD 1,724)
Average pathway length from diagnosis 1,017 days (SD 653)
Most common activity code P (90.5%)
Five most common start codes P (72.9%), X (11.7%), D (7.4%),
G (4.1%), L (1.2%)
Five most common terminal codes P (73.2%), Z (21%), G (3.1%), W
(0.6%), R (0.5%)
Total number of unique pathway sequences 694
Most common pathways’ sequence (repeti-
tions truncated)
〈P,D,G,H, P 〉 7.1%,
〈P,D,G,W, P 〉 6.8%
Most common treatment regimes (where first
and second treatment modality are within 92
days of each other)
H (47.6%), S (27.2%), W (16.7%),
SW (3.1%), SH (1.2%)
Table 4.17: Summary of pathway statistics from the core pathways dictionary.
The pathways data model and analysis engine allowed the computation of com-
pleteness scores for the purpose of selecting pathways with enough data to analyse
the biomarker trend. The following sections show the results of the application
of the rules and their impact on quality assessment.
Inspection of the positioning of readings
The application of rules on the positioning of the PSA biomarker allowed the
identification of 1,579 (82.9%) pathways where it was possible to plot the trend of
the biomarker through treatment (scores S3+S5 in Table 4.18). The framework
presented above made possible the inspection of data elements in relation to
other events plotted chronologically. It is also possible to compute the proximity
between elements. For example, treatment elements within 90 days were grouped
together to form treatment packages. The type of rules proposed here allow for
the assessment of the timeliness and completeness dimensions of data quality.
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Inspection of the substantiation rule
Overall it was possible to ascertain the biomarker variation substantiation rule
for 61.1% (n=1,321) of the pathways. It was also identified that 4.1% (n=79)
of all pathways with two or more PSA readings, had a constant or always rising
PSA trend. These were merged with the overall substantiation number, making
65.2% (n=1,242) the total number of pathways with a positive substantiation rule
(scores S4+S5 in Table 4.18). Substantiation does not occur when a treatment
element is not present in the biomarker interval of interest, or if the treatment
date is inaccurate. This may indicate missing information. The substantiation
rule allows for the elimination of 20.6% pathways with insufficiently accurate
information to study the biomarker trend. This rule enables the assessment of
the plausibility, completeness and timeliness dimensions of data quality.
A hybrid scoring system
A hybrid scoring system for the completeness of the pathways combines both
biomarker rules described above (positioning and substantiation) and it is given
in Table 4.18. The overall score ranges from least complete (score S0) to most
complete (score S5) and were automatically computed based on the criteria set
in the rules above. This particular set of rules aims to identify the completeness
of the pathways based on the prostate cancer biomarker. It is also possible to
extend the framework presented in this chapter to create other quality scenarios
involving more robust and detailed rules based on biomarkers or other aspects of
the pathways. Examples of pathway plots automatically drawn by the CaP VIS
system are available in Figure 4.14 and illustrate each of the five completeness
scores.
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Figure 4.14: Examples of pathway plots drawn by the developed CaP VIS system
for each of the six possible completeness scores.
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Table 4.18: Completeness scoring system for PSA trends in prostate cancer path-
ways.
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Further analysis of data quality
In order to understand further data quality issues in relation to completeness
scores, variations between key demographic information and completeness were
explored using the framework presented above. For example, with regards to the
UK indices of deprivation (ID 2004) obtained from the cancer registry, it was
possible to observe that 72.2% (n=65) of score S0 pathways were associated with
the least deprived patients (two quintiles). Similarly, the least deprived have the
lowest proportion of score S5 pathways (47%, n=116). This could be largely due
to wealthier patients seeking private health services, which would result in some
of their data missing from the HISs used to build the pathways. However, it is
difficult to confidently corroborate this observation given the collected data. Fur-
ther data sources would be required, particularly from primary care, to accurately
corroborate these findings.
A further analysis on surveillance regimes made possible the observation that 7%
(n=25) of those on surveillance (as first treatment) had a subsequent treatment
within at least a year, and therefore left surveillance. For those that did not
have a subsequent treatment (93%, n=317), it was possible to investigate any
substantial drops in PSA, which may be indicative of unrecorded treatments. By
establishing a drop ratio calculated as the maximum PSA drop divided by the
PSA at diagnosis, it was noted that, 31% (n=97) of pathways on surveillance
regimes show a drop over a 0.5 ratio whereas 16% (n=50) had a drop > 1. This
analysis is only preliminary, but it may indicate that patients received treatment
yet these have not been recorded or carried out at this hospital. Such pathways
could be excluded from analyses or be further explored to seek plausible reasons
for the unexplained variation in biomarker trend. Again, this is an example of
the type of analysis enabled by the framework and the pathways data structure.
The analyses on quality also led to improvements in the data collection process.
It was possible, for example, to identify patients that only had PSA readings after
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treatment as well as those without PSA readings before diagnosis. This process
yielded a small number of pathways (0.2%, n=38) where there had been earlier
PSA readings but these were not linked to the patients main hospital number in
the hospital data warehouses and hence were missed on retrieval (not present in
the ODS). Such cases are not expected to occur frequently and do not affect any
of the hospital administration or clinical operations. However, they can diminish
the amount of information available for the use of routinely collected hospital
data for analysis. In this instance, as only a small number of cases were affected,
they were manually fixed. The exercise, however, uncovered the need for further
checks by the hospital on the data warehouse to ensure consistency of recordings.
Framework and developed software
The developed framework and visualisation software enabled the visualisation of
all 1,904 patient pathways with their corresponding biomarker trends. This gives
clinicians access to trends that may have been previously much harder to observe.
Furthermore, the system is flexible and extensible to include other data elements
such as blood readings. For example, Figure 4.15 plots the PSA values and the
Haemoglobin (Hb) readings. The shaded area is the normal range for Hb. In
this case, the drop in Haemoglobin on the day of surgery reveals perioperative
bleeding. This information, when computed for all patients, would enable a study
of the length of time that patients take to recover after surgery. This illustrates
the flexibility of the combined framework and visualisation tool and provides
access to a number of studies with data that was otherwise not readily available
or contextualised.
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Figure 4.15: Pathway plot showing the PSA (round markers) and haemoglobin
readings (star markers) together. As a result of the prostatectomy event (S)
the PSA dropped and haemoglobin also dropped due to normal perioperative
bleeding. The shaded area denotes the normal range for haemoglobin.
Additionally, the framework presented made possible the inspection of all five
data quality dimensions described in [37], including those that are least often
assessed. Currency (or timeliness) has been considered a fundamental dimension
yet it is often not assessed and only measured using a single approach [37]. One
of the key variables of the pathway data structure presented here is the inclu-
274
4. Pathways Modelling, Mining and Visualisation
sion of time since pathways are arranged chronologically and allow for concurrent
elements. For example, in the case study, treatments within 90 days were consid-
ered a treatment package. It is also possible to identify and discard data elements
not relevant at particular intervals, as exemplified by the positioning rules. Fur-
thermore, the plausibility and concordance dimensions were assessed using the
substantiation rule, the completeness dimension using the positioning rule, and
correctness dimension assessed by cross-referencing against the cancer registry.
The proposed framework and developed software should also allow for the selec-
tion and extraction of particular datasets with complete data for process mining
and other analysis. It has been reported that the evaluation of the quality of
process mining event logs relies on trustworthiness (recorded events actually hap-
pened), completeness and well defined semantics [256]. These can be achieved
by selecting pathways with required data points using the proposed framework.
Furthermore, the visualisation system allows for the close inspection and contex-
tualisation of pathways, illustrating particular paths with similar features such
as the ones exemplified in the Figure 4.14. In summary, the proposed framework,
when used in hospitals, would facilitate the retrieval, selection and inspection of
patient pathways and also the further steps of data mining analysis using appro-
priate methodologies.
4.4 Conclusions
This chapter introduced a novel data model tailored to data-driven patient-centric
pathways and a novel framework for the construction of pathways and the sum-
marisation, visualisation and querying of complex clinical data. This can be seen
as an evidence based clinical decision support system that enables both clinicians
and researchers to query individual pathways and select cohorts with similar fea-
tures.
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Despite current data and process mining techniques not being extensively applied
in health care, they continue to be suggested to help uncover similar or frequent
trends in health care processes. Some applications in specific domains have been
fruitful but they rely on structured data carefully prepared for process mining and
systems that produce event logs. Section 4.2 explored the feasibility of state-of-
the-art process mining and association rule mining algorithms in detail and found
these to be unsuitable to mine simple system-level paths with low granularity
(where tasks are essentially binary). Therefore in more complex and unstructured
processes such as those depicted in section 4.3, such techniques would also be
found unsuitable.
A framework which enables the secondary uses of routinely collected hospital
data was developed and presented in this chapter. The main components of this
framework (Figure 4.9) are the ODS containing patient-centric data, used to build
the pathways based on the methodology presented in Figure 4.3.3, the pathways
engine, analysis engine, and the visualisation software. It has been noted that for
immediate decision-making by clinicians at the point of care, information needs to
be brief and easily interpreted [34]. The graphical representation of the pathways
has facilitated interpretation, communication and debate between experts, and
further work is needed to assess the pathway plots in other settings and domains.
The underlying pathway data structure proposed in this thesis, is in some as-
pects similar to the EAV data model; additionally, it retains patient privacy and
together with the dictionary provides a simplified, yet flexible and powerful, plat-
form for the complex querying and analysis of patient information and disease
pathways. It enables the summarisation and extension of pathways as well as the
aggregation of similar sequences. It is also possible to capture and plot pathways
with concurrent elements and to develop algorithms to further explore the data
and investigate quality issues. Furthermore the methodology used to build path-
way dictionary as well as the formalisms presented here can be transported to
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other domains and settings.
The process of integrating routinely collected electronic data may produce path-
ways that may not be informative or complete. A topic which has received little
attention in the literature is the computation of quality indicators for data-driven
pathways. Such indicators are important to enable the selection of study-relevant
high quality data for clinical investigation. The methods developed in this chapter
enable us to discard pathways, that because of the nature of electronically rou-
tinely collected hospital data as well as retrieval methods, fail to provide enough
or sufficiently accurate information to be used in clinical analysis.
It has been shown that methods for pathway quality measurement can rely on
biological marker trends, as they are often the response to some parallel process.
In the case of the PSA, a sharp decline in the average readings would indicate
treatment to the prostate, which suppressed the production of the antigen, so
can be use to ascertain if treatment records are missing. Algorithms were written
to compute completeness based on prostate cancer biomarker rules creating an
overall scoring system (Table 4.18). Once researchers are satisfied that the PSA
trends have sufficient data points and are substantiated (i.e. they receive a high
completeness score), they can investigate those PSA trends as predictors of prog-
nosis in the disease. Such research is seldom undertaken due to the unavailability
of data but may lead to improved outcomes for patients and health services.
We investigated the cohort of 1,904 patients, automatically built their respective
pathways, and computed completeness scores. Overall 65.2% of pathways at-
tained the two highest scores, while 82.9% attained the highest PSA positioning
rule. Hence, these pathways contain sufficient biomarker information to aid clini-
cal investigations on the biomarker trends. It was shown that routinely collected
data can be transformed and prepared for clinical research, decision making and
decision support but limitations still exist. Routine hospital data is also hetero-
geneous when it comes to quality and not all required information that would
277
4. Pathways Modelling, Mining and Visualisation
accurately explain a pathway is available using electronic health records alone.
Data paucity refers to the instances when there is not enough information in the
archives that satisfactorily describe a phenomenon or an occurrence [257]. As seen
in the case study in prostate cancer, events have start dates but rarely have end
dates, which makes it difficult to understand their timeliness and requires addi-
tional consultation with the domain experts. It is hoped and recommended that,
in the future, hospital information systems collect more details and metadata as
this would greatly improve the secondary uses of routine clinical data.
Nevertheless, the flexibility of the data structure presented in this chapter allows
the insertion and removal of new dictionary elements including additional blood
tests and comorbidities to the pathways, as depicted in Figures 4.13 and 4.16. It is
also possible to extend the data structure to include end-times for every activity.
The work presented here has also enabled future research into published path-
way adherence and variance metrics, particularly with respect to the UK NICE
guidelines. This chapter described methods for data collection, presentation and
quality assessment that can be applicable to build other disease pathways in other
settings. Further work is also envisaged on mining pathways, in particular, the
computation of similarity of biomarker trends, and the application of clustering
algorithms and survival analysis in the context of pathways.
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In summary, this chapter described the following contributions:
• A data model that describes patients’ system-level paths as the sequences
of digital footprints they leave in hospital systems;
• The potentials and limitations of data and process mining techniques in
analysing system-level paths and the trends found in this data;
• The flexible Pathways data model and structure, representing the journeys
that patients take through care, allowing for temporal abstraction, aggre-
gation, and summarisation of similar sequential pathways;
• A methodology to construct the pathways data dictionary from routine
hospital data collected from an operational data store;
• A novel graphical representation of a patient-centric pathway using rou-
tinely collected hospital data;
• A framework and software for the visualisation and analysis of complex
clinical information and pathways;
• A method of assessing the quality dimensions of routine hospital data.
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Conclusions
Routine clinical data is recorded on several different hospital systems but is rarely
analysed or linked. Upon linkage, pre-processing and integration of this data,
important and useful information can be obtained that benefits patients, their
doctors and health service planners. This thesis explored in detail the journey
from routinely collected hospital data to knowledge in a large NHS hospital with
a catchment area of up to 822,500 people.
Methodologies and computational techniques were applied and developed, and
the importance of clean integrated health records was demonstrated using two
clinical case studies. The prostate cancer case study allowed us to examine over
10 years of hospital data and their systems. On average, prostate cancer pa-
tients’ pathways spanned over a period of 7.6 years (SD 4.6) from their first
recorded biomarker test. This contrasts with the stroke case study, where the
acute episodic nature of the data in hospital showed an average length of stay of
14.4 days (SD 20.1). Both case studies complemented each other in this respect,
yet collecting and linking prostate cancer data was more difficult due to the sheer
number of systems as well as its lengthy time span. In contrast, the stroke register
provided a centralised way of selecting cohorts; however, the fact that there were
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three different versions of the database posed additional integration challenges
due to their semantic differences.
Overall, 15 different data sources were explored, including the regional cancer reg-
istry and the NHS national tracing service (now Personal Demographics Service).
This allowed for semantic differences as well as different types of heterogeneity
between sources and their data to be investigated. It is crucial to understand
the data, its semantics, changes over time, and its origins; the latter requires a
thorough understanding of the system, that is also bound to change over time and
which may or may not interchange data with other systems. Interoperability is a
much sought after goal in hospitals yet this thesis has demonstrated that it still
has not been achieved in a way that facilitates the linkage and data interchange
across hospital systems and with national sources. This is confirmed in recent
publications in other settings both nationally and internationally. The time and
effort spent on understanding, linking and preparing routine data will continue
to hinder research projects and prevent new research from being carried out. To
facilitate the process of retrieving and creating study databases, a methodology
was introduced in this thesis and applied successfully to the two case studies.
However, the journey from data to knowledge is far more encompassing than
data retrieval and integration; it relies on quality assessment and cleaning, on
additional semantic interpretation and contextualisation, and on preprocessing
techniques to extract relevant features from unstructured data. Data modeling
thus becomes a subsequent critical step to organise such information and to carry
out analyses. This thesis introduced techniques for data preprocessing as well as
modeling complex routine clinical information that enabled further research to
be undertaken. A detailed summary of the journey from data to knowledge is
provided in the next section.
281
5. Conclusions
5.1 The Journey from Data to Knowledge
i. Access
It has been and continues to be difficult and bureaucratic to obtain appropri-
ate credentials to carry out research using hospital data in the NHS. Hospital
database projects wanting to use anonymised patient data undergo the same
ethics process as large drug trial projects from pharmaceutical companies.
In addition, as a primary investigator for the prostate cancer study, little
guidance was available at the initial stages and support from the clinical
supervisor proved essential. The way in which clinicians and other staff re-
quest hospital data is idiosyncratic and unclear; in some cases junior doctors
manually collect the data while, in other cases, the system’s administrators
or the information services department can provide some help in achieving
this. However, some of the data available in hospital systems, and its qual-
ity, is unknown even to the system administrators. This is particularly true
for data that is outside the scope of planning, performance or audits. As a
result, investigating other available data with research potential, and negoti-
ating system access, becomes a laborious process, that is repeated as many
times as there are systems and managers. Because this data is not used,
there is limited accountability and a lack of understanding, which naturally
hinders the process of investigating its origins and its potential research uses.
Methods for evaluating the quality, completeness and plausibility of routine
data were explored in this thesis.
In this project, ethics approval was obtained for the prostate cancer study and
patient identifiable information such as names and addresses was not used.
The stroke case study was also approved by the local ethics and governance
committees which granted full access to the data for the purpose of building
the stroke register and linking information, yet only anomymised datasets
could be extracted and used for research. Access is an essential part of
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working with hospital data, and requires substantial amounts of time and
effort, in particular when the extent and availability of the data is not known.
Accessing data was accounted for in the proposed methodology, and was
discussed in Chapter 2.
ii. Data Retrieval
The collection of patient-centric data from multiple hospital sources is a
non-trivial task, and one that has received relatively little attention in the
literature. Chapter 2 introduced a novel methodology for the retrieval of
patient-centric data from multiple sources. The methodology can be used on
its own or built into existing data mining or data analysis methodologies; its
outputs are a study dataset for each source investigated, and a metadatabase
that contains system and data details. This leads to the creation of an oper-
ational data store (ODS), a semi-integrated database that replicates the host
environment and allows linkage, quality assurance and selection of cohorts.
Furthermore, the methodology allows the study of the systems and their host
environment; it highlights the changes in systems over time, and leads to a
preliminary selection of cohorts.
Selecting an appropriate prostate cancer cohort was a difficult task as there
was no single method or system to select patients diagnosed with the con-
dition. This led to recursively backtracking between the ODS, the systems
and the production of summary statistics for discussion with the clinical and
research teams. The methodology proved useful in streamlining this process.
Nevertheless, improvements in the way the hospital records information were
noted during the 10-year study period. In particular, the national cancer
waiting times audit required that hospitals account for the number of pa-
tients diagnosed with cancer, their waiting times and treatment modalities.
This particular national initiative has had an extremely positive effect in the
way information is recorded electronically in this particular hospital. Nev-
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ertheless, information that is outside the scope of national audits or beyond
the mandatory datasets continues to be “neglected”. This is, arguably, an
accountability issue that, despite not being a priority, should receive further
attention and resources.
iii. Preprocessing
Preparing and cleaning the retrieved data as well as dealing with its “con-
ceptual, organizational, logistical, managerial, and statistical-epidemiological
aspects” [7] is essential so that any analyses can be carried out. However,
this has not been studied comprehensively, and descriptions of preprocess-
ing methods are lacking in the literature. Chapter 3 introduced selected
techniques demonstrating the most relevant challenges in this respect. In
particular, a technique to extract information from histopathology text re-
ports provided interesting results, and enabled further study on the way
histopathologists report their findings. Beyond histopathology, clinical re-
ports continue to be written and stored with relatively little structure, and
improvements are needed in order entry and natural language processing
software so as to help authors assign conceptual mappings, keywords or rel-
evant clinical coding. This structure would make the process of information
retrieval more accurate and efficient rather than cumbersome and ad hoc as
reported in this thesis.
Data editing and imputation techniques were also investigated in Chapter
3, and an algorithm for continuous value estimation was introduced. This
was an important and relevant exercise as only some databases verify their
information at the time of imputation. For instance, information resulting
from a blood test for a patient that is not registered (or properly linked) in
a hospital administration system will contain values that were entered at the
time of consultation, but a percentage of these can be erroneous due to bias.
For such cases, a look-up service using NHS number (to the Personal Demo-
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graphics Service) could automatically return the patient’s accurate identity
and demographic information, which would ensure the quality of this data,
even when patients are not registered with the hospital. Preprocessing tools
and techniques will continue to be required not only to assess erroneous val-
ues or transform data and formats (for example, anonymisation) but also to
accurately link information across databases.
iv. Linkage and Integration
Data linkage can be considered a preprocessing technique in that it is allowing
distinct datasets to be merged before analyses can be undertaken. Two data
linkage exercises were included in Chapter 3 and demonstrated the value of
a technique that is often overlooked in intra-organisational exercises. One
of the exercises assessed the reliability and accuracy of hospital databases
in providing a correct date of death. The exercise compared the dates of
death recorded for stroke patients in the administration system with data
from the NHS national tracing service over a period of 15 years. A yearly
average of 10% (SD 3.6) of mismatches (5.6% were missing and 4.5% were
recorded incorrectly) with a highly varying distribution over the years was
observed. Changes to hospital services, data quality processes and national
systems (such as the introduction of the Summary Care Record) are likely
to have contributed to the volatile distribution of the mismatches over time.
Nevertheless, this illustrates that secondary care databases need to be used
with caution when retrieving this type of information and, where possible,
linkage to national systems should be sought. This exercise has also shown
that even deterministic record linkage within a hospital is prone to error
(2.2%) despite the use of unique identifiers.
The second linkage exercise aimed at providing additional biochemistry infor-
mation to the stroke register, and provided new insights into the availability
of electronic biochemistry records for stroke admissions and discharges. This
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is important as the amount of patients having a particular blood test was
previously not known, and cohorts including this information can now be
selected and used. This exercise provided groundwork for the development
of a new clinical data warehouse, the Norfolk & Norwich Research Stroke &
TIA Register (stroke register) with over 25 thousand patients.
The linkage exercises provided a level of data integration across hospital
databases and with national sources. However, the context in which infor-
mation was created in each source required additional semantic integration,
and the data collection methodology facilitated this. Nevertheless, further
work on integration continued to be carried out throughout this thesis. Data
interchange across hospital and other sources could be improved by the use of
international standards such as the health level-7 (HL7); however, it was not
possible to use any such standards with the systems studied in this thesis.
Arguably, HL7 and other standards may be themselves complex to imple-
ment, do not provide a full integration between different coded values, and
are difficult to reach without privileged access to the underlying information
system. Perhaps simpler implementations and data models would provide
better results and wider applicability.
v. Data modeling
Chapter 3 introduced the concepts of data warehousing and data modeling
in the context of developing the stroke register clinical data warehouse. The
latter was developed using a hybrid approach that took Inmon’s relational
model and technical focus, Kimball’s methodological principles and bottom-
up alignment, and Szirbik’s overarching methodological steps. We found this
approach to provide sound results in smaller environments within a large
organisation.
Based on the above, a methodology for the development of domain-specific
clinical data warehouses with routinely collected data was introduced and
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addresses all the challenges identified when producing the three versions of
the stroke register. The methodology is expected to have wider applicability
and a research paper is currently being prepared on this topic.
In Chapter 4, a new data model, inspired by the EAV model and RDF triples,
was introduced to describe the routes that patients take through care using
routine data. The accompanying methodology made this model adaptable
to new data elements and to changes in the host environment. The data
model made possible the integration and organisation of patient-centric data
and information for multiple purposes. The pathways model was extended to
include complex clinical information and to include its own data dictionary,
providing a level of ontological alignment and a description of the semantics
of patient activities. This work was carried out to model prostate cancer
pathways but it is expected to have wider applicability and reproducibility;
work is currently underway to develop stroke pathways, and a paper has been
submitted to a leading health informatics journal.
Overall, data modeling was shown to be an extremely important part of the
journey, particularly in contextualising information on patient activities as
well as providing new knowledge about the way in which activities relate
to one another. Furthermore, the simplified data structure that is platform
independent provided a straightforward way to manage the ever-changing
data and its model. Nevertheless, models similar to the EAV are less efficient
and require additional programming to perform tasks that other architectures
would do automatically. Integrated platforms that facilitate the interactions
between data model, system and users, could tackle these drawbacks.
vi. Visualisation, Quality and Analyses
Chapter 4 introduced a framework for the integration, visualisation and anal-
ysis of the prostate cancer pathways that could be applied to other domains.
The framework included the CaP VIS software and an analysis engine that
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enabled complex interactions with the pathways data model and its data.
Other work on frameworks with similar functions was published while this
research was ongoing [177; 178; 258]. However, at the time of writing, these
do not focus on pathways nor, to our knowledge, do they compute visualisa-
tions or the analyses that were carried out in this thesis.
In this thesis, patient-centric pathways were created for each prostate cancer
patient in the cohort and a novel graphical representation was introduced.
The compilation of several data points in a single patient-centric pathway
plot revealed aspects of the patient’s journey through care that would oth-
erwise remain hidden in databases. Furthermore, the framework enables the
summarisation and extension of pathways as well as the aggregation of sim-
ilar sequences. In turn, this allows the inspection of frequent paths that
patients take, and the data can be remodeled to focus on particular activ-
ities or events. The framework and its software can be seen as a clinical
and research decision support system that enables the inspection of complex
clinical information, its analysis, and the selection of high quality cohorts
for research. Software was also developed to compare the outcomes of given
patients’ profiles using the prostate cancer data.
Data and process mining techniques are often suggested for the analysis of
workflows and pathways. These techniques were evaluated in this thesis and
found unsuitable when applied to unstructured routine clinical data. The
framework proposed in this thesis allows for quality data to be selected, and
has the potential to facilitate data and process mining not only by providing
more structured data, but also by enabling further interpretation of complex
clinical data. Further work is required both on algorithms that can cope with
the complex nature of routine data, as well as software that can integrate and
prepare data for analyses.
The process of integrating routinely collected electronic data also produces
pathways that may not be informative or complete. Chapter 4 also discussed
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the additional data quality dimensions that are possible to explore thanks to
the proposed framework. In particular, a scoring system was developed to
rank pathways according to their quality in order to study the prostate cancer
biomarker. Rules can be implemented to ascertain, for example, whether a
treatment has indeed occurred at a particular time point based on the effect
it had on the biomarker readings.
The overall quality of routinely collected electronic data, based on the ob-
servations made in this thesis, vastly depends on the uses and importance of
that data (or system) to the clinicians and hospital. Quality data is often
found in systems used for audits, commissioning and performance, or auto-
mated order entry systems such as the one used in biochemistry. Conversely,
erroneous data, although limited, is mostly found in systems where back-
dated manual entry is performed, in systems where data points may not be
consistently relevant to a particular disease, or in systems where this data is
no longer used operationally. In such cases patient notes are still the most
accurate source of detailed information yet this may not be recorded elec-
tronically. Nevertheless the work carried out in this thesis should reassure
that de-identified patient data can be used for research and public good, and
that, by creating a greater demand for this data, their quality and accuracy
are improved.
vii. Further Research and Ongoing Clinical Studies
The work carried out in this thesis has already enabled clinical studies and
further research on stroke and prostate cancer. Due to the cumbersome jour-
ney from data to knowledge, time constraints and other limitations, these
are not included or discussed in detail in this thesis. Nevertheless the studies
that have been carried out and submitted for publication as well as those still
under preparation have been included as abstracts in Appendix E. Summary
statistics of the findings in prostate cancer are given in Appendix D. Further-
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more, data mining techniques such as the decision trees have been applied to
the prostate cancer data (with a comprehensive list of biochemistry tests as
potential predictors) and to the stroke dataset, and further work is currently
underway to interpret the results. In addition, the work presented here has
also enabled future research into published pathway adherence and variance
metrics, particularly with respect to the UK NICE guidelines. For example,
rules derived from the guidelines can be checked with the framework pre-
sented in this thesis, in a similar fashion to the work carried out in assessing
the data quality dimensions.
The above steps map the comprehensive journey from data to knowledge in hos-
pitals: access, retrieval, preprocessing, linkage and integration, data modelling,
visualisation, quality and analyses. The steps were carried out mostly in this
order, however, significant backtracking from the last steps to the first four was
noted. These first four steps (access, retrieval, cleansing and linkage) were also
the most time consuming, followed by data modelling and the development of the
framework, which required a substantial amount of consultation with the clini-
cal teams. One of the limitations of this work is that it studied a single large
hospital. However, given the reports in the literature, the consultation with the
clinical teams, and the two case studies, the steps and challenges are expected to
be similar elsewhere and in most other heterogeneous domains.
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5.2 Concluding Remarks and Further Work
This thesis has reported in detail the cumbersome journey from data to knowl-
edge in secondary health care centres and, as a result, provided unique insights
at every step of the way. The question of whether routinely collected data in
large hospital databases can be used for research, was answered in that, with
limitations, some of the information can indeed be used for this purpose. One of
the reasons for these limitations has to do with the fact that, in hospitals, there is
limited accountability for data that is not actively used for audits, management,
or planning and performance evaluation. Nevertheless, we have seen that it is
still possible to extract knowledge from large heterogeneous databases in hospi-
tals and that the extracted knowledge be used for research. We have also seen
that using additional data sources is beneficial in this respect as it validates and
complements hospital data.
Because of some of the work presented in this thesis, the hospital R&D depart-
ment has decided to invest in this area, and further work will continue in the
development of a sustainable stroke register infrastructure. This work has also
resulted in plans to expand and apply the pathways concept to other hospitals
and domains and a bid has also been sent for the continuation of this study.
Further work is needed to develop analytical tools that can cope with the unique
nature and heterogeneity of routine health data.
This project has encouraged further work in other problem domains and in the de-
velopment of tools to retrieve, model and analyse pathways from multiple sources.
It is becoming increasingly evident that, with the explosion of big data in hospitals
and in society, such tools will play an increasingly important role in the comput-
erised analysis of trends and knowledge discovery. The extraction of knowledge
from data is the goal of data science, and this emerging discipline shares fea-
tures with the work carried out in this thesis, where a broad range of skills, from
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analytical to “soft skills”, is required of its scientists and practitioners.
“For all its perils, medical data mining can also be the most rewarding. For an
appropriately formulated scientific question, thousands of data-elements can be
brought to bear on finding a solution. For an appropriately formulated medi-
cal question, finding an answer could mean extending a life, or giving comfort
to an ill person. These potential rewards more than compensate for the many
extraordinary difficulties along the pathway to success”, Cios and Moore [20].
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Appendix A - Information
Systems and Data Collection
Details
1.1 Summary of Information Systems
The section below summarises the 15 different Information Systems or data
sources investigated in this thesis.
• PACS and RIS - Picture Archiving Communication System (PACS)
and Radiology Information System (RIS)
The PACS is dedicated to radiological imaging storage and visualisation.
Administration information and imaging text reports are also stored in the
RIS and are retrieved using Business Objects (BO), a Business Intelligence
software. PACS Room staff produces reports and datasets from the latter.
• OPT - Operating Theatre Database (ORSOS)
The Operating Room Scheduling Office System (ORSOS) contains infor-
mation and coding (OPCS) on any surgical procedures. Datasets can be
requested from the ORSOS IT staff based on a particular OPCS code or
free-text keyword search.
• LAB - Histopathology and Biochemistry (ICE Database)
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This database contains all biochemistry test results as well as histopathol-
ogy text reports. Biochemistry data is retrieved using the BO software.
Histopathology data is retrieved based on a free-text keyword search with
the assistance of a consultant histopathologist who has built a querying
system to facilitate retrieval.
• CRE - Hospital Cancer Register (Somerset Cancer Registry)
This system was introduced in 2007 and stores the dataset for the Na-
tional Cancer Waiting Times Database. This database has the potential
to store almost all information on cancer patients (from biochemistry to
appointments and notes) and has more recently been fed data from other
systems as well as outcomes of Multidisciplinary Team Meetings (MDTs).
This is the most accurate database for counts of cancer patients. Datasets
are retrieved by liaising with the Cancer Information Services team but the
system includes built-in reporting tools.
• PAS - Patient Administration Systems (McKesson PAS)
The PAS system contains general admissions and demographics informa-
tion. Clinical coding for diagnoses (ICD) is only recorded for inpatients.
Procedures codes (OPCS) and procedure dates are also stored in this sys-
tem. Data is retrieved using the BO software but it is also possible to
request PAS data from the Information Services.
• ONC and ONT - Oncology Department Database (Varian ARI-
A/MedOncology) and the Notes Database System (ONT)
The oncology department database, which was originally created (2003) to
store radiotherapy information, now (2007) also stores detailed information
such as case notes and patient history from patients who are treated by
the oncology department. The Notes System, which is now obsolete, con-
tains free-text records such as case notes prior to 2008, from the Oncology
department. Data can be retrieved from this system by liaising with the
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Oncology staff and running back-end queries.
• CR - Eastern Cancer Registration and Information Centre (ECRIC)
The ECRIC database is the local cancer register. It stores a core dataset
which is agreed at national level and provides additional information, some
of which is not stored in hospital systems, such as coding for cause of death.
This system also stores tumour staging information in a canonical form, and
provides information on cancer diagnoses and treatments, even if the patient
receives treatment in other hospitals in the country.
• NSTS - NHS Strategic Tracing Service (NSTS)
The national tracing system contains most accurate and up-to-date infor-
mation on patients registered with the NHS. The information is essentially
demographic, including addresses and date of death. The information ser-
vices department at the NNUH liaises directly with the NSTS to process
lists of patients. This system does not provide causes of death.
• ORT - Orthopaedics System (Bluespier)
This system facilitates the retrieval of information on patients who have
been treated for pathological fractures from advanced metastatic cancers.
The orthopaedics IT staff can extract this data, or it can be obtained from
the Bluespier system, which includes a comprehensive query builder for data
retrieval.
• OSR/NSR, TIA and CST - Stroke Databases
The Stroke Register Database was initially set up in 1996. The initial
database, OSR (Old Stroke Register), now in Microsoft Access format, con-
tains a set number of attributes and its data spans from 1996 to 2008. The
new stroke register database (NSR) is an improved version of the OSR, still
in Microsoft Access where further attributes were introduced, and includes
strokes from 2008 to 2013. In 2013 the Capture Stroke system (CST) was
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introduced as a replacement for the NSR database and is currently the
preferred method for collection of stroke data and submission of data for
national audits. The CST system allows and encourages multiple users (in-
cluding nurses and clinicians) to add information directly onto the database.
At the time of writing the NSR database was still being used together with
CST. The TIA database is similar to the NSR database, also in Microsoft
Access, except it records mini-strokes and further attributes such as blood
pressure.
• AE - Accident and Emergency Database (Symphony)
The sole use of the Accident and Emergency (AE) system in this thesis was
the inspection of admissions regarding stroke patients. No data from this
system was used becasue the OSR/NSR systems will already contain the
most relevant information for stroke patients, however, this would still be
an interesting system to explore in the future.
1.2 Research Stroke Register Data Warehouse
A complete list of the Research Stroke Register Data Warehouse (RSR) is given
below, together with key figures of the cohort of stroke and TIA patients. The
details and numbers pertain to the RSR version 3.
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 Key Figures 
 
Strokes 
 
Average age 76.65 (SD 12), range [0, 105] 
Female 53.4%, Male 46.6% 
Average number of patients per year: 919 (SD 159) (1997-2011) 
Type of stroke: Ischemic 82%, Haemorrhagic + SAH 15%, other 3% 
 
TIAs  
 
Average age 71.74 (SD 12), range [4, 98] 
Female 53.7%, Male 46.3% 
Average number of patients per year: 847 (SD 217) (Jan 2003 - Nov 2013) 
 
 
 
Tables 
 
Patient Table 
LAB Data Source 
Records: 14,782 
Unique Patients IDs: 14,782 
 
List of Attributes: 
 
Patient Attribute Description 
Anon_ID Internal anonymised ID. 
HospNo Hospital Number. 
Surname Patient Last Name. 
NHS Number NHS Number. 
Gender Gender. 
DOB_SR Date of Birth in Stroke Register. 
DOB_PAS Date of Birth in PAS. 
Notes Notes on this patient, any linkage issues that need to be fixed. 
NSTS Validated Date Date when National Database was last checked for this patient. 
Duplicated NHS Number 
When there are patients with more than one NHS number, keep 
both until any linkage issues are resolved. 
Flag_Use 
Boolean value as to whether this record has been fully validated and 
can be used. 
  
 
 
Co-morbidities and Follow-up Table 
PAS Data Source 
Records: 409,539 
Unique Patient IDs: 10,562 
 
List of Attributes: 
 
Comorbid Attributes Description 
Cpkey (database use) Internal primary key (unique number for each row). 
anon_ID Anonymised patient ID. 
Episode End Date Episode end date. 
Episode Start Date Episode start date. 
Date of Birth Patient's date of birth. 
Date of Death Patient's date of death. 
Discharge Date Discharge date (from episode). 
Procedure Date Procedure date (relating to episode). 
Admission Date Admission date (relating to episode). 
Sex Gender. 
Alert Notes PAS Alerts (e.g. hospital infection, particular allergies, etc.). 
Ethnic Group Patient ethnic group. 
Alert Description PAS Alerts - further description. 
Diagnosis Codes ICD codes (primary code followed by any other co-morbid codes). 
Procedure Codes OPCS codes for any procedures pertaining to the episode. 
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Table Strokes 
Main Stroke Data Table, overlapping Data Sources NSR+OSR 
Records: 16,232 
Unique Patient IDs: 14,782 
 
List of Attributes: 
 
Stroke Attributes Stroke Attributes (cont.) 
HospNo PRENDS 
anon_ID APHASIA1 
Surname Bamford 
Source COMMUN7 
No SWALPR7 
Consultant STSEEN 
GPPC BSCAN 
Ward CT48HR 
DOB CT24HR 
Age Type of Stroke 
Gender Date of d/c from hosp 
Ethnic WARDD 
OnSetDate STATD 
OnSetTime DESTD 
AdmissionDate COGFUND 
AdmissionTime URIBID 
ArrivalDate ESTBID 
finalDate Physio 
Year OT 
First Ward SLT 
CONLEV0 Dietician 
SIDE PEG 
ARM0 SLT48 
LEG0 P24 
PRELIV AP/AD 
PRERANK AP/DC 
PREMOB IST 
PREDISA Rankin on discharge 
 
 
 
Biochemistry Table 
LAB Data Source 
Records: 142,920 (after granularity was reduced, was previously 518,464) 
Unique Patients IDs: 142,920 
 
List of Attributes: 
 
Biochemistry Attribute Description 
Bpkey (database use) Internal primary key (unique number for each row). 
hospNo NNUH hospital number. 
bloodName Blood name and internal hospital code. 
totalReadings Total number of blood readings between admission and discharge. 
Average Average for a particular numeric blood value. 
stDev Standard Deviation for the above average. 
Max Maximum blood value found between admission and discharge. 
Min Minimum blood value found between admission and discharge. 
admissionReading Blood value found at admission. 
dateAdmissionReading Date of blood value closest to admission. 
dischargeReading Blood value found at discharge. 
dateDischargeReading Date of blood value closest to discharge. 
linkageIssue (validation use) Validation of date of birth (stroke register - PAS). 
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 Table Strokes_OSR 
Old Stroke Register (OSR) Data Source 
Records: 10,769 
Unique Patient IDs: 10,033 
  
List of Attributes:  
 
HospNo ARM0 DEFDUR ESTBID 
Surname LEG0 COGFUN7 Physio 
No PRELIV COMMUN7 OccupationalTherapy 
Proforma PRERANK SWALPR7 SLT 
Consultant PREMOB BLAD7 Dietician 
NHSNO PREDISA PTSEEN PEG 
GPPC PRENDS OTSEEN Previous 
Ward CONLEV1 STSEEN AF 
DOB FACE1 BSCAN Diabetes 
Age ARM1 CT48HR Smoker 
Gender LEG1 CT24HR Hypertension 
Ethnic APHASIA1 FINDIAG IHD 
OnSetDate DYSARTH1 DisChargeDate Other Coronary Disease 
OnSetTime CONFUS1 WARDD Periph Vasc Disease 
ADMDate CGP1 STATD Hyperlipideamia 
ADMTime FIELD1 DESTD SLT48 
Delay NEGLECT1 COGFUND P24 
ADMWard BSTEM1 URIBID APADM 
CONLEV0 OTHDEF1 TRANSBID APD/C 
SIDE CLASS1 MOBID IST 
 
 
Table Strokes_NSR 
New Stroke Register (NSR) Data Source 
Records: 5,464 
Unique Patient IDs: 5,447 
 
List of Attributes: 
 
HospNo First Ward 
Time first 
contact st 
team 
ADM 
Gluc 
taken Time of OT 
Primary 
Diagnosis 
FINAL D/C 
DATE Repatriated from Included 3 
Surname ArrivalDate 
FirstContac
tSTDateAN
DTime 
ADM 
GLUC 
OT DATE 
AND TIME 
Date of d/c 
from hosp 
FINAL D/C 
TIME Repatriated to Date consented 3 
PCT ArrivalTime 
Clinically 
approp SU 
Swallow 
test 
indicated OT 
Time of d/c 
from hosp 
FINAL D/C 
DateANDTim
e 
Date repatriation 
requested 
Date randomised 
3 
No 
ArrivalDATE 
AND TIME 
ADM S U 
Date 
Date of 
swallow DATE SLT 
DateANDTi
meD/Cfrm
HOSP 
Any time 
spent in 
Neuro or CCU 
Time repatriation 
requested Date withdrawn 3 
BF 
DISCHARGE 
LOS 
ADM S U 
Time 
Time of 
swallow TIME SLT 
Date of d/c 
from stroke 
unit 
Appropriate 
days off SU 
Date of 
repatriation Divert Patient? 
NHS NO WARD LOS 
ADM SU 
Date and 
Time 
SWALLO
W DATE 
AND 
TIME 
SLT DATE 
AND TIME 
Time of d/c 
from stroke 
unit 
receive 
THROMB 
Time of 
repatriation 
Repatriation 
Destination 
Postcode % GUNT 
Reason 
Non Admit 
SU PRELIV SLT 
DateANDTi
meD/CfrmS
U 
Reason no 
thromb Trial 1 
Date of 
repatriation Pre-
Alert to DGH 
TRUST 
AdmissionD
ATE 
Imaging 
indicated PRERANK PEG DATE 
Rankin on 
discharge 
Date of 
Thrombolysis 
Date screened/PIS 
given 
Date of 
notification of 
estimated date of 
repatriation to 
DGH 
NNUHID 
AdmissionT
IME 
Date of 
imaging PREDISA PEG 
DISCHARGE 
DESTINATI
ON 
Time of 
Thrombolysis Included 
Date & Time 
formal 
notification of 
repatriation 
DOB 
AdmissionD
ateANDTim
e 
Time CT 
study PRENDS 
WEIGHED 
DATE 
TRANSFERR
ED 
Thrombolysis 
Date/Time Date consented 
Date & Time 
confirmation 
received at DGH 
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 Age Direct to 
Neuro or 
CCU 
Scan Date 
and Time 
Evidence 
of AF 
WEIGHED ESD Consultant Date randomised Time transport 
arrnaged 
Sex 
RETURNad
missionDAT
E 1 
Time CT 
approval 
Anticoag
ulant? Dietician ESD Area? Present Date withdrawn 
Date & Time of 
repatriation 
Ward 1 FROM CT or MRI AP/AD DIET  Date 
Eligible for 
joint care 
plan Speciality Trial 2 
Comments 
Repatriation 
OnSetDat
e 
RETURNad
mission 
DATE 2 
URGENTsca
n AP/DC MOOD 
Joint care 
plan 
Is there an 
established 
infarct? Date screened 2 
 OnSetTim
e 2 FROM ADM GCS NOTE 
MOOD 
Date 
Telemedici
ne NIHSS 2HRS Included 2 
 
STROKE in 
hosp FAST in A+E SIDE 
Date of 
physio 
MOOD 
Score 
D/C to 
BEECH 
DATE NIHSS 24HRS Date consented 2 
 
On 
waking 
Alert stroke 
date 
NIHSS on 
adm 
Time of 
physio SURGERY? 
D/C to 
BEECH 
TIME 
2ND SCAN 
DATE 
Date randomised 
2 
 
First 
contact 
Alert Stroke 
time 
NIHSS 
score 
PHYSIO 
DATE 
AND 
TIME 
Date of 
Surgery 
DATE D/C 
REHAB 
2ND SCAN 
CREAT TIME Date withdrawn 2 
 
ArrivalPOI
NT 
AlertStroke
DateANDTi
me 
Adm BP 
taken Physio 
Type of 
stroke 
TIME D/C 
REHAB HAEM? Trial 3 
 
Ambulanc
e 
First 
contact st 
team ADM BP 
Date of 
OT Bamford 
DateANDTi
meD/C 
REHAB Repatriated? Date screened 3 
  
 
Table TIAs 
TIA Database Data Source 
Records: 9,325 
  
List of Attributes:  
 
ID NO    ABCD taken 1st contact   Time of MRI      Notes 
NNUHID   ABCD2    Date/Time MRI    AF 
NHS      DATE OFFERED     Blood test done  GP SURGERY 
GP POSTCODE      DATE SEEN ECG done  MED AT-Time Refer Hrs 
AGE      TIME SEEN Aspirin indicated MED AT-Time Seen Hrs 
SEX      Date/Time Seen   Aspirin commenced MED AT-Time CT Hrs 
INPATIENT DNA Statin indicated  MED AT-Time Dop Hrs 
ADMISSION DATE   DIAGNOSIS Statin commenced          
DISCHARGE DATE   Detailed diagnosis       Warfarin indicated               
FORM COMPLETE    Doppler indicated Warfarin taken           
DATE OF ONSET    DATE OF DOPPLER  Referred for Surgery             
TIME OF ONSET    TIME OF DOPPLER  Date referred for surgery         
Date/Time Onset  Date/Time Doppler Time referred for surgery         
DATE sought med att 1st contact GP A+e   CT indicated     Date of surgery          
Time sought medical attention    Date of CT       Smoking          
Date/Time Med Att Time of CT       Diet/Salt         
DATE REFERRED    Date/Time CT     Alcohol          
TIME REFERRED    CT or MRI Exercise          
Date/Time Referral       MRI head scan indicated  Driving          
REFERRAL SOURCE  Date of MRI      Management plan given           
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1.3 Prostate Cancer Operational Data Store
Additional data tables containing further biochemistry data or comorbidities were
linked from the stroke databases (e.g. haemoglobin, full blood count, etc.) or
directly from the systems but were not in the ODS data store.
 
 
 
 
CaP ODS - Key Figures & Tables 
 
 
 
ODS Tables Overview 
 
The ODS comprises a total of 13 Tables and 4,464,055 records. 
A summary of the tables is given below. 
Descriptions of the tables and their attributes are given in the next pages. 
 
 
Table Name Code  Data Source  Short Description Records 
Table PAS_C61 PAS  Patient Administration System. Hospital episodes. 9,461 
Table Lab_OT1  LAB  Biochemistry System. Multiple blood tests. 4,016,561 
Table Lab_OT2 LAB  Biochemistry System. Testosterone readings. 15,524 
Table Lab_OT3 LAB  Biochemistry System. Vitamin D and Calcium. 224,952 
Table Lab_PSA  LAB  Biochemistry System. PSA tests. 176,472 
Table ORT ORT  Orthopaedics System. Femoral neck fractures. 1,783 
Table CRE CRE  
Hospital Cancer Register and 
Cancer Waiting Times System. 
Cancer Waiting Times. 3,064 
Table RAD RAD  Radiotherapy Database. Radiotherapy Sessions. 2,769  
Table RIS RIS  Radiology Information System. Imaging. 1,281 
Table OPT OPT 
Operating Theatre Information 
System. 
Operations. 4,637 
Table HIS LAB Histopathology System. Biopsies. 5,083 
Table ONT  ONT Oncology NOTES System. Oncology Treatment. 1,601 
Table ONC   ONC 
New Oncology Department 
System. 
Oncology Treatment. 867 
Total Records 4,464,055 
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ODS Table Details & Attributes 
 
 
 
Table PAS_C61 -  Patient Administration System 
 
Data Origin and Constraints 
PAS Data Source (via Business Intelligence software) where Diagnosis 
Code 1 = "C61" and Episode Start Date between 01/01/2001 - 30/12/2010. 
Records 9,461 
3.70  records per patient 
Unique Patient IDs 2,552 
Description 
This list of prostate cancers in this table was defined by any hospital 
discharge letters where the ICD code (C61) was coded. 
Retrieval Date (ODS) 11/08/2011 
 
List of Attributes: 
 
Attribute Name Description 
Patient Number Hospital Number. 
Episode End Date Episode end date. 
Episode Start Date Episode start date. 
Consultant Code Consultant code. 
Consultant Consultant name. 
NHS Number NHS Number. 
Date of Birth Date of Birth. 
Date of Death Date of Death. 
Diagnosis Codes 
List of all ICD diagnoses in discharge letter for episode (includes 
comorbidities). 
Diagnosis Code 1 First ICD code associated with the episode. 
Procedure Codes OPCS 4.5 codes for any procedures undertaken during episode. 
Discharge Date Date patient was discharged. 
Procedure Date Date of the procedure (if any). 
Discharge Destination Nat 
Code 
Discharge destination code. 
Discharge Destination Discharge destination name. 
Admission Date Admission Date. 
Sex Gender (always Male). 
Alert Notes Alert Notes (allergies, transport, infection). 
Alert Description Further text description of alerts. 
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Table Lab_OT1 -  Biochemistry System (multiple biochemistry tests) 
 
Data Origin and Constraints 
LAB Data Source (via Business Intelligence software) where 
Test Code = alkaline phosphatise or creatinine or urea or AST or GGT or  
total bilirubin, and Date of Entry between 01/01/2003 - 31/12/2007. 
Records 4,016,561 
10.15  records per patient 
Unique Patient IDs 395,531 
Retrieval Date (ODS) 23/06/2009 
 
List of Attributes: 
 
Attribute Name Description 
Hospital Number Hospital Number. 
Age at Episode Age recorded when blood sample was taken. 
Clinical History Free text clinical history manually entered when blood sample was taken. 
Date of Entry Date the blood sample was taken. 
Time of Entry Time the blood sample was taken. 
Date of Authorisation Date the blood sample was analysed. 
Test Data The blood reading. 
Fasting Indicator Indicator whether patient was fasting. 
 
 
Table Lab_OT2 -  Biochemistry System (Testosterone) 
 
Data Origin and Constraints 
LAB Data Source (via Business Intelligence software) where 
Test Code = testosterone 
and Date of Entry between 01/01/2003 - 31/12/2007. 
Records 15,524 
1.46  records per patient 
Unique Patient IDs 10,637 
Retrieval Date (ODS) 23/06/2009 
 
This table's list of attributes is the same as the previous table (Lab_OT2). 
 
 
Table Lab_OT3 -  Biochemistry System (Vitamin D and Calcium) 
 
Data Origin and Constraints 
LAB Data Source (via Business Intelligence software) where 
Test Code = Vitamin D or Calcium 
and Date of Entry between 01/01/2003 - 31/12/2007. 
Records 224,952 
3.39  records per patient 
Unique Patient IDs 66,455 
Retrieval Date (ODS) 23/06/2009 
 
This table's list of attributes is the same as the previous table (Lab_OT3). 
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Table Lab_PSA -  Biochemistry System (Prostatic Specific Antigen) 
 
Data Origin and Constraints 
LAB Data Source (via Business Intelligence software) where 
Test Code = Vitamin D or Calcium 
and Date of Entry between 01/01/2003 - 31/12/2011. 
Records 176,472 
2.90  records per patient 
Unique Patient IDs 60,794 
Retrieval Date (ODS) 22/01/2012 
 
This table's list of attributes is the same as the previous table (Lab_OT3). 
 
 
 
 
Table ORT -  Orthopaedics System (Femoral Neck) 
 
Data Origin and Constraints 
ORT Data Source (via own reporting software) where 
Diagnosis is neck of femur fracture, and Date of Entry between 01/01/2008 
- 31/10/2011. 
Records 1,783 
1.10  records per patient 
Unique Patient IDs 1,651 
Retrieval Date (ODS) 31/10/2011 
 
List of Attributes: 
 
Attribute Name Description 
Hospital Number Hospital Number. 
Operation Date Date of operation. 
Procedure Procedure Name, detail. 
Procedure 1 Name Procedure Name, general. 
Consultant Consultant code. 
Surgeon Surgeon code. 
Primary Diagnosis Desc Description of Primary Diagnosis. 
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Table CRE -  Hospital Cancer Register and Cancer Waiting Times Database 
 
Data Origin and Constraints 
CRE Data Source (via own reporting software and integrated between old 
and new cancer waiting times databases) where 
Diagnosis is ICD C61, and Date of Entry between 01/01/2001 - 
31/12/2010. 
Records 3,064 
1.12  records per patient 
Unique Patient IDs 2,714 
Retrieval Date (ODS) 10/10/2011 
 
List of Attributes: 
 
Attribute Name Description 
NHS# NHS Number. 
NoEps Number of episodes. 
Source 
Old Waiting Times Database: 2002 - 2008 
New Waiting Times Database: 2008 - 2010 
RefSource Source of Referral (GP, A&E, other) 
Prority Urgent Referral. 
RefDate Referral Date. 
BodySite Body Site (prostate). 
FirstSeen Date first seen. 
FirstSeenOrg Organisation first seen. 
DelayReasonCodeFirstSeen Reason for delay (if any) in first seen date. 
MDTDate Date of Multidisciplinary Team Meeting 
Laterality Tumour laterality (if any). 
EventType Pathway treatment primary/recurrent/metastatic/etc. 
DTTORG Organisation responsible for decision to treat. 
DTT Decision to treat date. 
Treat Treatment date. 
Modality Type of Treatment. 
ClinicalTrial Clinical Trial indicator (if any). 
CareSetting Inpatient admission, day case, out-patient, other. 
TreatORG Organisation responsible for treatment. 
RTIntent Radiotherapy Intent (palliative, anti-cancer, other). 
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Table RAD -  Radiotherapy Database 
 
Data Origin and Constraints 
RAD Data Source (via own reporting software and integrated between old 
and new radiotherapy databases) where 
Site is prostate and/or diagnosis is prostate cancer, and Date of Entry 
between 01/01/2003 - 31/12/2010. 
Records 2,769 
1.40 records per patient 
Unique Patient IDs 2,013 
Retrieval Date (ODS) 27/10/2011 
 
List of Attributes: 
 
Attribute Name Description 
Hospital Number Hospital Number. 
Intent Radiotherapy Intent (Palliative, Curative or other). 
Site treated Site treated. 
Date of Treatment Date Treatment Commenced. 
NoOfFractions Number of Fractions (Sessions). 
Fractions of Photons   Fractions of Photons (subset of NoOfFractions). 
Fractions of Superficial   Fractions of Superficial (subset of NoOfFractions). 
Fractions of Electrons Fractions of Electrons (subset of NoOfFractions). 
 
 
 
 
Table RIS -  Radiology Information System 
 
Data Origin and Constraints 
RIS Data Source (via business intelligence software) where 
word prostate appears in Report Text, and Date of Entry between 
01/01/2003 - 31/12/2010. 
Records 1,281 
1.50 records per patient 
Unique Patient IDs 866 
Retrieval Date (ODS) 11/02/2012 
 
List of Attributes: 
 
Attribute Name Description 
Hospital Number Hospital Number. 
Date of Birth Date of Birth. 
Report Date. Date the radiological report was produced. 
Exam Type Type of Imaging / Imaging Modality. 
Report Text Line Line of text report where word prostate appears. 
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Table OPT -  Operating Theatre Information System 
 
Data Origin and Constraints 
OPT Data Source (via own reporting software) where 
word prostate appears in Report Text, and Date of Entry between 
01/01/2003 - 31/12/2010. 
Records 4,637 
1.13 records per patient 
Unique Patient IDs 4,121 
Retrieval Date (ODS) 24/09/2011 
 
List of Attributes: 
 
Attribute Name Description 
ORSOS NO Internal Database Number. 
DATE OP Date of Operation. 
ADMITTING CONSULTANT Consultant code. 
1ST PROCEDURE_CODE 1st Procedure Code (OPCS). 
1ST PROCEDURE 1st Procedure Name. 
1ST PROCEDURE SITE 1st Procedure Site. 
2ND PROCEDURE_CODE 2nd Procedure Code (OPCS). 
2ND PROCEDURE 2nd Procedure Name. 
2 ND PROCEDURE SITE 2nd Procedure Site. 
3RD PROCEDURE_CODE 3rd Procedure Code (OPCS). 
3RD PROCEDURE 3rd Procedure Name. 
3RD PROCEDURE SITE 3rd Procedure Site. 
4TH PROCEDURE_CODE 4th Procedure Code (OPCS). 
4TH PROCEDURE 4th Procedure Name. 
4TH PROCEDURE SITE 4th Procedure Site. 
PT NO Hospital Number. 
BIRTHDATE Date of Birth. 
AGE Age at Operation. 
SEX Gender. 
Day of Week Operation week day. 
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Table HIS -  Histopathology System 
 
Data Origin and Constraints 
LAB Data Source (albeit different working space in the system; via own 
reporting software and business intelligence software, and integrated old 
and new attributes) where word prostate appears in Report Text, and Date 
of Entry between 01/01/2003 - 31/12/2010. 
Records 5,083 
1.17 records per patient 
Unique Patient IDs 4,342 
Retrieval Date (ODS) 29/11/2011 
 
List of Attributes: 
 
Attribute Name Description 
HospNo Hospital Number. 
Date of Entry Date of Histological Report was produced. 
Age Patient's age at the time of tissue sample taken. 
FullReport Full histopathology text report (integrated). 
SpecType Specimen Type. 
 
 
 
 
Table ONT -  Oncology NOTES System 
 
Data Origin and Constraints 
ONT Data Source (via own reporting software) where word prostate 
appears in primary site, and Date of Entry between 01/01/2000 - 
25/04/2007. 
Records 1,601 
1 record per patient 
Unique Patient IDs 1,601 
Retrieval Date (ODS) 07/10/2010 
 
List of Attributes: 
 
Attribute Name Description 
Hospital Number Hospital Number. 
Primary Site Primary Site = Prostate. 
Diagnosis Text diagnosis (no coding). 
Consultant Consultant code. 
Date Registered Date patient registered in the system (oncology department). 
Date of Birth Date of Birth. 
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Table ONC -  New Oncology Department System 
 
Data Origin and Constraints 
ONC Data Source (via own reporting software) where diagnosis code ICD 
C61, and Date of Entry between 01/01/2003 - 09/02/2012. 
Records 867 
1.004 records per patient 
Unique Patient IDs 863 
Retrieval Date (ODS) 09/02/2012 
 
List of Attributes: 
 
Attribute Name Description 
Hospital Number Hospital Number. 
Date of Birth Date of Birth. 
Age Age at Admission. 
Date Entered onto Aria Date patient was entered onto the system. 
Diagnosis Date Date of Diagnosis. 
Age at Diagnosis Age at Diagnosis. 
ICD Code ICD Diagnosis Code. 
Consultant Consultant Code. 
Last Visit Date Patient last visited Oncology department. 
Description 
Text line containing description of the diagnosis and tumour staging, 
Gleason grade, PSA or other information (not consistently recorded or 
coded). 
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Appendix B - Background on
Prostate Cancer
B.1 Carcinoma of the Prostate 
According to Cancer Research UK [b3], prostate cancer has overtaken lung cancer as the most 
common type of cancer in males (over 30,000 cases detected in 2001 in the UK). In the United States, 
the American Cancer Society estimated 30,200 deaths and 189,000 new detected cases for the year 
2002 [b6]. This type of cancer lacks effective detection methods when the disease is on its early 
stages and screening tests are not entirely reliable. Prostate cancer may spread to other anatomical 
sites without signs or symptoms for many years. Hormone escape is the most advanced stage of this 
disease. In this situation patients receive treatment but the cancer recurs and there is no control over 
its growth. The causes for this disease (Etiology) are still not well understood. All these issues make 
prostate cancer a major research topic in modern medicine. 
Cancer (malignant neoplasm) is a group of diseases characterized by uncontrolled growth of abnormal 
cells that have mutated from normal tissues [b1, b6]. Shall this uncontrolled growth affect vital organs 
or spread throughout the body, essential systems can be damaged, often leading to death. 
Normal cells grow, divide, and die. Cancer cells, instead of dying, continue to grow new abnormal 
cells. Apoptosis is the programmed process of eliminating cells (cell death). Cancer cells avoid this 
process and continue to multiply. These abnormal (cancer) cells often travel to other parts of the body 
where they grow further and replace normal tissue. This spreading process, called metastasis, occurs 
as the cancer cells get into the bloodstream or lymphatic system. 
The prostate is a gland in the male reproductive system that is responsible for the storage of seminal 
fluid and controlling urination. This seminal fluid is released to form part of semen [b2]. The prostate 
is located below the urinary bladder, in front of the rectum, as shown in figure 1.1. If the prostate 
grows too large, the flow of urine can be slowed or stopped. An enlarged prostate may be caused by a 
benign prostate hypertrophy (BPH). This is a common problem in elderly men with normally 
functioning testicles (producing testosterone). In fact, an enlarged prostate resulting of BPH can 
shrink in size if the testicles are surgically removed (orchidectomy) or by medication. BPH does not 
have any connection with cancer and it does not put patients at risk for prostate cancer [b1].  
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Similarly to BPH, prostate cancer in an advanced stage may result in an enlarged size of the prostate 
(due to the growth of the tumour, shown in figure 1.2). This may produce symptoms such as the 
inability to urinate. There are cases when prostate cancer can regress if testosterone levels are lowered 
(androgen ablation: orchidectomy or medication [b1]). The process of suppressing male hormones is 
called androgen ablation and focuses on blocking prostate cancer cells from getting  dihydrotestosterone 
(DHT), a hormone produced in the prostate [b2]. 
 
Figure 2.1. Basic male reproductive anatomy (MedLine, Adam). 
 
‘Prostate cancer is a malignant (cancerous) tumour (growth) that consists of cells from the prostate 
gland’ [b5]. This tumour normally grows slowly and only in an advanced stage can produce symptoms, 
and reach other areas of the body such as bones, lungs, and liver [b5]. Figure 2.3 shows the different 
zones of the prostate. 
 
 
Figure 2.2. Difference between normal prostate and prostate cancer (MedLine, Adam). 
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Figure 2.3. Front and side views of the prostate. In most cases, the peripheral zone (PZ) is 
where most malignant neoplasms develop [b8]. 
 
Carcinoma of the prostate is a type of malignant neoplasm (cancer) commonly known as prostate 
cancer. Carcinoma, however, is wrongly used as synonym for cancer. The definition of carcinoma is a 
malignant tumour (or malignant neoplasm) that arises in the epithelium (tissue that lines the skin and 
internal organs of the body [b5]). ‘Carcinomas invade the surrounding tissues and tend to metastasize to 
other anatomic sites’ [b8]. We shall use the term prostate cancer to refer to any type of cancer (including 
carcinomas) arising in the prostate. Figure 1.4 provides a clear representation of the different types of 
neoplasms, including carcinomas. 
 
Figure 2.4. Types of neoplasms. Examples of benign and malignant neoplasms. 
Advanced prostate cancer can be of two types. Locally advanced prostate cancer has spread from the 
prostate gland to neighbour tissues or glands. Metastatic prostate cancer has spread to the lymph nodes 
or other parts of the body (metastasized). Prostate cancer tends to spread to the bones and lymph nodes 
(glands involved in protecting the body against infection) [b10]. Bone metastases, therefore, are likely 
to occur in a patient with advanced prostatic cancer. ‘The spine, pelvis, ribs, and bones of the arm and 
thigh are the most common sites of bone metastases’ [b10]. Hormone escape happens in metastatic 
prostate cancer if the tumour grows back after a certain period of time when treatment is being 
administered. In this stage there is no control over the growth of the tumour, and therefore no effective 
treatment. This is the greatest clinical problem in men’s cancer. Palliative care (treatment aimed at 
reducing the severity of the symptoms) is administered in this situation. 
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Locally advanced 
prostate cancer
Localised prostate 
cancer
Metastatic prostate 
cancer
Cancer Diagnosed
Advanced prostate cancer
 
Figure 2.5. Types of prostate cancer: localised, locally advanced, and metastatic. 
 
The standard international codes that are regularly used for this disease are listed in figure 1.6 
(SNOMED is most common within the NHS). 
UMLS (Unified Medical 
Language System) 
ICD-9 (International 
Statistical Classification of 
Diseases 9th edition) 
ICD-10 (International Statistical 
Classification of Diseases 10th 
edition) 
SNOMED Clinical Terms 
Term Name: CA – 
Carcinoma of prostate 
Concept Unique 
Identifier: C0600139 
Term Unique Identifier: 
L0533491 
Term Name: Malignant 
neoplasm of prostate 
Code: 185 
Term Name: Malignant 
neoplasm of prostate 
Code: C61 
Term Name: CA – 
Carcinoma of prostate 
AUI: A3002443 
TTY: SY 
ID: 254900004 
 
Figure 2.6. International standard codes for prostate cancer. 
 
B.1.1 Etiology and Incidence 
The exact causes of prostate cancer are unknown. However, several studies have been carried out and 
it is possible to set a number of risk factors that contribute (or not) to the incidence of prostate cancer 
in men: 
 Age: The incidence of prostate cancer increases with age. More than 90% of men diagnosed 
with prostate cancer are older than 50 years [b10]. 
 Race: A large percentage of prostate cancer occurs in black elderly men. The lowest incidence 
occurs in vegetarians and Japanese men [b1]. 
 Family History (Genetic Factor): There is high incidence of prostate cancer in men whose 
father or brother has had the disease. There is also an increased risk for prostate cancer when 
breast cancer is or was present in close relatives. ‘Alteration of genes on chromosome 1, 17, 
and the X chromosome have been found in some patients with a family history of prostate 
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cancer. The hereditary prostate cancer 1 (HPC1) gene and the predisposing for cancer of the 
prostate (PCAP) gene are on chromosome 1, while the human prostate cancer gene is on the X 
chromosome’ [b9]. 
 Environmental: In general, exposure to carcinogenic substances increases the risk for prostate 
cancer. ‘Some studies show an increased chance for prostate cancer in men who are farmers, 
or those exposed to the metal cadmium while making batteries, welding, or electroplating’ 
[b7]. 
 Diet:  Men who eat a high-fat diet may have a greater chance of developing prostate cancer 
[b7]. The consumption of dietary fiber, soy protein, carotenoids containing lycopenes (found in 
tomato juice and tomato paste), and vitamin E with selenium, have been found to inhibit the 
growth of prostate cancer [b7]. 
The number of diagnosed cases of prostate cancer has risen significantly over the last two decades 
[b2]. Prostate cancer is rare in men under 50 years old. The median age of both diagnosis and mortality 
is 75 years old. Figure 2.7 shows in detail the number of new cases and the number of deaths from 
prostate cancer in the UK. 
 
 
Figure 2.7 Number of new cases of prostate cancer by age in 1997 (top). Number of deaths from 
prostate cancer by age in 1999 (bottom) [b3]. 
 
B.1.2 Diagnosis, Differentials and Screening 
Diagnosis is the process of identifying a disease by its signs, symptoms, and results of various 
diagnostic procedures. Screening may be described as the process of early diagnosis of a disease, 
although, it does not provide a conclusive diagnosis. A better definition of screening is the process of 
looking for evidence of a particular disease in people with no symptoms. Because there are usually no 
specific signs of early prostate cancer, screening is a very important test for men approaching 
andropause (age range from 40 to 55). It is therefore important for men on this age to screen for prostate 
cancer every two to three years. 
The relevant screening tools that can be major indicators for the diagnosis and management of prostate 
cancer are: 
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 Digital Rectal Examination (DRE)  
This procedure consists of palpating the prostate from inside the rectum. The physician inserts 
a gloved finger into the rectum through the anus and palpates the prostate gland [b10]. The 
physician then tries to feel the size and shape of the prostate and searches for hard or lumpy 
areas, which may indicate cancer. The DRE procedure only allows the palpation of a certain 
area of the prostate, the one felt through the rectum (the peripheral zone). This is the area 
where most prostate cancers arise [b2]. 
 Prostate-Specific Antigen (PSA) test 
The PSA test measures the levels of a protein (PSA, secreted by luminal cells in the epithelium, 
in the prostate [b12]) in a blood sample. The PSA test can also be referred as: kallikrein III, 
seminin, semenogelase, γ-seminoprotein and P-30 antigen. ‘PSA is produced for the ejaculate 
where it liquefies the semen and allows sperm to ‘swim’ freely’ [b2]. 
 
There are (arguably) three levels of PSA measurement to consider:  
Normal: from 0 to 4 nanograms per milliliter (ng/mL) 
Slightly elevated (intermediate): from 4 to 10 ng/mL 
Elevated: 10 ng/mL and above 
 
An age specific range may also be used. Patients under 60 years old have a threshold of 3 
ng/mL, patients between 60 and 69 a threshold of 4 ng/mL, and patients over 70 have a 
threshold of 5 ng/mL. Values above these thresholds may indicate prostate cancer. 
Results above 4 ng/mL may indicate: BPH, prostate cancer, prostatitis (inflamation of the 
prostate), urinary tract infection (cystitis), recent urinary tract operation. A PSA over 4 ng/mL 
normally requires further evaluation with a prostate biopsy or other relevant medical tests 
(cystoscopy, transrectal ultrasound, etc). To maximize the accuracy of the results, patients are 
recommended to avoid ejaculation and physical activity affecting the prostate (e.g. bicycle 
riding) for two days before the test. PSA testing may not help a man with a cancer that has 
already spread to other parts of his body before being detected. Correlations between PSA 
levels and other biochemistry tests may provide better clinical information for the screening, 
diagnosis or staging of prostate cancer. For instance, suggestions have been made that men with 
low testosterone levels might have higher rates of prostate cancer [79], and this would imply a 
negative correlation (PSA-Testosterone). 
Another test that can be carried out for screening purposes is a transrectal ultrasound (TRUS) [b11], 
further explored in section 3.2. DRE and PSA tests are not only important for screening purposes; they 
also help diagnosing prostate cancer. In order to diagnose prostate cancer, a physician should order 
further examinations, explored in section 3.2. 
Screening 
The basic purpose of screening for a given disease is to help separating large groups of healthy 
individuals from groups of individuals who have a high probability of having the disease [b11]. In the 
UK, the National Health Service (NHS) coordinates several national screening programmes but prostate 
cancer is not one of them. The NHS Cancer Screening states several reasons for not implementing a 
programme for prostate cancer [b1]: the natural history of the disease is not well understood; it is hard to 
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recognise at an early stage as even DRE and PSA examinations may throw false positives; it may 
introduce false alarms and anxiety; there is no effective examination to screen for prostate cancer. 
Therefore, instead of having a national screening programme, the NHS introduced information packs for 
general practitioners (GPs) so that they can assist their concerned patients. Even though the natural 
history is not yet well understood, Whitmore [b8] pioneered a study on this subject. He defines natural 
history of prostatic cancer as the ‘evolving clinical and pathologic manifestations of the disease in the 
untreated host’. In 1973, Whitmore concluded that it was ‘morally and ethically impossible’ to ‘obtain 
data regarding the natural history of the disease which might resolve some of the existing questions 
regarding therapy’. ‘Screening for prostate cancer is controversial because it is not clear if the benefits 
of screening outweigh the risks of follow-up diagnostic tests and cancer treatment’ [b2]. ‘Concerned 
middle-aged patients, or in fact most men reaching andropause, should be screened for prostate cancer 
every two to three years’ [b2]. Doctors may decide not to screen for prostate cancer in men older than 
75 years old because of ‘concern that prostate cancer therapy may do more harm than good as age 
progresses and life expectancy decreases’ [b2]. Prostate cancer grows very slowly and in most cases is 
never detected in early stages. Most prostate cancers never grow to the point where they cause 
symptoms, and most men die of other causes than cancer [b2]. According to the counselling leaflet on 
the PSA test published by the NHS Cancer Screening Programmes, for every 1000 men (ages between 
50 and 70) who have had the PSA test, about 100 men have a raised PSA level. Of these 100, about 74 
have a negative result in biopsy. Figure 2.8 illustrates these numbers. 
Raised PSA
~ 100
1000 men
Later Diagnosed with 
Prostate Cancer
~ 7 
Biopsy
Negative Cancer
~ 74
Positive Cancer
~ 26
False Positives
~ 67
Later Diagnosed with 
Prostate Cancer
~ 7
Normal PSA Range
 
Figure 2.8. The PSA Test in 1000 men, from the counselling leaflet by the NHS Cancer Screening 
Programmes. 
Differential diagnosis 
Differential diagnosis can be defined as the diagnosis of a condition whose signs and/or symptoms are 
shared by various other conditions. The most common differential diagnoses for prostate cancer are: 
 Benign prostatic hypertrophy (BPH) 
 Calculi (stones that may form in either kidney or bladder) 
 Prostatic cysts (closed sac, normal or abnormal, that contains liquid or semi-solid substance) 
 Prostatic tuberculosis (rare, contagious bacterial disease of the prostate) 
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 Prostatitis (inflammation of the prostate gland) 
 
Differential diagnoses from radiological findings are [b4]:  
 Paget Disease 
From hypoechoic (darker regions in ultrasound images) area in prostate peripheral zone (PZ) on 
Transrectal ultrasonography: 
 Cancer 
 Prostatitis 
 Prostatic infarct 
 Prostatic intraepithelial neoplasia 
 
From multiple sclerotic lesions (scar tissue) within bone: 
 Developmental: Bone islands, osteopoikilosis, Voorhoeve disease (osteopathia striata), and 
tuberose sclerosis (or tuberous sclerosis) 
 Neoplastic (abnormal tissues): Metastases, lymphoma, osteomata, and myeloma 
 Paget disease 
 Vascular: Bone infarcts 
 
B.1.3 Signs and Symptoms 
The following local symptoms are reported in a great majority of patients with one or more of the 
following:  
 Urinary frequency (especially at night) 
 Weak or interrupted flow of urine 
 Difficulty urinating or holding back urine 
 Inability to urinate 
 Pain or burning when urinating 
 Blood in the urine (hematuria) or semen 
 Painful ejaculation 
 Difficulty having an erection 
 Nagging pain in the lower back, hips, or pelvis 
 
The following symptoms are reported in patients with metastatic prostate cancer:  
 bone pain, with or without pathologic fracture (because prostate cancer 
           when metastatic, has a strong predilection for bone [b9]) 
 lower extremity pain (mainly legs and feet) 
 weight loss and loss of appetite 
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B.1.4 Tests 
DRE and PSA tests are useful as part of the initial investigations for prostate cancer. When these tests 
suggest the disease, further tests need to be carried out: 
 Transrectal ultrasonography (TRUS)  
Ultrasound are released into the rectum to produce a picture of the prostate (these pictures are 
called sonograms). TRUS plays an important role in the early diagnosis of prostate cancer, 
especially when more and more patients have tumours that are not palpable with DRE exams. 
Studies have been carried out and determined that TRUS is also helpful for a guided biopsy of 
the prostate [33].  
 Intravenous pyelogram (IVP)  
A series of X-Rays of the organs of the urinary tract. The radiologist injects a contrast agent 
(isotope) that once taken will travel through the urinary tract. The x-rays capture the flow of the 
contrast agent, determining any obstructions in the urinary tract. This test is performed to detect 
enlarged prostate, kidney tumours, and kidney or bladder stones. 
 Cystoscopy 
This is a procedure where the urologist can look into the urethra and bladder using a thin lighted 
tube. This test is recommended to patients with one of the following conditions: urinary tract 
infections, hematuria (blood in urine), incontinence or over active bladder, enlarged prostate, 
and tumours. 
 Biopsy 
Tissue samples are removed from the prostate to be further analysed by a pathologist. The 
pathologist will search for cancer cells and grade the tumour when cancer is present. This grade 
can suggest how fast the tumour is likely to grow, and appropriate treatment can then be 
recommended. The most common grading method is called the Gleason system, rating the 
tumours in a range from 2 to 10. The Gleason score combines two grades that range from 1 to 5. 
These grades are given from the two most common patterns observed in the biopsy results. A 
Gleason score from 7 to 10 indicates the worst prognosis: fast tumour growth [34]. Furthermore, 
a Gleason score of 7 or a PSA value of 10 ng/mL also puts patients at risk for progressing to 
advanced cancer. 
The following tests can help detecting bone metastases: 
 Bone scan (radionuclide scan)  
Bone scans can help physicians looking for the (metastatic) spread of cancer in bones. A bone 
scan is indicated in patients with prostate cancer who have symptoms suggesting bony 
metastases [b10]. 
Similarly to an IVP, a bone scan requires the injection of a harmless radioactive substance 
(radionuclide) into the blood stream. This substance (contrast agent) collects in bones, 
especially in areas where bones are repairing or fractured. Activity in the bone scan may not be 
observed until 5 years after metastases has occurred. Therefore, bone scans with negative results 
do not prove the absence of metastasis [b10]. Figure 2.9 shows a normal whole body scan on 
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the left. The image on the right shows the spread of prostate cancer to the spine.  
 
 
Figure 2.9. Normal body bone scan (on the left), and abnormal hot spot from prostate 
cancer in the spine (on the right). Intermountain Medical Imaging, Boise, Idaho. 
 
 Computed tomography (CT) or Computed axial tomography (CAT) 
A CAT scan of the abdomen and pelvis in patients suggested to have locally advanced disease 
may give an indication of extracapsular extension (tumour grows outside the prostate capsule), 
seminal vesical involvement, pelvic lymph node enlargement and liver metastases [b10]. A 
CAT scan takes several x-rays from different angles, compiling a final 3D image. The image 
data derived from a CAT scan is particularly useful as it can show different types of tissue: soft 
tissue, bone, and blood vessels. CT scans are unable to detect small bone metastases and 
therefore are not often used to assess metastatic bone disease [b7]. 
 Magnetic Resonance Imaging (MRI)  
MRI uses a large magnet, radio waves, and a computer to produce three-dimensional images of 
internal body structures. In prostate cancer, an MRI is used to examine the prostate and its 
surroundings (including lymph nodes) to differentiate benign and malignant areas. 
 Bone Biopsy 
Similarly to a biopsy of the prostate tissues, a bone biopsy can be carried out to establish a 
diagnosis of bone metastases. 
 Calcium and Alkaline Phosphatase 
Bony metastases can lead to hypercalcemia (elevated calcium in the blood) as they destroy the 
bone, however, calcium levels may be raised for other reasons and a supplementary imaging test 
would still be needed to confirm the diagnosis. Similarly, alkaline phosphatase may be 
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increased due to the presence of metastases in the bone, however, this enzyme is produced in 
the liver and it may also indicate liver conditions. 
 
B.1.5 Staging and Planning Treatment 
The most commonly used staging method is the international tumour, node, metastasis (TNM) staging 
system. When interpreting the stages, it is important to appreciate that prostate cancer may not 
progress in a sequential manner. In the primary tumour (T) stage, the numbers indicate the size of the 
tumour. 
The TNM system has the following stages: 
Primary Tumour (T) 
TX Primary tumour cannot be assessed 
T0 No evidence of primary tumour 
T1 Not palpable or visible by imaging 
T1a Tumour incidental (irrelevant) histologic (microscopic) finding in 5% or 
less of tissue resected (in prostatectomy)  
T1b Tumour incidental histologic finding in more than 5% of tissue resected 
T1c Tumour identified by needle biopsy (that was carried out due to elevated 
PSA) 
Common treatment: Prostatectomy or radiation therapy may be chosen. Hormonal 
therapy may also be used before, during, or after prostatectomy or radiation. In 
some cases, the physician may decide to wait and monitor mild symptoms 
(watchful waiting). 
 
 
T2 Confined within prostate 
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T2a Tumour involves one-half of 1 lobe or less 
T2b Tumour involves more than one-half of 1 lobe but not both lobes 
T2c Tumour involves both lobes 
Common treatment: Prostatectomy and radiation therapy. Hormonal therapy may 
be used before, during, or after prostatectomy or radiation. 
T3 Through prostatic capsule 
T3a Extracapsular extension (unilateral or bilateral) 
T3b Tumour invades seminal vesicle(s) 
Common treatment: Prostatectomy, radiation therapy, or both. Hormonal therapy 
may be used before, during, or after prostatectomy or radiation. 
T4 Tumour is fixed or invades adjacent structures other than seminal vesicles: bladder 
neck, external sphincter, rectum, levator muscles, and/or pelvic wall 
Common treatment: Same as in T3. However, prostatectomy is less frequent. 
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Metastases (M) 
MX Distant metastasis cannot be assessed (not evaluated by any modality) 
M0 No distant metastasis 
M1 Distant metastasis 
M1a Non-regional lymph node(s) 
M1b Spread to Bone(s) 
M1c Other site(s) with or without bone disease 
Common treatment: Hormonal therapy is generally used. Chemotherapy may be used later if 
hormonal therapy is no longer working. 
 
 
Lymph node involvement (N) 
NX Regional lymph nodes not assessed 
N0 No regional lymph node metastasis (lymph nodes confined to the true pelvis)  
N1 Metastasis in regional lymph node(s) 
Common treatment: Hormonal therapy is generally used. Prostatectomy or radiation may be used 
with hormonal therapy. Chemotherapy may be used later if hormonal therapy is no longer working. 
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The following excerpt from Dan Theodorescu et al. [b9] seems important as it states the current natural 
history of the prostate cancer. 
‘The natural history is still relatively unknown, and many aspects of progression are poorly 
understood. Symptoms or abnormal DRE findings in the pre-PSA era only brought 40-50% of 
patients with prostate cancer to medical attention, and these patients usually had locally 
advanced disease. The advent of PSA testing has helped identify patients with less-advanced, 
organ-confined disease.  
Evidence suggests that most prostate cancers are multifocal and heterogeneous. Cancers can 
start in the transitional zone or, more commonly, the peripheral zone. When these cancers are 
locally invasive, the transitional zone tumours spread to the bladder neck, while the 
peripheral zone tumours extend into the ejaculatory ducts and seminal vesicles. Penetration 
through the prostatic capsule and along the perineural or vascular spaces is a relatively late 
event.  
The mechanism for distant metastasis is poorly understood. The cancer spreads to bone early, 
occasionally without significant lymphadenopathy [b9]. 
B.1.6 Treatment Options 
The common treatments for each tumour stage are stated above, in section 4. However, it is important to 
understand them in more detail. Treatment options that may be used alone or in combinations are:  
 Orchidectomy 
 
The removal of both testicles to reduce the amount of testosterone produced.  
 Prostatectomy 
 
The surgical removal of the prostate, along with the tumour. If the tumour has not spread 
outside of the prostate surgery may be the best option to treat the disease [b37].  
 Hormone treatments (androgen ablation or withdrawal)  
A female hormone (estrogen) may be prescribed to help treat prostate cancer. The British 
National Formulary (BNF 45) states that ‘metastatic cancer of the prostate usually responds to 
hormonal treatment aimed at androgen depletion’ [b35]. The BNF 45 also states that 
occasionally patients respond to other hormone manipulation such as anti-androgen 
(cyproterone acetate, flutamide, bicalutamide). The BNF 45 also states that gonadorelin 
analogues are as effective as orchidectomy. However, they have a large list of side effects, 
including: sexual dysfunction, sweating, rashes, headaches, visual disturbances, dizziness, hair 
loss, gastro-intestinal disturbances, weight changes, sleep disorders, and mood changes amongst 
others. 
 Chemotherapy  
 
This type of therapy can be defined as ‘the prevention or treatment of a disease by the use of 
chemical substances’. Essentially, chemotherapy is the use of drugs to kill or reduce the growth 
of cancer cells. The drugs used are typically antimetabolites [b35] that prevent cells from 
growing. 
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 Radiotherapy (therapeutic radiology) 
This involves the exposure of the cancerous area of the metastasized bone to radiation (gamma-
rays). This technique may shrink the tumour or destroy some of the cancer cells. It often 
decreases pain associated with the spread to the bone [36]. Many forms of cancer are destroyed 
using this method. 
 Surveillance (watchful waiting or active monitoring)  
Instead of active treatment, the physician will monitor the patient’s condition by performing 
regular tests such as PSA, DRE, complete blood count (CBC) to look for signs of blood in urine 
(anemia), and general signs that may indicate a progression or regression of the disease. This 
process may be recommended in early stages of the disease or whenever the patient is not 
expected to tolerate other treatments. 
 Brachytherapy 
 
This procedure follows the same reasoning as general radiation therapy where ionising radiation 
is used to kill prostate cancer cells. However, this specific method involves the insertion of 
radioactive seeds (implants) into the prostate. The long term outcomes and effectiveness of this 
treatment are not yet known [b3]. 
 Cryosurgery 
 
Not as effective as surgery or radiation [b5], this method uses liquid nitrogen to freeze and kill 
cells in the prostate. ‘However, cryosurgery is potentially better than radical prostatectomy for 
recurrent cancer following radiation therapy. Cryosurgery is reserved for localized cancer 
within the prostate and in cases where conventional therapies like surgery or radiation could not 
be applied. Advantages of cryosurgery over general surgery include less blood loss, less pain 
and shorter recovery time’ [b2]. 
 Bone surgery 
This type of surgery is aimed at stabilizing or fixing the bone, generally prior to radiotherapy 
[b7].  
 Palliation 
Palliative care and support consists of reducing the severity of the symptoms, improving quality 
of life. This method does not cure the disease but it may be used in conjunction with curative 
therapies [b6].  
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B.1.7 Treatment of Metastatic Prostate Cancer  
Metastatic prostate cancer is the most advanced 
stage of prostate cancer. The most common site 
for the cancer cells to spread is the bone, 
eventually leading to fractures. Prostate cancer 
may also spread to the lymph nodes [b7]. The 
bones that are most frequently involved are 
those of the ‘pelvic girdle, lumbar spine, upper 
femurs, dorsal spine, and ribs’ [b10]. Metastases 
in spinal regions may lead to spinal cord 
compression (the spine is compressed by 
fragments originating from a tumour) and 
eventually paraplegia. According to the British 
Association of Urological Surgeons (BAUS) 
when patients reach this stage they should 
receive ‘ongoing help and support’, and further 
diagnostic tests may be recommended to assess 
the spread of the cancer. Because prostate cancer 
commonly spreads to the bone, imaging 
techniques that target the bones are often used 
(X-rays, radionuclide bone scanning, MRI). 
Hormonal therapy (androgen ablation) is the 
standard treatment for metastatic prostate cancer. This type of treatment may control prostate cancer 
for many years. If the cancer stops responding to this treatment it becomes hormone resistant (hormone 
escape) and only palliative care can help sustaining quality of life. Figure 2.10 shows some results of 
an interesting study on the effects of hormonal ablation on prostate cancer [b9]. This study shows that 
hormonal ablation caused a decrease in size of the tumour. Apart from painkillers and hormone 
ablation, there are three other important (palliative) treatments for metastatic bone disease (especially 
used on hormone escape) [b7]: 
 Bisphosponates 
This type of treatment therapy aims at preventing skeletal complications such as fractures and 
hypercalcaemia (high levels of calcium in the blood). Bisphosponates work by reducing the 
breakdown of bone caused by the cancer. Zoledronic acid is currently the only bisphosponate 
licensed in the UK that has proven effective [b7]. This treatment therapy can help sustaining 
quality of life. It is administered via a 15 minute intravenous infusion (injection into a vein) 
once every 28 days [b7]. Side effects may occur and are similar flu symptoms. Specialists may 
recommend this therapy prior the occurrence of any symptoms of metastatic bone disease. 
 Radiotherapy 
Local radiotherapy can be recommended as palliative care to alleviate bone pain. There are 
two ways of administering radiotherapy: by using an X-ray machine on the painful area; or by 
injecting radionuclides (e.g. strontium-89) into the veins. In the latter process the injected 
radionuclide will find its way to the bones where it releases radiation directly onto the cancer 
cells [b7]. 
 
 
 
 
Figure 2.10. Volume of prostate gland before and after 
hormonal ablation [51]. Reduction was seen in nine of 
10 patients. In case number two, hormone escape may 
justify the invariability.    
 Post-treatment 
 Pre-treatment 
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 Surgery (orthopaedic interventions)  
Prior to radiotherapy, orthopaedic interventions may be recommended to stabilise or fix a bone 
fracture. Patients can be mobile as soon as one day after an operation [b7]. This method may 
not be considered palliation in the sense that it fixes or stabilises fractures, but at the same time 
it only alleviates the symptoms of metastatic cancer bone disease, it does not cure this disease.  
 
The BAUS guidelines for the management of metastatic prostate cancer reveal a flow diagram 
illustrating the recommended approach to managing this disease (Figure 2.11). 
 
Hormone resistant 
metastatic bone disease
Bisphosphonate 
(Zoledronic)
No symptoms Symptoms
Monitoring Palliation Surgery
Painkillers Radiotherapy
External beam 
radiotherapy
Radionuclides
(strontium-89)  
 
 
Figure 2.11. BAUS recommendations for managing hormone resistant metastatic bone disease [b7]. 
 
 
B.1.8      Conclusion 
Prostate cancer is one of the very few types of cancer that may grow so slowly that it never produces 
any symptoms. Unfortunately in some other cases the tumour grows, metastases may spread, and 
spinal fractures may occur possibly leading to paraplegia. Androgen ablation delays the progression of 
this disease, but hormone resistance can soon develop in which case only palliative care can sustain 
quality of life.  
There are many treatment options and diagnostic tests. Some may be poor to effectively assess cancer 
spread, some may stop the growth of the tumour for many years, and some may produce unpleasant 
side effects. Specialists have many choices in their hands but lack key knowledge (such as the natural 
history) for decision making. The use of information and knowledge present in today’s electronic 
archives of imaging modalities, histological data, and patient record datasets may boost the 
understanding of this disease. 
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Scientists are researching other ways of detecting prostate cancer in early stages by using chemical 
methods and chemical information. Treatment approaches are also being perfected and new 
approaches such as cryosurgery may introduce more efficient and last longing control over the disease.  
In Chapter 5, correlation hypotheses are briefly investigated, but they merely indicate ways in which to 
use the prostate cancer data collected from multiple hospital sources. This is the case of life expectancy 
and the most common treatment types, PSA and testosterone (as mentioned before, there is a 
hypothesis that high grade prostate cancer and hence PSA correlate well with low levels of 
testosterone), and a study on the numbers of prostate cancers metastasising to bone. 
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Appendix C - Additional Data on
Pathways and Mining
1.4 System-level Paths
This section shows additional details on the system paths including the full list
of the sequential pairs, the results of the Apriori, PrefixSpan and CMRules al-
gorithms, and a detailed list of average times between systems. This section
also shows the results and interpretation of the application of process mining
techniques to the system paths.
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System Paths: Supplementary Information 
 
Detailed List of Sequential Pairs 
 
The first table shows (in two parts) the complete list of all possible interactions between the systems (permutations of any two systems 
in the path sequence); it gives the number of paths where the sequence occurs, the overall frequency across all paths, and the ratio 
(overall:paths). The second table (far right) shows the first 32 (from a total of 42) most common sequence pairs at the start of a path. 
 
Sequence Paths Overall Ratio  Sequence 
(cont.) 
Paths Overall Ratio  Start Seq. Paths 
LAB;LAB 3508 24246 6.9  ONC;PAS 55 55 1.0  LAB, LAB 1743 
LAB;HIS 2103 2134 1.0  RAD;IMG 42 44 1.0  LAB, HIS 1111 
HIS;LAB 2031 2136 1.1  IMG;ONC 39 39 1.0  LAB, PAS 201 
RAD;LAB 1032 1194 1.2  PAS;ONC 38 38 1.0  HIS, LAB 153 
LAB;PAS 983 2005 2.0  ONC;IMG 33 33 1.0  ONC, RAD 138 
PAS;LAB 809 1655 2.0  IMG;OPT 33 33 1.0  LAB, ONC 116 
PAS;HIS 692 727 1.1  IMG;IMG 28 35 1.3  LAB, OPT 116 
LAB;RAD 680 820 1.2  ONC;OPT 26 26 1.0  ONC, LAB 101 
OPT;HIS 632 658 1.0  LAB;ORT 19 19 1.0  PAS, LAB 93 
OPT;PAS 625 664 1.1  OPT;OPT 17 20 1.2  HIS, RAD 90 
ONC;LAB 580 587 1.0  ORT;LAB 10 10 1.0  OPT, PAS 71 
LAB;ONC 549 553 1.0  RAD;ONC 9 9 1.0  PAS, OPT 71 
LAB;OPT 504 571 1.1  IMG;HIS 8 8 1.0  HIS, ONC 66 
PAS;OPT 496 520 1.0  RAD;HIS 7 7 1.0  HIS, OPT 52 
ONC;RAD 484 484 1.0  OPT;ONC 7 7 1.0  OPT, HIS 48 
HIS;ONC 437 438 1.0  IMG;ORT 4 5 1.3  PAS, HIS 37 
HIS;OPT 404 409 1.0  ONC;ONC 4 4 1.0  HIS, PAS 37 
LAB;IMG 350 394 1.1  RAD;OPT 3 3 1.0  HIS, HIS 30 
IMG;LAB 344 382 1.1  OPT;RAD 3 3 1.0  OPT, LAB 24 
OPT;LAB 324 346 1.1  RAD;ORT 3 3 1.0  ONC, HIS 21 
HIS;PAS 291 306 1.1  PAS;ORT 2 2 1.0  HIS, IMG 17 
PAS;PAS 241 501 2.1  ORT;RAD 2 2 1.0  PAS, PAS 13 
HIS;RAD 237 237 1.0  OPT;IMG 1 1 1.0  LAB, IMG 11 
HIS;IMG 207 207 1.0  ORT;PAS 1 1 1.0  PAS, RAD 10 
PAS;RAD 151 181 1.2  ORT;IMG 1 1 1.0  RAD, PAS 8 
RAD;PAS 143 163 1.1  HIS;ORT 0 0 -  LAB, RAD 8 
IMG;RAD 105 113 1.1  ORT;HIS 0 0 -  ONC, PAS 7 
ONC;HIS 104 104 1.0  ONC;ORT 0 0 -  PAS, ONC 7 
RAD;RAD 91 117 1.3  OPT;ORT 0 0 -  ONC, OPT 5 
PAS;IMG 81 88 1.1  ORT;ONC 0 0 -  IMG, LAB 4 
HIS;HIS 75 77 1.0  ORT;OPT 0 0 -  RAD, RAD 4 
IMG;PAS 60 63 1.1  ORT;ORT 0 0 -  IMG, ONC 4 
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Results of Apriori Algorithm for Mining Frequently Closed Association Rules in System Paths 
The table shows the top 108 association rules with respective Support and Confidence.  
 
Rule Supp. Conf.   Rule (cont.) Supp. Conf.   Rule (cont.) Supp. Conf.  
PAS, IMG, HIS → 
LAB 
203 99.51%  
PAS, LAB, OPT, 
IMG → HIS 
138 95.17%  
ONC, OPT → LAB, 
HIS 
246 89.13% 
OPT, IMG → LAB 166 99.40%  PAS, RAD → LAB 590 95.16%  
RAD, OPT, HIS → 
PAS 
261 89.08% 
OPT, IMG, HIS → 
LAB 
159 99.38%  
PAS, OPT, IMG → 
LAB, HIS 
138 94.52%  RAD, HIS → LAB 914 88.57% 
PAS, OPT, IMG → 
LAB 
145 99.32%  LAB, OPT → HIS 1291 94.30%  
PAS, RAD, OPT → 
LAB, HIS 
250 88.34% 
PAS, OPT, IMG, HIS 
→ LAB 
138 99.28%  OPT → HIS 1394 94.25%  
RAD, OPT → LAB, 
HIS 
280 88.33% 
PAS, RAD, IMG → 
LAB 
186 98.41%  
RAD, ONC, HIS → 
LAB 
482 94.14%  
ONC, OPT, HIS → 
PAS 
226 88.28% 
PAS, IMG → LAB 341 97.99%  PAS → LAB 1869 93.87%  
LAB, ONC, OPT, 
HIS → PAS 
216 87.80% 
PAS, RAD, ONC → 
LAB 
328 97.91%  
PAS, LAB, OPT → 
HIS 
1073 93.55%  ONC, OPT → PAS 242 87.68% 
PAS, RAD, ONC, 
HIS → LAB 
186 97.89%  
PAS, LAB, ONC, 
OPT → HIS 
216 93.51%  OPT, IMG → PAS 146 87.43% 
RAD, ONC, IMG → 
LAB 
171 97.71%  ONC, HIS → LAB 762 93.50%  
LAB, OPT, IMG → 
PAS 
145 87.35% 
RAD, IMG, HIS → 
LAB 
238 97.54%  PAS, OPT → HIS 1162 93.48%  
RAD, ONC, OPT 
→ LAB, HIS 
145 87.35% 
IMG, HIS → LAB 485 97.39%  PAS, HIS → LAB 1291 93.42%  OPT → LAB, HIS 1291 87.29% 
RAD, ONC, IMG, HIS 
→ LAB 
111 97.37%  
PAS, ONC, OPT → 
HIS 
226 93.39%  
PAS, RAD, ONC, 
OPT → LAB, HIS 
130 87.25% 
RAD, ONC, OPT, 
HIS → LAB 
145 97.32%  HIS → LAB 3235 92.91%  
RAD, ONC, OPT, 
HIS → PAS, LAB 
130 87.25% 
RAD, IMG → LAB 345 97.18%  
LAB, ONC, OPT → 
HIS 
246 92.83%  
LAB, ONC, OPT → 
PAS 
231 87.17% 
ONC, IMG → LAB 232 97.07%  ONC, OPT → HIS 256 92.75%  
OPT, IMG, HIS → 
PAS 
139 86.88% 
IMG → LAB 650 97.01%  OPT, HIS → LAB 1291 92.61%  
OPT, IMG → PAS, 
LAB 
145 86.83% 
PAS, RAD, ONC, 
OPT, HIS → LAB 
130 97.01%  OPT → LAB 1369 92.56%  
LAB, OPT, IMG, 
HIS → PAS 
138 86.79% 
RAD, ONC, OPT → 
LAB 
161 96.99%  RAD, OPT → HIS 293 92.43%  
RAD, ONC, OPT 
→ PAS, LAB 
144 86.75% 
PAS, ONC → LAB 466 96.88%  
LAB, RAD, OPT → 
HIS 
280 92.41%  ONC → LAB 1166 86.63% 
PAS, RAD, HIS → 
LAB 
347 96.66%  
PAS, OPT, HIS → 
LAB 
1073 92.34%  
PAS, OPT → LAB, 
HIS 
1073 86.32% 
PAS, RAD, ONC, 
OPT → LAB 
144 96.64%  PAS, OPT → LAB 1147 92.28%  
OPT, IMG, HIS → 
PAS, LAB 
138 86.25% 
PAS, ONC, HIS → 
LAB 
286 96.62%  
PAS, LAB, RAD, 
OPT → HIS 
250 92.25%  
RAD, OPT → PAS, 
LAB 
271 85.49% 
ONC, IMG, HIS → 
LAB 
155 96.27%  
PAS, RAD, OPT → 
HIS 
261 92.23%  
RAD, OPT, HIS → 
PAS, LAB 
250 85.32% 
ONC, OPT, HIS → 
LAB 
246 96.09%  
PAS, LAB, RAD, 
ONC, OPT → HIS 
130 90.28%  
ONC, OPT, HIS → 
PAS, LAB 
216 84.38% 
ONC, OPT → LAB 265 96.01%  
LAB, RAD, ONC, 
OPT → HIS 
145 90.06%  PAS, HIS → OPT 1162 84.08% 
OPT, IMG → HIS 160 95.81%  
RAD, ONC, OPT, 
HIS → PAS 
134 89.93%  OPT → PAS 1243 84.04% 
PAS, RAD, OPT, HIS 
→ LAB 
250 95.79%  
PAS, RAD, ONC, 
OPT → HIS 
134 89.93%  LAB, OPT → PAS 1147 83.78% 
LAB, OPT, IMG → 
HIS 
159 95.78%  
RAD, ONC, OPT → 
PAS 
149 89.76%  
ONC, OPT → 
PAS, LAB 
231 83.70% 
PAS, RAD, OPT → 
LAB 
271 95.76%  
RAD, ONC, OPT → 
HIS 
149 89.76%  OPT, HIS → PAS 1162 83.36% 
RAD, OPT → LAB 303 95.58%  
LAB, RAD, ONC, 
OPT, HIS → PAS 
130 89.66%  
OPT, IMG → PAS, 
HIS 
139 83.23% 
PAS, ONC, OPT, HIS 
→ LAB 
216 95.58%  
LAB, RAD, ONC, 
OPT → PAS 
144 89.44%  RAD → LAB 1275 83.17% 
RAD, OPT, HIS → 
LAB 
280 95.56%  
LAB, RAD, OPT → 
PAS 
271 89.44%  
LAB, OPT, IMG → 
PAS, HIS 
138 83.13% 
PAS, ONC, OPT → 
LAB 
231 95.45%  
LAB, RAD, OPT, HIS 
→ PAS 
250 89.29%  
PAS, LAB, HIS → 
OPT 
1073 83.11% 
OPT, IMG → LAB, 
HIS 
159 95.21%  RAD, OPT → PAS 283 89.27%  
LAB, OPT, HIS → 
PAS 
1073 83.11% 
PAS, OPT, IMG → 
HIS 
139 95.21%  
PAS, ONC, OPT → 
LAB, HIS 
216 89.26%  RAD, ONC → LAB 742 82.72% 
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Results of PrefixSpan for Mining Frequently Closed Sequential Patterns in System Paths 
The table shows the top 72 sequential patterns with itemset length (L) > 2 and the number of unique systems (S), ordered by support.  
 
Sequence Supp. L S  Sequence (cont.) Supp. L S 
‹LAB, LAB, LAB› 3390 3 1  ‹PAS, LAB, LAB, LAB› 929 4 2 
‹LAB, LAB, LAB, LAB› 3068 4 1  ‹LAB, OPT, LAB› 929 3 2 
‹LAB, LAB, LAB, LAB, LAB› 2769 5 1  ‹RAD, LAB, LAB› 914 3 2 
‹HIS, LAB, LAB› 2545 3 2  ‹LAB, LAB, LAB, HIS› 907 4 2 
‹LAB, HIS, LAB› 2485 3 2  ‹LAB, PAS, LAB, LAB› 891 4 2 
‹LAB, LAB, LAB, LAB, LAB, LAB› 2483 6 1  
‹LAB, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB› 
890 13 1 
‹HIS, LAB, LAB, LAB› 2232 4 2  
‹LAB, HIS, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB, LAB› 
880 10 2 
‹LAB, HIS, LAB, LAB› 2209 4 2  ‹LAB, OPT, HIS› 874 3 3 
‹LAB, LAB, LAB, LAB, LAB, LAB, LAB› 2204 7 1  
‹LAB, LAB, HIS, LAB, LAB, LAB, 
LAB› 
869 7 2 
‹HIS, LAB, LAB, LAB, LAB› 1966 5 2  ‹LAB, RAD, LAB, LAB› 868 4 2 
‹LAB, HIS, LAB, LAB, LAB› 1956 5 2  
‹HIS, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB, LAB› 
861 10 2 
‹LAB, LAB, LAB, LAB, LAB, LAB, LAB, 
LAB› 
1948 8 1  ‹ONC, LAB, LAB› 840 3 2 
‹LAB, HIS, LAB, LAB, LAB, LAB› 1717 6 2  ‹PAS, LAB, LAB, LAB, LAB› 822 5 2 
‹HIS, LAB, LAB, LAB, LAB, LAB› 1690 6 2  ‹OPT, LAB, LAB, LAB› 816 4 2 
‹LAB, LAB, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB› 
1683 9 1  ‹LAB, LAB, RAD, LAB› 811 4 2 
‹LAB, LAB, HIS› 1498 3 2  ‹LAB, OPT, LAB, LAB› 810 4 2 
‹LAB, HIS, LAB, LAB, LAB, LAB, LAB› 1464 7 2  ‹OPT, HIS, LAB, LAB› 808 4 3 
‹LAB, LAB, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB› 
1459 10 1  ‹HIS, RAD, LAB› 805 3 3 
‹HIS, LAB, LAB, LAB, LAB, LAB, LAB› 1443 7 2  ‹LAB, LAB, OPT› 805 3 2 
‹LAB, LAB, HIS, LAB› 1304 4 2  ‹LAB, LAB, PAS, LAB› 789 4 2 
‹LAB, HIS, LAB, LAB, LAB, LAB, LAB, 
LAB› 
1245 8 2  ‹LAB, LAB, LAB, HIS, LAB› 784 5 2 
‹LAB, LAB, PAS› 1238 3 2  ‹LAB, PAS, LAB, LAB, LAB› 784 5 2 
‹HIS, LAB, LAB, LAB, LAB, LAB, LAB, 
LAB› 
1236 8 2  ‹LAB, OPT, HIS, LAB› 784 4 3 
‹LAB, LAB, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB, LAB› 
1232 11 1  ‹LAB, HIS, RAD› 782 3 3 
‹LAB, LAB, HIS, LAB, LAB› 1140 5 2  ‹LAB, LAB, LAB, LAB, PAS› 780 5 2 
‹PAS, LAB, LAB› 1074 3 2  ‹RAD, LAB, LAB, LAB› 780 4 2 
‹LAB, HIS, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB› 
1064 9 2  ‹LAB, ONC, LAB› 765 3 2 
‹LAB, LAB, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB, LAB, LAB› 
1048 12 1  ‹LAB, LAB, LAB, RAD› 762 4 2 
‹LAB, PAS, LAB› 1045 3 2  ‹ONC, LAB, LAB, LAB› 749 4 2 
‹HIS, LAB, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB› 
1037 9 2  ‹LAB, RAD, LAB, LAB, LAB› 746 5 2 
‹LAB, RAD, LAB› 1020 3 2  
‹LAB, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB› 
735 14 1 
‹LAB, LAB, HIS, LAB, LAB, LAB› 999 6 2  
‹LAB, LAB, HIS, LAB, LAB, LAB, 
LAB, LAB› 
733 8 2 
‹LAB, LAB, LAB, PAS› 978 4 2  
‹LAB, HIS, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB, LAB, LAB› 
731 11 2 
‹OPT, LAB, LAB› 955 3 2  
‹PAS, LAB, LAB, LAB, LAB, 
LAB› 
718 6 2 
‹LAB, LAB, RAD› 951 3 2  ‹LAB, HIS, PAS› 718 3 3 
‹OPT, HIS, LAB› 935 3 3  
‹HIS, LAB, LAB, LAB, LAB, LAB, 
LAB, LAB, LAB, LAB, LAB› 
715 11 2 
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Results of CMRules Algorithm for Mining Sequential Patterns in System Paths 
The table shows all 67 sequential patterns (minsup = 10%, confidence = 10%) and it is ordered by confidence.  
 
Rule Supp. Conf.   Rule (cont.) Supp. Conf. 
{RAD,HIS}  → {LAB} 702 96.34%  {PAS}  → {LAB,OPT,HIS} 590 53.87% 
{RAD,ONC}  → {LAB} 569 95.58%  {ONC}  → {RAD} 668 53.05% 
{PAS,HIS}  → {LAB} 1059 94.15%  {ONC}  → {LAB,RAD} 592 50.70% 
{RAD}  → {LAB} 959 94.13%  {LAB}  → {PAS} 1523 43.96% 
{ONC,HIS}  → {LAB} 596 93.89%  {LAB,HIS}  → {OPT} 599 40.93% 
{OPT,HIS}  → {LAB} 1058 93.58%  {LAB,HIS}  → {PAS} 754 40.87% 
{PAS,OPT,HIS}  → {LAB} 895 93.55%  {HIS}  → {OPT} 725 40.17% 
{HIS}  → {LAB} 2598 91.83%  {HIS}  → {PAS} 858 39.86% 
{PAS}  → {LAB} 1464 91.83%  {HIS}  → {LAB,OPT} 615 37.59% 
{PAS,LAB,OPT}  → {HIS} 688 91.77%  {HIS}  → {PAS,LAB} 750 37.53% 
{LAB,OPT}  → {HIS} 831 91.39%  {LAB,HIS}  → {PAS,OPT} 507 34.34% 
{PAS,OPT}  → {LAB} 950 91.03%  {HIS}  → {PAS,OPT} 600 33.71% 
{OPT}  → {LAB} 1139 90.75%  {LAB}  → {OPT} 1142 33.65% 
{PAS,OPT}  → {HIS} 799 89.30%  {HIS}  → {PAS,LAB,OPT} 509 31.53% 
{OPT}  → {HIS} 981 88.62%  {LAB}  → {OPT,HIS} 1029 30.75% 
{ONC}  → {LAB} 921 84.98%  {LAB}  → {PAS,HIS} 1040 30.70% 
{OPT,HIS}  → {PAS} 515 83.91%  {LAB}  → {RAD} 1080 28.54% 
{LAB,OPT,HIS}  → {PAS} 447 83.88%  {LAB}  → {PAS,OPT} 958 28.11% 
{PAS,OPT}  → {LAB,HIS} 688 83.54%  {LAB,HIS}  → {RAD} 784 27.60% 
{LAB,OPT}  → {PAS} 634 83.53%  {LAB}  → {ONC} 915 27.60% 
{OPT}  → {PAS} 768 83.28%  {HIS}  → {RAD} 839 26.31% 
{OPT}  → {LAB,HIS} 848 82.93%  {LAB}  → {PAS,OPT,HIS} 873 25.79% 
{LAB,OPT}  → {PAS,HIS} 475 76.66%  {HIS}  → {LAB,RAD} 769 25.35% 
{OPT}  → {PAS,LAB} 572 75.81%  {LAB,HIS}  → {ONC} 545 23.41% 
{LAB}  → {HIS} 2621 75.12%  {HIS}  → {ONC} 622 22.90% 
{OPT}  → {PAS,HIS} 542 74.37%  {HIS}  → {LAB,ONC} 549 21.50% 
{PAS,LAB}  → {HIS} 828 69.83%  {LAB}  → {RAD,HIS} 722 20.74% 
{OPT}  → {PAS,LAB,HIS} 455 69.57%  {LAB}  → {ONC,HIS} 596 17.59% 
{PAS}  → {HIS} 989 68.10%  {LAB}  → {RAD,ONC} 568 16.47% 
{PAS}  → {OPT} 721 64.49%  {LAB}  → {IMG} 537 14.03% 
{PAS}  → {LAB,HIS} 872 64.12%  {LAB}  → {PAS,RAD} 450 12.78% 
{PAS,LAB}  → {OPT} 584 63.93%     
{LAB,ONC}  → {RAD} 614 59.67%     
{PAS}  → {LAB,OPT} 657 58.70%     
{PAS,LAB}  → {OPT,HIS} 518 58.67%     
{PAS}  → {OPT,HIS} 629 57.59%     
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Detailed List of Average Times Between Systems 
 
This table shows (in two parts) the complete list of all possible interactions between two systems and the computed average time 
between them in days, the standard deviation, support, and 90th percentile. 
 
Sequence Time (avg.) St. Dev. Support  
90th 
%ile  
Sequence 
(cont.) 
Time (avg.) St. Dev. Support 
90th 
%ile 
PAS;HIS 1.7 1.9 727 3  LAB;HIS 64.1 95.5 2134 104 
ORT;IMG 3 0 1 3  LAB;IMG 64.3 107.5 394 153.4 
PAS;OPT 5.5 22 520 2.1  IMG;OPT 67.9 34.2 33 102.2 
OPT;PAS 6 52.6 664 0  IMG;LAB 68 73.1 382 157.6 
OPT;HIS 6.7 62.8 658 3  IMG;RAD 71.6 69.8 113 160 
PAS;IMG 11 18.1 88 22.8  HIS;PAS 71.7 72.3 306 139 
PAS;ORT 12 9 2 19.2  ORT;LAB 72.4 76.8 10 180.1 
ORT;RAD 20 6 2 24.8  OPT;ONC 77.7 33.2 7 121 
ONC;OPT 20.2 60.4 26 54.5  ONC;LAB 79.8 182.2 587 179 
IMG;IMG 20.4 26.6 35 61  RAD;LAB 82 95.1 1194 163.7 
ORT;PAS 22 0 1 22  RAD;ORT 101.7 131.9 3 233.6 
ONC;HIS 24.2 83.2 104 63  ONC;RAD 105.2 199.5 484 160 
PAS;PAS 26 28.6 501 50  RAD;RAD 111 201.6 117 228.2 
OPT;IMG 29 0 1 29  RAD;IMG 112.8 263.1 44 296.9 
PAS;RAD 31.4 74.9 181 91  LAB;OPT 117.5 180.3 571 252 
RAD;ONC 31.4 45.5 9 86.6  HIS;LAB 119.7 138.8 2136 210 
IMG;PAS 32.9 43.6 63 71.8  HIS;HIS 154.8 275.5 77 414.2 
ONC;PAS 33.4 46 55 71.6  LAB;LAB 167.3 173.7 24246 295 
HIS;IMG 35.5 57.7 207 48  OPT;LAB 181.1 318.1 346 281 
HIS;OPT 35.7 112.5 409 99.2  HIS;RAD 209.4 173.1 237 288.6 
PAS;LAB 36.9 69.5 1655 91  LAB;ORT 214.3 306.1 19 289.2 
IMG;ONC 39.1 33 39 71.6  IMG;ORT 247.8 280.7 5 555 
RAD;PAS 41.4 51.8 163 96.6  OPT;OPT 384.1 566.3 20 1331 
ONC;IMG 44.8 103.3 33 61.2  RAD;OPT 780 577.6 3 1362 
IMG;HIS 48.6 34.9 8 88  RAD;HIS 819.6 971 7 2255 
PAS;ONC 49 154.7 38 68.2  HIS;ORT - - 0 - 
LAB;PAS 51 125.2 2005 130  ORT;HIS - - 0 - 
HIS;ONC 54.6 71.3 438 111  ONC;ORT - - 0 - 
ONC;ONC 56.3 25.1 4 84.6  OPT;ORT - - 0 - 
LAB;ONC 58.2 98.1 553 111  ORT;ONC - - 0 - 
LAB;RAD 62 110.6 820 134  ORT;OPT - - 0 - 
OPT;RAD 63.7 52.5 3 117  ORT;ORT - - 0 - 
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Process Models built for the System Paths with the HeuristicsMiner Algorithm 
 
Pre-processing  
 
The ProM 5.2 framework was used with the algorithm's default input parameters. The System Paths Dataset was 
converted from comma separated values format to the required MXML format by ProM 5.2 using the Prom Import 
Framework software. By default a start and a complete audit trail entries are added but in the case of the System Paths 
Dataset they would contain the same information. Filters were applied so that only start event types are present. An 
excerpt of the final MXML format is given below, where process instances refer to a given patient path and audit trail 
entries encode the footprints (tasks) and respective timestamp. The excerpt shows a full path, ‹HIS, OPT, HIS, RAD›. 
 
  
<Process id="UnifiedSystemPaths" description="Unified single process"> 
 <ProcessInstance id="123456"> 
  <AuditTrailEntry> 
   <WorkflowModelElement>HIS</WorkflowModelElement> 
   <EventType>start</EventType> 
   <Timestamp>2001-01-01T09:00:00.000+00:00</Timestamp> 
  </AuditTrailEntry> 
  <AuditTrailEntry> 
   <WorkflowModelElement>OPT</WorkflowModelElement> 
   <EventType>start</EventType> 
   <Timestamp>2001-04-01T09:00:00.000+00:00</Timestamp> 
  </AuditTrailEntry> 
  <AuditTrailEntry> 
   <WorkflowModelElement>HIS</WorkflowModelElement> 
   <EventType>start</EventType> 
   <Timestamp>2001-04-02T09:00:00.000+00:00</Timestamp> 
  </AuditTrailEntry> 
  <AuditTrailEntry> 
   <WorkflowModelElement>RAD</WorkflowModelElement> 
   <EventType>start</EventType> 
   <Timestamp>2001-07-16T09:00:00.000+00:00</Timestamp> 
  </AuditTrailEntry> 
 </ProcessInstance> 
 ... 
 
 
 
Process Models: Datasets 
 
The System Paths Dataset was split into two datasets. A training set (I) containing 2212 paths and a test set (II) with 
2225 paths. The purpose of this is to verify whether the models generated using the training set still hold true with data 
from the test set, in which case the models can be considered representative of the underlying processes. 
Furthermore, for each dataset, several experiments were carried out, each resulting in a different process model. 
The experiments included here are: 
 
A. Default input parameters and data were used. 
B. Adjusted input parameters that maximize the model's fitness were used. 
C. Default input parameters with artificial start and end tasks (added to each path). 
D. Adjusted input parameters (same as B) and artificial start and end tasks. 
 
The HeuristicsMiner algorithm available in ProM 5.2 was used as it is a robust algorithm that copes with noisy data and 
has been previously applied to healthcare domains, albeit with mixed results. The output of the algorithm is a process 
model graph. 
 
 
Process Models: Graph Description 
  
The process models were built based on the system paths, where each task (represented in the graph as a box) is a 
hospital information system visited by a patient and the arches represent the dependencies between the tasks. The 
arches' labels indicate the dependency relation value (from 0 to 1, where 1 indicates 100% certainty that the 
dependency relationship exists between the connected tasks). 
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Generated Process Models: Summary 
 
 
    I. Training Set   (n= 2212)   II. Test Set   (n= 2225)  
     
Model    A B C D  A B C D  
 
Inputs 
Positive Observations (N)*  10 300 10 300  10 300 10 300 
 
Results            
Fitness    -.390 .248 .910 .876  -.226 .306 .916 .904 
Wrong Observations   1673 1266 10 3  1462 1464 9 9 
Connections    22 34 24 24  24 37 21 22 
Connections (Artificial Start)    5 5    6 5 
Connections (Artificial End)    8 7    8 7 
              
 
* The default number of positive observations is 10. The number of positive observations that maximised the fitness of models I B and 
II B was found to be 300. This value was used again in I D and II D. 
 
Interpretation 
 
When compared to using the default parameters (A), marginal improvements were observed in models where the 
parameters of the algorithm were adjusted (in B). However, this was not true for models where artificial start and end 
tasks were used (C and D). The use of artificial start and end tasks improved the models significantly in respect to 
fitness (i.e. how the observed process complies with the control flow specified by the process model). Introducing 
artificial bounds has a normalisation effect, producing models that are easier to read from a single start task. 
  
When comparing the training set to the test set, similar results were observed. In both cases model C outperformed all 
other models. However, fewer connection were observed in the test set in models C and D. An inspection of the best 
fitting model, C, revealed further differences between the models produces using the training and test set (model 
graphs are shown below and in larger formats in the next pages). For example, OPT does not appear after the artificial 
start in the test set. Instead, this task is exclusively connected to LAB in the test set. Similarly, ORT appears after the 
start task in the test set but not in the same position in the training set. Instead, ORT appears between IMG and the 
end task in a full sequence of connections ‹Start, HIS, IMG, ORT, End›. Note that in both cases, the tasks have similar 
frequencies in the overall training and test sets. The differences can be attributed to the second step of the heuristics 
miner algorithm, where splits and joins are learnt as well as the third step, where long distance relations are found. 
Nevertheless, such differences have a significant impact on interpretation of the models. The safer interpretation of the 
produced models would be to only take those connections that are in agreement between the training and test sets. As 
such, connection sequences ‹Start, ONC, RAD, End› and ‹Start, HIS, IMG, End› would be the only ones with an overall 
length larger than 3 (i.e. more than one system visit). 
 
 
  Model I C (Training)     Model II C (Test) 
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Process Models 
 
 
Model I. A - Training Set with Default Parameters 
 
Fitness: -.390 (improved continuous semantics fitness) 
Wrong observations: 1673 
Connections: 22 
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Model I. B - Training Set with Adjusted Parameters 
 
Fitness: .248 (improved continuous semantics fitness) 
Wrong observations: 1266 
Connections: 34 
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Model I. C - Training Set with Default Parameters and Artificial Start and End Tasks 
 
Fitness: .910 (improved continuous semantics fitness) 
Wrong observations: 10 
Connections: 24 
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Model I. D - Training Set with Adjusted Parameters and Artificial Start and End Tasks 
 
Fitness: .876  (improved continuous semantics fitness) 
Wrong observations: 3 
Connections: 24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C - System-level Paths
370
  
 
 
Model II. A - Test Set with Default Parameters 
 
Fitness: -.226 (improved continuous semantics fitness) 
Wrong observations: 1462 
Connections: 24 
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Model II. B - Test Set with Adjusted Parameters 
 
Fitness: .306  (improved continuous semantics fitness) 
Wrong observations: 1464 
Connections: 37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C - System-level Paths
372
  
 
Model II. C - Test Set with Default Parameters and Artificial Start and End Tasks 
 
Fitness: .916 (improved continuous semantics fitness) 
Wrong observations: 9 
Connections: 21 
 
 
 
 
 
Model II. D - Test Set with Adjusted Parameters and Artificial Start and End Tasks 
 
Fitness: .904  (improved continuous semantics fitness) 
Wrong observations: 9 
Connections: 22 
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Dependency Matrices for System Paths  
  
Similar to the previous exercise, the system paths dataset was split into a training and test set and a dependency 
matrix was computed for each. 
 
 
Training Set 
 
 
HIS IMG LAB ONC OPT ORT PAS RAD 
HIS 0.99 0.92 0.00 0.62 -0.23 0.00 -0.41 0.94 
IMG -0.92 0.97 -0.02 0.08 0.91 0.57 -0.16 0.44 
LAB 0.00 0.02 1.00 -0.03 0.25 0.30 0.10 -0.19 
ONC -0.62 -0.08 0.03 0.80 0.56 0.00 0.18 0.96 
OPT 0.23 -0.91 -0.25 -0.56 0.95 0.00 0.12 0.00 
ORT 0.00 -0.57 -0.30 0.00 0.00 0.00 -0.25 -0.17 
PAS 0.41 0.16 -0.10 -0.18 -0.12 0.25 1.00 0.05 
RAD -0.94 -0.44 0.19 -0.96 0.00 0.17 -0.05 0.99 
 
Test Set 
 
 
HIS IMG LAB ONC OPT ORT PAS RAD 
HIS 0.97 0.90 0.01 0.65 -0.25 0.00 -0.41 0.92 
IMG -0.90 0.94 0.00 0.22 0.77 0.40 -0.20 0.46 
LAB -0.01 0.00 1.00 -0.07 0.20 0.13 0.11 -0.17 
ONC -0.65 -0.22 0.07 0.50 0.82 0.00 0.24 0.96 
OPT 0.25 -0.77 -0.20 -0.82 0.86 0.00 0.08 -0.25 
ORT 0.00 -0.40 -0.13 0.00 0.00 0.00 0.00 0.00 
PAS 0.41 0.20 -0.11 -0.24 -0.08 0.00 1.00 0.01 
RAD -0.92 -0.46 0.17 -0.96 0.25 0.00 -0.01 0.99 
 
 
 
Difference between Training Set and Test Set (only computed for values >.5 in both training and test sets) 
 
 
 
HIS IMG LAB ONC OPT ORT PAS RAD 
HIS 0.02 0.03 
 
-0.04 
   
0.02 
IMG 
 
0.03 
  
0.15 
   
LAB 
  
0.00 
     
ONC 
    
-0.26 
  
0.00 
OPT 
    
0.10 
   
ORT 
        
PAS 
      
0.00 
 
RAD 
       
0.01 
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Appendix C - CaP VIS: Plotting PSA Curves
1.5 CaP VIS: Plotting PSA Curves
This section shows the first PSA plots created automatically from the pathway
data model and the first version of the developed software. The plots are grouped
by first treatment type as defined by the National Cancer Waiting Times Dataset.
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Appendix C - CaP VIS: Main Window Screenshot
1.6 CaP VIS v.2: Main Window Screenshot
Main Screen for patient (id 76) in CaP VIS version 2.
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1.7 CaP VIS v.3: Screenshots and Details
Main Screen for patient (id 76) in CaP VIS version 3.
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1.7.1 File System and Interactions
This figure shows the CaP VIS file system and interactions; it shows the main
program file (cvis gui.py) and how it interact with Python libraries, other files
and the pathway database (pwdb).
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1.7.2 Console Screenshot
C:\Users\J\capvis3 >python capvis.py
--- CaP VIS 3 ---
-----------------------------------------
-- Started on Sun Feb 23 11:54:26 2014 --
-----------------------------------------
Print detailed Pathways in console? [y/N]
Anchor & Summary pre -load
--------------------------
Do you want the anchor window to load a complete summary? [y/N] y
OK. Reading pathways in pwdb/ and checking annotations + summary , this may take a
while (Ctrl+C aborts )...
Done.
Frame created. Program Ready.
Activity log:
Time PatientID Action
11:55:24 10001 > Loading first screen
11:55:24 10001 > Display
11:55:47 20022 > Display
11:55:51 8808 > Display
11:57:46 20022 > Display (search)
11:57:46 20022 > Plot Kinetics Before Treatment
11:58:00 20022 > Display
11:58:09 20022 > Save note
11:58:09 8808 > Display
11:58:12 8808 > Saved plot snapshot as id2 -213451. png
11:58:32 122 > Display (anchor window)
11:58:39 122 > Save note
CaP VIS closed on Sun Feb 23 11:59:15 2014
C:\Users\J\capvis3 >
CaP VIS v3 console output showing user and system actions.
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1.7.3 Program Menus and Options
MENU SUB−MENU / OPTIONS
Appl i ca t ion −> In format ion
−> Open ExploraTree
−> CaP VIS RECON
−> Delete Annotations DB
−> Text S i z e
Navigat ion −> Next Pat ient
−> Previous Pat ient
−> Navigat ion Anchor
−> Type in Number
Coding Lookup −> Diagnoses ICD 10
−> Procedure OPCS 4 .5
Pathway −> Plot K ine t i c s
−> Before Diagnos i s
−> Before Treatment
−> After Treatment
−> Overa l l
−> Plot a d d i t i o n a l curve
−> Navigat ion Anchor
−> Options
−> Show bloods in pathway d e t a i l s
−> Hide ECRIC treatments
−> Show Hosp i ta l Episodes
−> Trans late coding ( slow )
CaP VIS v3 Main Window Menus and Options.
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Appendix D - Prostate Cancer
Trends
Trends of PSA testing in Norfolk 
• The total number of PSA tests is steadily increasing (8% a 
year SD 3.6) although the increase in 2011 was the lowest 
recorded (2.7%). 
 
• Average number of new patients having their first PSA test 
is constant or on a marginal decline (-3.72% (SD 8.23)). 
 
• Re-testing seems to be driving the overall increase. 
Overall 
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• Each patient has, on average, 3.21 (SD .7) tests. 
 
• Every year, 3% (SD .19) of the Norfolk male population 
(aged 45-84) have a PSA test for the first time. 
 
• And, on average, 6.7% (SD 1.7) have a re-test. 
 
• The average time to re-test is 7 months (SD 3) within 
two years. 
 8.2 months (SD 5) for PSAs <4 ng/ml 
 6.5 months (SD 5) for PSA 4-9 ng/ml 
 4.7 months (SD 7) for PSA >=10 ng/ml 
Trends of PSA testing in Norfolk 
Overall 
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Y<4 = 0.0086x + 0.016 
R² = 0.9526 
y 4-9= 0.0038x + 0.0082 
R² = 0.9429 
y ≥10= 0.0024x + 0.0129 
R² = 0.8549 
0% 
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• The number of normal PSA tests (<4 ng/ml) has increased the 
most. It is expected to continue to increase by 1% a year, R² .95. 
 
• Abnormal tests are expected to grow at 0.4% (4-9 ng/ml, R² .94) 
and 0.2% (>=10 ng/ml, R² .85) a year. 
 
Trends of PSA testing in Norfolk 
PSA Test Results 
PSA not 
age-
adjusted. 
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When looking at a cohort of 1,460 diagnosed 
prostate cancers (2005-2009) at the NNUH: 
 
• The number of PSA tests per patient is 5.37 (SD 2.79). 
• The rates of testing can be divided as follows: 
‘Screening’ 
(2 year period) 
Before Treatment 
(incl. diagnosis) 
After Treatment 
(2 year period) 
Total 
0.71 (SD 1.21) 0.88 (SD .73) 3.77 (SD 2.29) 5.37 (SD 2.79) 
Trends of PSA testing in Norfolk 
Diagnosed Cancers 
Screening was defined as the 2-year period up to 3 months before diagnosis. 
Follow-up was defined as the 2-year period after treatment. 
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• 35% of diagnosed prostate cancers were ‘screening’ 
before they were diagnosed (i.e. had 1 or more tests in 
the screening time window). 
 
• The number of patients on ‘screening’ declined 
marginally over the period 2005-2009. 
Trends of PSA testing in Norfolk 
Diagnosed Cancers: Screening 
53.40% 
65.87% 
61.71% 
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Trends of PSA testing in Norfolk 
Diagnosed Cancers: Screening 
No Screening Screening 
Age Group <45 0.11% 0.19% 
  45-54 2.22% 2.14% 
  55-69 38.05% 32.49% 
  70-74 19.13% 23.54% 
  75-84 31.50% 32.68% 
  84+ 8.99% 8.95% 
Deprivation 1 (Least Deprived) 12.90% 9.34% 
  2 22.73% 30.74% 
  3 29.70% 34.05% 
  4 25.05% 18.87% 
  5 (Most Deprived) 9.62% 7.00% 
PSA at Diagnosis N/A 6.34% 0.00% 
  High (>10) 41.86% 17.90% 
  Med (>4-10) 22.30% 29.38% 
  Low (<=4) 29.49% 52.72% 
Basis of Diagnosis clinical 17.34% 3.70% 
  histology 82.56% 96.11% 
  unknown 0.11% 0.19% 
• Characteristics between ‘Screening’  and ‘No Screening’ 
 
 
No significant difference in age. 
 
 
Those with a deprivation score of 2 or 
3 are ‘screening’ more actively. 
 
53% of those on screening 
have a low PSA at diagnosis, 
compared to 30% no screening. 
 
No screening were more often 
diagnosed clinically than those that 
were screening. 
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• Overall 9% of patients in the cohort died of prostate 
cancer within 3 years. 
 
• Of those Screened, 7% died of prostate cancer 
 and of those not screened, 10% died. 
 
 
 
 
 
 However, p-value = 0.11 indicates a weak correlation, 
not statistically significant at .05. 
 
Trends of PSA testing in Norfolk 
Diagnosed Cancers: Screening 
Status at 3 years Screening No Screening Total 
Alive 476 853 1,329 
Dead 38 93 131 
% deaths 7.4% 10% 9% 
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• Those with a low NICE risk of progression at diagnosis 
have a marginally higher number of tests in the screening 
period, 1.13 (SD 1.44). 
• Is screening bringing in unnecessary low risk cancers? 
Trends of PSA testing in Norfolk 
Diagnosed Cancers: NICE Risk 
Rates of Testing 
NICE Risk  N Screening Before Treat After Treat Overall Deaths (3 yrs) 
High 817 0.51 (SD 1.06) 0.92 (SD 0.72) 3.95 (SD 2.54) 5.38 (SD 2.9) 8.5% (n=124) 
Intermediate  601 0.95 (SD 1.33) 0.86 (SD 0.72) 3.56 (SD 1.9) 5.37 (SD 2.66) 0.4% (n=6) 
Low 42 1.13 (SD 1.44) 0.58 (SD 0.97) 3.43 (SD 1.94) 5.13 (SD 2.64) 0.1% (n=1) 
• A High NICE Risk of progression (PSA+Gleason+TNM) 
correlates with death within 3 years 
(p < .05, OR 16, CI 7.5-35).  
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• No particular treatment type associated with an 
increased rate of testing. 
Trends of PSA testing in Norfolk 
Diagnosed Cancers: Treatment Types 
Treatment  Package 
 
%   N 
 
Overall Rate of 
Testing 
% Deaths 
Overall (3yrs) 
% Deaths Relative 
to Tx  (3yrs) 
Hormone Therapy 52.7% 770 5.6 (SD 2.8) 6.6% (n=97) 12.6% 
Hormone + Radio 0.9% 13 5.3 (SD 1.3) nil nil 
Hormone + Surgery 0.3% 5 4.8 (SD 2.1) 0.1% (n=1) 20% 
Radiotherapy 0.2% 3 7.7 (SD 1.3) nil nil 
Surgery 28.6% 417 4.7 (SD 2.8) 1% (n=15) 3.6% 
Surgery + Hormone  1.1% 16 5 (SD 1.8) 0.3% (n=4) 25% 
Watchful Wait 16.2% 236 5.8 (SD 2.7) 1% (n=14) 6% 
1,460 5.37 (SD 2.79) 9% (n=131) 
• Watchful wait showed a similar rate of testing (overall or after 
decision to treat) to other treatment packages. 
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% Deaths (3 yrs) by Gleason grade 
Trends of PSA testing in Norfolk 
Diagnosed Cancers: Gleason Grades 
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• A high Gleason grade (>=8) shows increased mortality 
 (OR 5, CI 3.4-7.2, p <.05) 
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Appendix E - Publications
On creating a patient-centric database from multiple Hospital 
Information Systems 
 
J Bettencourt-Silva, B De La Iglesia, S Donell, V Rayward-Smith 
Status: Published in Methods of Information in Medicine, 2012; 51(3): 210-20. 
Abstract 
Background: The information present in Hospital Information Systems (HIS) is 
heterogeneous and is used primarily by health practitioners to support and improve patient 
care. Conducting clinical research, data analyses or knowledge discovery projects using 
electronic patient data in secondary care centres relies on accurate data collection, which is 
often an ad-hoc process poorly described in the literature. 
Objectives: This paper aims at facilitating and expanding on the process of retrieving and 
collating patient-centric data from multiple HIS for the purpose of creating a research 
database. The development of a process roadmap for this purpose illustrates and exposes 
the constraints and drawbacks of undertaking such work in secondary care centres. 
Methods: A data collection exercise was carried using a combined approach based on 
segments of well established data mining and knowledge discovery methodologies, previous 
work on clinical data integration and local expert consultation. A case study on prostate 
cancer was carried out at an English regional National Health Service (NHS) hospital. 
Results: The process for data retrieval described in this paper allowed patient-centric data, 
pertaining to the case study on prostate cancer, to be successfully collected from multiple 
heterogeneous hospital sources, and collated in a format suitable for further clinical 
research. 
Conclusions: The data collection exercise described in this paper exposes the lengthy and 
difficult journey of retrieving and collating patient-centric, multi-source data from a hospital, 
which is indeed a non-trivial task, and one which will greatly benefit from further attention 
from researchers and hospital IT management. 
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Changes in antiplatelet use prior to incident ischaemic stroke over 
7 years in a UK centre and the association with stroke subtype 
 
JR White, JH Bettencourt-Silva, JF Potter, YK Loke, PK Myint 
Status: Published in Age and Ageing, 2013; 42(5):594-598. 
Abstract 
Background: guidelines have changed in relation to the indication of antiplatelet therapy for 
the primary and secondary prevention of stroke. Of interest is how the proportion of patients 
who had or had not taken antiplatelet agents prior to an incident stroke has changed over 
time, whether the type of antiplatelet agents used has altered and whether prior antiplatelet 
use is associated with a particular ischaemic stroke subtype. 
Methods: a stroke register was retrospectively examined. All ischaemic stroke patients 
admitted between January 2004 and March 2011 to a single University Hospital with a 
catchment population of ∼750,000 were included. We excluded those who were on 
anticoagulants prior to the ischaemic stroke. 
Results: a total of 4,307 ischaemic stroke patients [male 47.5%, mean age 77.6 (SD 11.7) 
years] were included. Of them, 54.7% (SD 2.2%) were not on any antiplatelet therapy prior 
to their incident stroke. The type and pattern of antiplatelet use prior to stroke did not change 
significantly during the 7-year study period, and there were no statistically significant 
differences between different ischaemic stroke subtypes with regards to prior antiplatelet 
use. 
Conclusions: our findings highlight the requirement to improve currently available risk 
prediction scores as well as the potential clinical impact of antiplatelet resistance within the 
at risk population who are already on antiplatelets. These findings also indicate that targeting 
of multiple risk factors may be very important in stroke prevention. 
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Building data-driven pathways from routinely collected hospital 
data: a case study on prostate cancer 
 
JH Bettencourt-Silva, J Clark, CS Cooper, R Mills, VJ Rayward-Smith, B De La Iglesia 
Status: Submitted. 
Abstract 
Objectives: Routinely collected data in hospitals is complex, typically heterogeneous and 
scattered across multiple Hospital Information Systems (HIS). This paper explores how such 
data can be used to develop pathways and their potential uses in biomedical research. 
Methods: We describe a framework for the construction, visualisation and quality 
assessment of pathways using a case study on prostate cancer. Data pertaining to prostate 
cancer patients was extracted from a large UK hospital from eight different HIS, validated 
and complemented with information from the local cancer registry.  
Results: Data-driven pathways were built for all patients and an expert knowledge base, 
containing rules on the prostate cancer biomarker, was used to assess the completeness 
and utility of the pathways for specific clinical studies. 
The proposed framework enables the summarisation, visualisation and querying of complex 
clinical information as well as the computation of quality indicators. A novel graphical 
representation of the data-driven pathways allows the synthesis of such information. 
Conclusions: This work has enabled further research on prostate cancer and its biomarkers, 
and on the development and application of methods to mine, compare, analyse and visualise 
pathways constructed from routinely collected data. 
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Determinants of in-hospital mortality and length of stay in Total 
Anterior Circulation Stroke 
ND Gollop, JH Bettencourt-Silva, AB Clark, AK Metcalf, KM Bowles, MD Flather, JF Potter, 
PK Myint 
 
Status: Submitted. 
Abstract  
Background and Purpose: While the poor prognosis of total anterior circulatory stroke 
(TACS) is well documented, less is known about the factors associated with in-hospital 
mortality and prolonged length of hospital stay (LOS) following a TACS. 
Methods: We assessed 2977 consecutive cases of TACS admitted to a UK-based teaching 
hospital between 18/11/1996 to 07/06/2012. Data collected included age, sex, stroke sub-
type, pre-stroke functional status (pre-stroke modified Rankin score), pre-stroke residence, 
significant co-morbidities and outcomes including in-hospital mortality and LOS.  
Results: 2445 (82%) of patients had an ischemic stroke. Pre-stroke, 1480 (58%) of 
individuals were asymptomatic and fully independent. The median age was 81 years with an 
interquartile range of 74 to 86. Following multivariate analysis, male sex, advanced age, 
hemorrhagic stroke (without lateralisation), a history of congestive heart failure, and 
requirement of percutaneous endoscopic gastrostomy (PEG) were significantly associated 
with in-hospital mortality. Following multivariate analysis the LOS was extended in ischaemic 
stroke types compared to haemorrhagic, with maximum stay observed in those with the right 
sided lateralisation (left hemispheric TACS). PEG insertion to support feeding was 
statistically significantly associated with a shorter stay. A 6-point scoring system was 
developed, based on the results of multiple logistic regression modelling, to predict inpatient 
death from risk score and inpatient death rates by year.  
Conclusion: We report that male sex, advanced age, haemorrhagic stroke (without 
lateralisation), congestive heart failure and PEG are all indicators of in-hospital mortality risk 
and prolonged LOS following a TACS. Furthermore we propose a 6-point prognostic scoring 
system for prospective validation. 
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Age but not ABCD2 score predicts any level of carotid stenosis in 
either symptomatic or asymptomatic side in Transient Ischaemic 
Attack 
G Mannu, M Kyu, J Bettencourt-Silva, Y Loke, A Clark, A Metcalf, J Potter, P Myint 
Status: In Press. International Journal of Clinical Practice 
Abstract 
Background: The ABCD2 score is routinely used in assessment of transient ischaemic attack 
(TIA) to assess the risk of developing stroke. There remains uncertainty regarding whether 
the ABCD2 score could be used to help predict extent of carotid artery stenosis (CAS).  
Objectives: We aimed to (i) collate and analyse all available published literature on this topic 
and (ii) compare the data from our local population to the existing evidence-base. 
Materials and Methods:-We conducted a retrospective-observational study over a 6-month 
period using our East of England hospital-based TIA clinic data with a catchment population 
of ~750,000. We also searched the literature on studies reporting the association between 
ABCD2 score and CAS.  
Results: We included 341 patients in our observational study. The mean age in our cohort 
was 72.86 years (SD 10.91) with 52% male participants. ABCD2 score was not significantly 
associated with CAS (p = 0.78). Only age >60 years was significantly associated with - 
ipsilateral (>50%) and contralateral CAS (>50% and >70%) bilateral CAS (p<0.01) after 
controlling for other confounders. The systematic review identified 4 studies for inclusion and 
no significant association between ABCD2 score and CAS was reported, confirming our 
findings.   
Conclusion: Our systematic review and observational study confirm that the ABCD2 score 
does not predict CAS. However, our observational study has examined a larger number of 
possible predictors and demonstrates that age appears to be the single best predictor of 
CAS in patients presenting with a TIA.  Selection of urgent carotid ultrasound scan thus 
should be based on individual patient’s age and potential benefit of carotid intervention 
rather than ABCD2 score. 
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Rates of prostate-specific antigen testing in Norfolk: a 
retrospective study using secondary care databases 
 
JH Bettencourt-Silva, et al. 
Status: In preparation. 
Abstract 
Objective: To assess the overall rate of prostate-specific antigen (PSA) testing for prostate 
cancer in the Norfolk population and, following a smaller cohort of linked patient data within 
hospital information systems, to determine the rates of testing at key clinical events for 
patients diagnosed with prostate cancer.  
 
Methodological steps for the development and maintenance of 
domain-specific clinical data warehouses from routine hospital 
data: the Norwich Stroke register experience 
 
JH Bettencourt-Silva, et al. 
Status: In preparation. 
Abstract 
Purpose: We propose a simple methodological framework for the design and management 
of clinical data warehouses using routine data collected from hospital information systems. 
This method can be used alongside other software development frameworks and we argue 
that it improves on existing methodologies as it copes with volatile data environments. The 
methodology was used to develop and maintain the Norfolk & Norwich Research Stroke 
Register. 
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